{"chunk_type":"transcript_chunk","text":"# Finals archive\n[Neurology](Finals%20archive/Neurology%202d146f2986ee80f7a1a3fbf485dcaebf.md)\n[Hema](Finals%20archive/Hema%202e546f2986ee8016be2cdeeb27806221.md)\n[Mnemo](Finals%20archive/Mnemo%202e546f2986ee8059a937d53740312b31.md)\n[ENT](Finals%20archive/ENT%202e746f2986ee803e8769f26736748454.md)\n[pulmo](Finals%20archive/pulmo%202e746f2986ee805e834ce9e38827be43.md)\n[nephro](Finals%20archive/nephro%202f046f2986ee8011a1f5d23b6032fc8d.md)\n[nephro ì¦‰ë°˜](Finals%20archive/nephro%20%EC%A6%89%EB%B0%98%202f046f2986ee807a8db9e274de1558fe.md)\n[Psy](Finals%20archive/Psy%202ea46f2986ee807ab05efc7d2a0edd28.md)\n[Psy and number](Finals%20archive/Psy%20and%20number%202ec46f2986ee80a98293f3e61f584e06.md)\n[Cardio](Finals%20archive/Cardio%202eb46f2986ee80b9af19e02cbdc1795f.md)\n[LM_pulmo](Finals%20archive/LM_pulmo%202f246f2986ee8075b36bd165586e44fc.md)\n[LM_ pulmo 2](Finals%20archive/LM_%20pulmo%202%202f346f2986ee80569fd8ead7ca9bcf43.md)\n[DIP](Finals%20archive/DIP%202ec46f2986ee8056a3cedf522b3f7170.md)\n[UTI ì¹˜ë£Œ](Finals%20archive/UTI%20%EC%B9%98%EB%A3%8C%202ef46f2986ee8096b55ccd4f633547fb.md)\n[LM_endo 2](Finals%20archive/LM_endo%202%202f346f2986ee806b85b4c09245ef8c59.md)\n[LM_endo 1](Finals%20archive/LM_endo%201%202f346f2986ee80ca9e35c9ff88472722.md)\n[LM_cardio 1](Finals%20archive/LM_cardio%201%202f346f2986ee80e3baf9e27d823f4aec.md)\n[LM_cardio 2 5~](Finals%20archive/LM_cardio%202%205~%202f346f2986ee8091a918d9958d59899f.md)\n[LM_cardio 3](Finals%20archive/LM_cardio%203%202f346f2986ee80d9a857eb6585776d49.md)","subject":"Finals archive 2d146f2986ee809f85c5e7369f731832","page_title":"Finals archive 2d146f2986ee809f85c5e7369f731832","episode":"Finals archive 2d146f2986ee809f85c5e7369f731832","section_path":["Finals archive 2d146f2986ee809f85c5e7369f731832"],"source_doc_id":"Finals archive 2d146f2986ee809f85c5e7369f731832","source_page":null,"source_anchor":"Finals archive 2d146f2986ee809f85c5e7369f731832-1"}
{"chunk_type":"transcript_chunk","text":"[LM_gyne 1](Finals%20archive/LM_gyne%201%202f346f2986ee80ca9cf0e8a1de8f5e1d.md)\n[LM_gyne 2](Finals%20archive/LM_gyne%202%202f446f2986ee8041a277d7ea0baa58c8.md)\n[Gyne](Finals%20archive/Gyne%202f646f2986ee80f8b89eef6e8dc2f9f5.md)\n[LM_obs1](Finals%20archive/LM_obs1%202f646f2986ee80d3a4e8c9b5ab8a0b12.md)\n[LM_obs2](Finals%20archive/LM_obs2%202f646f2986ee80f98092f841aa85480b.md)\n[LM_obs3](Finals%20archive/LM_obs3%202f646f2986ee80daa439daec387f9ad7.md)\n[LM_GIT 1](Finals%20archive/LM_GIT%201%202f746f2986ee80c5bf7bfff60573e7e3.md)\n[LM_GIT2](Finals%20archive/LM_GIT2%202f946f2986ee80f58743c80a29f3f081.md)\n[LM_GIT3](Finals%20archive/LM_GIT3%202f946f2986ee805c848ac73de9876eba.md)\n[ACS](Finals%20archive/ACS%202f546f2986ee80e28108e122ed92ca06.md)\n[LM_Blood 1](Finals%20archive/LM_Blood%201%202fc46f2986ee801eb24dff366f2f482f.md)\n[LM_Blood2](Finals%20archive/LM_Blood2%202fd46f2986ee8009895af4ea339219a2.md)\n[LM_OSRHM](Finals%20archive/LM_OSRHM%2030046f2986ee8098921dc4e04b63ee22.md)\n[LM_OSRHM 2 (7-12)](Finals%20archive/LM_OSRHM%202%20(7-12)%2030246f2986ee8038ae5de91913b0c0ae.md)\n[LM_OSRHM RFR](Finals%20archive/LM_OSRHM%20RFR%2030646f2986ee80c7a4f5c94edb1e6b76.md)\n[immunology](Finals%20archive/immunology%2030146f2986ee807c94b7e1fc0e603538.md)\n[LM_Neuro 1](Finals%20archive/LM_Neuro%201%2030346f2986ee806abbb2fb0594cc1dd6.md)\n[LM_Neuro 2](Finals%20archive/LM_Neuro%202%2030346f2986ee80b5acf3eca919a5b8c6.md)\n[LM_Neuro 3](Finals%20archive/LM_Neuro%203%2030346f2986ee80f58240d21021eb2946.md)\n[LM_neuro 4](Finals%20archive/LM_neuro%204%2030646f2986ee8031999be873ddb66ad3.md)","subject":"Finals archive 2d146f2986ee809f85c5e7369f731832","page_title":"Finals archive 2d146f2986ee809f85c5e7369f731832","episode":"Finals archive 2d146f2986ee809f85c5e7369f731832","section_path":["Finals archive 2d146f2986ee809f85c5e7369f731832"],"source_doc_id":"Finals archive 2d146f2986ee809f85c5e7369f731832","source_page":null,"source_anchor":"Finals archive 2d146f2986ee809f85c5e7369f731832-21"}
{"chunk_type":"transcript_chunk","text":"[LM_Neuro RFR](Finals%20archive/LM_Neuro%20RFR%2030646f2986ee8065863ccd3c7f4f2834.md)","subject":"Finals archive 2d146f2986ee809f85c5e7369f731832","page_title":"Finals archive 2d146f2986ee809f85c5e7369f731832","episode":"Finals archive 2d146f2986ee809f85c5e7369f731832","section_path":["Finals archive 2d146f2986ee809f85c5e7369f731832"],"source_doc_id":"Finals archive 2d146f2986ee809f85c5e7369f731832","source_page":null,"source_anchor":"Finals archive 2d146f2986ee809f85c5e7369f731832-41"}
{"chunk_type":"transcript_chunk","text":"# Neurology\n# Brain stem localization\n## 1. The Golden Rule: \"Rule of 4\"\n*ë‡Œê°„ ë‹¨ë©´ë„ì—ì„œ ë³‘ë³€ì˜ ìœ„ì¹˜(Medial vs Lateral)ë¥¼ ê²°ì •í•˜ëŠ” ì ˆëŒ€ ë²•ì¹™*\n### ğŸ…°ï¸ Medial Structures (The 4 M's)\n*í˜ˆê´€: **ASA** (Medulla), **Basilar** (Pons)ë³‘ë³€ ì‹œ íŠ¹ì§•: **Motor(ìš´ë™)** ë¬¸ì œê°€ ì£¼ë¨*\n1. **M**otor Pathway (**Corticospinal Tract**): ë°˜ëŒ€ìª½ íŒ”ë‹¤ë¦¬ ë§ˆë¹„ (Hemiparesis)\n2. **M**edial Lemniscus (**DCML**): ë°˜ëŒ€ìª½ ì§„ë™/ìœ„ì¹˜ ê°ê° ì†Œì‹¤\n3. **M**LF (Medial Longitudinal Fasciculus): ëˆˆ ì›€ì§ì„ ì¡°ì ˆ (INO)\n4. **M**otor Nuclei (CN 3, 4, 6, 12): \"12ì˜ ì•½ìˆ˜\"ì¸ ë‡Œì‹ ê²½ë“¤. ì¤‘ì•™ì„  ê·¼ì²˜ì— ìœ„ì¹˜.\n    - *CN 12 (Medulla): í˜€ ë§ˆë¹„*\n    - *CN 6 (Pons): ëˆˆ ë°”ê¹¥ìª½ ì£¼ì‹œ ë¶ˆê°€*\n    - *CN 3 (Midbrain): ëˆˆêº¼í’€ ì²˜ì§, ëˆˆë™ì ì›€ì§ì„ ì œí•œ*\n### ğŸ…±ï¸ Lateral Structures (The 4 S's)\n*í˜ˆê´€: **PICA** (Medulla), **AICA** (Pons)ë³‘ë³€ ì‹œ íŠ¹ì§•: **Sensory(ê°ê°)**, **Cerebellar(ì†Œë‡Œ)**, **Autonomic(ììœ¨ì‹ ê²½)** ë¬¸ì œê°€ ì£¼ë¨*\n1. **S**pinothalamic Tract: ë°˜ëŒ€ìª½ ëª¸ í†µì¦/ì˜¨ë„ ê°ê° ì†Œì‹¤\n2. **S**pinocerebellar Tract: ë™ì¸¡ ì†Œë‡Œ ì‹¤ì¡° (Ataxia, ë¹„í‹€ê±°ë¦¼)\n3. **S**ensory Nucleus of CN 5: ë™ì¸¡ ì–¼êµ´ í†µì¦/ì˜¨ë„ ê°ê° ì†Œì‹¤\n4. **S**ympathetic Pathway: ë™ì¸¡ í˜¸ë„ˆ ì¦í›„êµ° (Horner's Syn - ëˆˆêº¼í’€ ì²˜ì§, ë™ê³µ ì¶•ì†Œ)\n> ğŸ’¡ Key Concept: Lateral ë³‘ë³€ì€ **\"Crossed Finding\"**ì´ íŠ¹ì§•ì´ë‹¤.\n(ì–¼êµ´ì€ ë³‘ë³€ ìª½ ê°ê° ì†Œì‹¤ vs ëª¸ì€ ë°˜ëŒ€ìª½ ê°ê° ì†Œì‹¤)\n>\n---\n## 2. Clinical Syndromes by Level (ì‹¤ì „ ë§¤í•‘)\ní™˜ìì˜ ë‡Œì‹ ê²½(CN) ì¦ìƒì„ ë³´ê³  ì¸µìˆ˜(Level)ë¥¼ ë¨¼ì € íŒŒì•…í•œë‹¤.\n| Level | Medial Syndrome (Anterior/Paramedian) | Lateral Syndrome (Side/Circumferential) |\n| --- | --- | --- |\n| **Midbrain**\n(CN 3, 4) | **Weber Syndrome**\nâ€¢ V: PCA\nâ€¢ Sx: CN 3 ë§ˆë¹„ + ë°˜ëŒ€ìª½ ì „ì‹  ë§ˆë¹„ | **Benedikt Syndrome**\nâ€¢ V: PCA\nâ€¢ Sx: CN 3 ë§ˆë¹„ + **Tremor/Ataxia** (Red nucleus ì¹¨ë²”) |\n| **Pons**\n(CN 5~8) | **Medial Pontine Syn.**\nâ€¢ V: Basilar A.\nâ€¢ Sx: **CN 6 ë§ˆë¹„** (ëˆˆ ëª» ëŒë¦¼) + ë°˜ëŒ€ìª½ ì „ì‹  ë§ˆë¹„ | **Lateral Pontine Syn.**\nâ€¢ V: **AICA**\nâ€¢ Sx: **CN 7(ì•ˆë©´ë§ˆë¹„), 8(ì²­ë ¥ì†Œì‹¤)** + 4S ì¦ìƒ |\n| **Medulla**\n(CN 9~12) | **Medial Medullary Syn.**\nâ€¢ V: **ASA**\nâ€¢ Sx: **CN 12 ë§ˆë¹„** (í˜€ê°€ ë³‘ë³€ ìª½ìœ¼ë¡œ íœ¨) + ë°˜ëŒ€ìª½ ì „ì‹  ë§ˆë¹„ | **Lateral Medullary (Wallenberg)**\nâ€¢ V: **PICA** (or Vertebral)\nâ€¢ Sx: **CN 9, 10, Ambiguus** (ì‚¼í‚´ê³¤ë€, ì‰° ëª©ì†Œë¦¬) + 4S ì¦ìƒ |\n---\n## 3. High-Yield Differentiation (ì‚¬ìˆ˜ ê¿€íŒ)\n### ğŸš¨ AICA vs PICA ê°ë³„ë²• (Lateral Pons vs Lateral Medulla)\n*ë‘˜ ë‹¤ ì–´ì§€ëŸ½ê³ , ê°ê° ì´ìƒí•˜ê³ , í˜¸ë„ˆ ì¦í›„êµ°ì´ ì˜¨ë‹¤. ê²°ì •ì  ì°¨ì´ëŠ”?*\n- **PICA (Medulla):** **\"ëª©êµ¬ë©\"** ë¬¸ì œ\n    - Nucleus Ambiguus ì¹¨ë²” â†’ **Dysphagia (ì‚¼í‚´ê³¤ë€), Hoarseness (ì‰° ëª©ì†Œë¦¬)**\n    - *Mnemonic: Don't **PICA** **H**orse (Hoarse) that can't eat.*\n- **AICA (Pons):** **\"ì–¼êµ´ & ê·€\"** ë¬¸ì œ\n    - Facial(7) & Vestibulocochlear(8) Nuclei ì¹¨ë²” â†’ **Facial Droop (ì•ˆë©´ë§ˆë¹„), Hearing Loss (ì²­ë ¥ì†Œì‹¤/ì´ëª…)**","subject":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","page_title":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","episode":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","section_path":["Neurology 2d146f2986ee80f7a1a3fbf485dcaebf"],"source_doc_id":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","source_page":null,"source_anchor":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf-1"}
{"chunk_type":"transcript_chunk","text":"### ğŸš¨ Motor Sparing (ìš´ë™ì‹ ê²½ ë³´ì¡´)\n- Lateral ë³‘ë³€(Wallenberg, Lat. Pontine)ì€ **íŒ”ë‹¤ë¦¬ í˜(Motor Power)**ì´ ì •ìƒì´ë‹¤.\n- ë§Œì•½ í˜ì´ ë¹ ì§„ë‹¤ë©´(Hemiparesis)? â†’ ë¬´ì¡°ê±´ **Medial** ë³‘ë³€ í˜¹ì€ ëŒ€ë‡Œ(MCA/ACA) ë¬¸ì œë‹¤.\n```mermaid\ngraph TD\n    %% ë…¸ë“œ ì •ì˜ (íŠ¹ìˆ˜ë¬¸ì í¬í•¨ëœ í…ìŠ¤íŠ¸ëŠ” ë¬´ì¡°ê±´ \"\"ë¡œ ê°ì‹¸ì•¼ í•¨)\n    Start[\"START: í™˜ìì˜ ì¦ìƒì€?\"] --> CheckLevel{\"1. ë‡Œì‹ ê²½(CN) í™•ì¸\"}\n%% 1. Midbrain\n    CheckLevel -->|\"CN 3, 4\"| Midbrain[\"Midbrain (ì¤‘ë‡Œ)\"]\n    Midbrain --> Mid_Path{\"ì•ˆìª½ vs ë°”ê¹¥ìª½?\"}\n    \n    Mid_Path -->|\"Motor + CN 3\"| Weber[\"Weber Syn<br/>(ì•ˆìª½: PCA)<br/>ë°˜ëŒ€ìª½ ë§ˆë¹„\"]\n    Mid_Path -->|\"Tremor + CN 3\"| Benedikt[\"Benedikt Syn<br/>(ë’¤ìª½: PCA)<br/>ë–¨ë¦¼/ì¡°í™”ìš´ë™ë¶ˆëŠ¥\"]\n%% 2. Pons\n    CheckLevel -->|\"CN 5, 6, 7, 8\"| Pons[\"Pons (êµë‡Œ)\"]\n    Pons --> Pons_Path{\"ì•ˆìª½ vs ë°”ê¹¥ìª½?\"}\nPons_Path -->|\"Motor + CN 6\"| MedPont[\"Medial Pontine<br/>(ì•ˆìª½: Basilar)<br/>ëˆˆ ê°€ìª½ì£¼ì‹œ ë¶ˆê°€\"]\n    Pons_Path -->|\"Face/Ear + CN 7,8\"| LatPont[\"Lateral Pontine<br/>(ë°”ê¹¥ìª½: AICA)<br/>ì•ˆë©´ë§ˆë¹„ + ì²­ë ¥ì†Œì‹¤\"]\n%% 3. Medulla\n    CheckLevel -->|\"CN 9~12\"| Medulla[\"Medulla (ì—°ìˆ˜)\"]\n    Medulla --> Med_Path_2{\"ì•ˆìª½ vs ë°”ê¹¥ìª½?\"}\nMed_Path_2 -->|\"Motor + CN 12\"| MedMed[\"Medial Medullary<br/>(ì•ˆìª½: ASA)<br/>í˜€ ë§ˆë¹„ + ë°˜ëŒ€ìª½ ë§ˆë¹„\"]\n    Med_Path_2 -->|\"Swallowing + CN 9,10\"| Wallenberg[\"Lateral Medullary<br/>(ë°”ê¹¥ìª½: PICA)<br/>ì‚¼í‚´ê³¤ë€ + ì‰°ëª©ì†Œë¦¬\"]\n%% ìŠ¤íƒ€ì¼ (ìƒ‰ìƒ ì ìš©)\n    style Weber fill:#fff3e0,stroke:#ff6f00\n    style MedPont fill:#fff3e0,stroke:#ff6f00\n    style MedMed fill:#fff3e0,stroke:#ff6f00\n    style Benedikt fill:#f3e5f5,stroke:#7b1fa2\n    style LatPont fill:#f3e5f5,stroke:#7b1fa2\n    style Wallenberg fill:#f3e5f5,stroke:#7b1fa2\n    style Start fill:#212121,stroke:#000,color:#fff\n```\n<aside>\nğŸ’¡\n### 1. NF1 & NF2 (ìˆ«ì ë†€ì´) #mnemonic\n- **NF1 (17ë²ˆ ì—¼ìƒ‰ì²´):** \"Von Recklinghausen\" ê¸€ì ìˆ˜ê°€ **17ê°œ**ì…ë‹ˆë‹¤!\n    - **CAFE SPOT:** **C**afe-au-lait, **A**xillary freckling, **F**ibroma, **E**ye(Lisch), **S**keletal, **P**heochromocytoma, **O**ptic **T**umor(Glioma).\n- **NF2 (22ë²ˆ ì—¼ìƒ‰ì²´):** \"2\"ê°€ ì£¼ì¸ê³µì…ë‹ˆë‹¤.\n    - **2** ears (Bilateral acoustic neuroma)\n    - **2** eyes (Juvenile cataracts)\n    - **2** CNS tumors (Meningioma, Ependymoma)\n### 2. Tuberous Sclerosis (TSC)\n- **\"HAMARTOMAS\"** ì•”ê¸°ë²•:\n    - **H**amartomas (CNS, í”¼ë¶€)\n    - **A**ngiofibromas (ì½” ì£¼ë³€ ë¾°ë£¨ì§€ ê°™ì€ ê²ƒë“¤)\n    - **M**itral regurgitation\n    - **A**sh-leaf spots (ìƒ‰ì†Œ ë¹ ì§„ ìì‚¬ê·€ ëª¨ì–‘) â˜…\n    - **R**habdomyoma (ì‹¬ì¥ ì¢…ì–‘ - ì•„ê¸° ë•Œ ë°œê²¬!)\n    - **T**ubers (ë‡Œì˜ ê²°ì ˆ)\n    - **O**minant (Autosomal Dominant ìœ ì „)\n    - **M**ental retardation\n    - **A**ngiomyolipoma (ì‹ ì¥ì˜ ê±°ëŒ€ ì¢…ì–‘) â˜…\n    - **S**hagreen patches (ê°€ì£½ ê°™ì€ í”¼ë¶€ íŒ)\n### 3. Sturge-Weber Syndrome (SWS)\n- **\"STURGE\"** ì•”ê¸°ë²•:\n    - **S**tain (Port-wine stain, V1/V2 ì˜ì—­)\n    - **T**ram-track calcification (ë‡Œ CT) â˜…\n    - **U**nilateral (í•œìª½ì—ë§Œ ì˜¤ëŠ” í¸ë§ˆë¹„)\n    - **R**etardation (ì§€ì  ì¥ì• )\n    - **G**laucoma (ì•ˆì•• ìƒìŠ¹!)\n    - **E**pilepsy (GNAQ ìœ ì „ì ëŒì—°ë³€ì´ë¡œ ì¸í•œ ë°œì‘)\n</aside>","subject":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","page_title":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","episode":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","section_path":["Neurology 2d146f2986ee80f7a1a3fbf485dcaebf"],"source_doc_id":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","source_page":null,"source_anchor":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf-21"}
{"chunk_type":"transcript_chunk","text":"# Hema\n<aside>\nğŸ’¡\n![image.png](Hema/image.png)\n[Mnemo](Mnemo%202e546f2986ee8059a937d53740312b31.md)\n</aside>\n![image.png](Hema/image%201.png)\n![image.png](Hema/image%202.png)","subject":"Hema 2e546f2986ee8016be2cdeeb27806221","page_title":"Hema 2e546f2986ee8016be2cdeeb27806221","episode":"Hema 2e546f2986ee8016be2cdeeb27806221","section_path":["Hema 2e546f2986ee8016be2cdeeb27806221"],"source_doc_id":"Hema 2e546f2986ee8016be2cdeeb27806221","source_page":null,"source_anchor":"Hema 2e546f2986ee8016be2cdeeb27806221-1"}
{"chunk_type":"transcript_chunk","text":"# Mnemo\n## Pulmo\n![image.png](Mnemo/image.png)\n![image.png](Mnemo/image%201.png)\n![image.png](Mnemo/image%202.png)\n![image.png](Mnemo/image%203.png)\n![image.png](Mnemo/image%204.png)\nCOPDì—ì„œ ì‚°ì†Œ ì¹˜ë£Œ ì ì‘ì¦ (ì§‘ì— ì‚°ì†Œ íƒ±í¬ ë†“ëŠ”ì‹œì )\n![image.png](Mnemo/image%205.png)\n![image.png](Mnemo/image%206.png)\n## Rheuma\nsystemic sclerosis\n![image.png](Mnemo/image%207.png)\n![image.png](Mnemo/image%208.png)\n[https://labs.google/fx/ko/tools/whisk/share/animate/4t1asdgfe0000](https://labs.google/fx/ko/tools/whisk/share/animate/4t1asdgfe0000)\n![image.png](Mnemo/image%209.png)\n![image.png](Mnemo/image%2010.png)\n![image.png](Mnemo/image%2011.png)\n![image.png](Mnemo/image%2012.png)\n---","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-1"}
{"chunk_type":"transcript_chunk","text":"## Endo\n<aside>\nğŸ’¡\nDKAëŠ” ë ˆëª¬(ì‚°ì„±) ë‹¤ì´ì–´íŠ¸ ì½œë¼ / HHSëŠ” ë¬´ê±°ìš´ ê¿€ë‹¨ì§€\n</aside>\n![image.png](Mnemo/image%2013.png)\n![image.png](Mnemo/image%2014.png)\n![acid. glucose 250. abdominal pain. breathing (kussmaul)](Mnemo/image%2015.png)\nacid. glucose 250. abdominal pain. breathing (kussmaul)\n![ê°€ê²© 600, íƒˆìˆ˜, stupor, old](Mnemo/image%2016.png)\nê°€ê²© 600, íƒˆìˆ˜, stupor, old\n![image.png](Mnemo/image%2017.png)\n![FKI (fluid, k, insulin) ](Mnemo/image%2018.png)\nFKI (fluid, k, insulin)\n![ì´ˆë¡ë¶ˆ. ì´ˆë¡ë¶ˆì•ˆì— ì˜¤ì´ 52 5.2 ë„˜ìœ¼ë©´ ì¸ìŠë¦° íŠ¸ëŸ­ ì¶œë°œê°€ëŠ¥. ë¹¨ê°„ìƒ‰ 33 3.3 í¬íƒ€ìŠ˜ ë¯¸ë§Œì´ë©´ ì¸ìŠë¦° stop. add banana on red light. 3.3ë¯¸ë§Œì´ë©´ ì¹¼ë¥¨ë¶€í„° ë³´ì¶©.](Mnemo/image%2019.png)\nì´ˆë¡ë¶ˆ. ì´ˆë¡ë¶ˆì•ˆì— ì˜¤ì´ 52 5.2 ë„˜ìœ¼ë©´ ì¸ìŠë¦° íŠ¸ëŸ­ ì¶œë°œê°€ëŠ¥. ë¹¨ê°„ìƒ‰ 33 3.3 í¬íƒ€ìŠ˜ ë¯¸ë§Œì´ë©´ ì¸ìŠë¦° stop. add banana on red light. 3.3ë¯¸ë§Œì´ë©´ ì¹¼ë¥¨ë¶€í„° ë³´ì¶©.\n---\n![image.png](Mnemo/image%2020.png)\nDepression, Diabetes, Diarrhea, Dermatitis (ê°€ìš´ë° ì©ëŠ” NME necrolytic migratory erythema), DVT\n---\n![image.png](Mnemo/image%2021.png)","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-21"}
{"chunk_type":"transcript_chunk","text":"![image.png](Mnemo/image%2022.png)\n![image.png](Mnemo/image%2023.png)\n![image.png](Mnemo/image%2024.png)\nAddison. primary adrenal insuff. ë¯¸ë„¤ë„ë¡œ, ì„¤íƒ•, í˜ˆì•• ë‹¤ ë‚®ì•„ì§. ACTHë§Œ ì˜¤ë¦„. ACTH bronze light. bronze pigmentation. Aê°€ ì‚°ì´ë¼ ì™¼ìª½ì— ìˆëŠ”ê±´ ì˜¬ë¼ê°€ê³  ì˜¤ë¥¸ìª½ì— ìˆëŠ”ê±´ ë‚´ë ¤ê°€ëŠ”ì¤‘.\n![image.png](Mnemo/image%2025.png)\n![image.png](Mnemo/image%2026.png)\n![image.png](Mnemo/image%2027.png)\n---\n## OSRHM\n![image.png](Mnemo/image%2028.png)\n![image.png](Mnemo/image%2029.png)\n---\n3â€™ hyper PTH: autonomy. calcium â†‘, P â†‘, PTH â†‘\n![image.png](Mnemo/image%2030.png)\n---\nthyroid storm ì¹˜ë£Œ\n![image.png](Mnemo/image%2031.png)\nThyroid storm ìˆ˜ìˆ í›„ **ë°œì—´** + ê°‘ìƒì„ í•­ì§„ì¦ ì¦ìƒ\n4P (P propranolol ì‹¬ì¥ beta ì–µì œ beta blocker), PTU (ê³µì¥íì‡„), P (ë°”ë‚˜ë‚˜ potassium, ê¹€ iodine) ë£¨ê³¨ìš©ì•¡ ë„£ì–´ì„œ ê°‘ìê¸° ê°‘ìƒì„ ì¬ë£Œ ë§ì´ë“¤ì–´ì˜¤ë©´ ê°‘ìƒì„  ê¸°ëŠ¥ì•ˆí•˜ëŠ” ìš°ë„ˆë¦¬ í™œìš©. P for prednisolone (ìŠ¤í…Œë¡œì´ë“œ ë³‘ ë‚ ë¼ë‹¤ë‹˜) T4 T3 conversion ì–µì œ\nPheo","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-41"}
{"chunk_type":"transcript_chunk","text":"![image.png](Mnemo/image%2032.png)\nParoxysmal! ì¹´í…Œì½œì•„ë¯¼ì´ ì¸ìŠë¦° ì–µì œí•´ì„œ ê³ í˜ˆë‹¹. headache. ë°œì—´ì€ ì—†ìŒ.\nalpha before beta. NF1 (cafesPot), VHL (harP), MEN (ë‡Œì²´ë¶€)ê³¼ ì—°ê´€.\ncalcitonin syndrome\n![image.png](Mnemo/image%2033.png)\n![image.png](Mnemo/image%2034.png)\n![image.png](Mnemo/image%2035.png)\n![image.png](Mnemo/image%2036.png)\n#GCA giant cell arterities\ní• ë¨¸ë‹ˆ, PMR ì–´ê¹¨, external carotid artery, aortic aneurysm (í’ì„ ), jaw, unilateral headache, ì‹œì•¼ê²°ì† â˜… â˜…\nì¹˜ë£Œ: ìŠ¤í…Œë¡œì´ë“œ, to-six-lizumab (IL-6 mab.)\n## hemato\n#lead #AIP\n![image.png](Mnemo/image%2037.png)\nleadëŠ” ì†Œë³€ ì •ìƒì´ê³  ALAë§Œ ì¦ê°€ (AIPëŠ” ala, pbg ëª¨ë‘ì¦ê°€)\nì¹˜ë£Œë„ edta, dimcarpol, succimer\nsuccimer >45\nedta, dimecarpol(BAL) >70\nì•„ê¸°\nì‡ëª¸ bruton blue line","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-61"}
{"chunk_type":"transcript_chunk","text":"![image.png](Mnemo/image%2038.png)\n![image.png](Mnemo/image%2039.png)\n| **ì‹œê°ì  ìš”ì†Œ (Visual Element)** | **ì˜í•™ì  í•µì‹¬ ê°œë… (Medical Concept)** | **ì„¤ëª… (Description)** |\n| --- | --- | --- |\n| **ë³´ë¼ìƒ‰ ì™•ì˜ ì˜ë³µ (Purple Robes)** | **Porphyria (í¬ë¥´í”¼ë¦°ì¦)** | ì§ˆë³‘ëª… 'Porphyria'ê°€ ê·¸ë¦¬ìŠ¤ì–´ë¡œ 'ë³´ë¼ìƒ‰'ì„ ëœ»í•˜ëŠ” ë‹¨ì–´ì—ì„œ ìœ ë˜í–ˆìŒì„ ì‹œê°ì ìœ¼ë¡œ ì—°ê²°í•©ë‹ˆë‹¤. |\n| **ë³µë¶€ì˜ ë¶‰ì€ ì‚¬ìŠ¬ (\"BELLY PAIN\")** | **Severe Abdominal Pain** | AIPì˜ ê°€ì¥ í”í•œ ì´ˆê¸° ì¦ìƒì¸ ê·¹ì‹¬í•œ ë³µí†µì„ ì‹œê°í™”í–ˆìŠµë‹ˆë‹¤. ë³´í†µ ì—¼ì¦ ë°˜ì‘ ì—†ì´ ì‹ ê²½í•™ì ìœ¼ë¡œ ë°œìƒí•©ë‹ˆë‹¤. |\n| **í’€ë ¤ê°€ëŠ” ì‹¤ ê°™ì€ ì†ë°œ (\"NERVE WEAKNESS\")** | **Peripheral Neuropathy** | ë§ì´ˆ ì‹ ê²½ ì†ìƒìœ¼ë¡œ ì¸í•œ ê·¼ìœ¡ ì•½í™”ì™€ ê°ê° ì´ìƒì„ 'í—¤ì§„ ì‹¤'ë¡œ í‘œí˜„í•˜ì—¬ ì‹ ê²½ë³‘ì¦ì„ ë¬˜ì‚¬í–ˆìŠµë‹ˆë‹¤. |\n| **ìŠ¤íŒŒí¬ê°€ íŠ€ëŠ” ì™•ê´€ (\"PSYCHOSIS\")** | **Neuropsychiatric Symptoms** | í™˜ê°, ë¶ˆì•ˆ, ì •ì‹ ë³‘ì  ì¦ìƒ ë“± AIPì˜ ì¤‘ì¶”ì‹ ê²½ê³„ ì¹¨ë²” ì¦ìƒì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. |\n| **ë³´ë¼ìƒ‰ ì•¡ì²´ê°€ ë‹´ê¸´ ìš”ê°• (\"URINE\")** | **Port-wine Urine** | ì†Œë³€ ë‚´ì˜ í¬ë¥´í¬ë¹Œë¦¬ë…¸ê²(PBG)ì´ ë¹›ì— ë…¸ì¶œë˜ì–´ ì‚°í™”ë˜ë©´ í¬íŠ¸ì™€ì¸ìƒ‰(ì–´ë‘ìš´ ë¶‰ì€ ë³´ë¼ìƒ‰)ìœ¼ë¡œ ë³€í•˜ëŠ” íŠ¹ì§•ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. |\n| **ê±°ëŒ€í•œ ì„¤íƒ• íë¸Œ (\"GLUCOSE\")** | **Glucose Loading (ì¹˜ë£Œ)** | ê³ ë†ë„ í¬ë„ë‹¹ íˆ¬ì—¬ëŠ” heme í•©ì„± ê²½ë¡œì˜ íš¨ì†Œë¥¼ ì–µì œí•˜ì—¬ ë…ì„± ì „êµ¬ë¬¼ì§ˆì˜ ìƒì„±ì„ ì¤„ì´ëŠ” 1ì°¨ ì¹˜ë£Œë²•ì…ë‹ˆë‹¤. |\n| **ê²€ì€ ìœ ë¦¬ë³‘ (\"HEMIN\")** | **Hemin/Heme Arginate (ì¹˜ë£Œ)** | ë¶€ì¡±í•œ hemeì„ ì§ì ‘ ë³´ì¶©í•˜ì—¬ ìŒì„± í”¼ë“œë°±ì„ í†µí•´ ìƒìœ„ ë‹¨ê³„ì˜ ë…ì„± ë¬¼ì§ˆ ì¶•ì ì„ ë§‰ëŠ” í•µì‹¬ ì¹˜ë£Œì œì…ë‹ˆë‹¤. |\n| **\"A.I.P.\" í…ìŠ¤íŠ¸ ë¼ë²¨** | **Acute Intermittent Porphyria** | ì§ˆë³‘ì˜ ì •ì‹ ëª…ì¹­ì„ ì´ë¯¸ì§€ì— ê°ì¸ì‹œì¼œ í•™ìŠµì˜ ëª©ì ì„±ì„ ëª…í™•íˆ í•©ë‹ˆë‹¤. |\nCLL\n![image.png](Mnemo/image%2040.png)\n- **ë…¸ì¸ ì—°ê¸ˆìˆ ì‚¬:** CLLì˜ ì£¼ëœ ë°œë³‘ ì—°ë ¹ì¸µì¸ **ë…¸ì¸(Elderly)**ì„ ìƒì§•í•©ë‹ˆë‹¤.\n- **ëª©ê³¼ ê²¨ë“œë‘ì´ì˜ íŒŒë€ ì§„ì£¼:** **ë¦¼í”„ì ˆ ì¢…ëŒ€(Lymphadenopathy)**ë¥¼ ì‹œê°í™”í–ˆìŠµë‹ˆë‹¤. (Cervical, Axillary)\n- **ë°”ë‹¥ì˜ ì‰í¬ ì–¼ë£© (Smudge Cells):** CLLì˜ ì§„ë‹¨ì  íŠ¹ì§•ì¸ **Smudge cell**ì„ 'ìœ¼ê¹¨ì§„ íŒŒë€ ì‰í¬'ë¡œ ë¬˜ì‚¬í–ˆìŠµë‹ˆë‹¤.\n- **ìˆ«ìê°€ ìƒˆê²¨ì§„ ìœ ë¦¬ë³‘:** ì§„ë‹¨ì— í•„ìˆ˜ì ì¸ **ìœ ì„¸í¬ ë¶„ì„(Flow cytometry)** ìˆ˜ì¹˜ì¸ **CD5, 19, 20, 23**ì„ ì•”ê¸° ìš”ì†Œë¡œ ë„£ì—ˆìŠµë‹ˆë‹¤. **CLLì€ ì¡°ì§ê²€ì‚¬ì•ˆí•¨!**\n- **ë…¹ì•„ë‚´ë¦¬ëŠ” ë¶‰ì€ ë§í† ì™€ ë¶‰ì€ í•´:** ìê°€ë©´ì—­ì„± ìš©í˜ˆì„± ë¹ˆí˜ˆ(**Warm AIHA**)ì„ 'ì—´ê¸°ì— ë…¹ëŠ” ë¹¨ê°„ìƒ‰'ìœ¼ë¡œ í‘œí˜„í–ˆìŠµë‹ˆë‹¤.\n- **ê´´ë¬¼ë¡œ ë³€í•˜ëŠ” ê·¸ë¦¼ì:** CLLì´ ê°‘ìê¸° ê³µê²©ì ì¸ ë¦¼í”„ì¢…ìœ¼ë¡œ ë³€í•˜ëŠ” **ë¦¬íˆí„° ë³€í™˜(Richter transformation)**ì„ ìƒì§•í•©ë‹ˆë‹¤.\n- **ë¶€í’€ì–´ ì˜¤ë¥¸ í—ˆë¦¬ ì£¼ë¨¸ë‹ˆ:** **ë¹„ì¥ ë¹„ëŒ€(Splenomegaly)**ì™€ ê·¸ë¡œ ì¸í•œ ì˜ˆí›„ ë¶ˆëŸ‰ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.\n#hairy cell leukemia\n![image.png](Mnemo/image%2041.png)\n- **Hairy Yeti & Hairy B-cells:** **í„¸ì´ ë‚œ ì„¸í¬(Hairy cell)**ì˜ íŠ¹ì§•ê³¼ ì£¼ëœ ë°œë³‘ ì—°ë ¹ì¸µ(ì¤‘ë…„)ì„ 'í„¸ë³µìˆ­ì´ ì˜ˆí‹°'ë¡œ ì‹œê°í™”í–ˆìŠµë‹ˆë‹¤.\n- **Golden Bear-Trap:** **TRAP ì–‘ì„±(TRAP positive)**ì„ 'ê³° ë«(Bear-Trap)'ì— ê±¸ë¦° ëª¨ìŠµìœ¼ë¡œ ì§ê´€ì ìœ¼ë¡œ í‘œí˜„í–ˆìŠµë‹ˆë‹¤.\n- **Massive Spleen vs. Smooth Neck:** **ê±°ëŒ€í•œ ë¹„ì¥(Massive Splenomegaly)**ì„ ë“  ëª¨ìŠµê³¼ **ë§¤ëˆí•˜ê³  ë¶€ì˜¤ë¥´ì§€ ì•Šì€ ëª©(without Lymphadenopathy)**ì„ ì‹œê°ì ìœ¼ë¡œ ê·¹ëª…í•˜ê²Œ ëŒ€ë¹„ì‹œì¼œ, ë¦¼í”„ì ˆ ì¢…ëŒ€ê°€ ì—†ë‹¤ëŠ” í•µì‹¬ ê°ë³„ í¬ì¸íŠ¸ë¥¼ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.\n- **Dry Bone Desert & Dust Faucet:** ê³¨ìˆ˜ ì„¬ìœ í™”ë¡œ ì¸í•œ **'Dry Tap'(ê³¨ìˆ˜ í¡ì¸ ì‹¤íŒ¨)**ì„ ë§ˆë¥¸ ë¼ˆ ì‚¬ë§‰ì—ì„œ ë¨¼ì§€ë§Œ ë‚˜ì˜¤ëŠ” ìˆ˜ë„ê¼­ì§€ë¡œ ë¬˜ì‚¬í–ˆìŠµë‹ˆë‹¤.\n- **BRAF V600E Flag:** ì§„ë‹¨ì— ì¤‘ìš”í•œ **BRAF V600E ëŒì—°ë³€ì´**ë¥¼ ê¹ƒë°œì— ëª…ì‹œí–ˆìŠµë‹ˆë‹¤.\n- **Silk Ribbons (Cladribine):** ì¹˜ë£Œì œì¸ **Cladribine**ì„ ë°œìŒì´ ë¹„ìŠ·í•œ **'Clad in Ribbons'(ë¦¬ë³¸ì„ ë‘ë¥¸)**ë¡œ ì—°ê²°í•˜ì—¬, ë¦¬ë³¸ì´ ë‚´ë ¤ì™€ ì˜ˆí‹°ë¥¼ ì¹˜ìœ í•˜ëŠ” ëª¨ìŠµìœ¼ë¡œ ì¹˜ë£Œ íš¨ê³¼ê°€ ìš°ìˆ˜í•¨ì„ í‘œí˜„í–ˆìŠµë‹ˆë‹¤.\nSickle cell disease SCD\n![image.png](Mnemo/image%2042.png)\nGenetics (The Crown): 6ë²ˆ ìœ„ì¹˜ì˜ Glutamate(ì¹œìˆ˜ì„±)ê°€ Valine(ì†Œìˆ˜ì„±)ìœ¼ë¡œ ì¹˜í™˜ë¨ì„ ì‹œê°í™”.\nDactylitis (The Gauntlets): ì˜ìœ ì•„ê¸° ì²« ì¦ìƒì¸ ìˆ˜ì¡± ì¦í›„êµ° (ë¶€ì–´ì˜¤ë¥¸ ì†).\nì°½ë°– ì„¤ì›: acute chest syndrome íí˜ˆê´€ì´ ë§‰í˜€ì„œ íë ´. (ê°ì—¼) í•­ìƒì œ ì¹˜ë£Œ\nAvascular Necrosis (The Armrests): ëŒ€í‡´ê³¨ë‘ ë¬´í˜ˆì„± ê´´ì‚¬ (USMLE ë¹ˆì¶œ í•©ë³‘ì¦).\nSalmonella Osteomyelitis (The Lizard): ë¹„ì¥ ê¸°ëŠ¥ ì €í•˜ë¡œ ì¸í•œ ì‚´ëª¨ë„¬ë¼ ê· ì˜ ê³¨ìˆ˜ì—¼ ê³µê²©.\nIsosthenuria (The Clear Water): ê¹¨ì§„ í•­ì•„ë¦¬. ì‹ ì¥ì˜ ë†ì¶• ëŠ¥ë ¥ ìƒì‹¤ë¡œ ì¸í•´ ë¬½ì€ ì†Œë³€ì´ ë‚˜ì˜´.\nPigment Gallstones (The Green Emeralds): ë§Œì„± ìš©í˜ˆë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ë¹Œë¦¬ë£¨ë¹ˆ(ë…¹ìƒ‰) ë‹´ì„.\nAplastic Crisis (The B19 Dragon): Parvovirus B19 ê°ì—¼ ì‹œ ì í˜ˆêµ¬ ìƒì„±ì´ ë©ˆì¶”ëŠ” ìœ„ê¸°.\nElectrophoresis (The Banner): HbSëŠ” ìŒì „í•˜ê°€ ì ì–´ ì–‘ê·¹(+) ìª½ìœ¼ë¡œ ì ê²Œ ì´ë™í•¨ (Diagnosis).","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-81"}
{"chunk_type":"transcript_chunk","text":"Hydroxyurea & HbF (The Cherub): ì¹˜ë£Œì œì¸ í•˜ì´ë“œë¡ì‹œìœ ë ˆì•„ê°€ íƒœì•„ í—¤ëª¨ê¸€ë¡œë¹ˆì„ ë†’ì—¬ ì¦ìƒì„ ì™„í™”í•¨\n---\nTTP: vwfë¥¼ ìë¥´ëŠ” ADAMSê°€ìœ„ê°€ ì˜ ì‘ë™ì•ˆí•œë‹¤.\nì¹˜ë£Œ: ê°€ìœ„ë¥¼ ìƒˆë¡œ ë³´ì¶© = plasma exchange, ê°€ìœ„ë¥¼ ë³´í˜¸ from ìê°€í•­ì²´ (rituximab, steroids)\n![image.png](Mnemo/image%2043.png)\n![image.png](Mnemo/image%2044.png)\nPNH\n![image.png](Mnemo/image%2045.png)\n---\nB12 vs B9\n![image.png](Mnemo/image%2046.png)\n| **Condition** | **MMA** | **Homocysteine** | **Neuro symptoms** |\n| --- | --- | --- | --- |\n| B12 deficiency | â†‘ | â†‘ | O |\n| Folate deficiency | Normal | â†‘ | X |\n**M-M-A:** **M**ethyl-**M**alonic **A**cidëŠ” **M**ake **M**yelin **A**bnormal (ë¯¸ì—˜ë¦°ì„ ë³‘ë“¤ê²Œ í•¨)!\n---\n**\"Iron Man Feels Bad\" (ì•„ì´ì–¸ë§¨ ê¸°ë¶„ì´ ë³„ë¡œì•¼...)**\n- **I**ron: **D**uodenum (1ë²ˆ íƒ€ì)\n- **F**eels (**F**olate): **J**ejunum (2ë²ˆ íƒ€ì)\n- **B**ad (**B**12): **I**leum (ë§ˆì§€ë§‰ íƒ€ì)\n![image.png](Mnemo/image%2047.png)\n---\n1. í—¤ëª¨ê¸€ë¡œë¹ˆ ì¡°í•©:\n(a) HbA: Î±2Î²2\n(b) HbA2: Î±2Î´2\n(c) HbF: Î±2Î³2\n(d) HbH: Î²4\n(e) Hb Barts: Î³4\n![image.png](Mnemo/image%2048.png)","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-101"}
{"chunk_type":"transcript_chunk","text":"1. ì•”ê¸°ë²•:\n(a) HbH: 'H'ì˜ ëª¨ì–‘ì´ ìˆ«ì '4'ì™€ ë¹„ìŠ·í•˜ê³ , 'b'ê°€ 'Beta'ë¥¼ ì—°ìƒì‹œí‚¤ë¯€ë¡œ 'Beta 4ê°œ'ë¡œ ì™¸ìš°ê¸°\n(b) Hb Barts: ë’¤ì˜ 'RT'ì—ì„œ 'R'ì„ 'Gamma(Î³)'ì™€ ì—°ê²°í•˜ê³ , 'T'ë¥¼ ìˆ«ì '4'ë¡œ ìƒê°í•´ì„œ 'Gamma 4ê°œ'ë¡œ ê¸°ì–µí•˜ê¸°\n2. ì§€ì¤‘í•´ì„± ë¹ˆí˜ˆ(Thalassemia)ì˜ íŠ¹ì§•:\n(a) ë² íƒ€ ì§€ì¤‘í•´ì„± ë¹ˆí˜ˆ: ë² íƒ€ ì²´ì¸ì„ ëª» ë§Œë“œë‹ˆê¹Œ ìƒëŒ€ì ìœ¼ë¡œ ì•ŒíŒŒê°€ ë„˜ì¹˜ê²Œ ë˜ê³ , ì´ë¡œ ì¸í•´ HbA2ì™€ HbFê°€ ë§ì•„ì§\n(b) ì•ŒíŒŒ ì§€ì¤‘í•´ì„± ë¹ˆí˜ˆ: ì•ŒíŒŒ ì²´ì¸ì´ ì•ˆ ë§Œë“¤ì–´ì§€ë‹ˆê¹Œ ë‚¨ëŠ” ë² íƒ€ë¼ë¦¬ ëª¨ì—¬ì„œ HbH(Î²4)ë¥¼ ë§Œë“¤ê±°ë‚˜, ê°ë§ˆë¼ë¦¬ ëª¨ì—¬ì„œ Hb Barts(Î³4)ë¥¼ í˜•ì„±í•¨\n## Psy\nDT:\nDë¥¼ ë³´ê³  ìˆ«ì 2ë¥¼, Të¥¼ ë³´ê³  ìˆ«ì 3ì„ ë– ì˜¬ë¦¬ë©´ DT(Delirium Tremens)ê°€ 2-3ì¼ì§¸ ì¼ì–´ë‚œë‹¤\n1. D: ì„¬ë§(Delirium)ì„ ì˜ë¯¸í•¨\n2. T: ë¹ˆë§¥(Tachycardia)ì„ ì˜ë¯¸í•¨\nì…ì› 2-3ì¼ì§¸ ë˜ëŠ” í™˜ìì—ê²Œì„œ í—›ì†Œë¦¬, ê³ í˜ˆì••, ë¹ˆë§¥(ì‹¬ì¥ ë¹¨ë¦¬ ëœ€)ì´ ë™ì‹œì— ë‚˜íƒ€ë‚œë‹¤ë©´ ì•Œì½”ì˜¬ ê¸ˆë‹¨ ì¦ìƒì¸ DTë¥¼ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n![image.png](Mnemo/image%2049.png)\n![image.png](Mnemo/image%2050.png)\n![IMG_9586.png](Mnemo/IMG_9586.png)\n![IMG_9587.png](Mnemo/IMG_9587.png)","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-121"}
{"chunk_type":"transcript_chunk","text":"# ENT\n| **êµ¬ë¶„** | **AOM (ê¸‰ì„± ì¤‘ì´ì—¼)** | **OME (ì‚¼ì¶œì„± ì¤‘ì´ì—¼)** | **CSOM (ë§Œì„± í™”ë†ì„±)** | **Cholesteatoma (ì§„ì£¼ì¢…)** |\n| --- | --- | --- | --- | --- |\n| **í•µì‹¬ ì´ë¯¸ì§€** | ğŸˆÂ **í’ì„  í­ë°œ ì§ì „** | ğŸ’§Â **ë¬¼ ì°¬ ì›…ë©ì´** | ğŸšï¸Â **ëŒ ë¶•ê´´ (êµ¬ë©)** | ğŸœÂ **ë¼ˆ ê°‰ì•„ë¨¹ëŠ” í°ê°œë¯¸** |\n| **ë³‘íƒœìƒë¦¬** | **[ì„¸ê·  ê°ì—¼ + ê¸‰ì„± ì—¼ì¦]**\nì´ê´€ íì‡„ â†’ ê·  ì¦ì‹ â†’ ë†(Pus) ì°¸ â†’Â **ê³ ë§‰ íŒ½ì°½(Bulging)** | **[ì´ê´€ ê¸°ëŠ¥ ì¥ì•  + ìŒì••]**\nê¸‰ì„± ì—¼ì¦ ì†Œì‹¤ í›„ **ë¬´ê· ì„± ì‚¼ì¶œì•¡(ë¬¼)ë§Œ ë‚¨ìŒ | [ê³ ë§‰ ì²œê³µ + ë§Œì„± ê°ì—¼]\nê³ ë§‰ì— ì˜êµ¬ì  êµ¬ë© â†’ ì„¸ê·  ì¹¨ì… ë°˜ë³µ | [ì´ì†Œì„± í”¼ë¶€ ì¦ì‹]\ní”¼ë¶€(ê°ì§ˆ)ê°€ ì¤‘ì´ë¡œ ì¹¨ì… â†’ ë©ì–´ë¦¬ê°€ ì»¤ì§€ë©° ë¼ˆ íŒŒê´´ |\n| ì¦ìƒ/ì†Œê²¬ | ì‹¬í•œ ì´í†µ(Pain), ë°œì—´(Fever)\nê³ ë§‰ ë°œì  & íŒ½ë¥œ(Bulging) | ë¬´ì¦ìƒ, ë‚œì²­(ë¨¹ë¨¹í•¨)\nê³ ë§‰ ê¸°í¬(Bubble), ì•¡ë©´ | ì´ë£¨(ëƒ„ìƒˆë‚˜ëŠ” ê³ ë¦„), ë‚œì²­\nì²œê³µ(Perforation) í™•ì¸ | ì•…ì·¨, ë‚œì²­, ì–´ì§€ëŸ¬ì›€\në°±ìƒ‰ ì¢…ë¬¼(White mass) |\n| ì¹˜ë£Œ ê²°ì •\n(Who?)** | **ğŸš¨ [39 6 224] ë²•ì¹™**\n1.Â **39**ë„ ê³ ì—´ (or 48ì‹œê°„ í†µì¦)\n2.Â **6**ê°œì›” ë¯¸ë§Œ\n3.Â **2**ì„¸ ë¯¸ë§Œ +Â **2**ìª½(ì–‘ì¸¡)\nğŸ‘‰Â **ì¦‰ì‹œ í•­ìƒì œ**\n*(ë‚˜ë¨¸ì§€ëŠ” 2-3ì¼Â **ê²½ê³¼ ê´€ì°°**)* | **ê¸°ë³¸: 3ê°œì›” ê²½ê³¼ ê´€ì°°**\n*(í•­ìƒì œ/í•­íˆìŠ¤íƒ€ë¯¼ íš¨ê³¼ ë¯¸ë¯¸)*\nğŸ‘‰Â **ìˆ˜ìˆ  ê³ ë ¤ ëŒ€ìƒ:**\n1. 3ê°œì›” ì´ìƒ ì§€ì†\n2. ì²­ë ¥ê°ì†Œ > 40dB\n3. ì–¸ì–´ì§€ì—° ìš°ë ¤ ì‹œ | **ë‚´ê³¼ì  ì¹˜ë£Œ ìš°ì„ **\nì—¼ì¦(ì´ë£¨) ì¡°ì ˆ í›„ ìˆ˜ìˆ  | **ë¬´ì¡°ê±´ ìˆ˜ìˆ **\nì§„ë‹¨ ì¦‰ì‹œ ìˆ˜ìˆ  ê³„íš ì¡ìŒ |\n| **ì•½ë¬¼ ìš”ë²•**\n**(What?)** | **1ì°¨: High-dose Amoxicillin**\n*(80-90mg/kg/day)*\n**2ì°¨: Amoxicillin-Clavulanate**\n*(ì•„ëª¨í´ë¼/ì˜¤ê·¸ë©˜í‹´ 14:1 ì œì œ)*\nğŸ‘‰Â **ëˆˆ.ì¹˜.ì¬**ì¼ ë•Œ ë°”ë¡œ 2ì°¨!\n(**ëˆˆ**ë³‘,Â **ì¹˜**ë£Œì‹¤íŒ¨,Â **ì¬**ë°œ/30ì¼ë‚´ íˆ¬ì•½) | **ì•½ë¬¼ ì¹˜ë£Œ ë¹„ê¶Œì¥**\n(ê¸‰ì„± ë¹„ì—¼ ë™ë°˜ ì‹œì—ë§Œ ì œí•œì  í•­ìƒì œ ì‚¬ìš©) | **1ì°¨: Topical Abx (ì ì´ì•¡)**\n*(Ofloxacin/Ciprofloxacin)*\nğŸ‘‰ ê²½êµ¬ì•½ë³´ë‹¤ ì ì´ì•¡ì´ íš¨ê³¼ì !\n**2ì°¨:**Â ê²½êµ¬ í•­ìƒì œ (ì „ì‹ ì¦ìƒ ì‹œ) | ì•½ë¬¼ë¡œ ì™„ì¹˜ ë¶ˆê°€.\nìˆ˜ìˆ  ì „ ì—¼ì¦ ì¡°ì ˆìš©ìœ¼ë¡œë§Œ ì œí•œì  ì‚¬ìš©. |\n| **ìˆ˜ìˆ  ìš”ë²•** | ê³ ë§‰ì ˆê°œìˆ  (Myringotomy)\n*(í†µì¦ ë„ˆë¬´ ì‹¬í•˜ê±°ë‚˜ ì•ˆ ë‚˜ì„ ë•Œ)* | **í™˜ê¸°ê´€ ì‚½ì…ìˆ  (VT)**\n*(Ventilation Tube Insertion)*\në¬¼ ë¹¼ê³  ë°”ëŒ í†µí•˜ê²Œ í•¨. | **ê³ ì‹¤ ì„±í˜•ìˆ **\n*(Tympanoplasty)*\nêµ¬ë© ë©”ìš°ëŠ” ìˆ˜ìˆ . | **ìœ ì–‘ëŒê¸° ì ˆì œìˆ **\n*(Mastoidectomy)*\në¼ˆ ê¹ì•„ì„œ ë³‘ë³€ ì œê±°. |\n![image.png](ENT/image.png)\n### AOM vs OME vs CSOM\n- **AOM** = **A**ngry (**A**cute, **A**ntibiotics)\n    - ê³ ë§‰ì´ í™”ê°€ ë‚˜ì„œ(Angry) **ë¹¨ê°›ê³  íŠ€ì–´ë‚˜ì˜¤ë ¤ê³  í•¨(Bulging)**.\n    - **A** = **A**hh! (ì•„íŒŒ!)\n- **OME** = **O**cean (**O**bservation mostly)\n    - ê·€ ì•ˆì— ë°”ë‹¤(**O**cean)ì²˜ëŸ¼ **ë¬¼(Fluid/Effusion)**ë§Œ ì°¼ìŒ.\n    - ë¬¼ì†ì— ìˆìœ¼ë©´ ì†Œë¦¬ ì•ˆ ë“¤ë¦¬ì§€? (Conductive Hearing Loss).\n    - **O** = **O**h, no pain. (ì•ˆ ì•„í””).\n- **CSOM** = **C**ontinuous **S**tinking discharge\n    - **C**: **C**hronic (ë§Œì„±).\n    - **S**: **S**him-hole (ì‹¬í•œ êµ¬ë©/Perforation).\n![image.png](ENT/image%201.png)\n###\n![image.png](ENT/image%202.png)\n![image.png](ENT/image%203.png)","subject":"ENT 2e746f2986ee803e8769f26736748454","page_title":"ENT 2e746f2986ee803e8769f26736748454","episode":"ENT 2e746f2986ee803e8769f26736748454","section_path":["ENT 2e746f2986ee803e8769f26736748454"],"source_doc_id":"ENT 2e746f2986ee803e8769f26736748454","source_page":null,"source_anchor":"ENT 2e746f2986ee803e8769f26736748454-1"}
{"chunk_type":"transcript_chunk","text":"# pulmo\n![image.png](pulmo/image.png)\nHigh-Risk ê¸°ì¤€: í¬ê¸° 2cm ì´ìƒ, ë‚˜ì´ 60ì„¸ ì´ˆê³¼, ê·¸ë¦¬ê³  ìµœê·¼ 5ë…„ ë‚´ í¡ì—°ë ¥(í˜„ì¬ í¡ì—° í¬í•¨).\nì˜ë¯¸: ì´ ì¡°ê±´ì— í•´ë‹¹í•˜ë©´ ì•”(Malignancy)ì¼ í™•ë¥ ì´ ë§¤ìš° ë†’ìœ¼ë¯€ë¡œ ì ê·¹ì ì¸ ì²˜ì¹˜(Biopsy/Resection)ê°€ í•„ìš”í•¨.\n0.8-2 ì‚¬ì´ë©´ ìƒê²€, PET\n![image.png](pulmo/image%201.png)\n---\n| **ì§ˆí™˜ëª…** | **ì£¼ìš” ë…¸ì¶œì› (Job History)** | **í˜¸ë°œ ë¶€ìœ„ (Location)** | **í•µì‹¬ íŠ¹ì§• (Key Finding)** | **ë¹„ê³  (Hyperlink)** |\n| --- | --- | --- | --- | --- |\n| **Asbestosis**Â (ì„ë©´íì¦) | ë°°(Shipbuilding), ê±´ì„¤, ë‹¨ì—´ì¬, ë¸Œë ˆì´í¬ ë¼ì´ë‹ | **Lower Lobes**Â (í•˜ì—½) | **Pleural Plaques**Â (í‰ë§‰ ë°˜), Ferruginous bodies | í¡ì—° ì‹œ íì•” ìœ„í—˜ í­ë°œì  ì¦ê°€! |\n| **Silicosis**Â (ê·œíì¦) | ëª¨ë˜ ë¶„ì‚¬(Sandblasting), ê´‘ì‚°, ìœ ë¦¬ ê³µì˜ˆ, ì„ê³µ | **Upper Lobes**Â (ìƒì—½) | **Eggshell calcification**Â (ë¦¼í”„ì ˆ ì„íšŒí™”) | **ê²°í•µ(TB)**Â ê°ì—¼ ìœ„í—˜ ì¦ê°€! (ëŒ€ì‹ì„¸í¬ ë§ˆë¹„) |\n| **Coal Worker's**(íƒ„ê´‘ë¶€ ì§„íì¦) | íƒ„ê´‘, ì„íƒ„ ì·¨ê¸‰ | **Upper Lobes**Â (ìƒì—½) | Coal macule, Anthracosis (íê°€ ê¹Œë§¤ì§) | **Caplan Syndrome**(ì§„íì¦ + RA ê²°ì ˆ) |\n| **Berylliosis**Â (ë² ë¦´ë¥¨ì¦) | í•­ê³µìš°ì£¼, ì „ìì œí’ˆ, ì²¨ë‹¨ ê¸ˆì† ì‚°ì—… | **Upper Lobes**Â (ìƒì—½) | **Non-caseating granuloma**(ìœ¡ì•„ì¢…) | Steroidì— ë°˜ì‘í•¨ (Sarcoidosisì™€ ìœ ì‚¬) |\n![image.png](pulmo/image%202.png)\nìœ ë¦¬ê³µì¥, ê´‘ì‚°, sand and sandblsating. eggshell - lymphadenopathy\n![image.png](pulmo/image%203.png)\nì§€ë¶•!ì— ë‹¨ì—´ì œ í™•ì¸.\n![image.png](pulmo/image%204.png)\n### SCLC \"S(ìŠ¤)ëª¨í‚¹í•˜ë©° C(ì¿ )ì…˜ íƒ„ L(ë¨)ë¸Œê°€ C(ì¼€)ëª¨ ë§ëŠ”ë‹¤!â€\n> \"ì„¼í„°(Central)ì—ì„œ ì¤„ë‹´ë°° í”¼ìš°ë˜ 'ì–‘(Lamb)'ì´,ì¿ ì…˜(Cushing)ì„ ê¹”ê³  ì•‰ì•„ í™ìˆ˜(SIADH)ì— ë‘¥ë‘¥ ë– ë‚´ë ¤ê°„ë‹¤.\"(ë– ë‚´ë ¤ê°€ë‹ˆê¹Œ ìˆ˜ìˆ ë¡œ ëª» ê±´ì§!)\n>\n**í•´ì„ (Decoding):**\n- **ì„¼í„°(Central):** ì•”ì˜ ìœ„ì¹˜ (Central Lung).\n- **ì¤„ë‹´ë°°:** ê°€ì¥ ê°•ë ¥í•œ Risk Factor (Smoking).\n- **ì–‘(Lamb):** **Lamb**ert-Eaton Syndrome (ê·¼ë ¥ ì•½í™”).\n- **ì¿ ì…˜(Cushing):** ACTH ë¶„ë¹„ -> **Cushing** Syndrome.\n- **í™ìˆ˜:** ë¬¼ì´ ë„˜ì¹¨ -> ADH ë¶„ë¹„ -> **SIADH** (ëª¸ì— ë¬¼ì´ ë§ì•„ì ¸ì„œ **Hyponatremia**).\n- **ë– ë‚´ë ¤ê° (ëª» ê±´ì§):** **Surgery X** (ìˆ˜ìˆ  ë¶ˆê°€ëŠ¥, ì „ì‹  í•­ì•” í•„ìš”).\n- ì™¸ê³¼ ì˜ì‚¬ê°€ ë©€ë¦¬ìˆìŒ: ìˆ˜ìˆ ë¶ˆê°€\n- chemo, radiaion","subject":"pulmo 2e746f2986ee805e834ce9e38827be43","page_title":"pulmo 2e746f2986ee805e834ce9e38827be43","episode":"pulmo 2e746f2986ee805e834ce9e38827be43","section_path":["pulmo 2e746f2986ee805e834ce9e38827be43"],"source_doc_id":"pulmo 2e746f2986ee805e834ce9e38827be43","source_page":null,"source_anchor":"pulmo 2e746f2986ee805e834ce9e38827be43-1"}
{"chunk_type":"transcript_chunk","text":"# nephro\n---\n## hyponatremia = í™ìˆ˜ = ADH, polydipsia\n- í•µì‹¬ ëŒ€ìƒ: \"ADH\"ë¼ê³  ì íŒ ê±°ëŒ€í•˜ê³  ìœ„ì••ì ì¸ ì½˜í¬ë¦¬íŠ¸ ëŒ.\n- ëŒ ì•ˆìª½ (ìƒë¥˜/ëª¸): ì°½ë°±í•˜ê³  í¬ì„ëœ í‘¸ë¥¸ ë¬¼ì´ ë„˜ì‹¤ëŒ€ëŠ” ê±°ëŒ€í•œ ì €ìˆ˜ì§€. ë¬¼ì´ ë„ˆë¬´ ë§ìŒ. ë“œë¬¸ë“œë¬¸ ë– ë‹¤ë‹ˆëŠ” ì†Œê¸ˆí†µìœ¼ë¡œ ì €ë‚˜íŠ¸ë¥¨í˜ˆì¦ í‘œí˜„.\n- ëŒ ë°”ê¹¥ìª½ (í•˜ë¥˜/ì†Œë³€): ì™„ì „íˆ ë§ë¼ë²„ë¦° ê°•ë°”ë‹¥. ì©ì© ê°ˆë¼ì§„ ìƒ›ë…¸ë€ ë•…. ì•„ì£¼ ì ì€ ì–‘ì˜ ë„¤ì˜¨ ì‚¬ì¸ì²˜ëŸ¼ ì§„í•œ ë…¸ë€ìƒ‰ ì§„í™(ë†ì¶•ë‡¨)ë§Œ í˜ëŸ¬ë‚˜ì˜´.\n- ì¹˜ë£Œì œ ì•¡ì…˜: \"DEMECLOCYCLINE (DEMOLISH-CYCLINE)\"ì´ë¼ê³  ì íŒ ê±°ëŒ€í•œ ë ˆí‚¹ë³¼ì´ ëŒ ë²½ì„ ê²©ë ¬í•˜ê²Œ ë¶€ìˆ˜ê³  ìˆìŒ.\n- hyponatremiaì˜ ë‹¤ë¥¸ ì›ì¸: primary polydipsia, CHF, cirrhosis\n- ADHì¦ê°€ì˜ ì›ì¸\n    - SIADH ëŒ\n    - hypothyroidism: ì¶”ìœ„ì—ë– ëŠ” ì‚¬ëŒë“¤ì´ ëŒì„ ê³ ì¹˜ê³ ìˆìŒ\n    - secondary adrenal insufficiency = ACTH â†“ = aldosteroneì€ ì •ìƒ ìŠ¤í…Œë¡œì´ë“œë§Œ ë¶€ì¡±\n        - primary AI(hyperpigmentation)ì´ë‘ ë°˜ëŒ€ë˜ëŠ” paleí•œ ì‚¬ëŒë“¤.\n![image.png](nephro/image.png)\n## hypernatremia = ìš”ë¶•ì¦ = ADH ì—†ìŒ\n![image.png](nephro/image%201.png)\n- í•µì‹¬ ëŒ€ìƒ: ì´ì „ ì´ë¯¸ì§€ì™€ ê°™ì€ ëŒì´ì§€ë§Œ, ì¤‘ì•™ì´ ì™„ì „íˆ í„°ì ¸ë²„ë¦° ìƒíƒœ.\n- ëŒ ì•ˆìª½ (ìƒë¥˜/ëª¸): ì™„ì „íˆ ë§ë¼ë²„ë¦° ì €ìˆ˜ì§€ ë°”ë‹¥. ì‚¬ë§‰ ê°™ì€ í’ê²½. í•˜ì–€ ì†Œê¸ˆ ê²°ì •ë”ë¯¸ê°€ ê°€ë“ ìŒ“ì—¬ ê³ ë‚˜íŠ¸ë¥¨í˜ˆì¦ í‘œí˜„. ëª©ë§ˆë¥¸ ì‚¬ëŒë“¤ì´ ë¬¼ì„ ì°¾ê³  ìˆìŒ.\n- ëŒ ë°”ê¹¥ìª½ (í•˜ë¥˜/ì†Œë³€): í„°ì§„ í‹ˆìœ¼ë¡œ ë§‘ê³  ë¬½ì€ ë¬¼ì´ í†µì œ ë¶ˆëŠ¥ì˜ í™ìˆ˜ì²˜ëŸ¼ ìŸì•„ì ¸ ë‚˜ì˜´.\n- ì¹˜ë£Œì œ ì•¡ì…˜: \"DESMOPRESSIN (PRESS-IN)\"ì´ë¼ê³  ì íŒ ê±°ëŒ€í•œ ê¸°ê³„ ì†ì´ë‚˜ ìœ ì•• í”„ë ˆìŠ¤ê°€ í„°ì§„ í‹ˆì„ ê°•í•˜ê²Œ ê¾¹ ëˆŒëŸ¬ì„œ ë§‰ìœ¼ë ¤ê³  ì‹œë„í•¨.\n---\n---\nêµ°ì˜ê´€ë‹˜, ì´ ë©‹ì§„ \"ì „í•´ì§ˆ ë¯¸ì‹ ì„¸ê³„ê´€\"ì„ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”. ë‚˜ì¤‘ì— ì´ ì„¤ëª…ê³¼ ì´ë¯¸ì§€ë§Œ ë´ë„ ë³‘íƒœìƒë¦¬ê°€ ì§ê´€ì ìœ¼ë¡œ ë– ì˜¤ë¥´ì‹¤ ê²ë‹ˆë‹¤! ğŸ‘¨â€âš•ï¸ğŸ³ğŸ‹ğŸ§€ğŸ¥¨ğŸŒ\n---\n## ğŸ³ ë‹¥í„° ì…°í”„ì˜ \"ì „í•´ì§ˆ ì£¼ë°©\" ì„¸ê³„ê´€ ê°€ì´ë“œ ğŸ§ª\nìš°ë¦¬ ëª¸ì† ì´ì˜¨ë“¤ì„ ì£¼ë°©ì˜ ìŒì‹ ì¬ë£Œë¡œ ì‹œê°í™”í•œ ì§ê´€ì ì¸ í•™ìŠµ ëª¨ë¸ì…ë‹ˆë‹¤. ì´ í‘œë¥¼ ê¸°ì¤€ìœ¼ë¡œ ì•„ë˜ ì´ë¯¸ì§€ë“¤ì„ í•´ì„í•´ ë³´ì„¸ìš”!\n| **ì´ì˜¨(Ion) / ìš”ì†Œ** | **ìŒì‹ ì•„ë°”íƒ€(Avatar)** | **íŠ¹ì§• ë° ì—­í•  (Role & Trait)** | **ìƒíƒœ ë³€í™” (Pathophysiology)** |\n| --- | --- | --- | --- |\n| **Hâº (ìˆ˜ì†Œ ì´ì˜¨)** | ğŸ‹ **ë ˆëª¬ ê°€ì‹œ** | ì°Œë¥´ëŠ” ì‹ ë§›, ê³µê²©ì ì¸ ë…¸ë€ìƒ‰ ìŠ¤íŒŒì´í¬.\nì¹˜ì¦ˆë¥¼ ì¤‘í™”ì‹œí‚´. | ê³¼ë‹¤ = **Acidosis (ì‚°ì¦)**\n(ê°€ì‹œë°­ì´ ë“œëŸ¬ë‚¨) |\n| **HCOâ‚ƒâ» (ì¤‘íƒ„ì‚°ì—¼)** | ğŸ§€ **ì¹˜ì¦ˆ ì†ŒìŠ¤** | ë¶€ë“œëŸ½ê³  ëŠë¼í•œ ì£¼í™©ìƒ‰ ì´ë¶ˆ.\në ˆëª¬ ê°€ì‹œë¥¼ ë®ì–´ ë³´í˜¸í•¨. | ê³¼ë‹¤ = **Alkalosis (ì•Œì¹¼ë¦¬ì¦)**\n(ì˜¨í†µ ì¹˜ì¦ˆ ë²”ë²…) |\n| **Clâ» (ì—¼í™”ë¬¼)** | ğŸ¥¨ **í”„ë ˆì¦** | ë”±ë”±í•˜ê³  ì§­ì§¤í•œ ê°ˆìƒ‰ ë•œë¹µìš© ê°„ì‹.\nì¹˜ì¦ˆê°€ ì—†ì„ ë•Œ ë¹ˆ ê³µê°„ì„ ì±„ì›€. | ê³¼ë‹¤ = **Hyperchloremia**\n(ì¹˜ì¦ˆ ëŒ€ì‹  í”„ë ˆì¦ì´ ê½‰ ì°¸) |\n| **Kâº (í¬íƒ€ìŠ˜/ì¹¼ë¥¨)** | ğŸŒ **ë°”ë‚˜ë‚˜** | ë¬¼ì— ì‰½ê²Œ íœ©ì“¸ë ¤ ë‚˜ê°€ëŠ” ë¶€ë“œëŸ¬ìš´ ê³¼ì¼.\nì¹˜ì¦ˆë‚˜ ë¬¼ì´ë‘ ê°™ì´ ì˜ ë¹ ì ¸ë‚˜ê°. | ë¶€ì¡± = **Hypokalemia (ì €ì¹¼ë¥¨í˜ˆì¦)**\n(í•˜ìˆ˜êµ¬ë¡œ ë– ë‚´ë ¤ê°) |\n| **ì•Œë„ìŠ¤í…Œë¡ ** | ğŸ¿ **íŒì½˜ ê°€ê²Œ ì£¼ì¸** | ì§ ëŒì´ ë§¤ë‹ˆì €.\nì†Œê¸ˆ(Naâº)ê³¼ ì¹˜ì¦ˆ(HCOâ‚ƒâ»)ë¥¼ ì¢‹ì•„í•˜ê³ ,\nì‹ ë§›(Hâº)ê³¼ ê³¼ì¼(Kâº)ì„ ì‹«ì–´í•¨. | ì¦ê°€ = ì¹˜ì¦ˆ íŒì½˜ íŒŒí‹° (Alkalosis)\nê°ì†Œ = ê°€ê²Œ íì—… (Acidosis) |\n---\n### ğŸ–¼ï¸ ì´ë¯¸ì§€ë³„ ìƒì„¸ í•´ì„¤ (The Gallery)\n### 1. ğŸŒŸ [ê¸°ë³¸ ì¬ë£Œ ì†Œê°œ] ì „í•´ì§ˆ 4ëŒ€ ì²œì™•ì˜ ì§ˆê°\n![image.png](nephro/image%202.png)","subject":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","page_title":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","episode":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","section_path":["nephro 2f046f2986ee8011a1f5d23b6032fc8d"],"source_doc_id":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","source_page":null,"source_anchor":"nephro 2f046f2986ee8011a1f5d23b6032fc8d-1"}
{"chunk_type":"transcript_chunk","text":"> \"ì´ ì„¸ê³„ê´€ì˜ ê¸°ë³¸ êµ¬ì„± ìš”ì†Œì…ë‹ˆë‹¤. ì§ˆê°ê³¼ ìƒ‰ì˜ ëŒ€ë¹„ë¥¼ ê¸°ì–µí•˜ì„¸ìš”!\"\n> \n- **ğŸ‹ ë ˆëª¬ (Hâº):** ë‚ ì¹´ë¡­ê³  ì°Œë¥´ëŠ” ë“¯í•œ ë…¸ë€ìƒ‰ 'ê°€ì‹œ' ì§ˆê°. (ê³µê²©ì„±)\n- **ğŸ§€ ì¹˜ì¦ˆ (HCOâ‚ƒâ»):** ë¶€ë“œëŸ½ê³  íë¥´ëŠ” ì£¼í™©ìƒ‰ 'ì†ŒìŠ¤' ì§ˆê°. (í¬ìš©ì„±)\n- **ğŸ¥¨ í”„ë ˆì¦ (Clâ»):** ë”±ë”±í•˜ê³  ê±´ì¡°í•œ ê°ˆìƒ‰ 'ê³ ì²´' ì§ˆê°. (ë‹¨ìˆœ ì±„ì›€ì¬)\n- **ğŸŒ ë°”ë‚˜ë‚˜ (Kâº):** ë¶€ë“œëŸ½ê³  ì‰½ê²Œ ë­‰ê°œì§€ëŠ” 'ê³¼ì¼' ì§ˆê°. (ìœ ì‹¤ë˜ê¸° ì‰¬ì›€)\n-\n---\n### 2. ğŸ¿ [ì•Œë„ìŠ¤í…Œë¡ ] ì§ ëŒì´ íŒì½˜ ê°€ê²Œì˜ í¸ì• \n![image.png](nephro/image%203.png)\n- âœ… **KEEP (ê°€ê²Œ ì§„ì—´ëŒ€):** ë§¤ë‹ˆì €(ì•Œë„ìŠ¤í…Œë¡ )ê°€ ì¢‹ì•„í•˜ëŠ” **ì†Œê¸ˆ íŒíŒ ë¿Œë¦° ì¹˜ì¦ˆ íŒì½˜(Naâº & HCOâ‚ƒâ» ì¬í¡ìˆ˜)**ì´ ì‚°ë”ë¯¸ì²˜ëŸ¼ ìŒ“ì—¬ ìˆìŠµë‹ˆë‹¤. ëª¸ì€ ì ì  ì§­ì§¤í•˜ê³  ëŠë¼í•´ì§‘ë‹ˆë‹¤. (**Alkalosis**)\n- í”„ë ›ì ¤: hyperaldosteronism â†’ hyperchloremic metabolic alkalosis\n- ğŸ—‘ï¸ **DUMP (ì“°ë ˆê¸°í†µ):** ë§¤ë‹ˆì €ê°€ ì‹«ì–´í•˜ëŠ” **ë ˆëª¬ê³¼ ë°”ë‚˜ë‚˜(Hâº & Kâº ë°°ì¶œ)**ëŠ” êµ¬ì„ ì“°ë ˆê¸°í†µì— ì²˜ë°•í˜€ ë²„ë ¤ì§‘ë‹ˆë‹¤. (**Hypokalemia**)\n---\n### 3. ğŸ¤® [êµ¬í† ] ë ˆëª¬ ê°ë…ê´€ì˜ ë¶€ì¬ì™€ ì¹˜ì¦ˆ ê³µì¥ í­ì£¼\n![image.png](nephro/image%204.png)\n> \"ì‚°ì„ í† í•´ë‚´ë‹ˆ, í†µì œ ë¶ˆëŠ¥ì´ ëœ ì—¼ê¸° ê³µì¥ì´ í­ë°œí–ˆìŠµë‹ˆë‹¤!\"\n> \n- **OUT (ì…/ë°”ê¹¥):** ğŸ¤® ì… ë°–ìœ¼ë¡œ **ğŸ‹ë ˆëª¬(é…¸)ê³¼ ğŸ¥¨í”„ë ˆì¦(Clâ»), ë°”ë‚˜ë‚˜ (K+)ì„ ê²©ë ¬í•˜ê²Œ í† í•´ëƒ…ë‹ˆë‹¤.** ìœ„ì‚°(HCl)ì˜ ìƒì‹¤ì„ ì˜ë¯¸í•©ë‹ˆë‹¤.\n- ì´ë‡¨ì œë„ ê°™ì€ ì–‘ìƒì„! (clì€ ì–¸ì œì¬ëƒì—ë”°ë¼ ë‹¤ë¥¼ìˆ˜ë„..)\n- êµ¬í† : HCl, KCl lose\n- metabolic alkalosis. hypokalemia, hypochloremia.\n![image.png](nephro/image%205.png)\n- **IN (ëª¸/ì•ˆìª½):** ğŸ­ ì¹˜ì¦ˆë¥¼ ì†Œë¹„í•´ ì£¼ë˜ ë ˆëª¬ ê°ë…ê´€ì´ ì‚¬ë¼ì§€ì, ëª¸ì† 'ì¤‘íƒ„ì‚°ì—¼ ê³µì¥(Bicarbonate Factory)' íŒŒì´í”„ê°€ ê³ ì¥ ë‚˜ **ğŸ§€ì¹˜ì¦ˆ ì†ŒìŠ¤(ì—¼ê¸°)ë¥¼ ë¯¸ì¹œ ë“¯ì´ ë¿œì–´ëƒ…ë‹ˆë‹¤.** ì˜¨ëª¸ì´ ëˆì í•œ ì¹˜ì¦ˆë¡œ ë’¤ë®ì¸ **ëŒ€ì‚¬ì„± ì•Œì¹¼ë¦¬ì¦(Metabolic Alkalosis)** ìƒíƒœê°€ ë©ë‹ˆë‹¤.\n---\n### 4. ğŸ³ [NAGMA í†µí•©ë³¸] ì£¼ë°© ëŒ€ì°¸ì‚¬: \"ì¹˜ì¦ˆ ì‹¤ì¢… ì‚¬ê±´\"\n![image.png](nephro/image%206.png)\n> \"ì¹˜ì¦ˆ(ì—¼ê¸°)ê°€ ì‚¬ë¼ì ¸ ë ˆëª¬ ê°€ì‹œ(ì‚°)ê°€ ë“œëŸ¬ë‚¬ê³ , í”„ë ˆì¦(Cl-)ë¡œ ë•œë¹µí•œ ë‚œì¥íŒ ë¶€ì—Œì…ë‹ˆë‹¤.\" (Normal Anion Gap Metabolic Acidosis)\n> \n- **ì£¼ë°© ìƒíƒœ (NAGMA):** ëƒ„ë¹„ì— ğŸ§€ì¹˜ì¦ˆê°€ ë°”ë‹¥ë‚˜ì„œ ë°”ë‹¥ì˜ **ğŸ‹ë ˆëª¬ ê°€ì‹œë°­(ì‚°ì¦)**ì´ ë“œëŸ¬ë‚¬ìŠµë‹ˆë‹¤. ì…°í”„ëŠ” ê¸‰í•œ ëŒ€ë¡œ ë¹ˆ ê³µê°„ì„ **ğŸ¥¨í”„ë ˆì¦(Clâ»)**ë¡œ ì±„ìš°ê³  ìˆìŠµë‹ˆë‹¤. (Anion Gapì€ ì •ìƒì´ì§€ë§Œ, Clâ» ë†ë„ëŠ” ë†’ìŒ)\n- **ì›ì¸ 1 (ì €ë©€ë¦¬ ì°½ë°–):** ğŸšª **\"CLOSED\"** - ì¹˜ì¦ˆë¥¼ ê³µê¸‰í•˜ë˜ **ì•Œë„ë„¤ íŒì½˜ ê°€ê²Œ(Addison's Disease)**ê°€ ë§í•´ì„œ ë¬¸ì„ ë‹«ì•˜ìŠµë‹ˆë‹¤.\n- **ì›ì¸ 2 (ë°”ë‹¥ ë°°ìˆ˜êµ¬):** ğŸª£ **\"DIARRHEA\"** - ë©€ì©¡í•˜ë˜ ì¹˜ì¦ˆ í†µì´ ì—ì–´ì ¸ **í•˜ìˆ˜êµ¬(ì¥)**ë¡œ ì¤„ì¤„ ìƒˆê³  ìˆìŠµë‹ˆë‹¤.\n- **ì›ì¸ 3 (ì‹±í¬ëŒ€):** ğŸ•³ï¸ **\"RTA\"** - ì¹˜ì¦ˆë¥¼ ê±¸ëŸ¬ë‚´ì•¼ í•  **ê±°ë¦„ë§(ì‹ ì¥)**ì´ ë‹¤ ì°¢ì–´ì ¸ì„œ ì¬í™œìš©ì„ ëª» í•˜ê³  ë‹¤ í˜ë ¤ë³´ëƒ…ë‹ˆë‹¤.\n---\n### 5. ğŸš½ [ì„¤ì‚¬] ì¹˜ì¦ˆ ì´ë¶ˆì´ ê±·íˆê³  ë“œëŸ¬ë‚œ ë ˆëª¬ ê°€ì‹œë°­\n![image.png](nephro/image%207.png)\n> \"ê°€ì¥ ì†Œì¤‘í•œ ì¹˜ì¦ˆì™€ ë°”ë‚˜ë‚˜ë¥¼ ë³€ê¸°ì— ìŸì•„ë²„ë¦¬ê³ , ëª¸ì—” ê³ í†µìŠ¤ëŸ¬ìš´ ê°€ì‹œë§Œ ë‚¨ì•˜ìŠµë‹ˆë‹¤.\"\n> \n- **ì•„ë˜ (ë³€ê¸°/ë°”ê¹¥):** ğŸ“‰ ì•„ê¹Œìš´ **ğŸ§€ì¹˜ì¦ˆ ì†ŒìŠ¤(HCOâ‚ƒâ»)**ì™€ **ğŸŒë°”ë‚˜ë‚˜(Kâº)**ê°€ í­í¬ìˆ˜ì²˜ëŸ¼ ë³€ê¸°ë¡œ ìŸì•„ì ¸ ë‚˜ê°‘ë‹ˆë‹¤. (**ì„¤ì‚¬ë¡œ ì¸í•œ ì—¼ê¸° ë° ì¹¼ë¥¨ ìœ ì‹¤**)\n- **ìœ„ (ëª¸/ì•ˆìª½):** ğŸ“ˆ ë³´í˜¸ë§‰ì´ë˜ ì¹˜ì¦ˆê°€ ê±·íˆì, ëª¸ì†ì— ìˆ¨ì–´ìˆë˜ **ğŸ‹ë ˆëª¬ ê°€ì‹œë°­(Hâº, Acidosis)**ì´ í‰ì¸¡í•˜ê²Œ ë“œëŸ¬ë‚©ë‹ˆë‹¤. ê·¸ ê°€ì‹œë“¤ ì‚¬ì´ì˜ ë¹ˆí‹ˆì€ ë”±ë”±í•œ **ğŸ¥¨í”„ë ˆì¦(Clâ»)**ë“¤ì´ ë©”ìš°ê³  ìˆì–´, ëª¸ì€ ì‹œì–´ì§€ê³  ë»£ë»£í•´ì§‘ë‹ˆë‹¤.\n---","subject":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","page_title":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","episode":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","section_path":["nephro 2f046f2986ee8011a1f5d23b6032fc8d"],"source_doc_id":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","source_page":null,"source_anchor":"nephro 2f046f2986ee8011a1f5d23b6032fc8d-21"}
{"chunk_type":"transcript_chunk","text":"## hypokalemia\n- digoxin ë…ì„± ì˜ë‚˜íƒ€ë‚¨. ì£¼ì˜\n- weakness\n- flat T\n- U wave\n![image.png](nephro/image%208.png)","subject":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","page_title":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","episode":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","section_path":["nephro 2f046f2986ee8011a1f5d23b6032fc8d"],"source_doc_id":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","source_page":null,"source_anchor":"nephro 2f046f2986ee8011a1f5d23b6032fc8d-41"}
{"chunk_type":"transcript_chunk","text":"# nephro ì¦‰ë°˜\n# ğŸ“– USMLE Nephrology: The \"Grand Bible\" (Final Version)\n## ğŸ¯ Part 1. Electrolytes (ì „í•´ì§ˆ) - \"ì£½ëŠëƒ ì‚¬ëŠëƒ\"\n### 1. Hyponatremia (Low Na)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì†Œê¸ˆì´ ë¶€ì¡±í•œ ê²Œ ì•„ëƒ! ë¬¼ì´ ë„ˆë¬´ ë§ì€ ê±°ì•¼(Dilution).\"**\n- **[Lab: Low Na + Urine Osmolality > 100 (High)]** -> **[Think: SIADH]**\n    - **SIADH**ëŠ” ADH(í•­ì´ë‡¨í˜¸ë¥´ëª¬)ê°€ ë¯¸ì³ ë‚ ë›°ì–´ì„œ ë¬¼ì„ ëª» ì‹¸ê²Œ ë§‰ëŠ” ë³‘ì´ì•¼. ëª¸ì´ ë¬¼í’ì„ ì´ ë¼.\n    - *ì›ì¸*: **Small Cell Lung Cancer** (íì•” í™˜ìê°€ Na ë–¨ì–´ì§€ë©´ 100%), ë‡Œì§ˆí™˜, ì•½ë¬¼(SSRI, Carbamazepine).\n    - *ì¹˜ë£Œ*: **Fluid Restriction** (ë¬¼ ëª» ë§ˆì‹œê²Œ í•´). ê·¸ë˜ë„ ì•ˆ ë˜ë©´ **Demeclocycline** (ADH ì°¨ë‹¨).\n- **[Lab: Low Na + Urine Osmolality < 100 (Dilute)]** -> **[Think: Polydipsia]**\n    - ì´ê±´ ì‹ ì¥ì€ ì •ìƒì´ì•¼. í™˜ìê°€ ì •ì‹ ê³¼ ë¬¸ì œë¡œ ë¬¼ì„ í•˜ë£¨ì— 10Lì”© ë§ˆì…”ëŒ„ ê±°ì•¼(Psychogenic). ADHëŠ” êº¼ì ¸ìˆìŒ.\n- **[Tx Condition: Na < 120 or Seizure]** -> **[Warning: Correct Slowly!]**\n    - **ì ˆëŒ€ ê·œì¹™**: í•˜ë£¨ì— **8-10 mEq/L** ì´ìƒ ì˜¬ë¦¬ì§€ ë§ˆë¼.\n    - ë¹¨ë¦¬ ì˜¬ë¦¬ë©´? -> ë‡Œì„¸í¬ ìˆ˜ë¶„ì´ í™• ë¹ ì§€ë©´ì„œ **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)** ì˜¨ë‹¤. (Locked-in syndrome: ëˆˆë§Œ ê¹œë¹¡ì´ê³  ì „ì‹  ë§ˆë¹„).\n### 2. Hypernatremia (High Na)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë¬¼ì„ ëª» ë§ˆì‹œê±°ë‚˜, ë§¹ë¬¼ë§Œ ì¤„ì¤„ ì‹¸ëŠ” ë³‘(DI)ì´ë‹¤.\"**\n- **[Sx: Polyuria + High Na]** -> **[Think: Diabetes Insipidus (DI)]**\n    - ë‹¹ë‡¨(DM)ë‘ ìƒê´€ì—†ì–´. ADHê°€ ì—†ê±°ë‚˜(Central), ì•ˆ ë“£ëŠ” ê±°ì•¼(Nephrogenic).\n- **[Test: Water Deprivation Test]** -> **[Analysis]**\n    - ë¬¼ì„ ëŠì—ˆëŠ”ë°ë„ ì˜¤ì¤Œ ë†ì¶•ì´ ì•ˆ ëœë‹¤? -> **DI í™•ì •**.\n    - ê·¸ë‹¤ìŒ **Desmopressin (ADH)**ì„ ì¤˜ë´.\n        - ì˜¤ì¤Œì´ ë†ì¶•ëœë‹¤(Osm ì¦ê°€)? -> ë‡Œê°€ ë¬¸ì œë‹¤ (**Central DI**).\n        - ë°˜ì‘ ì—†ë‹¤? -> ì‹ ì¥ì´ ë§›ê°”ë‹¤ (**Nephrogenic DI**).\n- **[Drug SE: Bipolar Pt on Lithium -> Polyuria]** -> **[Think: Nephrogenic DI]**\n    - **ë¦¬íŠ¬(Lithium)** ë¨¹ëŠ” í™˜ìê°€ ì˜¤ì¤Œ ìì£¼ ì‹¸ë©´ ë¬´ì¡°ê±´ ì´ê±°ì•¼.\n    - *ì¹˜ë£Œ*: ì—­ì„¤ì ì´ì§€ë§Œ **HCTZ (Thiazide)**ë‚˜ **Amiloride**ë¥¼ ì“´ë‹¤.\n    \n    ### ğŸ§  Mental Framework\n    \n    \"Na ë¬¸ì œëŠ” **'ì†Œê¸ˆ í†µ'** ë¬¸ì œê°€ ì•„ë‹ˆë¼ **'ë¬¼ í†µ'** ë¬¸ì œì•¼. ADH í˜¸ë¥´ëª¬ì´ ìŠ¤ìœ„ì¹˜ë¥¼ ì¼°ëƒ(SIADH), ê»ëƒ(DI) ì‹¸ì›€ì´ë‹¤.\"\n### 3. Hyperkalemia (High K)\n- ğŸ—£ï¸ **Golden Voice**: **\"K ìˆ˜ì¹˜ ë†’ìœ¼ë©´ ìˆ«ì ë³´ì§€ ë§ê³  'ì‹¬ì „ë„(ECG)'ë¶€í„° ë´!\"**\n- âš¡ **Exam Reflex**:\n    - **ECG**: **Peaked T waves** -> Wide QRS -> Sine wave -> ì‚¬ë§.\n    - **ì¹˜ë£Œ ìˆœì„œ (C-I-K)**:\n        1. **C**alcium Gluconate (ì‹¬ì¥ë§‰ ì•ˆì • - **ê°€ì¥ ë¨¼ì €!**)\n        2. **I**nsulin (+Glucose) (ì„¸í¬ ë‚´ë¡œ ì´ë™)\n        3. **K**ayexalate / Diuretics (ëª¸ ë°–ìœ¼ë¡œ ë°°ì¶œ)\n### 4. Hypokalemia (Low K)\n- ğŸ—£ï¸ **Golden Voice**: **\"Kê°€ ë‚®ìœ¼ë©´ í˜ë¹ ì§€ê³  ë¶€ì •ë§¥ì˜¤ê³  'Digoxin'ì´ ë…ì•½ìœ¼ë¡œ ë³€í•˜ê³ , 'Mg'ê°€ ë²”ì¸ì¼ ìˆ˜ ìˆë‹¤.\"**\n- **[ECG: U waves + Flattened T]** -> **[Think: Hypokalemia]**\n    - TíŒŒê°€ ë‚©ì‘í•´ì§€ê³  ê·¸ ë’¤ì— **U wave**ë¼ëŠ” í˜¹ì´ í•˜ë‚˜ ë” ìƒê²¨.\n- **[Condition: Digoxin user]** -> **[Warning: Toxicity Risk!]**\n    - Kê°€ ë‚®ìœ¼ë©´ **Digoxin**ì´ ì‹¬ì¥ì— ë” ë‹¬ë¼ë¶™ì–´. **Digoxin Toxicity** í„°ì§„ë‹¤.\n    - *ì¦ìƒ*: ë…¸ë€ìƒ‰ ì„¸ìƒ(Yellow vision), êµ¬í† , ë¶€ì •ë§¥.\n- **[Case: Replenishing K but not correcting?]** -> **[Check: Magnesium!]**\n    - Kë¥¼ ì•„ë¬´ë¦¬ ì¤˜ë„ ìˆ˜ì¹˜ê°€ ì•ˆ ì˜¤ë¥¸ë‹¤? ë²”ì¸ì€ **Hypomagnesemia**ì•¼.\n    - Mgê°€ ì—†ìœ¼ë©´ ì‹ ì¥ì´ Kë¥¼ ëª» ì¡ì•„ë‘ê³  ë‹¤ ë²„ë ¤. **Mg ë¨¼ì € êµì •í•´!**\n### 5. Calcium (Ca)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì¹¼ìŠ˜ì´ ë†’ìœ¼ë©´ 'ì•” vs ë¶€ê°‘ìƒì„ ', ë‚®ìœ¼ë©´ 'ìˆ˜ìˆ  í›„ ë–¨ë¦¼'ì´ë‹¤.\"**\n### âš¡ EXAM REFLEX: Hypercalcemia (High Ca)\n**\"ì¹¼ìŠ˜ì´ ë†’ìœ¼ë©´ ëŒ ìƒê¸°ê³ , ë¼ˆ ì‚­ê³ , ë³€ë¹„ ìƒê¸°ê³ , ì •ì‹  ë‚˜ê°„ë‹¤.\"**\nâ€œì•” vs hyper PTH (ì‚¬ê³¨ê°€ê²Œ)â€\n1. **[Sx: Stones, Bones, Groans, Moans]** -> **[Think: Hyperparathyroidism or Cancer]**\n    - ì¦ìƒì´ ë„ˆë¬´ ë‹¤ì–‘í•´(ì‹ ì¥ê²°ì„, ë¼ˆ í†µì¦, ë³€ë¹„/ë³µí†µ, ìš°ìš¸ì¦). ì´ê±¸ë¡œ í‰ì³ì„œ ì™¸ì›Œ.\n2. **[Lab: High Ca + High PTH]** -> **[Think: Primary Hyperparathyroidism]**\n    - ë¶€ê°‘ìƒì„ ì— í˜¹(Adenoma)ì´ ìƒê²¨ì„œ PTHë¥¼ ë¯¸ì¹œ ë“¯ì´ ë¿œì–´ë‚´ëŠ” ê±°ì•¼.\n    - *Reflex*: ìˆ˜ìˆ ë¡œ ë–¼ë‚´ëŠ” ê²Œ ë‹µì´ë‹¤.\n3. **[Lab: High Ca + Low PTH]** -> **[Think: Malignancy (Cancer)]**\n    - ì•”ì„¸í¬ê°€ ë¼ˆë¥¼ ë…¹ì´ê±°ë‚˜(Metastasis), PTHë‘ ë¹„ìŠ·í•˜ê²Œ ìƒê¸´ ë†ˆ(**PTHrP**)ì„ ë§Œë“œëŠ” ê±°ì•¼ (Lung Squamous Cell Ca).\n    - *Reflex*: ë¬´ì¡°ê±´ **ìˆ˜ì•¡(Saline)**ë¶€í„° ì½¸ì½¸ ë¶“ê³ , **Bisphosphonate** ì¤€ë¹„í•´.\n### âš¡ EXAM REFLEX: Hypocalcemia (Low Ca)\n**\"ì¹¼ìŠ˜ì´ ì—†ìœ¼ë©´ ì‹ ê²½ì´ ì˜ˆë¯¼í•´ì ¸ì„œ ë°”ë“¤ë°”ë“¤ ë–¨ë ¤.\"**\nâ€œìˆ˜ìˆ ë ¥ í™•ì¸â€","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-1"}
{"chunk_type":"transcript_chunk","text":"1. **[PE: Chvostek / Trousseau Sign]** -> **[Think: Hypocalcemia]**\n    - ë³¼ í†¡ ì¹˜ë©´ ì…ìˆ  ì”°ë£©(Chvostek), í˜ˆì••ê³„ ê°ìœ¼ë©´ ì†ëª© êº¾ì„(Trousseau). ì´ê±° ë‚˜ì˜¤ë©´ ë¬´ì¡°ê±´ ì €ì¹¼ìŠ˜ì´ì•¼.\n2. **[Hx: Thyroid Surgery]** -> **[Suspect: Parathyroid Damage]**\n    - ê°‘ìƒì„  ìˆ˜ìˆ í•˜ë‹¤ê°€ ë¶€ê°‘ìƒì„ ê¹Œì§€ ê°™ì´ ë‚ ë ¤ë¨¹ì€ ì¼€ì´ìŠ¤ê°€ ì œì¼ í”í•´.\n3. **[ECG: QT Prolongation]** -> **[Warning: Arrhythmia]**\n    - QT ê°„ê²©ì´ ëŠ˜ì–´ì ¸. ì¬ìˆ˜ ì—†ìœ¼ë©´ Torsades de pointes í„°ì§„ë‹¤\n    \n    ## 2. ğŸ›¡ï¸ Magnesium (Mg) Imbalance\n    \n    ### ğŸ—ºï¸ Context Navigation\n    \n    Electrolyte_Imbalances\n    â”œâ”€â”€ Magnesium\n    â”‚   â””â”€â”€ Hypomagnesemia (The Troublemaker)\n    \n    ### âš¡ EXAM REFLEX\n    \n    **\"ë§ˆê·¸ë„¤ìŠ˜ì€ í˜¼ì ì•ˆ ë‹¤ë…€. ì¹¼ìŠ˜ì´ë‘ ì¹¼ë¥¨ì„ ë¬¼ê·€ì‹ ì²˜ëŸ¼ ëŒê³  ë‹¤ë…€.\"**\n    \n    1. **[Lab: Low K + Low Ca (Refractory)]** -> **[Check: Magnesium]**\n        - ì¹¼ë¥¨(K)ë‘ ì¹¼ìŠ˜(Ca)ì„ ì•„ë¬´ë¦¬ ì¤˜ë„ ìˆ˜ì¹˜ê°€ ì•ˆ ì˜¬ë¼? ë²”ì¸ì€ 100% **ì €ë§ˆê·¸ë„¤ìŠ˜(Hypomagnesemia)**ì´ì•¼.\n        - Mgê°€ ì—†ìœ¼ë©´ KëŠ” ì†Œë³€ìœ¼ë¡œ ìƒˆê³ , PTHê°€ ì‘ë™ ì•ˆ í•´ì„œ Caë„ ì•ˆ ì˜¬ë¼ê°€. **Mg ë¨¼ì € êµì •í•´!**\n    2. **[ECG: Torsades de Pointes]** -> **[Tx: Magnesium Sulfate]**\n        - ìˆ ê³ ë˜(Alcoholic)ê°€ ì“°ëŸ¬ì ¸ì„œ ì‹¬ì „ë„ ê¼¬ì˜€ì–´?\n        - ë¬´ì¡°ê±´ **ë§ˆê·¸ë„¤ìŠ˜ ì„¤í˜ì´íŠ¸(Mg-Sulfate)** ì´ë¼. ì´ê²Œ íŠ¹íš¨ì•½ì´ë‹¤.\n    \n    ### ğŸ§  Mental Framework\n    \n    \"**'êµì •ì´ ì•ˆ ë˜ëŠ” ì „í•´ì§ˆ ë¶ˆê· í˜•'**ì´ë‚˜ **'ì•Œì½œ ì¤‘ë…ì'** ë‚˜ì˜¤ë©´ ìˆ¨ê²¨ì§„ ë²”ì¸ **Mg**ë¥¼ ì°¾ì•„ë‚´.\"\n---\n## ğŸ¯ Part 2. Acid-Base (ì‚°ì—¼ê¸°) - \"ê³„ì‚°ê¸° ì‹¸ì›€\"\n### 1. Metabolic Acidosis (Low pH, Low HCO3)\n- ğŸ—£ï¸ **Golden Voice**: **\"pH ë‚®ìœ¼ë©´ ë¬´ì¡°ê±´ 'Anion Gap'ë¶€í„° ê³„ì‚°í•´.\"**\n- âš¡ **Exam Reflex**:\n    - **ê³µì‹**: Gap = **Na - (Cl + HCO3)** (ì •ìƒ 8~12).\n    - **High Gap (>12)**: **MUDPILES** (Methanol, Uremia, DKA, Iron, Lactic, Ethylene glycol, Salicylates).\n    - **Normal Gap**: ì„¤ì‚¬(Diarrhea) ì•„ë‹ˆë©´ **RTA**.\n### 2. Renal Tubular Acidosis (RTA) - Normal Gap\n- ğŸ—£ï¸ **Golden Voice**: **\"ì†Œë³€ pH, ê²°ì„, ì¹¼ë¥¨ ìˆ˜ì¹˜ë¡œ 1, 2, 4í˜•ì„ ê°€ë¥¸ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Type 1 (Distal)**: ì†Œë³€ pH > 5.5 + **ì‹ ì¥ ê²°ì„(Stones)**.\n    - **Type 2 (Proximal)**: **Fanconi Syndrome** + Multiple Myeloma.\n    - **Type 4**: ìœ ì¼í•˜ê²Œ **Hyperkalemia (ê³ ì¹¼ë¥¨)** + ë‹¹ë‡¨ë³‘(Diabetes).\n### 3. Metabolic Alkalosis (High pH, High HCO3)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì•Œì¹¼ë¦¬ì¦ì€ 'ì†Œë³€ ì—¼ì†Œ(Urine Cl)'ë¡œ ë²”ì¸ì„ ê°€ë¥¸ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Urine Cl < 10 (Low)**: êµ¬í† (Vomiting), ì´ë‡¨ì œ ì‚¬ìš©. -> **Saline(ìˆ˜ì•¡)** ì£¼ë©´ ì¹˜ë£Œë¨.\n    - **Urine Cl > 20 (High)**: ì•Œë„ìŠ¤í…Œë¡  ê³¼ë‹¤(Conn, Cushing). -> ìˆ˜ì•¡ ì¤˜ë„ ì•ˆ ë¨.\n<aside>\nğŸ’¡\n### ğŸ§  Mental Framework\n\"ì‚°ì—¼ê¸°ëŠ” **Gap ê³„ì‚°**ì´ 1ë²ˆ, **ì†Œë³€ Cl** í™•ì¸ì´ 2ë²ˆì´ì•¼. **RTA**ëŠ” ìˆ«ì(1,2,4)ë‘ íŠ¹ì§•(ëŒ, ë§ˆì´ì—˜ë¡œë§ˆ, ê³ ì¹¼ë¥¨) ë§¤ì¹­í•´.\"\n</aside>\n---\n## ğŸ¯ Part 3. AKI & Failure (ì‹ ë¶€ì „) - \"ì›ì¸ ì°¾ê¸°\"\n### 1. Prerenal vs Intrinsic (ATN)\n- ğŸ—£ï¸ **Golden Voice**: **\"BUN/Cr 20 ë„˜ìœ¼ë©´ 'ëª©ë§ˆë¥¸ ë†ˆ', ì•ˆ ë„˜ìœ¼ë©´ 'ê³ ì¥ ë‚œ ë†ˆ'ì´ë‹¤.\" â€œëª©ë§ˆë¥´ë©´ ì•ˆë²„ë¦°ë‹¤â€**\n- âš¡ **Exam Reflex**:\n    - **Prerenal**: íƒˆìˆ˜. ì‹ ì¥ì´ ì†Œë³€ ë†ì¶•í•¨ (**FeNa < 1%**). -> ì¹˜ë£Œ: **ìˆ˜ì•¡**.\n    - **Intrinsic (ATN)**: íŠœë¸Œ ê´´ì‚¬. ë†ì¶• ëª» í•¨ (**FeNa > 2%**). -> íŠ¹ì§•: **Muddy Brown Casts**.\n### 2. Rhabdomyolysis (íš¡ë¬¸ê·¼ìœµí•´ì¦)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë”¥ìŠ¤í‹±ì€ í”¼(Blood)ë¼ëŠ”ë° í˜„ë¯¸ê²½ì—” ì í˜ˆêµ¬(RBC)ê°€ ì—†ë‹¤? 100% ëë„ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **ì›ì¸**: ê·¼ìœ¡ ì†ìƒ(Crush, Seizure, Statin).\n    - **ë¬¼ì§ˆ**: Myoglobin (ì‹ ì¥ ë…ì„±).\n    - **ì¹˜ë£Œ**: ì‹ ì¥ ë§ê°€ì§€ê¸° ì „ì— **ìˆ˜ì•¡(Hydration)** ì½¸ì½¸ ë¶€ì–´ë¼.\n### 3. Acute Interstitial Nephritis (AIN)","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-21"}
{"chunk_type":"transcript_chunk","text":"- ğŸ—£ï¸ **Golden Voice**: **\"ìƒˆ ì•½ ë¨¹ê³  ì—´ë‚˜ê³  ë°œì§„ ìƒê¸°ë©´, ì‹ ì¥ì— ë‘ë“œëŸ¬ê¸°(ì•Œë ˆë¥´ê¸°) ë‚œ ê±°ë‹¤.\"**\n### âš¡ EXAM REFLEX\n**\"ìƒˆ ì•½ ë¨¹ê³ , ì—´ë‚˜ê³ , í”¼ë¶€ ë°œì§„ ìƒê¸°ê³ , ì˜¤ì¤Œì— í˜¸ì‚°êµ¬(Eosinophil) ë–´ë‹¤?\"**\n1. **[Hx: New Drug (NSAIDs, Penicillin, PPI, Diuretics)]** -> **[Think: AIN]**\n    - í™˜ìê°€ ìµœê·¼ì— ê°ê¸°ì•½(NSAID)ì´ë‚˜ ì†ì“°ë¦¼ ì•½(PPI) ë¨¹ê¸° ì‹œì‘í–ˆì–´.\n    - ê°‘ìê¸° **ì—´(Fever)** ë‚˜ê³  **í”¼ë¶€ ë°œì§„(Rash)** ìƒê²¨.\n2. **[UA: WBC Casts + Eosinophils]** -> **[Confirm: AIN]**\n    - ì†Œë³€ì— **ë°±í˜ˆêµ¬(WBC)**ê°€ ë³´ì´ëŠ”ë° ê°ì—¼(UTI)ì€ ì•„ë‹ˆì•¼(ê· ì´ ì•ˆ ìë¼).\n    - Hansel stainì´ë‚˜ Wright stainìœ¼ë¡œ **í˜¸ì‚°êµ¬(Eosinophil)** ë³´ì´ë©´ 100%ë‹¤.\n    - *Reflex*: **ì•½ ëŠì–´(Stop the drug)!** ê·¸ê²Œ ì¹˜ë£Œì•¼. ìŠ¤í…Œë¡œì´ë“œëŠ” ê·¸ ë‹¤ìŒ.\n### ğŸ§  Mental Framework\n\"**AIN**ì€ ì‹ ì¥ì— ìƒê¸´ **ë‘ë“œëŸ¬ê¸°(Allergy)**ì•¼. ë²”ì¸(ì•½)ë§Œ ì¡ìœ¼ë©´ í•´ê²°ë¼.\"\n### Renal osteodystrophy\n### âš¡ EXAM REFLEX\n**\"ì¸ì€ ì•ˆ ë‚˜ê°€ê³ , ë¹„íƒ€ë¯¼ DëŠ” ì•ˆ ë§Œë“¤ì–´ì ¸. ê²°êµ­ ë¼ˆë¥¼ ë…¹ì—¬ì„œ ì¹¼ìŠ˜ì„ ë½‘ì•„ ì“´ë‹¤.\"**\n1. **[Lab: High Phosphate (PO4)]** -> **[Mechanism Start]**\n    - ì‹ ì¥ì´ ë§›ê°€ì„œ **ì¸(PO4)** ë°°ì¶œì„ ëª» í•´. ëª¸ì— ì¸ì´ ìŒ“ì—¬.\n    - ì¸ì€ ì¹¼ìŠ˜ì´ë‘ ìì„ì²˜ëŸ¼ ë¶™ì–´(**Ca-PO4 ê²°í•©**). -> í˜ˆì¤‘ **ì¹¼ìŠ˜(Free Ca)ì´ ëš ë–¨ì–´ì§**.\n2. **[Lab: Low Vit D (Calcitriol)]** -> **[Worsening Low Ca]**\n    - ì‹ ì¥ì˜ ì¤‘ìš”í•œ ì—­í• ì´ ë¹„íƒ€ë¯¼ D í™œì„±í™”(1-alpha hydroxylation)ì•¼. ì´ê±¸ ëª» í•˜ë‹ˆê¹Œ ì¥ì—ì„œ ì¹¼ìŠ˜ í¡ìˆ˜ë¥¼ ëª» í•´.\n3. **[Result: High PTH (Secondary Hyperparathyroidism)]** -> **[Bone Loss]**\n    - ì¹¼ìŠ˜ ë‚®ìœ¼ë‹ˆê¹Œ **ë¶€ê°‘ìƒì„ (Parathyroid)**ì´ ë¯¸ì³ ë‚ ë›°ì–´. \"ë¼ˆì—ì„œ ì¹¼ìŠ˜ ë¹¼ì™€!!\"\n    - ê²°ê³¼: **Osteitis Fibrosa Cystica** (ë¼ˆê°€ ë…¹ê³  êµ¬ë©ì´ ìˆ­ìˆ­ ëš«ë¦¼).\n    - *ì¹˜ë£Œ*: **Phosphate binder** (ì¸ ë¬¶ì–´ì£¼ëŠ” ì•½) ì£¼ê³  **Vit D** ë„£ì–´ì¤˜.\n### ğŸ§  Mental Framework\n\"**ì‹ ì¥ ë§ê°€ì§ -> ì¸(PO4) ìƒìŠ¹ -> ì¹¼ìŠ˜(Ca) í•˜ë½ -> PTH í­ì£¼ -> ë¼ˆ ìš©í•´.**\nì´ ì•…ìˆœí™˜ ê³ ë¦¬(Chain Reaction)ë¥¼ ìˆœì„œëŒ€ë¡œ ê·¸ë¦´ ì¤„ ì•Œì•„ì•¼ í•´.\"\n## 3. ğŸ©¸ Uremia Complications - \"The Toxins\"\n*ìš”ë…(Urea)ì´ ìŒ“ì´ë©´ ì˜¨ëª¸ì„ ê³µê²©í•´.*\n### âš¡ EXAM REFLEX\n**\"ì‹ ì¥ í™˜ìê°€ í”¼ê°€ ì•ˆ ë©ˆì¶”ê±°ë‚˜, ê°€ìŠ´ì´ ì•„í”„ë‹¤?\"**\n1. **[Sx: Bleeding (Nosebleed, Bruising)]** -> **[Lab: Normal PT/PTT, High Bleeding Time]**\n    - ì´ê²Œ í•µì‹¬ì´ì•¼! í˜ˆì•¡ì‘ê³ ì¸ì(Factor)ëŠ” ë©€ì©¡í•´ì„œ **PT/PTTëŠ” ì •ìƒ**ì´ì•¼.\n    - ìš”ë…(Uremia)ì´ **í˜ˆì†ŒíŒ(Platelet) ê¸°ëŠ¥**ì„ ë§ˆë¹„ì‹œí‚¤ëŠ” ê±°ì•¼. (Qualitative defect).\n    - *Reflex*: **Desmopressin** (vWF ë°©ì¶œ) ì“°ê±°ë‚˜ íˆ¬ì„í•´.\n2. **[Sx: Chest Pain + Friction Rub]** -> **[Think: Uremic Pericarditis]**\n    - ìš”ë…ì´ ì‹¬ì¥ë§‰(Pericardium)ì„ ê¸ì–´. ìˆ¨ ë“¤ì´ë§ˆì‹¤ ë•Œ ë” ì•„íŒŒ.\n    - ì‹¬ì „ë„(ECG)ì— **Diffuse ST elevation** ë³´ì¼ ìˆ˜ ìˆì–´.\n    - *Reflex*: ì´ê±´ **ì‘ê¸‰ íˆ¬ì„(Dialysis)** ì ì‘ì¦ì´ì•¼. ì•½ìœ¼ë¡œ ì•ˆ ë¼.\n### 4. CKD Complications (ë§Œì„± í•©ë³‘ì¦)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì‹ ì¥ì´ ë§ê°€ì§€ë©´ ì¸(PO4)ì„ ëª» ë²„ë ¤ì„œ ë¼ˆê°€ ë…¹ê³ , ìš”ë…ì´ ìŒ“ì—¬ì„œ í”¼ê°€ ì•ˆ ë©ˆì¶˜ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Renal Osteodystrophy**: ì¸ ìƒìŠ¹ -> Ca í•˜ë½ -> **PTH í­ì£¼** -> ë¼ˆ í¡ìˆ˜. (Tx: Phosphate Binder).\n    - **Uremic Bleeding**: í˜ˆì†ŒíŒ **ê¸°ëŠ¥** ì¥ì•  (ìˆ˜ì¹˜ëŠ” ì •ìƒ). **Bleeding Time**ë§Œ ì—°ì¥. (Tx: Desmopressin).\n    - **Calciphylaxis**: í”¼ë¶€ ê´´ì‚¬(Necrosis) + í†µì¦\n### 5. Dialysis (íˆ¬ì„ ì ì‘ì¦)","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-41"}
{"chunk_type":"transcript_chunk","text":"- ğŸ—£ï¸ **Golden Voice**: **\"ì•½ìœ¼ë¡œ ì•ˆ ë˜ë©´ ê¸°ê³„ ëŒë ¤. 'AEIOU' ìƒí™©ì´ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **A**cidosis, **E**lectrolytes (Hyper-K), **I**ntoxication, **O**verload (Lung edema), **U**remia (Pericarditis).\n---\n## ğŸ¯ Part 4. Glomerular (ì‚¬êµ¬ì²´ì‹ ì—¼) - \"í”¼ vs ë‹¨ë°±ì§ˆ\"\n### 1. Nephritic Syndrome (Blood - Inflammation)\n- ğŸ—£ï¸ **Golden Voice**: **\"RBC Casts ë³´ì´ë©´ 'ì—¼ì¦'ì´ ë‚˜ì„œ í•„í„°ê°€ ì°¢ì–´ì§„ ê±°ë‹¤.\"**\n### âš¡ EXAM REFLEX: The \"Blood\" Trigger\n**\"í˜ˆë‡¨(Hematuria) + ê³ í˜ˆì••(HTN) + ë¶“ê¸°(Edema) + RBC Casts = Nephritic\"**\n1. **[Hx: Sore Throat -> Hematuria]** -> **[Check: Timing (Latent Period)]**\n    - **1~3ì¼ ë’¤ (Synpharyngitic)**: ê°ê¸° ê±¸ë¦¬ìë§ˆì í”¼ì˜¤ì¤Œ? -> **IgA Nephropathy**.\n        - C3 ìˆ˜ì¹˜ ì •ìƒ. ë°˜ë³µì ìœ¼ë¡œ ì¬ë°œí•¨.\n    - **2~3ì£¼ ë’¤ (Post-infectious)**: ê°ê¸° ë‹¤ ë‚«ê³  ë‚˜ì„œ í”¼ì˜¤ì¤Œ? -> **PSGN**.\n        - **C3 ê°ì†Œ(Low)**. ì–¼êµ´(Periorbital) ë¶“ê¸°.\n        - *Biopsy*: **\"Subepithelial Humps\"** (ë‚™íƒ€ ë“±ì²˜ëŸ¼ íŠ€ì–´ë‚˜ì˜´).\n2. **[Sx: Hemoptysis (Coughing Blood) + Hematuria]** -> **[Think: Lung + Kidney]**\n    - **Linear IF (Anti-GBM)** -> **Goodpasture Syndrome**. (ì Šì€ ë‚¨ì, íì¶œí˜ˆ).\n    - **Sinusitis + c-ANCA** -> **Wegener (GPA)**. (ì½§ë¬¼ ì¤„ì¤„ + ì½”í”¼ + ì‹ ì¥).\n3. **[Sx: Can't Hear / Can't See + Hematuria]** -> **[Think: Alport Syndrome]**\n    - **\"Can't see, can't pee, can't hear a bee.\"**\n    - Type IV Collagen ìœ ì „ì ëŒì—°ë³€ì´. (ê°€ì¡±ë ¥ ì¤‘ìš”).\n    - *Biopsy*: **\"Basket-weave\"** appearance (GBMì´ ìª¼ê°œì§).\n### ğŸ§  Mental Framework\n\"ê°ê¸° ê±¸ë¦¬ê³  **'ë°”ë¡œ'**ë©´ IgA, **'í•œì°¸ ë’¤'**ë©´ PSGN. **'í'**ê¹Œì§€ í”¼ í† í•˜ë©´ Goodpasture ì•„ë‹ˆë©´ Wegener.\"\n### 2. RPGN (Rapidly Progressive) - Pulmonary-Renal\n- ğŸ—£ï¸ **Golden Voice**: **\"íì—ì„œ í”¼ í† í•˜ê³  ì½©íŒ¥ë„ ë§ê°€ì§€ë©´ 'Goodpasture' ì•„ë‹ˆë©´ 'Wegener'ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Goodpasture**: **Anti-GBM í•­ì²´** (Linear IF). ì Šì€ ë‚¨ì.\n    - **Wegener (GPA)**: **c-ANCA** + **ì¶•ë†ì¦/ì½§ë¬¼(Sinusitis)**.\n    - **Alport Syndrome**: **ëˆˆ(Eye) + ê·€(Ear)** + ì½©íŒ¥. (Basket-weave GBM).\n### 3. Nephrotic Syndrome (Protein - Leakage)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì„±ì¸ì´ ë¶“ê³  ë‹¨ë°±ë‡¨ ë‚˜ì˜¤ë©´ 'ê¸°ì €ì§ˆí™˜', ì• ë“¤ì€ ë¬´ì¡°ê±´ 'MCD'ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **íŠ¹ì§•**: ë‹¨ë°±ë‡¨ > 3.5g, ë¶€ì¢…, **Fatty Casts**, Hyperlipidemia.\n- âš”ï¸ **VS ë†€ì´ [ì›ì¸ë³„ ë¶„ë¥˜]**\n1. **[Pt: Child (2-6yo) + Sudden Edema]** -> **[Think: Minimal Change Disease (MCD)]**\n    - í˜„ë¯¸ê²½(LM)ìœ¼ë¡œ ë³´ë©´ ë©€ì©¡í•´(Minimal). ì „ìí˜„ë¯¸ê²½(EM)ìœ¼ë¡œ ë´ì•¼ **Foot process effacement(ë°œ ëŒê¸° ì†Œì‹¤)** ë³´ì„.\n    - *Reflex*: ìƒê²€(Biopsy) í•˜ì§€ ë§ˆ! ê·¸ëƒ¥ ë°”ë¡œ **ìŠ¤í…Œë¡œì´ë“œ(Steroids)** ë•Œë ¤ë°•ìœ¼ë©´ ì”»ì€ ë“¯ì´ ë‚«ëŠ”ë‹¤.\n2. **[Pt: í‘ì¸ Adult + HIV / Heroin / Sickle Cell]** -> **[Think: FSGS]**\n    - ê°€ì¥ í”í•œ ì–´ë¥¸ ì‹ ì¦í›„êµ° ì¤‘ í•˜ë‚˜. í‘ì¸(African American)í•œí…Œ ë§ìŒ.\n    - ìŠ¤í…Œë¡œì´ë“œ? **ì•ˆ ë“¤ì–´.** (Steroid-resistant). ì˜ˆí›„ê°€ ë”ëŸ¬ì›Œ.\n3. **[Pt: Adult + ì•” Hepatitis B/C or SLE or Drugs + í˜ˆì „ìˆìŒ ]** -> **[Think: Membranous Nephropathy]**\n    - ë‘êº¼ì›Œì§„ ê¸°ì €ë§‰ (Thickened GBM).\n    - *Biopsy*: **\"Spike and Dome\"** pattern (ê°€ì‹œì²˜ëŸ¼ ë‹ì•„ë‚¨).\n    - *Risk*: **Renal Vein Thrombosis** (Antithrombin IIIê°€ ì˜¤ì¤Œìœ¼ë¡œ ë¹ ì ¸ì„œ í”¼ê°€ ëˆì í•´ì§). ì˜†êµ¬ë¦¬ ì•„í”„ë‹¤ í•˜ë©´ ì´ê±° ì˜ì‹¬í•´!\n4. **[Pt: Chronic Disease (RA, TB) + Nephrotic]** -> **[Think: Amyloidosis]**\n    - *Biopsy*: **Congo Red Stain** -> **\"Apple-green Birefringence\"** (ì‚¬ê³¼ìƒ‰ í˜•ê´‘). ì´ê±° ë‚˜ì˜¤ë©´ ê²Œì„ ë.\n5. **[Pt: Long-standing Diabetes]** -> **[Think: Diabetic Nephropathy]**\n    - ê°€ì¥ í”í•œ ì›ì¸.\n    - *Biopsy*: **Kimmelstiel-Wilson nodules** (ë™ê¸€ë™ê¸€í•œ ê²°ì ˆ).\n    - *Tx*: ë‹¨ë°±ë‡¨ ë³´ì´ë©´ ë¬´ì¡°ê±´ **ACE inhibitor / ARB** ì¨ì„œ ì§„í–‰ ë§‰ì•„!\n### ğŸ§  Mental Framework\n\"**ì• ë“¤(Child)**ì€ ë¬´ì¡°ê±´ **MCD** (ìŠ¤í…Œë¡œì´ë“œ ì¤˜).\n**ì–´ë¥¸(Adult)**ì€ ì›ì¸ì„ ë´. **ê°ì—¼/ì•½ë¬¼/ìƒ‰ì „ìˆ**ì´ë©´ **Membranous**, í‘ì¸/**HIV/ë§ˆì•½**ì´ë©´ **FSGS**.\n**ë‹¹ë‡¨** í™˜ìëŠ” **ACEi**ê°€ ìƒëª…ì¤„ì´ë‹¤.\"\n---\n## ğŸ¯ Part 5. Structural & Urology (êµ¬ì¡°) - \"ëª¨ì–‘ & ë‚˜ì´\"\n### 1. Kidney Stones (ê²°ì„)\n- ğŸ—£ï¸ **Golden Voice**: **\"ëŒì€ 'ëª¨ì–‘'ìœ¼ë¡œ í‘¼ë‹¤. ë´‰íˆ¬ëŠ” ì¹¼ìŠ˜, ê´€ ëšœê»‘ì€ ê°ì—¼ì´ë‹¤.\"**\n- âš¡ **Exam Reflex**:","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-61"}
{"chunk_type":"transcript_chunk","text":"**\"X-rayì— ë³´ì´ëƒ ì•ˆ ë³´ì´ëƒ? í˜„ë¯¸ê²½ ëª¨ì–‘ì´ ë­ëƒ?\"**\n1. **[Microscopy: Envelope / Dumbbell Shape]** -> **[Think: Calcium Oxalate]**\n    - ê°€ì¥ í”í•´(80%). X-rayì— í•˜ì–—ê²Œ ì˜ ë³´ì—¬(Radio-opaque).\n    - *ì›ì¸*: **Ethylene Glycol** (ë¶€ë™ì•¡) ë§ˆì…¨ì„ ë•Œë‚˜ **Vit C** ê³¼ë‹¤ ë³µìš©.\n    - *ì¹˜ë£Œ*: **Thiazide Diuretics** (ì¹¼ìŠ˜ ì¬í¡ìˆ˜ ì‹œì¼œì„œ ì†Œë³€ ë‚´ ì¹¼ìŠ˜ ì¤„ì„).\n    - *í•¨ì •*: **Low Calcium Diet í•˜ì§€ ë§ˆ!** (ì˜¤íˆë ¤ ì¥ì—ì„œ Oxalate í¡ìˆ˜ ëŠ˜ì–´ì„œ ëŒ ë” ìƒê¹€).\n2. **[Microscopy: Coffin Lid (ê´€ ëšœê»‘) / Staghorn Calculus]** -> **[Think: Struvite]**\n    - ì›ì¸ì€ **Urease (+) Bugs**: **Proteus**, Saprophyticus, Klebsiella.\n    - ì†Œë³€ì„ **ì•Œì¹¼ë¦¬ì„±(Alkaline)**ìœ¼ë¡œ ë§Œë“¤ì–´ì„œ ìƒê²¨. í•­ìƒì œë§Œìœ¼ë¡  ì•ˆ ë¼, ìˆ˜ìˆ ë¡œ ê¸ì–´ë‚´ì•¼ í•´.\n3. **[X-ray: Invisible (Radio-lucent)]** -> **[Think: Uric Acid]**\n    - **CTì—ëŠ” ë³´ì´ëŠ”ë° X-rayì—” ì•ˆ ë³´ì—¬.**\n    - ëª¨ì–‘ì€ **Rhomboid (ë§ˆë¦„ëª¨)**.\n    - *ì¹˜ë£Œ*: ì†Œë³€ì„ **ì•Œì¹¼ë¦¬í™”(Alkalinization)** ì‹œì¼œë¼ (Potassium Citrate). Allopurinolë„ ì”€.\n4. **[Microscopy: Hexagonal (ìœ¡ê°í˜•)]** -> **[Think: Cystine]**\n    - ì–´ë¦°ì• (Child)ê°€ ëŒ ìƒê²¼ë‹¤? ì´ê±° ì˜ì‹¬í•´. ìœ ì „ë³‘ì´ì•¼.\n    - *ì§„ë‹¨*: **Cyanide-nitroprusside test (+)**.\n### ğŸ§  Mental Framework\n\"**ë´‰íˆ¬(Envelope)**ëŠ” ì¹¼ìŠ˜, **ê´€ ëšœê»‘(Coffin)**ì€ ê· (Proteus), **íˆ¬ëª…ì¸ê°„(Invisible)**ì€ ìš”ì‚°(Uric Acid), **ìœ¡ê°í˜•(Hexagon)**ì€ ì• ë“¤(Cystine).\"\n### 2. Cancer (ì¢…ì–‘)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë…¸ì¸ í¡ì—°ìì˜ í†µì¦ ì—†ëŠ” í˜ˆë‡¨ëŠ” ë¬´ì¡°ê±´ 'ì•”'ì´ë‹¤.\"**\n### âš¡ EXAM REFLEX\n**\"ì–´ë¥¸ì´ëƒ ì• ëƒ? ì•„í”„ëƒ ì•ˆ ì•„í”„ëƒ?\"**\n1. **[Pt: Smoker + Painless Hematuria]** -> **[Think: Bladder Cancer / RCC]**\n    - ì•„í”„ì§€ ì•Šì€ë° í”¼ê°€ ë‚˜ì˜¨ë‹¤? ëŠ™ì€ ë‚¨ì í¡ì—°ìë©´ ë¬´ì¡°ê±´ **ë°©ê´‘ì•”(Urothelial Ca)** ì˜ì‹¬.\n    - *íŠ¹ì´ ì¼€ì´ìŠ¤*: ì´ì§‘íŠ¸ ì—¬í–‰ ê°”ì—ˆë‹¤? -> **Schistosoma** (Squamous Cell Ca).\n2. **[Lab: Polycythemia (High Hct) + Flank Mass]** -> **[Think: RCC]**\n    - ì‹ ì¥ì•” ì„¸í¬ê°€ **EPO**ë¥¼ ë¿œì–´ë‚´ì„œ ì í˜ˆêµ¬ê°€ ë§ì•„ì ¸. (Paraneoplastic).\n    - **VHL gene** (Chromosome 3) ê²°ì†ì´ë‘ ì—°ê´€ë¨. (Clear Cell type).\n    - *ì „ì´*: í(Lung)ë‚˜ ë¼ˆ(Bone)ë¡œ ì˜ ê°. (**Cannonball lesions**).\n3. **[Pt: Child (2-4yo) + Unilateral Flank Mass]** -> **[Think: Wilms Tumor]**\n    - ì—„ë§ˆê°€ ëª©ìš•ì‹œí‚¤ë‹¤ ë°°ì—ì„œ ë©ì–´ë¦¬ ë§Œì ¸ì ¸ì„œ ì˜´.\n    - **ì¤‘ì•™ì„ (Midline)ì„ ì•ˆ ë„˜ì–´ê°!** (ë„˜ì–´ê°€ë©´ Neuroblastoma).\n    - **WAGR complex**: **W**ilms, **A**niridia(í™ì±„ ì—†ìŒ), **G**enitourinary malformation, **R**etardation.\n### ğŸ§  Mental Framework\n\"**í¡ì—°ì í˜ˆë‡¨**ëŠ” ì•”ì´ë‹¤. **RCC**ëŠ” í˜¸ë¥´ëª¬(EPO, PTHrP) ê³µì¥ì´ê³ , **Wilms**ëŠ” ì„ ì„ ì•ˆ ë„˜ëŠ” ì°©í•œ(?) ë©ì–´ë¦¬.\"\n### 3. Cystic Disease (ë¬¼í˜¹)\n- ğŸ—£ï¸ **Golden Voice**: **\"ADPKDëŠ” ì‹ ì¥ë³´ë‹¤ 'ë¨¸ë¦¬(ë‡Œì¶œí˜ˆ)'ê°€ í„°ì ¸ì„œ ì£½ëŠ”ë‹¤.\"**\n**\"ìœ ì „ ë°©ì‹(Dominant vs Recessive)ì´ ë‚˜ì´ì™€ ì˜ˆí›„ë¥¼ ê²°ì •í•´.\"**\n1. **[Pt: Young Adult + HTN + Family Hx]** -> **[Think: ADPKD]**\n    - **A**utosomal **D**ominant = **A**dult. (ì„±ì¸).\n    - ì‹ ì¥ë§Œ ë³´ì§€ ë§ˆ! **ë‡Œë™ë§¥ë¥˜(Berry Aneurysm)** í„°ì ¸ì„œ ì£½ê±°ë‚˜, **ìŠ¹ëª¨íŒ íƒˆì¶œì¦(MVP)** ì˜¨ë‹¤.\n    - *ì¦ìƒ*: ì˜†êµ¬ë¦¬ í†µì¦, í˜ˆë‡¨, ê³ í˜ˆì••.\n2. **[Pt: Newborn + Oligohydramnios (ì–‘ìˆ˜ë¶€ì¡±)]** -> **[Think: ARPKD]**\n    - **A**utosomal **R**ecessive = **P**ediatric. (ì†Œì•„).\n    - ì–‘ìˆ˜ê°€ ë¶€ì¡±í•´ì„œ íê°€ ëª» ìë¼(**Pulmonary Hypoplasia**) -> ìˆ¨ ëª» ì‰¬ì–´ì„œ ì£½ì–´ (**Potter Sequence**).\n    - ê°„(Liver)ë„ êµ³ì–´ (**Hepatic Fibrosis** -> Portal HTN).\n###\n### ğŸ§  Mental Framework\n\"**Dominant(ìš°ì„±)**ëŠ” ì–´ë¥¸, ë‡Œì¶œí˜ˆ ì¡°ì‹¬. **Recessive(ì—´ì„±)**ëŠ” ì• ê¸°, íë‘ ê°„ì´ ë¬¸ì œ.\"\n### 4. UTI (ìš”ë¡œê°ì—¼)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë°©ê´‘ì—¼ì€ ì—´ ì•ˆ ë‚œë‹¤. ì—´ë‚˜ê³  ì˜†êµ¬ë¦¬ ì•„í”„ë©´ 'ì‹ ìš°ì‹ ì—¼'ì´ë‹¤.\"**","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-81"}
{"chunk_type":"transcript_chunk","text":"### âš¡ EXAM REFLEX\n**\"ì—´ì´ ë‚˜ëƒ(Fever)? ì–¸ì œ ì˜¤ì¤Œì´ ìƒˆëƒ(Leak)?\"**\n1. **[Sx: Dysuria + Suprapubic Pain (No Fever)]** -> **[Think: Cystitis]**\n    - ë°©ê´‘ì—¼. ê· ì€ ëŒ€ì¥ê· (**E. coli**)ì´ 1ë“±. ì Šì€ ì—¬ìëŠ” **Staph. saprophyticus**ë„ ê°€ëŠ¥.\n2. **[Sx: Fever + Flank Pain + WBC Casts]** -> **[Think: Pyelonephritis]**\n    - ì‹ ìš°ì‹ ì—¼. ì˜†êµ¬ë¦¬ ì¹˜ë©´ ìì§€ëŸ¬ì§ (**CVA Tenderness**).\n    - **WBC Casts** ë‚˜ì˜¤ë©´ ë¬´ì¡°ê±´ ì‹ ì¥ê¹Œì§€ ê· ì´ ì˜¬ë¼ê°„ ê±°ì•¼.\n3. **[Sx: Leak when sneezing/laughing]** -> **[Think: Stress Incontinence]**\n    - ì•  ë§ì´ ë‚³ì€ ì•„ì¤Œë§ˆ. ìš”ë„ ê´„ì•½ê·¼ì´ ì•½í•´ì§.\n    - *ì¹˜ë£Œ*: **Kegel Exercise**.\n4. **[Sx: Sudden strong urge -> Leak]** -> **[Think: Urge Incontinence]**\n    - ê³¼ë¯¼ì„± ë°©ê´‘(Overactive Bladder). ë°©ê´‘ ê·¼ìœ¡ì´ ì§€ ë©‹ëŒ€ë¡œ ìˆ˜ì¶•í•´.\n    - *ì¹˜ë£Œ*: **Anticholinergics** (Oxybutynin) - ë°©ê´‘ ì§„ì •ì‹œì¼œ.\n5. **[Sx: Constant dribbling + Incomplete emptying]** -> **[Think: Overflow Incontinence]**\n    - ê¸¸ì´ ë§‰í˜€ì„œ(BPH) ë„˜ì³íë¥´ëŠ” ê±°ì•¼. ë°©ê´‘ì´ ê½‰ ì°¨ ìˆì–´.\n    - *ì¹˜ë£Œ*: ë§‰íŒ ê±° ëš«ì–´ (**Alpha-blocker**, Foley catheter).\n### ğŸ§  Mental Framework\n\"ì›ƒì„ ë•Œ ìƒˆë©´ **Stress** (ìš´ë™í•´), ëª» ì°¸ê² ìœ¼ë©´ **Urge** (ì•½ ë¨¹ì–´), ì§ˆì§ˆ ìƒˆë©´ **Overflow** (ëš«ì–´).\"","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-101"}
{"chunk_type":"transcript_chunk","text":"# Psy\n![image.png](Psy/image.png)\n- **Mummy (Anticholinergic):**Â Dryí•¨ì„ ê°•ì¡°.\n- **Wet T-shirt (Cocaine):**Â ë•€ë‚˜ê³  í¥ë¶„ ìƒíƒœ.\n- **Slime (Cholinergic):**Â ëª¨ë“  ë¶„ë¹„ë¬¼ì´ ì½¸ì½¸(Leaking).\n- **Kicking leg (SS):**Â Clonus(ë°˜ì‚¬ í•­ì§„) ì‹œê°í™”.\n- **Metal Statue (NMS):**Â Lead-pipe rigidity(ê°•ì§) ì‹œê°í™”.\n![image.png](Psy/image%201.png)\n| **ì§ˆí™˜ (Syndrome)** | **ì›ì¸ (Trigger)** | **ë™ê³µ (Pupil)** | **í”¼ë¶€/ë•€ (Skin)** | **ì¥ìŒ (Bowel)** | **ê·¼ìœ¡/ë°˜ì‚¬ (Muscle) ğŸ”¥** | **í•µì‹¬ ì•”ê¸°ë²• (Mnemonic)** |\n| --- | --- | --- | --- | --- | --- | --- |\n| **SS**Â (Serotonin) | SSRI, Tramadol | **í™•ëŒ€ (Big)** | **Wet** | ì¦ê°€ (ì„¤ì‚¬) | **Clonus (íˆ­ ì¹˜ë©´ íŠ€ì–´ì˜¤ë¦„)** | **S**ky-high Reflex / ìŠ¥ìŠ¥(ë•€, ë°œ) |\n| **NMS**Â (Neuroleptic) | Antipsychotics | **ì •ìƒ (Normal)** | Wet (ê°€ë” Dry) | ì •ìƒ/ê°ì†Œ | **Rigid (ë‚© íŒŒì´í”„ ê°•ì§)** | **N**oÂ **M**ovement /Â **N**o **M**ydriasis |\n| **MH**Â (Malignant Hyper) | ë§ˆì·¨ì œ (Succinyl) | ì •ìƒ (Normal) | Wet | ê°ì†Œ | **Rigid (í„±ë¶€í„° êµ³ìŒ)** | ìˆ˜ìˆ ë°©ì—ì„œ ë¶ˆë‚¬ë‹¤ |\n| **DT**Â (Delirium T) | Alcohol ëŠìŒ | **í™•ëŒ€ (Big)** | **Wet** | ì¦ê°€ | **Tremor (ì „ì‹  ë–¨ë¦¼)** | **D**olÂ **D**ol (ëœëœ) / D(dual)T(tri) = 2-3ì¼ / D for ëœëœ T for tachycardia |\n| **Sympathomimetic** | Cocaine, Meth | **í™•ëŒ€ (Big)** | **Wet. êµê°ì‹ ê²½ì´ì–´ë„ ì‹¬ì¥ì´ ê³¼ë¶€í™”ë˜ì–´ ë°œì—´, ì—´ì‹íˆë ¤ê³  ë•€ë‚¨.** | ì¦ê°€ | ê¸´ì¥ë¨ (Not Rigid) | **C**razyÂ **W**et (ë¯¸ì¹œ ë“¯ì´ ì –ìŒ) |\n| **Anticholinergic** | Atropine | **í™•ëŒ€ (Big)** | **DRY (í•µì‹¬!)** | **ê°ì†Œ (ë³€ë¹„)** | ì •ìƒ/Clonus ë“œë¬¾ | **ì‚¬ë§‰**ì˜ í† ë¼ (ë¹¨ê°›ê³  ë§ˆë¥´ê³  ëˆˆ í¼)\na-DRY-pine. Antiì½¸ì½¸ |\n| **Cholinergic** | ë†ì•½, Nerve gas | **ì¶•ì†Œ (Pinpoint)** | **WET (í™ìˆ˜)** | **ì¦ê°€ (ì„¤ì‚¬)** | ìœ„ì•½ê°, Fasciculation | **ì½¸ì½¸**Â (ìœ„ì•„ë˜ë¡œ ë‹¤ ìƒ˜) |\n### 1. Serotonin Syndrome (SS)\n- **One-Line Vibe:**Â **\"ì –ì€ ì±„ë¡œ í„ì© ë›°ëŠ” ì‚¬ë§‰ ì•„ì €ì”¨\"**Â (ê³ ì—´ + ë•€ + ê·¼ìœ¡ íŠ)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"S\"**haking, **\"S\"**weating, **\"S\"**ky-high reflex\n    - **ìŠ¥ìŠ¥:**Â ë•€ ë‹¦ëŠë¼Â **ìŠ¥ìŠ¥**, ë°œëª© ì¹˜ë©´Â **ìŠ¥ìŠ¥**Â íŠ€ì–´ ì˜¤ë¦„ (**Clonus**).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**.\n![image.png](Psy/image%202.png)\n### 2. Neuroleptic Malignant Syndrome (NMS)\n- **One-Line Vibe:**Â **\"ë¶ˆíƒ€ëŠ” ë‚© ë™ìƒ\"**Â (ê³ ì—´ + ë•€ + ê¼¼ì§ë„ ì•ˆ í•¨)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"N\"**o **\"M\"**otion **\"S\"**yndrome\n    - **No Motion:**Â ê·¼ìœ¡ì´ ë‚© íŒŒì´í”„ì²˜ëŸ¼ êµ³ìŒ (**Lead-pipe Rigidity**).\n    - **Normal Pupil:**Â ë™ê³µì€ ë³´í†µÂ **ì •ìƒ**Â (SSì™€ ê²°ì •ì  ì°¨ì´!).\n### 3. Delirium Tremens (DT)\n- **One-Line Vibe:**Â **\"ìˆ  ëŠê³  ì°¾ì•„ì˜¨ í­í’\"**Â (ë¯¸ì¹œ ë“¯í•œ ë–¨ë¦¼ + ììœ¨ì‹ ê²½ í­ì£¼)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"D\"**ual - **\"T\"**ri (2-3) &Â **\"ëœëœ\"**\n    - **Dual-Tri:**Â **2~3ì¼(48~72h)**Â í›„ í”¼í¬ íƒ€ì„.\n    - **ëœëœ:**Â ì˜¨ëª¸ì„Â **ëœëœ**Â ë–ª (**Tremor**).\n    - **T:**Â **T**achycardia &Â **T**emperature (ì‹¬ì¥ ë›°ê³  ì—´ ë‚¨).\n### 4. Anticholinergic (Atropine)\n- **One-Line Vibe:**Â **\"ì‚¬ë§‰ì— ê³ ë¦½ëœ ë¯¸ì¹œ í† ë¼\"**Â (ë°”ì§ ë§ˆë¦„ + ë¹¨ê°œì§ + ëˆˆ í¼)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"A-Dry-Pine\"**Â &Â **\"Anti-Cola\"**\n    - **A-Dry-Pine:**Â ì•„íŠ¸ë¡œí•€ì€Â **Dry**í•˜ë‹¤ (ê²¨ë“œë‘ì´ ë½€ì†¡ë½€ì†¡ =Â **í•µì‹¬ ê°ë³„ì **).\n    - **Anti-Cola:**Â ì•ˆí‹°-ì½œë¼ë¼Â **ëª©ë§ë¼**Â (ì¹¨ë„ ì•ˆ ë‚˜ì˜´).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**Â & ì™•ëˆˆì´ í† ë¼.\n![image.png](Psy/image%203.png)\n### 5. Cholinergic (Organophosphate/ë†ì•½)\n- **One-Line Vibe:**Â **\"ìˆ˜ë„ê¼­ì§€ ê³ ì¥ ë‚œ ë¬¼í’ì„ \"**Â (ìœ„ì•„ë˜ë¡œ ë‹¤ ìƒœìŒ)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"Chol\"**inergic = **\"ì½¸\"**ë¦¬ë„ˆì§\n    - **ì½¸ì½¸:**Â ëˆˆë¬¼, ì¹¨, ë•€, ì„¤ì‚¬, ì†Œë³€ ë‹¤ ì½¸ì½¸ (**Wet í™ìˆ˜**).\n    - **Pupil:**Â **ì¶•ì†Œ (Pinpoint)**Â (ìˆ˜ì•• ë•Œë¬¸ì— ìª¼ê·¸ë¼ë“¦).\n### 6. Sympathomimetic (Cocaine)\n- **One-Line Vibe:**Â **\"ëƒ‰ê°ìˆ˜ í„°ì§„ ìŠ¤í¬ì¸ ì¹´\"**Â (í’€ ì—‘ì…€ + ë•€ë²”ë²…)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"C\"**razy **\"W\"**et\n    - **Wet:**Â êµê°ì‹ ê²½ í•­ì§„ì¸ë°Â **ë•€ì´ ë‚¨**Â (Anticholinergicê³¼ ë°˜ëŒ€!).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**.\n![image.png](Psy/image%204.png)","subject":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","page_title":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","episode":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","section_path":["Psy 2ea46f2986ee807ab05efc7d2a0edd28"],"source_doc_id":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","source_page":null,"source_anchor":"Psy 2ea46f2986ee807ab05efc7d2a0edd28-1"}
{"chunk_type":"transcript_chunk","text":"![image.png](Psy/image%205.png)\n![image.png](Psy/image%206.png)\n---\n![image.png](Psy/image%207.png)\nì¹˜ë£Œ: NahCo3\n![image.png](Psy/image%208.png)\n![image.png](Psy/image%209.png)\n![image.png](Psy/image%2010.png)\n![image.png](Psy/image%2011.png)\n![image.png](Psy/image%2012.png)\n![image.png](Psy/image%2013.png)\n![image.png](Psy/image%2014.png)\n![image.png](Psy/image%2015.png)\nì•”ê¸°ë²• 2: \"G-P\" (ë‹¤ë¦¬ë¥¼ ê³ ì •í•˜ëŠ” í•€)\në‹¤ë¦¬ê°€ ì œë©‹ëŒ€ë¡œ ì›€ì§ì´ë ¤ê³  í•  ë•Œ, ë°”ë‹¥ì— ê³ ì •í•´ë²„ë¦¬ëŠ” ì´ë¯¸ì§€ë¥¼ ë– ì˜¬ë ¤ë´.\nStory: ëœëœê±°ë¦¬ê³  ì›€ì§ì´ëŠ” ë‹¤ë¦¬ë¥¼ Ground(ë°”ë‹¥)ì— Pin(í•€)ìœ¼ë¡œ ê½‚ì•„ì„œ ê³ ì •í•´ë²„ë¦¬ì.\nMnemonic: G-P (Ground-Pin)\nG: Gabapentin\nP: Pregabalin\nì—°ê²°: ì›€ì§ì´ëŠ” ë‹¤ë¦¬ë¥¼ ê³ ì •(Pin)í•˜ëŠ” G-P ì½¤ë¹„!","subject":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","page_title":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","episode":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","section_path":["Psy 2ea46f2986ee807ab05efc7d2a0edd28"],"source_doc_id":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","source_page":null,"source_anchor":"Psy 2ea46f2986ee807ab05efc7d2a0edd28-21"}
{"chunk_type":"transcript_chunk","text":"# Psy and number\nUSMLE Step 2 ì¤€ë¹„ ê³¼ì •ì—ì„œ ì •ì‹ ê³¼ ì§ˆí™˜ì˜ ì§„ë‹¨ ê¸°ì¤€, íŠ¹íˆ 'ìˆ«ì(ê¸°ê°„, ë‚˜ì´, ë¹ˆë„)'ê°€ í—·ê°ˆë¦¬ëŠ” ê²ƒì€ ë§¤ìš° í”í•œ ì¼ì…ë‹ˆë‹¤. ì •ì‹ ê³¼ ì§„ë‹¨ì€ ì¦ìƒì˜ **ì§€ì† ê¸°ê°„(Duration)**ê³¼ **ë°œë³‘ ì—°ë ¹(Onset Age)**ì´ ë‹¤ë¥¸ ì§ˆí™˜ê³¼ì˜ ê°ë³„ í¬ì¸íŠ¸(Differential Diagnosis)ê°€ ë˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤.\nì œê³µí•´ì£¼ì‹  ìë£Œë¥¼ ë°”íƒ•ìœ¼ë¡œ, ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” í—·ê°ˆë¦¬ëŠ” ì§ˆí™˜ë“¤ì„ 'ìˆ«ì'ë¥¼ ì¤‘ì‹¬ìœ¼ë¡œ ì¬êµ¬ì„±í•˜ì—¬ ì •ë¦¬í•´ ë“œë¦½ë‹ˆë‹¤.\n1. íƒ€ì„ë¼ì¸ psychotic :1, 6\n2. stress: 1ê¸°ì¤€ìœ¼ë¡œ ë°”ë€œ\n3. anxiety: 6ê°œì›”ì´ìƒ\n4. ê¸°ë¶„ì¥ì•  2ì˜ ë²•ì¹™. ë§Œì„± 2ë…„ì´ìƒ\n---\n### **1. Psychotic Disorders (ì •ì‹ ë³‘ì  ì¥ì• ): \"ê¸°ê°„\"ì´ ì§„ë‹¨ëª…ì´ë‹¤**\nì´ íŒŒíŠ¸ì˜ í•µì‹¬ì€ ì¦ìƒ(ë§ìƒ, í™˜ê° ë“±)ì€ ê°™ì§€ë§Œ, **ì¦ìƒì´ ì–¼ë§ˆë‚˜ ì§€ì†ë˜ì—ˆëŠ”ê°€**ì— ë”°ë¼ ì§„ë‹¨ëª…ì´ ë°”ë€ë‹¤ëŠ” ì ì…ë‹ˆë‹¤.\n- **General Rule:** ì¦ìƒì´ 1ê°œì›” ë¯¸ë§Œì´ë©´ Brief, 6ê°œì›” ë„˜ìœ¼ë©´ Schizophrenia, ê·¸ ì‚¬ì´ë©´ Schizophreniformì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Brief Psychotic Disorder** | **1ì¼ ì´ìƒ ~ 1ê°œì›” ë¯¸ë§Œ** | ê¸‰ê²©í•œ ë°œë³‘, ê¸°ëŠ¥ì˜ ì™„ì „í•œ íšŒë³µ. |\n| **Schizophreniform Disorder** | **1ê°œì›” ì´ìƒ ~ 6ê°œì›” ë¯¸ë§Œ** | Schizophreniaì™€ ì¦ìƒì€ ê°™ìœ¼ë‚˜, ì‚¬íšŒì /ì§ì—…ì  ê¸°ëŠ¥ ì €í•˜ëŠ” í•„ìˆ˜ ì•„ë‹˜. |\n| **Schizophrenia** | **6ê°œì›” ì´ìƒ** | í™œì„±ê¸° ì¦ìƒ(Active symptoms) 1ê°œì›” ì´ìƒ í¬í•¨, ê¸°ëŠ¥ ì €í•˜ í•„ìˆ˜. |\n| **Delusional Disorder** | **1ê°œì›” ì´ìƒ** | ê¸°ì´í•˜ì§€ ì•Šì€ í–‰ë™, ë§ìƒ ì™¸ì—ëŠ” ê¸°ëŠ¥ì´ ì •ìƒì ì„. |\n| **Schizoaffective Disorder** | **2ì£¼ (2 weeks)** | í‰ìƒ ë™ì•ˆ ê¸°ë¶„ ì‚½í™”(Mood episode) **ì—†ì´** ë§ìƒì´ë‚˜ í™˜ê°ë§Œ ìˆëŠ” ê¸°ê°„ì´ **2ì£¼ ì´ìƒ** ìˆì–´ì•¼ í•¨ (ê¸°ë¶„ ì¥ì• ì™€ ê°ë³„í•˜ëŠ” í•µì‹¬ í¬ì¸íŠ¸). |\n---\n### **2. Mood Disorders (ê¸°ë¶„ ì¥ì• ): \"ê¸‰ì„± vs ë§Œì„±\" 2**\nê¸°ë¶„ ì¥ì• ëŠ” **ì‚½í™”(Episode)ì˜ ì§€ì† ê¸°ê°„**ê³¼ **ë§Œì„±ë„(Chronicity)**ê°€ ìˆ«ìì˜ í•µì‹¬ì…ë‹ˆë‹¤.\n- **General Rule:** ManiaëŠ” ì‘ê¸‰ ìƒí™©(ì…ì› ë˜ëŠ” 1ì£¼), HypomaniaëŠ” 4ì¼, ìš°ìš¸ì¦ì€ 2ì£¼ì…ë‹ˆë‹¤. ë§Œì„±(Chronic)ì´ ë¶™ìœ¼ë ¤ë©´ ì„±ì¸ì€ 2ë…„ì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Manic Episode** | **1ì£¼ ì´ìƒ** (í˜¹ì€ ì…ì› í•„ìš” ì‹œ ì¦‰ì‹œ) | ì‹¬ê°í•œ ì‚¬íšŒì  ê¸°ëŠ¥ ì†ìƒ. |\n| **Hypomanic Episode** | **4ì¼ ì´ìƒ** (ì—°ì†) | ê¸°ëŠ¥ì˜ ë³€í™”ëŠ” ìˆìœ¼ë‚˜ ì…ì›í•  ì •ë„ëŠ” ì•„ë‹˜. |\n| **Major Depressive Disorder (MDD)** | **2ì£¼ ì´ìƒ** | ìš°ìš¸ ê¸°ë¶„ í¬í•¨ 5/9 ì¦ìƒ ì¶©ì¡±. |\n| **Persistent Depressive Disorder (Dysthymia)** | **2ë…„ ì´ìƒ** (ì†Œì•„/ì²­ì†Œë…„ì€ 1ë…„) | ë¬´ì¦ìƒ ê¸°ê°„ì´ **2**ê°œì›”ì„ ë„˜ì§€ ì•ŠìŒ. |\n| **Cyclothymic Disorder** | **2ë…„ ì´ìƒ** | ê²½ë¯¸í•œ Hypomanic/Depressive ì¦ìƒì˜ ë°˜ë³µ (MDD ê¸°ì¤€ ë§Œì¡± X), ì •ìƒ ê¸°ê°„ 2ê°œì›” ë¯¸ë§Œ,. |\n| **Adjustment Disorder** | **3ê°œì›” ì´ë‚´** ë°œë³‘ | ìŠ¤íŠ¸ë ˆìŠ¤ ìš”ì¸ ë°œìƒ í›„ 3ê°œì›” ë‚´ ì‹œì‘. ë‹¤ë¥¸ ì •ì‹  ì§ˆí™˜ ê¸°ì¤€ì„ ë§Œì¡±í•˜ì§€ ì•Šì•„ì•¼ í•¨. |\n| **Rapid Cycling (Bipolar)** | **12ê°œì›” ë‚´ 4íšŒ ì´ìƒ** | 1ë…„ ë™ì•ˆ 4ë²ˆ ì´ìƒì˜ ê¸°ë¶„ ì‚½í™” ë°œìƒ. |\n---\n### **3. Anxiety & Trauma (ë¶ˆì•ˆ ë° ì™¸ìƒ): \"1ê°œì›”ê³¼ 6ê°œì›”ì˜ ë²•ì¹™\"**\në¶ˆì•ˆ ì¥ì• ëŠ” ì¼ì‹œì ì¸ ë°˜ì‘ê³¼ ë³‘ì ì¸ ìƒíƒœë¥¼ êµ¬ë¶„í•˜ê¸° ìœ„í•´ íŠ¹ì • ê¸°ê°„ì„ ìš”êµ¬í•©ë‹ˆë‹¤.\n- **General Rule:** íŠ¸ë¼ìš°ë§ˆ ê´€ë ¨ì€ **1ê°œì›”**ì„ ê¸°ì¤€ìœ¼ë¡œ ë³‘ëª…ì´ ë°”ë€ë‹ˆë‹¤. ì¼ë°˜ì ì¸ ë¶ˆì•ˆ/ê³µí¬ì¦ì€ **6ê°œì›”** ì´ìƒ ì§€ì†ë˜ì–´ì•¼ ì§„ë‹¨í•©ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Acute Stress Disorder (ASD)** | **3ì¼ ì´ìƒ ~ 1ê°œì›” ì´ë‚´** | íŠ¸ë¼ìš°ë§ˆ í›„ 1ê°œì›” ë‚´ ì¦ìƒ ë°œìƒ ë° ì¢…ë£Œ. |\n| **Post-Traumatic Stress Disorder (PTSD)** | **1ê°œì›” ì´ˆê³¼** | íŠ¸ë¼ìš°ë§ˆ í›„ ì¦ìƒì´ 1ê°œì›” ì´ìƒ ì§€ì†. |\n| **Panic Disorder** | **1ê°œì›” ì´ìƒ** | ê³µí™© ë°œì‘ í›„, ì¶”ê°€ ë°œì‘ì— ëŒ€í•œ ê±±ì •ì´ë‚˜ íšŒí”¼ê°€ 1ê°œì›” ì´ìƒ ì§€ì†. |\n| **Generalized Anxiety Disorder (GAD)** | **6ê°œì›” ì´ìƒ** | í†µì œí•˜ê¸° í˜ë“  ê³¼ë„í•œ ê±±ì •. |\n| **Specific Phobia** | **6ê°œì›” ì´ìƒ** | íŠ¹ì • ëŒ€ìƒì— ëŒ€í•œ í˜„ì €í•œ ê³µí¬. |\n| **Social Anxiety Disorder** | **6ê°œì›” ì´ìƒ** | ì‚¬íšŒì  ìƒí™©ì— ëŒ€í•œ ë¶ˆì•ˆ. |\n---","subject":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","page_title":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","episode":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","section_path":["Psy and number 2ec46f2986ee80a98293f3e61f584e06"],"source_doc_id":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","source_page":null,"source_anchor":"Psy and number 2ec46f2986ee80a98293f3e61f584e06-1"}
{"chunk_type":"transcript_chunk","text":"### **4. Childhood Disorders (ì†Œì•„ ì§ˆí™˜): \"ë‚˜ì´ì™€ ì§€ì† ê¸°ê°„\"**\nì†Œì•„ê³¼ëŠ” **\"ëª‡ ì‚´ë¶€í„° ì§„ë‹¨ ê°€ëŠ¥í•œê°€?\"**ì™€ **\"ì¦ìƒì´ ì–¸ì œ ì‹œì‘ë˜ì—ˆëŠ”ê°€?\"**ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- **General Rule:** ë°°ì„¤ ì¥ì• ëŠ” ë°œë‹¬ ì—°ë ¹(4~5ì„¸)ì„ ê³ ë ¤í•´ì•¼ í•˜ë©°, ADHDëŠ” 12ì„¸ ì´ì „ ë°œë³‘ì´ í•„ìˆ˜ì…ë‹ˆë‹¤.\n- 5ì¤Œ\n- 4ë³€\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ë‚˜ì´/ê¸°ê°„ (Key Age/Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **ADHD** | **12ì„¸ ì´ì „** ë°œë³‘ / **6ê°œì›” ì´ìƒ** ì§€ì† | ë‘ êµ°ë° ì´ìƒì˜ ì¥ì†Œ(ì§‘, í•™êµ ë“±)ì—ì„œ ì¦ìƒ ë°œí˜„. |\n| **Tourette Syndrome** | **18ì„¸ ì´ì „** ë°œë³‘ / **1ë…„ ì´ìƒ** ì§€ì†\nddx. ì•„ë™ê¸° ì¼ê³¼ì„± í‹±ì¥ì•  | ìš´ë™ í‹±(Motor) + ìŒì„± í‹±(Vocal)ì´ ëª¨ë‘ ìˆì–´ì•¼ í•¨ (ë™ì‹œì¼ í•„ìš”ëŠ” ì—†ìŒ). |\n| **Encopresis (ìœ ë¶„ì¦)** | **4ì„¸ ì´ìƒ** | ëŒ€ë³€ì„ ê°€ë ¤ì•¼ í•  ë‚˜ì´. |\n| **Enuresis (ìœ ë‡¨ì¦)** | **5ì„¸ ì´ìƒ** | ì†Œë³€ì„ ê°€ë ¤ì•¼ í•  ë‚˜ì´. |\n| **Reactive Attachment Disorder** | **5ì„¸ ì´ì „** ì§•í›„ | ë°©ì„ ë“±ìœ¼ë¡œ ì¸í•´ ì–‘ìœ¡ìì—ê²Œ ì •ì„œì  ë°˜ì‘ì„ ë³´ì´ì§€ ì•ŠìŒ. |\n| **Oppositional Defiant Disorder (ODD)** | **6ê°œì›” ì´ìƒ** | ê¶Œìœ„ì— ëŒ€í•œ ì ëŒ€ì , ë°˜í•­ì  í–‰ë™ íŒ¨í„´. |\n| **Intermittent Explosive Disorder** | **6ì„¸ ì´í›„** ë°œë³‘ / ë°œì‘ **30ë¶„ ë¯¸ë§Œ(ì§§ê°•)**\n**vs. disruptive DMDD:** 10ì„¸ì´ì „. 6ì„¸ì´ì „ 18ì„¸ ì´í›„ ì§„ë‹¨ë¶ˆê°€. ì‚¬ì´ì‚¬ì´ì—ë„ í™”ë‚˜ìˆìŒ. ì§€ì†ì  | ë„ë°œì— ë¹„í•´ ê³¼ë„í•œ ê³µê²©ì„±, ê³„íšë˜ì§€ ì•ŠìŒ. í›„íšŒ. |\n---\n### **5. Somatic & Eating Disorders (ì‹ ì²´ ë° ì„­ì‹ ì¥ì• ): \"ë¹ˆë„ì™€ ìˆ˜ì¹˜\"**\n- **General Rule:** ì„­ì‹ ì¥ì• ëŠ” **3ê°œì›”** ë™ì•ˆ **ì£¼ 1íšŒ** ì´ìƒ í–‰ë™ì´ ë°˜ë³µë˜ì–´ì•¼ í•˜ë©°, AnorexiaëŠ” ì²´ì¤‘(BMI)ì´ ê²°ì •ì ì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ìˆ˜ì¹˜ (Key Metrics)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Anorexia Nervosa** | **BMI < 18.5 kg/mÂ²** | ì €ì²´ì¤‘ì´ í•„ìˆ˜ ì§„ë‹¨ ê¸°ì¤€. ì…ì› ê¸°ì¤€ì€ **BMI < 15** ë˜ëŠ” í™œë ¥ì§•í›„ ë¶ˆì•ˆì •,. |\n| **Bulimia Nervosa** | **ì£¼ 1íšŒ ì´ìƒ, 3ê°œì›”ê°„** | í­ì‹ + ë³´ìƒ í–‰ë™(êµ¬í†  ë“±). ì²´ì¤‘ì€ ì •ìƒì´ê±°ë‚˜ ê³¼ì²´ì¤‘ì¼ ìˆ˜ ìˆìŒ. |\n| **Somatic Symptom Disorder** | **6ê°œì›” ì´ìƒ** | 1ê°œ ì´ìƒì˜ ì‹ ì²´ ì¦ìƒ + ê³¼ë„í•œ ê±±ì •/ì‹œê°„ ì†Œë¹„. |\n| **Gender Dysphoria** | **6ê°œì›” ì´ìƒ** | ì§€ì •ëœ ì„±ë³„ê³¼ ê²½í—˜í•˜ëŠ” ì„±ë³„ì˜ ë¶ˆì¼ì¹˜ë¡œ ì¸í•œ ê³ í†µ. |\n---\n### **6. ì•½ë¬¼ ë° ì¹˜ë£Œ ê´€ë ¨ ìˆ«ì (Pharmacology & Management)**\n- **Antidepressant Trial:** ì¹˜ë£Œ íš¨ê³¼ë¥¼ íŒì •í•˜ê¸° ìœ„í•´ **4~6ì£¼** ë™ì•ˆ ì¹˜ë£Œ ìš©ëŸ‰ì„ ìœ ì§€í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Maintenance Therapy (ìš°ìš¸ì¦):**\n    - ì²« ë°œë³‘(Single episode): ê´€í•´ í›„ **6ê°œì›”** ì¶”ê°€ ìœ ì§€.\n    - ì¬ë°œ(Recurrent): **1~3ë…„** ë˜ëŠ” ë¬´ê¸°í•œ ìœ ì§€.\n- **Alcohol Withdrawal Timeline:**\n    - 6-24ì‹œê°„: ê²½ë¯¸í•œ ì¦ìƒ, ë¶ˆì•ˆ, ë–¨ë¦¼.\n    - 12-48ì‹œê°„: ë°œì‘(Seizures), ì•Œì½”ì˜¬ í™˜ê°(Alcoholic hallucinosis - ì˜ì‹ ëª…ë£Œí•¨).\n    - 48-96ì‹œê°„: ì§„ì „ ì„¬ë§(Delirium Tremens - ì˜ì‹ í˜¼íƒ, í™œë ¥ì§•í›„ ë¶ˆì•ˆì •).\nì´ ì •ë¦¬ê°€ USMLE Step 2 ì¤€ë¹„ì— í° ê·¸ë¦¼ì„ ê·¸ë¦¬ëŠ” ë° ë„ì›€ì´ ë˜ê¸°ë¥¼ ë°”ëë‹ˆë‹¤. íŠ¹íˆ **2ì£¼(Schizoaffective)**, **1ê°œì›”(Psychosis/PTSD ê²½ê³„)**, **6ê°œì›”(Anxiety/Schizophrenia)** ê°™ì€ ê¸°ì¤€ì ë“¤ì€ ì‹œí—˜ì— ë¹ˆì¶œë˜ë¯€ë¡œ ê¼­ ìˆ™ì§€í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.","subject":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","page_title":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","episode":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","section_path":["Psy and number 2ec46f2986ee80a98293f3e61f584e06"],"source_doc_id":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","source_page":null,"source_anchor":"Psy and number 2ec46f2986ee80a98293f3e61f584e06-21"}
{"chunk_type":"transcript_chunk","text":"# Cardio\n- **K+ (ê°€ì¶œ ì†Œë…„):**Â í‰ì†Œì—” 'ì „ì•• ì¶©ì „', ë‚˜ì¤‘ì—” 'ì „ì•• ë¦¬ì…‹'ì„ ë‹´ë‹¹í•˜ëŠ”Â **ë‚˜ê°€ëŠ” ë†ˆ.**\n    - ì„¸í¬ì•ˆì— K+ê°€ ë§ì€ë° ê³„ì† ê°€ì¶œí•´ â†’ RMP ìŒì „í•˜\n    - ë‚˜ì¤‘ì— phase 3ë•Œ ì¬ë¶„ê·¹ë•Œ  K+ [í¬]íƒ€ìŠ˜ì´ [í¬]ê¸° í•˜ê³  ë‚˜ê°€ë©´ì„œ íƒˆë¶„ê·¹ì„ ë‹¤ì‹œ ìŒì „í•˜ë¡œ ì¬ë¶„ê·¹.\n- **Na+ (ë‚˜ ì§€ê¸ˆ ë“¤ì–´ê°€!):**Â ì‹¬ì¥ ìˆ˜ì¶•ì˜ ë°©ì•„ì‡ ë¥¼ ë‹¹ê¸°ëŠ”Â **ì³ë“¤ì–´ì˜¤ëŠ” ë†ˆ.**\n- **Pump (í•˜ìš°ìŠ¤í‚¤í¼):**Â ì´ ëª¨ë“  ê°œíŒ(?)ì„ ì •ë¦¬í•˜ê³ Â Na+ëŠ” ë°–ìœ¼ë¡œ K+ì€ ì•ˆìœ¼ë¡œ **ìœ„ì¹˜ ì‹œí‚¤ëŠ” ì—„ë§ˆ.**\n**[ì „ì•¼ì œ: í‰í™”ë¡œì›Œ ë³´ì´ì§€ë§Œ ê°€ì¥ ë°”ìœ 'ì¶©ì „' ì‹œê°„]**\n![image.png](Cardio/image.png)\në¬´ëŒ€ì˜ ì£¼ì¸ê³µì€ **'í•˜ìš°ìŠ¤í‚¤í¼(Na/K íŒí”„)'**ì•¼. ì–˜ëŠ” ì—ë„ˆì§€ë¥¼ íŒíŒ ì¨ê°€ë©° ì§‘ì•ˆ(ì„¸í¬ ì•ˆ)ìœ¼ë¡œ ì„±ê²© ê¸‰í•œ **'ê°€ì¶œ ì†Œë…„(í¬íƒ€ìŠ˜)'**ë“¤ì„ ì–µì§€ë¡œ ëŒì–´ë‹¤ ë†“ê³ , ê¸°ì›ƒê±°ë¦¬ë˜ **'ë‚˜íŠ¸ë¥¨ ë¶ˆëŸ‰ë°°'**ë“¤ì€ ë°–ìœ¼ë¡œ ì°¨ë²„ë ¤.\nê·¸ëŸ°ë° ë¬¸ì œê°€ ìƒê²¨. ì´ ê°€ì¶œ ì†Œë…„ë“¤ì´ ë„ˆë¬´ ë‹µë‹µí•œ ë‚˜ë¨¸ì§€, ì„¸í¬ë§‰ì— ëš«ë¦° ì‘ì€ ìª½ë¬¸(leak k+ channel) ìœ¼ë¡œ ìê¾¸ë§Œ ë°–ìœ¼ë¡œ ë„ë§ì„ ê°€ë²„ë¦¬ëŠ” ê±°ì•¼. [ì¹´]ã„¹ë¥¨ : [ì¹´]ì¶œ\n(ë°–ì— hyperkalemiaë©´ ëœ ê°€ì¶œí•¨. ëœ ê°€ì¶œí•˜ë‹ˆ ëœ ìŒì „í•˜ -70ì •ë„)\ní”ŒëŸ¬ìŠ¤(+) ì„±ì§ˆì„ ê°€ì§„ ì†Œë…„ë“¤ì´ ìê¾¸ ë‚˜ê°€ë²„ë¦¬ë‹ˆê¹Œ, ì§‘ì•ˆì€ ê²°êµ­ í…… ë¹„ê³ Â **'ì™¸ë¡œìš´ ë§ˆì´ë„ˆìŠ¤(-90mV)'**Â ìƒíƒœê°€ ë¼. í•˜ì§€ë§Œ ì´ê±´ ë¶ˆí–‰ì´ ì•„ë‹ˆì•¼. ì„¸í¬ëŠ” ì¼ë¶€ëŸ¬ ì´ 'ì™¸ë¡œì›€(ì „ì••)'ì„ ìœ ì§€í•˜ê³  ìˆëŠ” ê±°ì•¼.\nì–¸ì œë“  ë°–ì˜ ë‚˜íŠ¸ë¥¨ì´ ì³ë“¤ì–´ì˜¬ ë•Œ í­ë°œì ì¸ ë°˜ì‘ì„ ë³´ì¼ ìˆ˜ ìˆë„ë¡ ì—ë„ˆì§€ë¥¼Â **'í’€ì¶©ì „'**Â í•´ë†“ì€ ìƒíƒœì¸ ê±°ì§€.\n**[ì œ1ë§‰: ë‚˜íŠ¸ë¥¨ì˜ ì¹¨ê³µê³¼ ì¹¼ìŠ˜ì˜ ì§€ì›]**\n![image.png](Cardio/image%201.png)\nì´ë•Œ ê°‘ìê¸° ë°–ì—ì„œ ëŒ€ê¸°í•˜ë˜ **'ë‚˜íŠ¸ë¥¨(Na)'**ë“¤ì´\n\"ë‚˜(Na) ì§€ê¸ˆ ë“¤ì–´ê°„ë‹¤!\"\në¼ê³  ì†Œë¦¬ì¹˜ë©° ì •ë¬¸ì„ ë°•ì°¨ê³  ìŸì•„ì ¸ ë“¤ì–´ì™€.\nì™¸ë¡œì› ë˜ ì§‘ì•ˆì€ ìˆœì‹ê°„ì— í”ŒëŸ¬ìŠ¤(+) ê¸°ìš´ìœ¼ë¡œ ê°€ë“ ì°¨ë©° ì—´ê´‘ì˜ ë„ê°€ë‹ˆê°€ ë˜ì§€. ì´ê²Œ ë°”ë¡œ ì‹¬ì¥ì´ ìˆ˜ì¶•ì„ ì‹œì‘í•˜ëŠ” **'íƒˆë¶„ê·¹'**ì´ì•¼. ê·¸ëŸ°ë° ë‚˜íŠ¸ë¥¨ë§Œìœ¼ë¡œëŠ” í˜ì´ ì¢€ ë¶€ì¡±í•´.\nê·¸ë˜ì„œ **'ì¹¼ìŠ˜(Ca)'**ì´ë¼ëŠ” ë©ì¹˜ í° ì¹œêµ¬ê°€ ë’¤ë”°ë¼ ë“¤ì–´ì™€. ì¹¼ìŠ˜ì€ ì§‘ì•ˆì— ë¨¸ë¬¼ë©´ì„œ ì‹¬ì¥ ê·¼ìœ¡ì´ \"ìœ¼ëì°¨ì°¨!\" í•˜ê³  í”¼ë¥¼ ì§œë‚¼ ìˆ˜ ìˆê²Œ ì‹œê°„ì„ ë²Œì–´ì£¼ê³  í˜ì„ ë³´íƒœì¤˜.\n**[ì œ2ë§‰: ê°€ì¶œ ì†Œë…„ì˜ ì§‘ë‹¨ íƒˆì¶œê³¼ ë¦¬ì…‹]**\n![image.png](Cardio/image%202.png)\nì¶•ì œê°€ ì˜ì›í•  ìˆœ ì—†ê² ì§€? íŒŒí‹°ê°€ ëë‚  ë•Œì¯¤, ì•„ì§ë„ ì•ˆì— ë” ìˆë˜ **'ê°€ì¶œ ì†Œë…„(í¬íƒ€ìŠ˜)'**ë“¤ì´ ì´ë²ˆì—” ìª½ë¬¸ì´ ì•„ë‹ˆë¼ ***'ì •ë¬¸'***ì„ ì—´ê³  ë–¼ê±°ì§€ë¡œ ë°–ìœ¼ë¡œ ë‚˜ê°€ë²„ë ¤.","subject":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","page_title":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","episode":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","section_path":["Cardio 2eb46f2986ee80b9af19e02cbdc1795f"],"source_doc_id":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","source_page":null,"source_anchor":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f-1"}
{"chunk_type":"transcript_chunk","text":"í”ŒëŸ¬ìŠ¤ ì´ì˜¨ë“¤ì´ ë¬´ë”ê¸°ë¡œ ë¹ ì ¸ë‚˜ê°€ë‹ˆê¹Œ, ëœ¨ê±°ì› ë˜ ì§‘ì•ˆ ì—´ê¸°ëŠ” ìˆœì‹ê°„ì— ì‹ì–´ë²„ë¦¬ê³  ë‹¤ì‹œ ì°¨ê°€ìš´Â **'ë§ˆì´ë„ˆìŠ¤'**Â ìƒíƒœë¡œ ëŒì•„ê°€ê²Œ ë¼. ì´ê±¸ **'ì¬ë¶„ê·¹'**ì´ë¼ê³  ë¶ˆëŸ¬.\n**[ì œ3ë§‰: í•˜ìš°ìŠ¤í‚¤í¼ì˜ ë’·ì •ë¦¬]**\nì´ì œ ì§‘ì•ˆì€ ì—‰ë§ì§„ì°½ì´ì•¼. ì›ë˜ ì•ˆì— ìˆì–´ì•¼ í•  í¬íƒ€ìŠ˜ì€ ë°–ì— ìˆê³ , ë°–ì— ìˆì–´ì•¼ í•  ë‚˜íŠ¸ë¥¨ê³¼ ì¹¼ìŠ˜ì€ ì•ˆì— ë“¤ì–´ì™€ ìˆì§€.\nì´ë•Œ ë‹¤ì‹œ ìš°ë¦¬ì˜ **'í•˜ìš°ìŠ¤í‚¤í¼(íŒí”„)'**ê°€ ë“±íŒí•´. íˆ¬ëœëŒ€ë©´ì„œë„ **ë“¤ì–´ì˜¨ ë‚˜íŠ¸ë¥¨ì€ ë‚´ì«“ê³ , ë„ë§ê°”ë˜ í¬íƒ€ìŠ˜ì€ ë‹¤ì‹œ ì¡ì•„ë‹¤ê°€ ì§‘ì•ˆì— ì±„ì›Œ** ë„£ì–´. ê·¸ë˜ì•¼ë§Œ ë‹¤ìŒ ë°•ë™, ë‹¤ìŒ ì—°ê·¹ì„ ë‹¤ì‹œ ì‹œì‘í•  ìˆ˜ ìˆê±°ë“ . ì´ê²Œ ë°”ë¡œ ìš°ë¦¬ê°€ ì‚´ì•„ìˆëŠ” ë§¤ ìˆœê°„ ë°˜ë³µë˜ëŠ” ê¸°ì  ê°™ì€ ìŠ¤í† ë¦¬ì•¼.\n![image.png](Cardio/image%203.png)\n- **Class I Antiarrhythmics:**Â $Na^+$ê°€ ë“¤ì–´ì˜¤ëŠ” ë¬¸ì„ ì‚´ì§ ì ê°€ì„œ ì‹¬ì¥ ë°•ë™ì„ ëŠ¦ì¶¤.\n- **Class III Antiarrhythmics (Amiodarone):**Â K+Â ê°€ì¶œ(Phase 3)ì„ ëŠ¦ì¶°ì„œ ì „ì²´ ì‚¬ì´í´ì„ ê¸¸ê²Œ ëŠ˜ë¦¼.\n- **Calcium Channel Blockers (Verapamil):**Â $Ca^{2+}$ê°€ ë“¤ì–´ì˜¤ëŠ” ê±¸ ë§‰ì•„ ì‹¬ì¥ ìˆ˜ì¶•ë ¥ê³¼ í˜ˆì••ì„ ë‚®ì¶¤.\n---\nHeyde syndrome\n### 1. ì„¸ ì¤„ ìš”ì•½ (3-Line Summary)\n- **AS (Aortic Stenosis):** ì¢ì•„ì§„ ëŒ€ë™ë§¥íŒë§‰ì´ **'ë¶„ì‡„ê¸°'** ì—­í• ì„ í•¨. âš™ï¸\n- **vWF (von Willebrand Factor):** íŒë§‰ì„ ì§€ë‚˜ë‹¤ê°€ ê°ˆê¸°ê°ˆê¸° ì°¢ê²¨ì„œ ê¸°ëŠ¥ì„ ìƒìŒ (Acquired vWD).\n- **GI Bleed:** í˜ˆì•¡ì˜ 'ì ‘ì°©ì œ'ê°€ ì—†ìœ¼ë‹ˆ ëŒ€ì¥ì˜ **Angiodysplasia(í˜ˆê´€í˜•ì„±ì´ìƒ)**ì—ì„œ í”¼ê°€ í‘í‘! ğŸ©¸\n![image.png](Cardio/image%204.png)\n![image.png](Cardio/image%205.png)\n![image.png](Cardio/image%206.png)","subject":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","page_title":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","episode":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","section_path":["Cardio 2eb46f2986ee80b9af19e02cbdc1795f"],"source_doc_id":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","source_page":null,"source_anchor":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f-21"}
{"chunk_type":"transcript_chunk","text":"# LM_pulmo\n# Physiology\n---\n## 1. Verification (Dictation: 00:10 ~ 00:30)\n> \"We are moving out of the library and walking straight through the double doors of the intensive care unit. We're tackling a topic that strikes fear into the hearts of third-year medical students, interns, and honestly, anyone who hasn't done a pulmonary fellowship. Oh, for sure. But it is absolutely critical for anyone staring down the barrel of the USMLE Step 2.\"\n>\n---\n## 2. The Ventilator Framework: A Mental Model ğŸ§ \nICUì˜ ì¸ê³µí˜¸í¡ê¸°(Ventilator)ëŠ” ë³µì¡í•´ ë³´ì´ì§€ë§Œ, ë³¸ì§ˆì ìœ¼ë¡œ **ë‘ ê°€ì§€** ë³„ê°œì˜ ë¬¸ì œë¥¼ ê´€ë¦¬í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n| **ê¸°ëŠ¥** | **ëª©í‘œ** | **ì¡°ì ˆ ë ˆë²„ (Controls)** |\n| --- | --- | --- |\n| **Oxygenation (ì‚°ì†Œí™”)** | í˜ˆì•¡ì— ì‚°ì†Œ ê³µê¸‰ (Raise PO2) | **FiO2** (ì‚°ì†Œ ë†ë„), **PEEP** (í˜¸ê¸°ë§ ì–‘ì••) |\n| **Ventilation (í™˜ê¸°)** | ì´ì‚°í™”íƒ„ì†Œ ë°°ì¶œ (Remove CO2) | **Respiratory Rate** (RR), **Tidal Volume** (TV) |\n### A. Oxygenation Controls (ì‚°ì†Œí™” ì¡°ì ˆ) ğŸ”´\n1. **FiO2 (Fraction of Inspired Oxygen)**: í¡ì… ì‚°ì†Œ ë†ë„. (ëŒ€ê¸° 21% ~ 100%)\n2. **PEEP (Positive End-Expiratory Pressure)**: í˜¸í¡ ëì— íí¬ê°€ ìª¼ê·¸ë¼ë“¤ì§€ ì•Šê²Œ ì¡ì•„ì£¼ëŠ” ì••ë ¥.\n    - *Rule*: SpO2ê°€ ë‚®ìœ¼ë©´(ì €ì‚°ì†Œì¦), **FiO2**ë¥¼ ì˜¬ë¦¬ê±°ë‚˜ **PEEP**ì„ ì˜¬ë¦½ë‹ˆë‹¤.\n    - â˜… **Safety Rule**: 100% ì‚°ì†Œë¥¼ ì˜¤ë˜ ì“°ë©´ **Oxygen Toxicity** (Free radical ì†ìƒ)ê°€ ë°œìƒí•©ë‹ˆë‹¤. ëª©í‘œëŠ” FiO2ë¥¼ 60% ë¯¸ë§Œìœ¼ë¡œ ë‚®ì¶”ëŠ” ê²ƒì…ë‹ˆë‹¤. ì´ë¥¼ ìœ„í•´ **PEEPì„ ë†’ì—¬ì„œ** íí¬ë¥¼ ì—´ì–´ë‘ê³  ì‚°ì†Œ ë†ë„ëŠ” ì¤„ì´ëŠ” ì „ëµì„ ì”ë‹ˆë‹¤.\n### B. Ventilation Controls (í™˜ê¸° ì¡°ì ˆ) ğŸ”µ\n1. **Respiratory Rate (RR)**: í˜¸í¡ìˆ˜.\n2. **Tidal Volume (TV)**: 1íšŒ í™˜ê¸°ëŸ‰.\n    - *Rule*: CO2ê°€ ë†’ìœ¼ë©´(ì‚°ì¦), **RR**ì„ ë†’ì´ê±°ë‚˜ **TV**ë¥¼ í‚¤ì›Œì„œ CO2ë¥¼ ì”»ì–´ëƒ…ë‹ˆë‹¤ (Blow off).\n    - **Minute Ventilation (ë¶„ë‹¹ í™˜ê¸°ëŸ‰)** = RR Ã— TV. ë‘˜ ì¤‘ í•˜ë‚˜ë¥¼ ì˜¬ë¦¬ë©´ ë¨.\n    - â˜… **Safety Rule**: **Tidal Volumeì€ Ideal Body Weight (IBW) ê¸°ì¤€ 6-8 mL/kg**ë¡œ ì„¤ì •í•´ì•¼ í•©ë‹ˆë‹¤. (ì‹¤ì œ ì²´ì¤‘ ì•„ë‹˜! 150kg í™˜ìë„ í‚¤ê°€ ì‘ìœ¼ë©´ í ìš©ì ì€ ì‘ìŒ). ê³¼ë„í•œ TVëŠ” íë¥¼ í„°ëœ¨ë¦´ ìˆ˜ ìˆìŒ (**Barotrauma/Volutrauma**).\n---\n## 3. ARDS Strategy: \"Baby Lung\" Concept ğŸ‘¶ğŸ«\n**ARDS (Acute Respiratory Distress Syndrome)** í™˜ìì˜ íëŠ” ë”±ë”±í•˜ê³  ë¬´ê²ê³  ì –ì–´ ìˆìŠµë‹ˆë‹¤(Stiff, wet, heavy). ê¸°ëŠ¥í•˜ëŠ” í ìš©ì ì€ ì•„ì£¼ ì‘ìŠµë‹ˆë‹¤ (Baby lung).\n- **Lung Protective Ventilation (í ë³´í˜¸ í™˜ê¸°)** ì „ëµ:\n    1. **Low Tidal Volume**: ì‘ì€ íì— ë§ì¶° TVë¥¼ ë‚®ê²Œ ì„¤ì • (**4-6 mL/kg**ê¹Œì§€ ì¤„ì„).\n    2. **High PEEP**: ì –ì€ íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ëŠ” ê²ƒì„ ë§‰ê¸° ìœ„í•´ PEEPì„ ë†’ê²Œ ì„¤ì • (> 10 cmH2O).\n    3. **Permissive Hypercapnia**: TVë¥¼ ì¤„ì˜€ìœ¼ë‹ˆ CO2ê°€ ì¢€ ìŒ“ì—¬ë„(pH > 7.25) ìš©ì¸í•©ë‹ˆë‹¤. íë¥¼ í„°ëœ¨ë¦¬ëŠ” ê²ƒë³´ë‹¤ ë‚˜ìŒ.\n    4. **Prone Positioning (ì—ë“œë¦° ìì„¸)**: ë“± ìª½ í(Dorsal lung)ë¥¼ í´ì„œ ì‚°ì†Œí™”ë¥¼ ê°œì„ í•˜ê³  ì‚¬ë§ë¥ ì„ ë‚®ì¶¤. (â˜… **Mortality Benefit** ìˆìŒ!)\n---\n## 4. The Pressure Puzzle: PIP vs. Plateau ğŸ§©\në²¤í‹¸ë ˆì´í„° ì•ŒëŒì´ \"High Pressure!\"ë¼ê³  ìš¸ë¦´ ë•Œ, ë‘ ê°€ì§€ ìˆ«ìë¥¼ í™•ì¸í•˜ë©´ ì§„ë‹¨ì´ ëë‚©ë‹ˆë‹¤.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-1"}
{"chunk_type":"transcript_chunk","text":"1. **PIP (Peak Inspiratory Pressure)**: ì „ì²´ ì••ë ¥ (Resistance + Compliance).\n2. **Plateau Pressure (P_plat)**: í ìì²´ì˜ ì••ë ¥ (Lung Compliance only). (ìˆ¨ì„ ë©ˆì·„ì„ ë•Œ ì¸¡ì •).\n### Algorithm ğŸ“‰\n- **Scenario A: PIP High â¬†ï¸ + Plateau Normal â¡ï¸**\n    - *ì˜ë¯¸*: ì €í•­(Resistance) ë¬¸ì œ. ê¸°ë„ê°€ ì¢ì•„ì§.\n    - *ì›ì¸*: **Bronchospasm** (Asthma/COPD), **Mucus Plug** (ê°€ë˜), Tube biting (í™˜ìê°€ íŠœë¸Œë¥¼ ê¹¨ë¬¾).\n- **Scenario B: PIP High â¬†ï¸ + Plateau High â¬†ï¸**\n    - *ì˜ë¯¸*: ìœ ìˆœë„(Compliance) ë¬¸ì œ. í ìì²´ê°€ ë”±ë”±í•´ì§.\n    - *ì›ì¸*: **Pneumothorax** (ê¸°í‰), **Pulmonary Edema**, **Pneumonia**, **ARDS**, Right Mainstem Intubation.\n---\n## 5. Capnography (EtCO2): The Truth Teller ğŸ“‰\n- *Capnography (í˜¸ê¸°ë§ ì´ì‚°í™”íƒ„ì†Œ ë¶„ì••)**ëŠ” íŠœë¸Œê°€ ì œëŒ€ë¡œ ë“¤ì–´ê°”ëŠ”ì§€, ì‹¬ì¥ì´ ë›°ëŠ”ì§€ ë³´ì—¬ì¤ë‹ˆë‹¤.\n1. **Tube Verification**: ì‹ë„ë¡œ ë“¤ì–´ê°€ë©´ EtCO2 íŒŒí˜•ì´ Flatline. ê¸°ê´€ì§€ë¡œ ë“¤ì–´ê°€ë©´ ë„¤ëª¨ë‚œ íŒŒí˜•(Square wave)ì´ ë³´ì„.\n2. **Cardiac Arrest (CPR)**:\n    - CPR ì¤‘ EtCO2ê°€ ê°‘ìê¸° í™• ì˜¤ë¥´ë©´? â†’ **ROSC (ìë°œìˆœí™˜ íšŒë³µ)** ì‹ í˜¸! (í”¼ê°€ íë¡œ ê°€ì„œ CO2ë¥¼ ë±‰ì–´ë‚´ê¸° ì‹œì‘í•¨).\n### Waveform Shapes ã€°ï¸\n- **Shark Fin (ìƒì–´ ì§€ëŠëŸ¬ë¯¸)** ğŸ¦ˆ: **Obstructive Disease** (Asthma, COPD). ê³µê¸°ê°€ ì²œì²œíˆ ë‚˜ì™€ì„œ íŒŒí˜•ì´ ê¸°ìš¸ì–´ì§.\n---\n## 6. PFTs & DLCO (Pulmonary Function Tests) ğŸ“Š\níê¸°ëŠ¥ ê²€ì‚¬ëŠ” íŒ¨í„´ ì¸ì‹ì…ë‹ˆë‹¤.\n### A. Obstructive vs. Restrictive\n- **Obstructive** (ëª» ë‚˜ê°): FEV1/FVC < 0.7. (COPD, Asthma)\n- **Restrictive** (ëª» ë“¤ì–´ì˜´): FEV1/FVC Normal or High (> 0.7), but **Total Lung Capacity (TLC)** is Low. (Fibrosis)\n### B. DLCO (Diffusing Capacity) : The Tie Breaker âš–ï¸\nê°€ìŠ¤ êµí™˜ ëŠ¥ë ¥(ë§‰ì˜ ìƒíƒœ)ì„ ë´…ë‹ˆë‹¤.\n1. **Low DLCO** (ë§‰ì´ ë§ê°€ì§/ë‘êº¼ì›Œì§):\n    - Obstructive + Low DLCO = **Emphysema** (íê¸°ì¢…).\n    - Restrictive + Low DLCO = **ILD (Fibrosis)**.\n2. **Normal DLCO** (ë§‰ì€ ì •ìƒ):\n    - Obstructive + Normal DLCO = **Chronic Bronchitis** or **Asthma**.\n    - Restrictive + Normal DLCO = **Chest Wall Disease** (ë¹„ë§Œ, ì²™ì¶”ì¸¡ë§Œì¦) or Neuromuscular (ALS). (íëŠ” ë©€ì©¡í•œë° íŒí”„ê°€ ê³ ì¥ ë‚¨).\n3. **High DLCO** (í”¼ê°€ ë„ˆë¬´ ë§ìŒ):\n    - **Pulmonary Hemorrhage** (Goodpasture's), **Obesity** (Increased blood volume), **Asthma** (Acute attack).\n---\n## 7. Hypoxemia & The A-a Gradient ğŸ§ª\ní™˜ìê°€ íŒŒë—ê²Œ ì§ˆë ¸ì„ ë•Œ(Hypoxemia), ì›ì¸ì„ ì°¾ëŠ” ì•Œê³ ë¦¬ì¦˜ì…ë‹ˆë‹¤.\n1. **A-a Gradient (Alveolar-arterial gradient)** ê³„ì‚°.\n    - ì •ìƒì¹˜: (Age/4) + 4. ëŒ€ëµ < 10~15.\n2. **Scenario A: Normal Gradient** (íëŠ” ì •ìƒ)\n    - *ì›ì¸*: **Hypoventilation** (Opioid overdose - ìˆ¨ì„ ì•ˆ ì‰¼), **High Altitude** (ì‚°ì†Œê°€ í¬ë°•í•¨).\n    - *ì¹˜ë£Œ*: ì‚°ì†Œ ì£¼ë©´ ë°”ë¡œ í•´ê²°ë¨.\n3. **Scenario B: High Gradient** (í ë¬¸ì œ ë°œìƒ)\n    - **V/Q Mismatch**: PE(í˜ˆì „), Pneumonia, COPD. (ì‚°ì†Œ ì£¼ë©´ êµì •ë¨).\n    - **Shunt**: Alveoliê°€ ê½‰ ì°¸ (Edema, Complete collapse). (â˜… **ì‚°ì†Œë¥¼ ì¤˜ë„ êµì •ì´ ì•ˆ ë¨**).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-21"}
{"chunk_type":"transcript_chunk","text":"### The Silent Killer: Carbon Monoxide (CO) â˜ ï¸\n- Pulse OximeterëŠ” 100%ë¼ê³  ê±°ì§“ë§í•¨ (Red herring).\n- **Co-oximetry** (ë™ë§¥í˜ˆ ê°€ìŠ¤)ë¡œ ì§„ë‹¨í•´ì•¼ í•¨.\n- ì¹˜ë£Œ: **100% Oxygen** (ë°˜ê°ê¸° ë‹¨ì¶•). ì‹¬í•˜ë©´ **Hyperbaric Oxygen**.\n---\n## 8. Rapid Fire Recap ğŸ”¥\n- **Ventilator Basics**:\n    - Low O2 â†’ Increase **FiO2** or **PEEP**.\n    - High CO2 â†’ Increase **Rate** or **Tidal Volume**.\n    - Ideal Body Weightë¡œ TV ì„¤ì • (6-8 mL/kg).\n- **ARDS**: Low TV, High PEEP, Dry lungs, Prone position.\n- **Pressure Alarm**:\n    - High PIP only = **Resistance** (Asthma, Tube kink).\n    - High PIP + High Plateau = **Compliance** (Pneumothorax, Edema).\n- **PFTs**:\n    - Obstructive: FEV1/FVC < 0.7.\n    - Emphysema: Low DLCO. Bronchitis/Asthma: Normal DLCO.\n    - Restrictive: Low TLC. Chest wall issue: Normal DLCO.\n- **Shunt vs V/Q**: ShuntëŠ” ì‚°ì†Œë¥¼ ì¤˜ë„ ë°˜ì‘ ì—†ìŒ (Refractory hypoxemia).\n- **Fluid Balance**: ARDS í™˜ìëŠ” **Dry Lungs (Happy Lungs)**ê°€ ëª©í‘œ. ì´ë‡¨ì œ ì¨ì„œ ë§ë¦´ ê²ƒ.\n# Methemoglobinemia, CO, Cyanide, Hemoptysis\n---\n> \"Definitely high stakes. We've got sources here that are, I mean, they're the bible for anyone who's in the trenches of USMLE Step 2 prep right now. But here's the thing. Even if you're not staring down a board exam, these concepts, they're the kind of things that save lives in the ER when everyone else is, you know, scratching their heads.\"\n>\n---\n### 2. Tissue Hypoxia Framework (Mental Model) ğŸ§ \nì¡°ì§ ì €ì‚°ì†Œì¦(Tissue Hypoxia)ì€ **ê³µê¸‰ë§(Supply Chain) ë¬¸ì œ**ë¡œ ì´í•´í•´ì•¼ í•©ë‹ˆë‹¤.\n1. **Hemoglobin Binding Issue (Trucking Problem)** ğŸš›:\n    - íŠ¸ëŸ­(í—¤ëª¨ê¸€ë¡œë¹ˆ)ì€ ìˆëŠ”ë°, ì§(ì‚°ì†Œ)ì„ ëª» ì‹£ê±°ë‚˜ ì˜ëª»ëœ ì§ì„ ì‹£ê³  ìˆëŠ” ê²½ìš°.\n    - **CO Poisoning, Methemoglobinemia**.\n2. **Mitochondrial Usage Issue (Kitchen Problem)** ğŸ³:\n    - íŠ¸ëŸ­ì´ ì‚°ì†Œë¥¼ ë¬¸ ì•ê¹Œì§€ ë°°ë‹¬í–ˆì§€ë§Œ, ì£¼ë°©(ë¯¸í† ì½˜ë“œë¦¬ì•„)ì´ ê³ ì¥ ë‚˜ì„œ ìš”ë¦¬(ì—ë„ˆì§€ ìƒì„±)ë¥¼ ëª» í•˜ëŠ” ê²½ìš°.\n    - **Cyanide Poisoning**.\n---\n### 3. Carbon Monoxide (CO) Poisoning â˜ ï¸\nì¼ì‚°í™”íƒ„ì†ŒëŠ” í—¤ëª¨ê¸€ë¡œë¹ˆì— ëŒ€í•œ ì¹œí™”ë ¥(Affinity)ì´ ì‚°ì†Œë³´ë‹¤ **200~240ë°°** ë†’ìŠµë‹ˆë‹¤. ì‚°ì†Œë¥¼ ë°€ì–´ë‚´ê³  ìë¦¬ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤.\n### A. Pathophysiology (The Bully)\n- **Left Shift**: COê°€ í•œ ìë¦¬ë¥¼ ì°¨ì§€í•˜ë©´, ë‚˜ë¨¸ì§€ ìë¦¬ì— ë¶™ì€ ì‚°ì†Œë“¤ë„ ê½‰ ì¡ê³  ë†“ì•„ì£¼ì§€ ì•ŠìŒ (Oxygen-Hemoglobin Dissociation Curveì˜ ì¢Œì¸¡ ì´ë™). ì¡°ì§ì— ì‚°ì†Œë¥¼ ì£¼ì§€ ì•ŠìŒ.\n### B. Clinical Presentation (The Silent Killer)\n- **History**: ê²¨ìš¸ì²  ê³ ì¥ ë‚œ ë‚œë°©ê¸°, ë°€íëœ ì°¨ê³ ì˜ ìë™ì°¨ ë°°ê¸°ê°€ìŠ¤, í™”ì¬ í˜„ì¥(House fires).\n- **Symptoms**: ë‘í†µ, êµ¬ì—­ì§ˆ, í˜¼ë€(Confusion) â†’ ë…ê°(Flu)ê³¼ ë¹„ìŠ·í•´ì„œ ë†“ì¹˜ê¸° ì‰¬ì›€. ê°€ì¡± ì „ì²´ê°€ ì¦ìƒì„ ë³´ì´ë©´ ì˜ì‹¬.\n- **Exam Findings**:\n    - **Cherry Red Skin** ğŸ’: êµê³¼ì„œì—ëŠ” ë‚˜ì˜¤ì§€ë§Œ ì‹¤ì œë¡œëŠ” ì£½ê¸° ì§ì „ì´ë‚˜ ì‚¬í›„ì— ë‚˜íƒ€ë‚¨. (ê±°ì˜ ì•ˆ ë³´ì„).\n    - **Retinal Hemorrhage**: ì•ˆì € ê²€ì‚¬ì—ì„œ ë³´ì¼ ìˆ˜ ìˆìŒ.\n### C. Diagnosis (The Trap âš ï¸)","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-41"}
{"chunk_type":"transcript_chunk","text":"- **Pulse Oximeter**: â˜… **ê±°ì§“ë§ìŸì´(Liar)**. ë¶‰ì€ìƒ‰ íŒŒì¥ì˜ í¡ìˆ˜ìœ¨ë¡œ ì¸¡ì •í•˜ëŠ”ë°, Carboxyhemoglobinë„ ë¶‰ì€ìƒ‰ì´ë¼ **SpO2 100%**ë¡œ ë‚˜ì˜´.\n- **Confirm**: **ABG with Co-oximetry**. (ë°˜ë“œì‹œ Co-oximetryë¥¼ ëª…ì‹œí•´ì•¼ í•¨).\n- **MRI Brain**: **Globus Pallidus** (ì°½ë°±í•µ)ì˜ ì–‘ì¸¡ì„± ë³‘ë³€ (Bilateral hyperintensity).\n### D. Treatment\n- **100% Oxygen**: COì˜ ë°˜ê°ê¸°ë¥¼ 4~5ì‹œê°„ì—ì„œ 1ì‹œê°„ìœ¼ë¡œ ì¤„ì—¬ì¤Œ.\n- **Hyperbaric Oxygen (ê³ ì•• ì‚°ì†Œ)**: ì‹¬í•œ ê²½ìš°(í˜¼ìˆ˜, ë°œì‘, ì„ì‚°ë¶€ ë“±) ì‚¬ìš©. ë°˜ê°ê¸°ë¥¼ 20ë¶„ìœ¼ë¡œ ë‹¨ì¶•.\n---\n### 4. Methemoglobinemia (Chocolate Blood) ğŸ«\ní—¤ëª¨ê¸€ë¡œë¹ˆì˜ ì² (Iron)ì´ ì‚°í™”ë˜ì–´ ì‚°ì†Œë¥¼ ìš´ë°˜í•˜ì§€ ëª»í•˜ëŠ” ìƒíƒœì…ë‹ˆë‹¤.\n### A. Pathophysiology\n- **Oxidation**: ì² ì´ **Fe2+(Ferrous, Good)**ì—ì„œ **Fe3+(Ferric, Bad/Icky)**ë¡œ ë°”ë€œ. Fe3+ëŠ” ì‚°ì†Œì™€ ê²°í•© ëª» í•¨.\n- **Causes**:\n    - **Dapsone** (ë‚˜ë³‘/í”¼ë¶€ì§ˆí™˜ ì•½).\n    - **Nitrites** (ì‹ìˆ˜ ì˜¤ì—¼, ì¼ë¶€ ìŒì‹).\n    - **Local Anesthetics**: **Benzocaine** (ë‚´ì‹œê²½ ìŠ¤í”„ë ˆì´, ì•„ê¸° ì¹˜ë°œê¸° ì ¤).\n### B. Diagnosis (The Saturation Gap)\n- **Patient Color**: **Blue/Cyanotic** (íŒŒë—ê²Œ ì§ˆë¦¼). ì‚°ì†Œë¥¼ ì¤˜ë„ ì•ˆ ëŒì•„ì˜´ (**Refractory Cyanosis**).\n- **Pulse Ox**: **85%** ê·¼ì²˜ì—ì„œ ê³ ì •ë¨ (Plateau). ì•„ë¬´ë¦¬ ì‚°ì†Œë¥¼ ì¤˜ë„ ë³€í•˜ì§€ ì•ŠìŒ.\n- **Blood Appearance**: ì±„í˜ˆ ì‹œ í”¼ ìƒ‰ê¹”ì´ **Dark Chocolate Brown**. ğŸ«\n- **Lab**: **Saturation Gap** (Pulse OxëŠ” 85%ì¸ë°, ABGì˜ ì‚°ì†Œ í¬í™”ë„ëŠ” ì •ìƒìœ¼ë¡œ ë‚˜ì˜´).\n### C. Treatment\n- **Methylene Blue** ğŸ”µ: í™˜ì›ì œ. Fe3+ë¥¼ ë‹¤ì‹œ Fe2+ë¡œ ëŒë ¤ë†“ìŒ.\n- **Contraindication**: **G6PD Deficiency** í™˜ìì—ê²ŒëŠ” ê¸ˆê¸° (ìš©í˜ˆ ìœ ë°œ). ì´ ê²½ìš° **Vitamin C** ì‚¬ìš©.\n---\n### 5. Cyanide Poisoning (The Kitchen Fire) ğŸ”¥\në¯¸í† ì½˜ë“œë¦¬ì•„ë¥¼ ì§ì ‘ ê³µê²©í•˜ëŠ” ëŒ€ì‚¬ì„± ì‚¬ë³´íƒ€ì£¼(Metabolic Sabotage)ì…ë‹ˆë‹¤.\n### A. Causes & Pathophysiology\n- **Causes**:\n    - **House Fires**: í”Œë¼ìŠ¤í‹±, ìš¸, ì‹¤í¬ ë“±ì´ íƒˆ ë•Œ ë°œìƒ. (CO ì¤‘ë…ê³¼ ê°™ì´ ì˜¤ëŠ” ê²½ìš°ê°€ ë§ìŒ).\n    - **Nitroprusside**: ê³ í˜ˆì•• ì‘ê¸‰ì•½(Vasodilator)ì„ ì¥ê¸°ê°„/ê³ ìš©ëŸ‰ ì‚¬ìš© ì‹œ, í˜¹ì€ ì‹ ë¶€ì „ í™˜ìì—ì„œ ë°œìƒ.\n- **Mechanism**: ì „ìì „ë‹¬ê³„(Complex IV) ì°¨ë‹¨ â†’ ATP ìƒì„± ë¶ˆê°€ â†’ ê°•ì œ í˜ê¸°ì„± ëŒ€ì‚¬ â†’ ì –ì‚°(Lactate) í­ë°œ.\n### B. Clinical Presentation\n- **Symptoms**: ê¸‰ê²©í•œ ì˜ì‹ ì†Œì‹¤, ë°œì‘, ì‹¬í˜ˆê´€ ë¶•ê´´.\n- **Smell**: **Bitter Almonds** (ì“´ ì•„ëª¬ë“œ ëƒ„ìƒˆ). ğŸ§¬ (ìœ ì „ì ìœ¼ë¡œ ë§¡ì„ ìˆ˜ ìˆëŠ” ì‚¬ëŒë§Œ ë§¡ìŒ).\n### C. Diagnosis","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-61"}
{"chunk_type":"transcript_chunk","text":"- **Lactic Acidosis**: **Severe Anion Gap Metabolic Acidosis** + **High Lactate**.\n- **Venous Blood**: ì •ë§¥í˜ˆì´ ë™ë§¥í˜ˆì²˜ëŸ¼ ë°ì€ ë¹¨ê°„ìƒ‰ì¼ ìˆ˜ ìˆìŒ (ì„¸í¬ê°€ ì‚°ì†Œë¥¼ ì•ˆ ì¨ì„œ).\n### D. Treatment\n- **Hydroxocobalamin**: 1ì°¨ ì¹˜ë£Œì œ. Cyanideì™€ ê²°í•©í•´ Vitamin B12ê°€ ë˜ì–´ ì†Œë³€ìœ¼ë¡œ ë°°ì¶œë¨.\n- **Nitrites (Sodium Nitrite)**:\n    - ì›ë¦¬: ì¼ë¶€ëŸ¬ **Methemoglobinemia**ë¥¼ ìœ ë°œí•¨. MetHbê°€ Cyanideë¥¼ ê½‰ ì¡ì•„ì„œ ë¯¸í† ì½˜ë“œë¦¬ì•„ì—ì„œ ë–¼ì–´ëƒ„.\n    - *ì£¼ì˜*: í™”ì¬ í”¼í•´ì(Smoke inhalation)ì—ê²ŒëŠ” ê¸ˆê¸°! (ì´ë¯¸ CO ë•Œë¬¸ì— ì‚°ì†Œ ìš´ë°˜ì´ ì•ˆ ë˜ëŠ”ë° MetHbê¹Œì§€ ë§Œë“¤ë©´ ì¹˜ëª…ì ).\n- **Sodium Thiosulfate**: ë³´ì¡° ì¹˜ë£Œì œ.\n---\n### 6. Massive Hemoptysis (Massive Bleeding) ğŸ©¸\nëŒ€ëŸ‰ ê°í˜ˆì€ ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n### A. Definition\n- **> 600 mL / 24hr** ë˜ëŠ” **> 100 mL / hr**. (ì»µìœ¼ë¡œ í”¼ë¥¼ ìŸëŠ” ìˆ˜ì¤€).\n### B. Initial Management (Life Saving Move)\n1. **Airway**: ì‚½ê´€(Intubation) ê³ ë ¤.\n2. **Positioning**: â˜… **Bad Lung Down**.\n    - ì¶œí˜ˆì´ ìˆëŠ” íë¥¼ **ì•„ë˜ìª½**ìœ¼ë¡œ ê°€ê²Œ ëˆ•í˜.\n    - ì¤‘ë ¥ì— ì˜í•´ í”¼ê°€ ê±´ê°•í•œ í(Good lung)ë¡œ ë„˜ì–´ê°€ëŠ” ê²ƒì„ ë§‰ìŒ. ê±´ê°•í•œ íë¼ë„ ì‚´ë ¤ì•¼ í•¨.\n### C. Localization & Treatment\n- **Bronchoscopy**: ì¶œí˜ˆ ë¶€ìœ„ í™•ì¸ ë° ì§€í˜ˆ ì‹œë„.\n- **Embolization**: ì˜ìƒì˜í•™ê³¼(Interventional Radiology)ì—ì„œ ê¸°ê´€ì§€ ë™ë§¥ ìƒ‰ì „ìˆ  ì‹œí–‰.\n- **Surgery**: ìµœí›„ì˜ ìˆ˜ë‹¨.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-81"}
{"chunk_type":"recap_summary","text":"### 7. Rapid Fire Recap ğŸ”¥\n- **Carbon Monoxide (CO)**:\n    - House fires, heaters.\n    - Headache, Confusion.\n    - Pulse Ox reads 100% (False).\n    - Dx: ABG with Co-oximetry.\n    - Tx: 100% O2.\n- **Methemoglobinemia**:\n    - Dapsone, Benzocaine, Nitrites.\n    - Blue patient, Chocolate blood.\n    - Pulse Ox ~85%. Saturation Gap.\n    - Tx: Methylene Blue.\n- **Cyanide**:\n    - House fires (Plastics), Nitroprusside.\n    - Bitter Almond smell.\n    - Lactic Acidosis.\n    - Tx: Hydroxocobalamin (Avoid Nitrites in fire victims!).\n- **Massive Hemoptysis**:\n    - **Bad Lung Down** (ì¶œí˜ˆ ë¶€ìœ„ë¥¼ ì•„ë˜ë¡œ).\n    - Protect the good lung.\n---\n# ğŸ“ USMLE Step 2 CK: Head, Neck & Nose Deep Dive\nì´ ê°•ì˜ëŠ” í•´ë¶€í•™ì˜ \"Junk Drawer(ì¡ë™ì‚¬ë‹ˆ ì„œë)\"ì²˜ëŸ¼ ëŠê»´ì§€ëŠ” Head & Neck íŒŒíŠ¸ë¥¼ **ë…¼ë¦¬ì ì¸ Decision Tree(ì˜ì‚¬ê²°ì • ë‚˜ë¬´)** ë¡œ ì •ë¦¬í•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì•”ê¸°í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì„ìƒê°€ì²˜ëŸ¼ ìƒê°í•˜ê³  ë¬¸ì œë¥¼ í•´ê²°í•˜ëŠ” **Framework**ë¥¼ êµ¬ì¶•í•©ë‹ˆë‹¤.\n## 1. Introduction: The \"Noise\" Decision Tree ğŸŒ³\nê°•ì˜ì˜ í•µì‹¬ ì ‘ê·¼ë²•ì€ **\"Stridor(í˜‘ì°©ìŒ)\"** ì™€ ê°™ì€ **Noise(ì†ŒìŒ)** ë¥¼ ê¸°ì¤€ìœ¼ë¡œ ì§„ë‹¨ì„ ì¢í˜€ê°€ëŠ” ê²ƒì…ë‹ˆë‹¤.\n- **The First Question:** Acute(ê¸‰ì„±)ì¸ê°€ Chronic(ë§Œì„±)ì¸ê°€?\n- **Acute:** ì§€ê¸ˆ ë‹¹ì¥ ì‘ê¸‰ ìƒí™©ì¸ê°€? (ìˆ˜ì£¼ ê°„ ì§€ì†ëœ ê²ƒì´ ì•„ë‹ˆë¼ ê°‘ìê¸° ë°œìƒí–ˆëŠ”ê°€?)\n- **Chronic:** ëª‡ ì£¼/ëª‡ ë‹¬ ë™ì•ˆ ì§€ì†ë˜ì—ˆëŠ”ê°€?\n---\n## 2. Acute Pediatric Stridor (ê¸‰ì„± ì†Œì•„ í˜‘ì°©ìŒ) ğŸš¨","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-94"}
{"chunk_type":"transcript_chunk","text":"ê°‘ì‘ìŠ¤ëŸ¬ìš´ í˜¸í¡ ê³¤ë€ê³¼ ì†ŒìŒì´ ë°œìƒí–ˆì„ ë•Œ ê°€ì¥ ë¨¼ì € êµ¬ë¶„í•´ì•¼ í•  ë‘ ê°€ì§€ì…ë‹ˆë‹¤.\n| **êµ¬ë¶„** | **Croup (Laryngotracheobronchitis)** | **Foreign Body Aspiration (ì´ë¬¼ì§ˆ í¡ì¸)** |\n| --- | --- | --- |\n| **ì¦ìƒ** | Barking Seal Cough (ì§–ëŠ” ë“¯í•œ ê¸°ì¹¨) ğŸ¦­, ì—´(Fever), ì½§ë¬¼(Runny nose) | **No Fever**, **Sudden Onset** (ê°‘ì‘ìŠ¤ëŸ¬ìš´ ë°œìƒ) |\n| **íŠ¹ì§•** | ì•¼ê°„ì— ì•…í™”ë¨, Viral Protoplasms | ì•„ì´ê°€ ì˜ ë†€ë‹¤ê°€ ê°‘ìê¸° ì¼ì¼ê±°ë¦¼ (LEGO ë“± ì‚¼í‚´) |\n| **ì²­ì§„ ì†Œê²¬** | ìƒê¸°ë„ ì „ì²´ì— ì—¼ì¦ ì†Œê²¬ | â˜… **Focal Finding** (í•œìª½ì—ì„œë§Œ ì†Œë¦¬ê°€ ê°ì†Œí•¨ - Diminished breath sounds on one side) |\n| **í•µì‹¬ ë‹¨ì„œ** | \"Steeple sign\" (X-ray), Barking cough | History is King! (ë³´í˜¸ìê°€ ëª» ë´¤ì–´ë„ ì˜ì‹¬í•´ì•¼ í•¨) |\n---\n## 3. Chronic Pediatric Stridor: The Big Three ğŸ‘¶\në§Œì„±ì ì¸ Stridor(ìˆ˜ì£¼ ì´ìƒ ì§€ì†)ì˜ ê²½ìš°, **Top 3 ì›ì¸**ì„ ë°˜ë“œì‹œ êµ¬ë³„í•´ì•¼ í•©ë‹ˆë‹¤.\n### A. Laryngomalacia (í›„ë‘ì—°í™”ì¦) - The MVP ğŸ†\n- **ì •ì˜:** ì„ ì²œì ìœ¼ë¡œ í›„ë‘ ì¡°ì§ì´ ë„ˆë¬´ ë¶€ë“œëŸ¬ì›Œ(Floppy), ìˆ¨ì„ ë“¤ì´ë§ˆì‹¤ ë•Œ ìŒì••ìœ¼ë¡œ ì¸í•´ ê¸°ë„ê°€ ì°Œê·¸ëŸ¬ì§€ëŠ” í˜„ìƒ.\n- **Visual:** \"Wet paper straw\" ğŸ¥¤ (ì –ì€ ì¢…ì´ ë¹¨ëŒ€ë¡œ ì‰ì´í¬ë¥¼ ë§ˆì‹¤ ë•Œ ë¹¨ëŒ€ê°€ ë‹¬ë¼ë¶™ëŠ” ê²ƒê³¼ ê°™ìŒ).\n- **ì•…í™”/ì™„í™” ìš”ì¸ (Position is Everything!):**\n    - **Supine (ëˆ„ì› ì„ ë•Œ):** ì¤‘ë ¥ì— ì˜í•´ ì¡°ì§ì´ ë’¤ë¡œ ì³ì ¸ ì¦ìƒ ì•…í™” ğŸ“‰.\n    - **Prone (ì—ë“œë ¸ì„ ë•Œ):** ì¤‘ë ¥ì— ì˜í•´ ê¸°ë„ê°€ ì—´ë ¤ ì¦ìƒ ì™„í™” ğŸ“ˆ.\n- **ì§„ë‹¨:** Flexible Fiberoptic Laryngoscopy â†’ **Omega (Î©) shaped epiglottis** í™•ì¸.\n- **ì¹˜ë£Œ:** â˜… **Reassurance (ì•ˆì‹¬ì‹œí‚¤ê¸°).** ìƒí›„ 18ê°œì›”ê²½ ì—°ê³¨ì´ ë‹¨ë‹¨í•´ì§€ë©° ìì—° ì¹˜ìœ ë¨. (ìˆ˜ìˆ ì€ ì•„ì´ê°€ ì„±ì¥ë¶€ì§„/ì €ì‚°ì†Œì¦ì´ ìˆì„ ë•Œë§Œ ì‹œí–‰ - Supraglottoplasty).\n    - *Management Note:* GERD(ì—­ë¥˜)ê°€ ë™ë°˜ë˜ë©´ ì¦ìƒì´ ì•…í™”ë˜ë¯€ë¡œ ì—­ë¥˜ ì¹˜ë£Œê°€ ë„ì›€ì´ ë¨.\n### B. Vascular Ring (í˜ˆê´€ ê³ ë¦¬) ğŸ’\n- **ë©”ì»¤ë‹ˆì¦˜:** ëŒ€ë™ë§¥ê¶(Aortic arch) ë“±ì˜ í˜ˆê´€ì´ ë¹„ì •ìƒì ìœ¼ë¡œ í˜•ì„±ë˜ì–´ ê¸°ë„(Trachea)ì™€ ì‹ë„(Esophagus)ë¥¼ ë‘˜ëŸ¬ì‹¸ê³  ì¡°ì´ëŠ” ìƒíƒœ.\n- **ì°¨ë³„ì :** â˜… **Neck Extension(ëª© ì‹ ì „) ì‹œ í˜¸ì „ë¨.**\n    - ë¬´ì–¸ê°€ ëª©ì„ ì¡°ì¼ ë•Œ ë³¸ëŠ¥ì ìœ¼ë¡œ ëª©ì„ ë’¤ë¡œ ì –í˜€ ê¸°ë„ë¥¼ í™•ë³´í•˜ë ¤ëŠ” ìì„¸ë¥¼ ì·¨í•¨.\n- **ì¦ìƒ:** í˜¸í¡ê³¤ë€ + **Dysphagia (ì—°í•˜ê³¤ë€/êµ¬í† ).** (ì‹ë„ë„ ê°™ì´ ëˆŒë¦¬ê¸° ë•Œë¬¸).\n### C. Airway Hemangioma (ê¸°ë„ í˜ˆê´€ì¢…) ğŸ“\n- **ì •ì˜:** ê¸°ë„ ë‚´ë¶€ì— ìƒê¸´ ì–‘ì„± í˜ˆê´€ ì¢…ì–‘.\n- **ë‹¨ì„œ (Clue):** â˜… **Beard Distribution Hemangioma** (í„± ë¼ì¸ì„ ë”°ë¼ í”¼ë¶€ì— ë”¸ê¸° ê°™ì€ ë¶‰ì€ ë°˜ì ì´ ìˆëŠ” ê²½ìš°, ê¸°ë„ ì•ˆì—ë„ ìˆì„ í™•ë¥  ë†’ìŒ).\n- **ì¦ìƒ:** Biphasic Stridor (í¡ê¸°/í˜¸ê¸° ëª¨ë‘ì—ì„œ ì†Œë¦¬ê°€ ë‚¨).\n---\n## 4. Adult & Older Kids Airway Issues ğŸ§‘\nì„±ì¸ì´ë‚˜ í° ì•„ì´ë“¤ì˜ í˜¸í¡ ê³¤ë€ ì›ì¸ì€ ë‹¤ë¦…ë‹ˆë‹¤.\n### A. Tracheal Stenosis (ê¸°ê´€ í˜‘ì°©)\n- **ë³‘ë ¥ (History):** â˜… **ICU ì…ì› ë˜ëŠ” ì¥ê¸°ê°„ ì‚½ê´€(Intubation) ê³¼ê±°ë ¥.**\n- **ë©”ì»¤ë‹ˆì¦˜:** ì‚½ê´€ íŠœë¸Œì˜ ì»¤í”„(Cuff) ì••ë ¥ìœ¼ë¡œ ì¸í•œ í‰í„°(Scarring) í˜•ì„± â†’ ê³ ì •ëœ ì¢ì€ ê¸°ë„(Fixed rigid narrowing).\n- **íŠ¹ì§•:** ë°œê´€(Extubation) í›„ ê´œì°®ë‹¤ê°€ ëª‡ ì£¼ ë’¤ ìŒ•ìŒ•ê±°ë¦¼(Wheezing) ì‹œì‘. ì²œì‹ìœ¼ë¡œ ì˜¤ì§„í•˜ê¸° ì‰¬ì›€.\n### B. Vocal Cord Dysfunction (VCD, ì„±ëŒ€ ê¸°ëŠ¥ ë¶€ì „)\n- **ë³„ëª…:** \"The Asthma that isn't Asthma\" (ì²œì‹ì´ ì•„ë‹Œ ì²œì‹).\n- **í™˜ìêµ°:** ì Šì€ ì—¬ì„±, ìš´ë™ì„ ìˆ˜, ìŠ¤íŠ¸ë ˆìŠ¤ ìƒí™©, Type A ì„±ê²©.\n- **ì¦ìƒ:** ìˆ¨ì„ ë“¤ì´ë§ˆì‹¤ ë•Œ(Inspiration) ì„±ëŒ€ê°€ ì—´ë ¤ì•¼ í•˜ëŠ”ë° ì—­ì„¤ì ìœ¼ë¡œ ë‹«í˜(Adduct). í—ë–¡ê±°ë¦¼(Gasping).\n- **ê°ë³„ í¬ì¸íŠ¸:** ê¸°ê´€ì§€í™•ì¥ì œ(Albuterol)ë¥¼ ì¨ë„ íš¨ê³¼ ì—†ìŒ âŒ.\n- **ì§„ë‹¨:** Laryngoscopyë¡œ í¡ê¸° ì‹œ ì„±ëŒ€ê°€ ë‹«íˆëŠ” ê²ƒì„ í™•ì¸.\n- **ì¹˜ë£Œ:** **Speech Therapy (ì–¸ì–´ ì¹˜ë£Œ)** & â˜… **Sniffing Maneuver** (ê½ƒ ëƒ„ìƒˆ ë§¡ë“¯ ì½”ë¡œ í‚í‚ê±°ë¦¬ë©´ ë°˜ì‚¬ì ìœ¼ë¡œ ì„±ëŒ€ê°€ ì—´ë¦¼ - Physiological trick).\n---\n## 5. Oral Masses (ì…ì•ˆì˜ ë©ì–´ë¦¬) ğŸ‘„","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-104"}
{"chunk_type":"transcript_chunk","text":"| **ì§„ë‹¨ëª…** | **íŠ¹ì§• ë° ì†Œê²¬** | **ê´€ë¦¬/ì¹˜ë£Œ (Management)** |\n| --- | --- | --- |\n| **Torus Palatinus** | ì…ì²œì¥(Hard Palate) ì¤‘ì•™ì˜ ëŒì²˜ëŸ¼ ë”±ë”±í•œ ë©ì–´ë¦¬(Bony mass). ì•”ì´ ì•„ë‹˜. | **Leave it alone (ê´€ì°°).** ì˜ì¹˜(Denture) ì œì‘ ì‹œ ë°©í•´ë  ë•Œë§Œ ì œê±°. |\n| **Leukoplakia** | í˜€ë‚˜ ì…ì•ˆì˜ í•˜ì–€ ë°˜ì  (White patch). | **ë¨¼ì € ë‹¦ì•„ë³¸ë‹¤ (Wipe it off!).** |\n| (1) ë‹¦ì¸ë‹¤ë©´? | **Oral Thrush (Candidiasis).** ê¸°ì € ì§ˆí™˜ ì˜ì‹¬. | Anti-fungal ì¹˜ë£Œ + â˜… **HIV/Diabetes ê²€ì‚¬.** |\n| (2) ì•ˆ ë‹¦ì¸ë‹¤ë©´? | **True Leukoplakia.** ì „ì•”ì„± ë³‘ë³€(Pre-malignant) ê°€ëŠ¥ì„±. | â˜… **Biopsy (ì¡°ì§ê²€ì‚¬)** í•„ìˆ˜. (Squamous Cell Ca ë°°ì œ) |\n| **Hairy Leukoplakia** | í˜€ì˜ ì¸¡ë©´(Lateral border)ì— ê¹ƒí„¸/ì£¼ë¦„ì§„ ëª¨ì–‘. | **EBV (Epstein-Barr Virus)** ê´€ë ¨. ë©´ì—­ì €í•˜ì(HIV)ì—ì„œ ë°œìƒ. ì „ì•”ì„± ì•„ë‹˜. |\n---\n## 6. Deep Neck Space Infections (ì‹¬ê²½ë¶€ ê°ì—¼) ğŸ¦ \n### A. Retropharyngeal Abscess (ì¸ë‘í›„ ë†ì–‘)\n- **ëŒ€ìƒ:** **Toddlers (2~4ì„¸).** (Retropharyngeal ë¦¼í”„ì ˆì€ 6ì„¸ ì´í›„ í‡´í™”ë¨).\n- **ì¦ìƒ:** ê³ ì—´, ì¹¨ í˜ë¦¼, **Stiff Neck (ëª©ì„ ëª» ì›€ì§ì„).**\n- **ìœ„í—˜ì„±:** \"Danger Space\"ë¥¼ í†µí•´ ê°€ìŠ´(Mediastinum)ìœ¼ë¡œ ë†ì–‘ì´ ë‚´ë ¤ê°€ **Mediastinitis** ìœ ë°œ ê°€ëŠ¥ ğŸ’€.\n### B. Peritonsillar Abscess (í¸ë„ì£¼ìœ„ ë†ì–‘)\n- **ëŒ€ìƒ:** **Teenagers & Adults.**\n- **ì¦ìƒ:**\n    - **Trismus (ê°œêµ¬ì¥ì• ):** ì…ì„ ë²Œë¦¬ì§€ ëª»í•¨.\n    - **Hot Potato Voice:** ëœ¨ê±°ìš´ ê°ìë¥¼ ë¬¸ ë“¯í•œ ëª©ì†Œë¦¬.\n    - **Uvula Deviation:** ëª©ì –ì´ ë³‘ë³€ ë°˜ëŒ€ìª½ìœ¼ë¡œ ë°€ë ¤ë‚¨.\n- **ì¹˜ë£Œ:** Needle Aspiration (ë°”ëŠ˜ í¡ì¸) or I & D + Antibiotics.\n---\n## 7. Sinusitis (ë¶€ë¹„ë™ì—¼) ğŸ¤§\nëŒ€ë¶€ë¶„ ë°”ì´ëŸ¬ìŠ¤ì„±ì´ë¯€ë¡œ í•­ìƒì œê°€ í•„ìš” ì—†ìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ **ì„¸ê· ì„±(Bacterial)** ì„ ì‹œì‚¬í•˜ëŠ” **3ê°€ì§€ ì¡°ê±´** ì¤‘ í•˜ë‚˜ë¼ë„ ë§Œì¡±í•˜ë©´ í•­ìƒì œ(Amoxicillin-Clavulanate)ë¥¼ ì‚¬ìš©í•©ë‹ˆë‹¤.\n1. â˜… **Persistence:** ì¦ìƒì´ **10ì¼ ì´ìƒ** ì§€ì†ë˜ë©° í˜¸ì „ ì—†ìŒ.\n2. **Severe Onset:** ì‹œì‘ë¶€í„° 39ë„ ì´ìƒì˜ ê³ ì—´(102Â°F+) + í™”ë†ì„± ì½§ë¬¼(Purulent discharge)ì´ 3ì¼ ì´ìƒ ì§€ì†.\n3. **Double Sickening:** ê°ê¸°ê°€ ë‚«ëŠ” ë“¯í•˜ë‹¤ê°€(Day 5~6) ê°‘ìê¸° ë‹¤ì‹œ ê³ ì—´ê³¼ ë‘í†µìœ¼ë¡œ ì•…í™”ë¨.\n---\n## 8. Nasopharyngeal Carcinoma (ë¹„ì¸ë‘ì•”) & Neck Masses\n### Nasopharyngeal Carcinoma (NPC)\n- **ì—°ê´€ì„±:** **EBV (Epstein-Barr Virus)**, ì¤‘êµ­ ë‚¨ë¶€ ì¶œì‹ (Southern China).\n- **ì„±ì¸ì˜ Triad ì¦ìƒ:**\n    1. Nasal Congestion (ì½”ë§‰í˜).\n    2. Epistaxis (ì½”í”¼).\n    3. **Serous Otitis Media (ì‚¼ì¶œì„± ì¤‘ì´ì—¼):** ì„±ì¸ì—ì„œ í•œìª½ ê·€ì— ë¬¼ì´ ì°¼ë‹¤ë©´ ì¢…ì–‘ì´ ìœ ìŠ¤íƒ€í‚¤ì˜¤ê´€(Eustachian tube)ì„ ë§‰ê³  ìˆëŠ”ì§€ ì˜ì‹¬í•´ì•¼ í•¨.\n### Neck Masses (ê²½ë¶€ ì¢…ê´´) ìœ„ì¹˜ë³„ ê°ë³„\n- **Midline (ì •ì¤‘ì•™):**\n    - **Thyroglossal Duct Cyst:** í˜€ë¥¼ ë‚´ë°€ë©´(Protrude tongue) ë©ì–´ë¦¬ê°€ ìœ„ë¡œ ì›€ì§ì„ ğŸ‘…. (ìˆ˜ìˆ ì  ì œê±° í•„ìš” - Sistrunk procedure).\n- **Lateral (ì¸¡ë©´, SCM ê·¼ìœ¡ ì•):**\n    - **Branchial Cleft Cyst:** ì„ ì²œì„± ë‚­ì¢…. ë•Œë•Œë¡œ ëˆ„ê³µ(Fistula) í˜•ì„±.\n- **Posterior Triangle / Transilluminates:**\n    - **Cystic Hygroma (Lymphangioma):** ë¹›ì„ ë¹„ì¶”ë©´ í†µê³¼í•¨(Transilluminate). í„°ë„ˆ ì¦í›„êµ°(Turner Syndrome)ê³¼ ì—°ê´€.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-124"}
{"chunk_type":"recap_summary","text":"## 9. Rapid Fire Recap (í•µì‹¬ ìš”ì•½) ğŸ”¥\n1. **Inspiratory Stridor (Supine worse):** Laryngomalacia (Floppy tissues).\n2. **Stridor improves with Neck Extension:** Vascular Ring.\n3. **Sudden Choking + Unilateral Findings:** Foreign Body Aspiration.\n4. **Barking Cough + Steeple Sign:** Croup.\n5. **Beard Hemangioma + Stridor:** Airway Hemangioma.\n6. **Hard Palate Mass:** Torus Palatinus (Leave it alone).\n7. **White Patch (Wipes off):** Thrush (Check HIV/DM).\n8. **White Patch (Doesn't wipe):** Leukoplakia (Biopsy).\n9. **Lateral Tongue White Patch:** Hairy Leukoplakia (EBV/HIV).\n10. **Hot Potato Voice + Uvula Deviation:** Peritonsillar Abscess.\n11. **Toddler + Stiff Neck:** Retropharyngeal Abscess.\n12. **Sinusitis Antibiotics Criteria:** >10 days, Severe onset, or Double sickening.\n13. **Adult with Serous Otitis Media:** Check for Nasopharyngeal Carcinoma (NPC).\n---\n### â˜… Closing Thought: The Sound of Danger ğŸ”‡\nê°•ì˜ì˜ ë§ˆì§€ë§‰ì—ì„œ ê°•ì¡°í•œ ê°€ì¥ ì¤‘ìš”í•œ ê°œë…ì…ë‹ˆë‹¤.\n**\"Silence is not always a good sign.\" (ì¹¨ë¬µì€ í•­ìƒ ì¢‹ì€ ì‹ í˜¸ê°€ ì•„ë‹ˆë‹¤.)**\nì²œì‹ì´ë‚˜ ê¸°ë„ íì‡„ í™˜ìê°€ ìŒ•ìŒ•ê±°ë¦¬ë©° ìˆ¨ì„ ì‰¬ë‹¤ê°€(Noisy), ê°‘ìê¸° ì¡°ìš©í•´ì¡Œë‹¤ë©´?\nì´ëŠ” í™˜ìê°€ í˜¸ì „ëœ ê²ƒì´ ì•„ë‹ˆë¼, **ê³µê¸°ë¥¼ ì´ë™ì‹œí‚¬ í˜ì¡°ì°¨ ì—†ì´ ì§€ì³ë²„ë¦° ìƒíƒœ(Respiratory Failure)** ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤. ì´ë•ŒëŠ” **Silent Chest**ë¥¼ ê²½ê³„í•˜ê³  ì¦‰ì‹œ ê°œì…(Intubation ë“±)í•´ì•¼ í•©ë‹ˆë‹¤.\nì œê³µí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼(ìŠ¤í¬ë¦½íŠ¸) ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ **USMLE Step 2 CK - Upper Respiratory Tract Infection Deep Dive** ê°•ì˜ë¡ì„ ì‘ì„±í–ˆìŠµë‹ˆë‹¤. ìš”ì²­í•˜ì‹  ê·œì¹™ì„ ì—„ê²©íˆ ì¤€ìˆ˜í•˜ì—¬ ë¶„ì„ëœ ë‚´ìš©ì…ë‹ˆë‹¤.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-142"}
{"chunk_type":"transcript_chunk","text":"### **0. Verify (ê²€ì¦): 0:00~0:30 Dictation**\n> \"Welcome back to the deep dive. Today we are putting the textbooks aside and uh getting right into the trenches. We are tackling a topic that feels, you know, incredibly routine on the surface, sniffles, sore throats, coughs, but it actually carries some of the highest stakes you'll face on the USMLE Step 2. And in the emergency room frankly.\"\n>\n---\n# ğŸ“ USMLE Step 2 CK: Upper Respiratory Tract & Airway Emergencies Deep Dive\nì´ ê°•ì˜ëŠ” ë‹¨ìˆœí•œ êµê³¼ì„œì  ì§€ì‹ì´ ì•„ë‹Œ, **\"Sick vs Not Sick\" (ìœ„ê¸‰í•œê°€ ì•„ë‹Œê°€)** ì„ ìˆœì‹ê°„ì— íŒë‹¨í•´ì•¼ í•˜ëŠ” ì„ìƒì  ì§ê´€ê³¼ USMLE ì‹œí—˜ì˜ í•¨ì •ì„ í”¼í•˜ëŠ” **Decision Tree**ë¥¼ êµ¬ì¶•í•˜ëŠ” ë° ì´ˆì ì„ ë§ì¶¥ë‹ˆë‹¤.\n## 1. Introduction: The Core Mindset ğŸ§ \n- **Routine but Deadly:** ì½§ë¬¼, ì¸í›„í†µ, ê¸°ì¹¨ì€ í”í•˜ì§€ë§Œ, ì´ ì£¼ì œëŠ” USMLE Step 2ì™€ ì‘ê¸‰ì‹¤ì—ì„œ ê°€ì¥ **High Stakes (ìƒëª…ì´ ì˜¤ê°€ëŠ”)** ìƒí™©ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n- **Pattern Recognition:** ì‹œí—˜ê´€ì€ ë‹¹ì‹ ì´ 'ì½§ë¬¼'ì„ ì‹ë³„í•˜ëŠ”ì§€ ë³´ëŠ” ê²Œ ì•„ë‹ˆë¼, **Clinical Vignette(ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤)** ë¥¼ ë³´ê³  1ì´ˆ ë§Œì— íŒ¨í„´ì„ ì¸ì‹í•˜ëŠ”ì§€ ë´…ë‹ˆë‹¤.\n- **The Decision:** í™˜ìë¥¼ ì•ˆì‹¬ì‹œì¼œ ê·€ê°€ì‹œí‚¬ ê²ƒì¸ê°€(Reassurance), ì•„ë‹ˆë©´ ê¸°ë„ë¥¼ í™•ë³´í•˜ì§€ ì•Šìœ¼ë©´ ë‚´ ëˆˆì•ì—ì„œ ì‚¬ë§í•  ê²ƒì¸ê°€(Airway emergency)?\n---\n## 2. Epiglottitis (í›„ë‘ê°œì—¼) - The Airway Emergency ğŸš¨\n### Clinical Vignette (ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤)\n- ì•„ì´ë‚˜ ì„±ì¸ì´ ë§¤ìš° **Toxic(ë…ì„±/ìœ„ì¤‘)** í•´ ë³´ì„.\n- **The 4 Ds (í•µì‹¬ ì¦ìƒ):**\n    1. **D**rooling (ì¹¨ í˜ë¦¼ - ì‚¼í‚¤ì§€ ëª»í•´ì„œ)\n    2. **D**ysphagia (ì—°í•˜ê³¤ë€)\n    3. **D**istress (í˜¸í¡ê³¤ë€/ê´´ë¡œì›€)\n    4. **D**yspnea (í˜¸í¡ê³¤ë€)\n- **Tripod Position (ì‚¼ê°ëŒ€ ìì„¸):** ì•‰ì•„ì„œ ëª¸ì„ ì•ìœ¼ë¡œ ìˆ™ì´ê³  ëª©ì„ ê¸¸ê²Œ ë¹¼ë©°(Extending neck), ì†ìœ¼ë¡œ ë¬´ë¦ì„ ì§šê³  ìˆëŠ” ìì„¸.\n    - â˜… **Physiology:** ì¤‘ë ¥ì„ ì´ìš©í•´ ë¶€ì€ í›„ë‘ê°œ(Epiglottis)ë¥¼ ê¸°ë„ë¡œë¶€í„° ë–¨ì–´ëœ¨ë ¤ ìˆ¨ê¸¸ì„ í™•ë³´í•˜ë ¤ëŠ” ìƒì¡´ ë³¸ëŠ¥ì  ìì„¸. ì ˆëŒ€ ëˆ•íˆë©´ ì•ˆ ë¨(Trap doorê°€ ë‹«í˜).\n### Diagnosis & Pathogen (ì§„ë‹¨ ë° ì›ì¸ê· )\n- **Difference from Croup:**\n    - **Croup:** Subglottic(ì„±ëŒ€ í•˜ë¶€) ë¬¸ì œ. \"Barking cough(ì§–ëŠ” ê¸°ì¹¨)\". ë¶„ë¹„ë¬¼ì„ ì²˜ë¦¬í•  ìˆ˜ ìˆìŒ.\n    - **Epiglottitis:** Supraglottic(ì„±ëŒ€ ìƒë¶€) ë¬¸ì œ. **\"Hot potato voice(ì›…ì–¼ê±°ë¦¬ëŠ” ëª©ì†Œë¦¬)\"**. ì¹¨ì„ ì‚¼í‚¤ì§€ ëª»í•´ í˜ë¦¼.\n- **Epidemiology:** ê³¼ê±°ì—” *H. influenzae type B (Hib)* ê°€ ì™•ì´ì—ˆìœ¼ë‚˜ ë°±ì‹ ìœ¼ë¡œ ê°ì†Œ. í˜„ì¬ëŠ” **S. pneumoniae, S. aureus**, Non-typeable H. fluê°€ ì£¼ì›ì¸. (ë°±ì‹  ë¯¸ì ‘ì¢…ìë‚˜ ì´ë¯¼ìì—ì„œëŠ” ì—¬ì „íˆ Hib ê°€ëŠ¥ì„± ìˆìŒ).\n- **Diagnostic Imaging:**\n    - â˜… **Thumbprint Sign (ì—„ì§€ì†ê°€ë½ ì§•í›„):** Lateral Neck X-rayì—ì„œ í›„ë‘ê°œê°€ ì—„ì§€ì†ê°€ë½ì²˜ëŸ¼ ë¶€ì–´ ë³´ì„ (ì •ìƒì€ ì–‡ì€ ì†ê°€ë½ ëª¨ì–‘).\n    - **ì£¼ì˜:** ë¶ˆì•ˆì •í•œ ì•„ì´ì˜ ëª©ì„ ì–µì§€ë¡œ ë³´ë ¤ í•˜ì§€ ë§ˆë¼(Tongue depressor ì‚¬ìš© ê¸ˆì§€). Laryngospasm(í›„ë‘ê²½ë ¨)ì„ ìœ ë°œí•˜ì—¬ ê¸°ë„ë¥¼ ì™„ì „íˆ ë§‰ì„ ìˆ˜ ìˆìŒ.\n### Management (ì¹˜ë£Œ) - Order matters!\n1. â˜… **Secure the Airway:** ì´ê²ƒì´ ìµœìš°ì„ (Priority #1). ìˆ˜ìˆ ì‹¤(OR) ë“± í†µì œëœ í™˜ê²½ì—ì„œ ê°€ì¥ ìˆ™ë ¨ëœ ì‚¬ëŒì´ ì‚½ê´€(Intubation) ì¤€ë¹„. (ì•ˆ ë˜ë©´ Surgical Cricothyrotomy ì¤€ë¹„).\n2. **Antibiotics:** **IV Ceftriaxone + Vancomycin** (Broad coverage).\n3. **Do NOT agitate:** ì•„ì´ë¥¼ ìš¸ë¦¬ë©´ í¡ê¸°ì••(Inspiratory negative pressure)ì´ ë†’ì•„ì ¸ ê¸°ë„ê°€ íì‡„ë  ìˆ˜ ìˆìŒ.\n---\n## 3. Retropharyngeal Abscess (ì¸ë‘í›„ ë†ì–‘) ğŸ§±\n### Anatomy & Danger\n- **ìœ„ì¹˜:** ì¸ë‘ë²½(Pharyngeal wall)ê³¼ ì²™ì¶” ì• ê·¼ë§‰(Prevertebral fascia) ì‚¬ì´ì˜ ê³µê°„.\n- **Danger Space:** ì´ ê³µê°„ì€ í‰ê³½(Posterior Mediastinum)ê¹Œì§€ ì—°ê²°ë˜ì–´ ìˆì–´, ê³ ë¦„ì´ ë‚´ë ¤ê°€ë©´ **Acute Necrotizing Mediastinitis (ê¸‰ì„± ê´´ì‚¬ì„± ì¢…ê²©ë™ì—¼)** ë¼ëŠ” ì¹˜ëª…ì ì¸ í•©ë³‘ì¦ ìœ ë°œ ê°€ëŠ¥ ğŸ’€.\n### Clinical Features (ì„ìƒ íŠ¹ì§•)","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-152"}
{"chunk_type":"transcript_chunk","text":"- **Target Demographic:**\n    - **ì–´ë¦° ì•„ì´ (2~4ì„¸):** Retropharyngeal lymph nodesê°€ í¬ê¸° ë•Œë¬¸ (ë‚˜ì´ ë“¤ë©´ í‡´í™”). URI í›„ ë¦¼í”„ì ˆì´ ê³ªìŒ.\n    - **ì„±ì¸/í° ì•„ì´:** â˜… **Trauma (ì™¸ìƒ)** ë³‘ë ¥. ì˜ˆ: **\"Swallowing a fish bone\" (ìƒì„  ê°€ì‹œ ì‚¼í‚´)** í˜¹ì€ ì¹˜í‚¨ ìœ™ ë¨¹ê³  ë‚œ ë’¤.\n- **Symptoms:** ê³ ì—´(Fever), ì—°í•˜í†µ(Odynophagia).\n- **Physical Exam Clue:** â˜… **Limited Neck Extension (ëª© ì‹ ì „ ì œí•œ).**\n    - ê³ ë¦„ì´ ì²™ì¶” ì•ì— ìˆì–´ ëª©ì„ ë’¤ë¡œ ì –íˆë©´(Extension) í†µì¦ì´ ì‹¬í•´ ë»£ë»£í•˜ê²Œ êµ³ìŒ(Rigidity).\n### Diagnosis & Management\n- **Imaging:**\n    - **X-ray:** **Widened Prevertebral Space** (ì²™ì¶” ì• ì—°ì¡°ì§ì´ ì²™ì¶”ë¼ˆ ëª¸í†µë³´ë‹¤ ë‘êº¼ì›Œì§).\n        - *Rule of thumb:* C2 ë ˆë²¨ì—ì„œ 7mm, C6 ë ˆë²¨ì—ì„œ 14mm ì´ìƒì´ë©´ ì˜ì‹¬.\n    - **CT Scan with Contrast:** í™•ì§„ì„ ìœ„í•œ **Gold Standard**. ë‹¨ìˆœ ì—°ì¡°ì§ì—¼(Cellulitis)ì¸ì§€ ë†ì–‘(Abscess)ì¸ì§€ êµ¬ë¶„.\n- **Treatment:** **Surgical Drainage** + Antibiotics.\n---\n## 4. Peritonsillar Abscess (PTA, í¸ë„ì£¼ìœ„ ë†ì–‘) ğŸ¥”\n### Concept\n- **Tonsillitis Complication:** í¸ë„ì—¼ì´ ì‹¬í•´ì ¸ í¸ë„ ì˜† ê³µê°„(Peritonsillar space)ì— ê³ ë¦„ì´ ì°¸.\n- **Key Distinction:** í¸ë„ì—¼(Tonsillitis)ì€ í¸ë„ ìì²´ì˜ ê°ì—¼, PTAëŠ” í¸ë„ *ì˜†*ì˜ ê³ ë¦„ì£¼ë¨¸ë‹ˆ.\n### The \"Aha!\" Moments (ì§„ë‹¨ í¬ì¸íŠ¸)\n1. â˜… **Trismus (ê°œêµ¬ì¥ì• /Lockjaw):** ì…ì„ ë²Œë¦¬ì§€ ëª»í•¨. ì—¼ì¦ì´ ìµìƒê·¼(Pterygoid muscle - ì”¹ëŠ” ê·¼ìœ¡)ìœ¼ë¡œ í¼ì¡Œê¸° ë•Œë¬¸. ë‹¨ìˆœ ì¸ë‘ì—¼ì—ì„œëŠ” ë³´ì´ì§€ ì•ŠìŒ.\n2. **Uvula Deviation (ëª©ì – í¸ìœ„):** ë†ì–‘ì´ ëª©ì –ì„ **ë°˜ëŒ€ìª½(Away from affected side)** ìœ¼ë¡œ ë°€ì–´ëƒ„. (mass effect)\n3. **Hot Potato Voice:** ì…ì•ˆì— ëœ¨ê±°ìš´ ê°ìë¥¼ ë¬¸ ë“¯í•œ ì›…ì–¼ê±°ë¦¬ëŠ” ëª©ì†Œë¦¬.\n### Management\n- **Drainage is Key:** í•­ìƒì œë§Œìœ¼ë¡œëŠ” ì¹¨íˆ¬ê°€ ì–´ë ¤ì›€.\n    - **Needle Aspiration (ë°”ëŠ˜ í¡ì¸)** ë˜ëŠ” **I&D (Incision and Drainage)**.\n    - ì´í›„ Antibiotics ì¶”ê°€.\n- **CT Scan:** ì„ìƒ ì¦ìƒ(Trismus + Uvula deviation)ì´ ëª…í™•í•˜ë©´ êµ³ì´ CT ì°ì„ í•„ìš” ì—†ìŒ.\n---\n## 5. Bacterial Tracheitis (ì„¸ê· ì„± ê¸°ê´€ì—¼) - The \"Croup Imposter\" ğŸ­\n### Clinical Narrative (ì´ì•¼ê¸° íë¦„)\n- **Scenario:** ì•„ì´ê°€ ë©°ì¹  ì „ Croup(ë°”ì´ëŸ¬ìŠ¤ì„±) ì§„ë‹¨ì„ ë°›ìŒ. ì¡°ê¸ˆ í˜¸ì „ë˜ëŠ” ë“¯í•˜ë‹¤ê°€ ê°‘ìê¸° **\"Sick as shit\" (ë§¤ìš° ìœ„ì¤‘í•´ì§)** ìƒíƒœê°€ ë¨.\n- **Symptoms:** ê³ ì—´, ì‹¬í•œ í˜¸í¡ê³¤ë€, ë…ì„±(Toxic) ì™¸ëª¨.\n- **Pathogen:** **Staphylococcus aureus** (Viral croupì´ ì ë§‰ì„ ì†ìƒì‹œí‚¨ í›„ ì¹¨íˆ¬í•˜ëŠ” 2ì°¨ ê°ì—¼).\n### Diagnosis (í•¨ì • í”¼í•˜ê¸°)\n- **Croupê³¼ì˜ ì°¨ì´ì :** Croup ì¹˜ë£Œì œì¸ **Racemic Epinephrine(ë¼ì„¸ë¯¹ ì—í”¼ë„¤í”„ë¦°)ì— ë°˜ì‘í•˜ì§€ ì•ŠìŒ**.\n- **X-ray Trap:** X-rayì—ì„œ Croupì²˜ëŸ¼ **Steeple Sign(ì²¨íƒ‘ ì§•í›„)** ì´ ë³´ì¼ ìˆ˜ ìˆìŒ! X-rayë§Œ ë¯¿ê³  Croupì´ë¼ ìƒê°í•˜ë©´ ì•ˆ ë¨.\n- **Definitive Diagnosis:** **Endoscopy (ë‚´ì‹œê²½)** or **Bronchoscopy**.\n    - â˜… **Findings:** **Thick Purulent Secretions (Pseudomembranes)** - ë‘êº¼ìš´ ê³ ë¦„ ë”±ì§€ê°€ ê¸°ë„ë¥¼ ë§‰ê³  ìˆìŒ.\n### Management\n- **Intubation:** ë‹¨ìˆœí•œ í˜¸í¡ ë³´ì¡°ê°€ ì•„ë‹ˆë¼, **Toileting (ì„¸ì²™/í¡ì¸)** ì„ ìœ„í•´ í•„ìš”. ë‘êº¼ìš´ ê³ ë¦„ì„ ë¹¨ì•„ë‚´ì•¼ í•¨.\n- **Antibiotics:** IV Antibiotics.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-172"}
{"chunk_type":"transcript_chunk","text":"## 6. Acute Rhinosinusitis (ê¸‰ì„± ë¹„ë¶€ë¹„ë™ì—¼) ğŸ‘ƒ\n### Viral vs. Bacterial (ë°”ì´ëŸ¬ìŠ¤ì„± vs ì„¸ê· ì„±)\n- 98%ëŠ” ë°”ì´ëŸ¬ìŠ¤ì„±. í•­ìƒì œ ë¶ˆí•„ìš”. \"Wait and see\".\n- **Bacterial Sinusitis Criteria (í•­ìƒì œë¥¼ ì“°ëŠ” 3ê°€ì§€ ì¡°ê±´):** ë‹¤ìŒ ì¤‘ **í•˜ë‚˜ë¼ë„** í•´ë‹¹ë˜ë©´ ì„¸ê· ì„± ì˜ì‹¬.\n    1. â˜… **Persistence (ì§€ì†ì„±):** ì¦ìƒì´ **10ì¼ ì´ìƒ** ì§€ì†ë˜ë©° í˜¸ì „ ì—†ìŒ.\n    2. â˜… **Severity (ì‹¬ê°ì„±):** ê³ ì—´(>39Â°C) + í™”ë†ì„± ì½§ë¬¼/ì•ˆë©´ í†µì¦ì´ **3ì¼ ì´ìƒ** ì§€ì†.\n    3. â˜… **Double Sickening (ì´ì¤‘ ì•…í™”):** ê°ê¸°ê°€ ë‚«ëŠ” ë“¯í•˜ë‹¤ê°€(5~6ì¼ì°¨) ê°‘ìê¸° ë‹¤ì‹œ ê³ ì—´ê³¼ ë‘í†µì´ ìƒê¸°ë©° ì•…í™”ë¨ (\"Worsening after improvement\").\n### Clinical Signs & Treatment\n- **Physical Exam:**\n    - **Shoe-tying Sign:** ì‹ ë°œ ëˆì„ ë¬¶ìœ¼ë ¤ê³  í—ˆë¦¬ë¥¼ ìˆ™ì´ë©´(Leaning forward) ì•ˆë©´ í†µì¦/ì••ë ¥ì´ ì‹¬í•´ì§.\n    - **Maxillary Tooth Pain:** ìœ„ìª½ ì¹˜ì•„ í†µì¦ (ìƒì•…ë™ì´ ì¹˜ì•„ ë¿Œë¦¬ì™€ ê°€ê¹ê¸° ë•Œë¬¸).\n- **Bugs:** *S. pneumoniae, H. influenzae, Moraxella catarrhalis*.\n- **Treatment:**\n    - 1st Line: **Amoxicillin-Clavulanate**.\n    - **Avoid:** Macrolides (Azithromycin ë“±)ëŠ” ë‚´ì„± ë•Œë¬¸ì— ë” ì´ìƒ ì¶”ì²œë˜ì§€ ì•ŠìŒ.\n    - **ICU Context:** ë¹„ìœ„ê´€(NG tube)ì´ë‚˜ ì‚½ê´€ëœ í™˜ìê°€ ì›ì¸ ë¶ˆëª…ì˜ ì—´ì´ ë‚œë‹¤ë©´? -> Sinusitis ì˜ì‹¬ (íŠœë¸Œê°€ ë°°ì¶œêµ¬ë¥¼ ë§‰ìŒ). ì§„ë‹¨ì€ CT.\n---\n## 7. Laryngeal Papillomatosis (í›„ë‘ ìœ ë‘ì¢…) ğŸ—£ï¸\n- **Cause:** **HPV 6 & 11**. (Vertical transmission - ì—„ë§ˆë¡œë¶€í„° ì‚°ë„ ê°ì—¼).\n- **Symptom:** ì•„ì´ê°€ ì‰° ëª©ì†Œë¦¬(**Hoarseness**)ë¥¼ ëƒ„.\n- **Findings:** ì„±ëŒ€(Vocal cords)ì— **Finger-shaped growths (Warts/ì‚¬ë§ˆê·€)**.\n- **Treatment:** **Surgical Debridement (ìˆ˜ìˆ ì  ì œê±°)**. ì¬ë°œì´ ì¦ì•„ ì—¬ëŸ¬ ë²ˆ ìˆ˜ìˆ í•´ì•¼ í•  ìˆ˜ ìˆìŒ (\"Recurrent\").\n- DDx with laryngomalacia: worse when supine, 18ê°œì›” ì´í›„ ì¢‹ì•„ì§ (LPëŠ” ì•ˆì¢‹ì•„ì§), inspiratory stridor.\n- smoking audlt: oropharyngeal carcinoma (HPV 16)\n---\n## ğŸ”¥ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n1. **Epiglottitis:** Drooling + Tripod + Toxic. **Thumbprint sign**. **Secure Airway** first! (OR). Ceft+vancomycin\n2. **Retropharyngeal Abscess:** Neck pain + **Inability to extend neck**. Fish bone history. Widened prevertebral space.\n3. **Peritonsillar Abscess:** **Trismus** (Lockjaw) + **Uvula deviation**. Drainage needed.\n4. **Bacterial Tracheitis:** Croup that got toxic (\"Sick as shit\"). **No response to Racemic Epi**. Thick pus(bronchoscopy)\n5. **Bacterial Sinusitis Criteria:** >10 days, Severe onset (>3 days), or **Double Sickening**. Treat with Amox-Clav.\n6. **Laryngeal Papillomatosis:** Child with hoarseness + Warts on cords. HPV 6/11. Surgery.\n---\n### ğŸ’¡ Provocative Final Thought\n\"ì „ìŸ(ê°ì—¼)ì€ ì (ë³‘ì›ê· )ì´ ìµìˆ™í•´ ë³´ì´ë”ë¼ë„ ì–‘ìƒì´ ë³€í•©ë‹ˆë‹¤. ë°±ì‹ ìœ¼ë¡œ ì¸í•´ Epiglottitisì˜ ì›ì¸ê· ì´ ë³€í•˜ê³ , í•­ìƒì œ ë‚´ì„±ìœ¼ë¡œ Sinusitis ì¹˜ë£Œì œê°€ ë³€í•˜ë“¯, **Clinical Presentation(ì„ìƒ ì–‘ìƒ)** ì€ ë³€í•˜ì§€ ì•Šì§€ë§Œ **Epidemiology(ì—­í•™)** ëŠ” ê³„ì† ë³€í•©ë‹ˆë‹¤. í•´ë¶€í•™ì  êµ¬ì¡°(Anatomy)ë¥¼ ë¨¸ë¦¿ì†ì— ì‹œê°í™”í•˜ê³  'Sick vs Not Sick'ì„ êµ¬ë³„í•˜ëŠ” ê²ƒì´ Step 2ì˜ í•µì‹¬ì…ë‹ˆë‹¤.\"\nì œê³µí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ **USMLE Step 2 CK - Rhinitis & Neck Masses Deep Dive** ê°•ì˜ë¡ì„ ì‘ì„±í–ˆìŠµë‹ˆë‹¤. ìš”ì²­í•˜ì‹  ê·œì¹™ì„ ì—„ê²©íˆ ì¤€ìˆ˜í•˜ì—¬ ë¶„ì„ëœ ë‚´ìš©ì…ë‹ˆë‹¤.\n---\n### **0. Verify (ê²€ì¦): 0:00~0:30 Dictation**\n> \"Welcome back to the deep dive. Today we're tackling something pretty specific. We're sifting through uh a whole stack of high yield notes clinical guidelines all focused on the USMLE Step 2. And what's really obvious reading this stuff is how different it is from Step 1. It feels like the training wheels are off. It really is a different beast. Step 1 was all about the how, you know, what's the mechanism, what's the biochemistry. Step 2 is it's much more pragmatic. It's asking what do you do right now.\"\n>\n---\n# ğŸ“ USMLE Step 2 CK: Rhinitis & Neck Masses Deep Dive","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-192"}
{"chunk_type":"transcript_chunk","text":"ì´ ê°•ì˜ëŠ” USMLE Step 2ì˜ ì‹¤ìš©ì ì¸ ì ‘ê·¼ë²•(Pragmatic approach)ì— ì´ˆì ì„ ë§ì¶¥ë‹ˆë‹¤. ë‹¨ìˆœíˆ ê¸°ì „ì„ ì•„ëŠ” ê²ƒ(Step 1)ì„ ë„˜ì–´, **\"ì§€ê¸ˆ ë‹¹ì¥ ë¬´ì—‡ì„ í•´ì•¼ í•˜ëŠ”ê°€?\"** ë¥¼ ê²°ì •í•˜ëŠ” Decision Treeë¥¼ êµ¬ì¶•í•©ë‹ˆë‹¤.\n## 1. Introduction: Step 2 Mindset ğŸ§ \n- **No Training Wheels:** Step 1ì´ ìƒí™”í•™ê³¼ ê¸°ì „(How)ì´ì—ˆë‹¤ë©´, Step 2ëŠ” **Hospital Ward(ë³‘ë™)** ì…ë‹ˆë‹¤.\n- **The Missing Adjective:** ì‹œí—˜ ì¶œì œìë“¤ì€ í™˜ì ë³‘ë ¥ì—ì„œ **í˜•ìš©ì‚¬ í•˜ë‚˜**ë¥¼ ë¹ ëœ¨ë¦¬ê±°ë‚˜ ìˆ¨ê²¨ì„œ ì ìˆ˜ë¥¼ ê°€ë¦…ë‹ˆë‹¤. (ì˜ˆ: \"Allergic\" vs \"Non-allergic\").\n- **Target Topics:** ì˜¤ëŠ˜ ë‹¤ë£° 3ê°€ì§€ ì£¼ì œëŠ” ì¦ìƒì´ ê²¹ì³ì„œ í—·ê°ˆë¦¬ê¸° ì‰¬ìš´ **Rhinitis (ë¹„ì—¼), Neck Masses (ê²½ë¶€ ì¢…ê´´), Septal Hematomas (ë¹„ì¤‘ê²© í˜ˆì¢…)** ì…ë‹ˆë‹¤.\n---\n## 2. The Runny Nose: Rhinitis Decision Tree ğŸ‘ƒ\nì½§ë¬¼ì´ íë¥´ëŠ” í™˜ìë¥¼ ë³´ì•˜ì„ ë•Œ, ê°€ì¥ ë¨¼ì € ë‚´ë ¤ì•¼ í•  ê²°ì •ì€ **\"Allergic(ì•Œë ˆë¥´ê¸°ì„±)ì¸ê°€ Non-allergic(ë¹„ì•Œë ˆë¥´ê¸°ì„±)ì¸ê°€?\"** ì…ë‹ˆë‹¤.\n### A. Allergic Rhinitis (ì•Œë ˆë¥´ê¸° ë¹„ì—¼) ğŸ¤§\n- **The Clue:** ëˆˆ(Eyes).\n    - **Ocular Itching & Tearing:** í™˜ìê°€ ëˆˆì„ ë¹„ë¹„ê³  ìˆë‹¤ë©´ ê±°ì˜ í™•ì‹¤íˆ ì•Œë ˆë¥´ê¸°ì…ë‹ˆë‹¤.\n- **Physical Exam Signs:**\n    - **Allergic Shiners:** ëˆˆ ë°‘ ì •ë§¥ ìš¸í˜ˆë¡œ ì¸í•œ ë‹¤í¬ì„œí´.\n    - **Allergic Salute:** ì½”ë¥¼ ì†ë°”ë‹¥ìœ¼ë¡œ ìœ„ë¡œ ë°€ì–´ ì˜¬ë¦¬ëŠ” í–‰ë™(ê°€ë ¤ì›Œì„œ).\n    - â˜… **Transverse Nasal Crease:** Allergic Saluteë¥¼ ìˆ˜ë…„ê°„ ë°˜ë³µí•´ì„œ ìƒê¸´ ì½§ë“±ì˜ ê°€ë¡œ ì£¼ë¦„.\n    - **Allergic Facies:** High-arched palate(ë†’ì€ ì…ì²œì¥), Open-mouth breathing(êµ¬í˜¸í¡).\n- **The Money Shot (Internal Exam):** ë¹„ê²½ ê²€ì‚¬ ì‹œ ë¹„ì ë§‰(Nasal mucosa)ì´ **Pale, Boggy, Blueish (ì°½ë°±í•˜ê³ , ë¬¼ê¸°ê°€ ë§ê³ , í‘¸ë¥´ìŠ¤ë¦„í•¨).**\n- **Treatment:**\n    - **Allergen Avoidance (íšŒí”¼ìš”ë²•).**\n    - **Intranasal Corticosteroids (ë¹„ê°• ìŠ¤í…Œë¡œì´ë“œ).**\n### B. Non-Allergic Rhinitis (NAR, í˜ˆê´€ìš´ë™ì„± ë¹„ì—¼) ğŸ›‘\n- **Patient Profile:** 30ì„¸ ì´ìƒì˜ ì„±ì¸ (ì¦ìƒ ë°œí˜„ì´ 20ì„¸ ì´í›„ë¡œ ëŠ¦ìŒ).\n- **Symptoms:** 1ë…„ ë‚´ë‚´ ì½”ë§‰í˜(Perennial), ëˆˆ ì¦ìƒ ì—†ìŒâŒ, ì¬ì±„ê¸° ë°œì‘ ì—†ìŒâŒ.\n- **Internal Exam:** ë¹„ì ë§‰ì´ **Beefy Red (ì†Œê³ ê¸°ì²˜ëŸ¼ ë¶‰ê³ ), Erythematous (ë°œì ë¨).** í™”ë‚œ ê²ƒì²˜ëŸ¼ ë³´ì„(Inflamed/Angry).\n- **Treatment:**\n    - **Avoidance:** ì•Œë ˆë¥´ê¸° í•­ì› íšŒí”¼ëŠ” íš¨ê³¼ ì—†ìŒ.\n    - **Management:** ì¦ìƒì´ ì¤‘ë“±ë„ ì´ìƒ(Moderate to Severe)ì´ë©´ **Combination Therapy** (Intranasal Antihistamine + Corticosteroid)ë¡œ ê³µê²©ì ì¸ ì¹˜ë£Œ í•„ìš”.\n### C. Rhinitis Medicamentosa (ì•½ë¬¼ ìœ ë°œì„± ë¹„ì—¼) ğŸ’Š\n- **Cause:** ì²˜ë°©ì „ ì—†ì´ ì‚´ ìˆ˜ ìˆëŠ” ë¹„ì¶©í˜ˆ ì œê±°ì œ ìŠ¤í”„ë ˆì´(**Afrin/Phenylephrine** ë“±) ì¤‘ë….\n- **Mechanism:** 3ì¼ ì´ìƒ ì‚¬ìš© ì‹œ ìˆ˜ìš©ì²´(Receptor)ê°€ í•˜í–¥ ì¡°ì ˆ(Down-regulation)ë˜ì–´, ì•½ì„ ëŠìœ¼ë©´ ë°˜ë™ì„±ìœ¼ë¡œ ì½”ê°€ ë” ë§‰í˜(**Rebound Congestion**).\n- **Treatment:** **Stop the spray immediately** + Start **Nasal Glucocorticoids**. (í™˜ìì—ê²Œ ë§¤ìš° í˜ë“  ì£¼ê°„ì´ ë  ê²ƒì„).\n---\n## 3. Acute Rhinosinusitis (ê¸‰ì„± ë¹„ë¶€ë¹„ë™ì—¼) Decision ğŸ¦ \nê°€ì¥ í° í•¨ì •ì€ **Viral(ë°”ì´ëŸ¬ìŠ¤ì„±)** ê³¼ **Bacterial(ì„¸ê· ì„±)** ì˜ êµ¬ë¶„ì…ë‹ˆë‹¤. ëŒ€ë¶€ë¶„ì€ ë°”ì´ëŸ¬ìŠ¤ì„±ì…ë‹ˆë‹¤.\n### Bacterial Sinusitis Criteria (í•­ìƒì œ íˆ¬ì—¬ ê¸°ì¤€)\nUSMLEëŠ” í•­ìƒì œë¥¼ ì–¸ì œ ì“¸ì§€ ì •í™•í•œ íƒ€ì´ë°ì„ ë¬»ìŠµë‹ˆë‹¤. ë‹¤ìŒ 3ê°€ì§€ ì¤‘ í•˜ë‚˜ë¥¼ ë§Œì¡±í•´ì•¼ í•©ë‹ˆë‹¤. ë°•í…Œë¦¬ì•„ê°€ ì˜ì‹¬ë ë•Œ!\n1. â˜… **Duration:** ì¦ìƒì´ **10ì¼ ì´ìƒ** ì§€ì†ë˜ë©° í˜¸ì „ ì—†ìŒ.\n2. â˜… **Severity:** ê³ ì—´(>39Â°C) + í™”ë†ì„± ì½§ë¬¼/ì•ˆë©´ í†µì¦ì´ **3ì¼ ì´ìƒ** ì§€ì†.\n3. â˜… **Double Sickening:** ê°ê¸°ê°€ ë‚«ëŠ” ë“¯í•˜ë‹¤ê°€(Day 4~5) ê°‘ìê¸° ë‹¤ì‹œ ê³ ì—´ê³¼ ë‘í†µìœ¼ë¡œ ì•…í™”ë¨ (\"Biphasic pattern\"). ë°”ì´ëŸ¬ìŠ¤ì˜€ë‹¤ê°€ ë‘ë²ˆì§¸ ëŠ”ë°•í…Œë¦¬ì•„ë¼ê³  ì˜ì‹¬í•˜ëŠ”ìƒí™©.\n### ICU Context Trap ğŸ¥\n- **Scenario:** ì¤‘í™˜ìì‹¤(ICU)ì—ì„œ ì‚½ê´€(Intubated)ë˜ì—ˆê±°ë‚˜ ë¹„ìœ„ê´€(NG tube)ì„ ë‚€ í™˜ìê°€ ì›ì¸ ë¶ˆëª…ì˜ ì—´ì´ ë‚¨.\n- **Diagnosis:** **Sinusitis.** íŠœë¸Œê°€ ë¶€ë¹„ë™ ë°°ì¶œêµ¬(Drainage holes)ë¥¼ ë§‰ì•„ ê³ ë¦„ì´ ì°¸.\n- **Action:** ì§„ë‹¨ì„ ìœ„í•´ **CT Scan** í•„ìš” (í™˜ìê°€ ì¦ìƒì„ ë§ ëª» í•˜ë¯€ë¡œ).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-212"}
{"chunk_type":"transcript_chunk","text":"---\n## 4. Septal Hematoma (ë¹„ì¤‘ê²© í˜ˆì¢…) - An Emergency ğŸš¨\n- **Scenario:** ì½”ë¥¼ ë¶€ë”ªíŒ ì•„ì´(Nasal trauma).\n- **Exam Finding:** ë¹„ì¤‘ê²©(Septum)ì— **Soft, Fluctuant Swelling (ë§ë‘ë§ë‘í•œ ë¶“ê¸°)**.\n- **Why the Panic?:** ë¹„ì¤‘ê²© ì—°ê³¨(Cartilage)ì€ í˜ˆê´€ì´ ì—†ìŠµë‹ˆë‹¤(Avascular). ì—°ê³¨ë§‰(Perichondrium)ì—ì„œ ì˜ì–‘ì„ ê³µê¸‰ë°›ëŠ”ë°, í˜ˆì¢…(í”¼ ê³ ì„)ì´ ì´ ê³µê¸‰ì„ ì°¨ë‹¨í•©ë‹ˆë‹¤.\n- **Consequence:** ì—°ê³¨ì´ êµ¶ì–´ ì£½ìŒ(Necrosis) â†’ **Saddle Nose Deformity (ì•ˆì¥ì½” ë³€í˜•)** + **Septal Perforation (ë¹„ì¤‘ê²© ì²œê³µ)**.\n    - *Exam Pearl:* ì™¸ìƒ í›„ í˜¸í¡ ì‹œ **Whistling sound (íœ˜íŒŒëŒ ì†Œë¦¬)** ê°€ ë“¤ë¦°ë‹¤ë©´ ì´ë¯¸ ì²œê³µëœ ê²ƒ.\n- **Treatment:** â˜… **Immediate Incision and Drainage (I&D).** ê¸°ë‹¤ë¦¬ë©´ ì•ˆ ë¨.\n---\n## 5. Neck Masses: Location is King ğŸ“\nëª©ì— ë§Œì ¸ì§€ëŠ” ë©ì–´ë¦¬ëŠ” **ìœ„ì¹˜(Location)** ë¡œ ì§„ë‹¨í•©ë‹ˆë‹¤.\n### A. Midline Masses (ì •ì¤‘ì•™)\n- **Thyroglossal Duct Cyst (ê°‘ìƒì„  ì„¤ê´€ ë‚­ì¢…):**\n    - **Embryology:** ê°‘ìƒì„ ì´ í˜€ ê¸°ì €ë¶€ì—ì„œ ë‚´ë ¤ì˜¤ë©´ì„œ ìƒê¸´ ê´€(Tract)ì´ ë‚¨ìŒ.\n    - **Key Sign:** â˜… **Moves UP with swallowing or tongue protrusion.** (í˜€ë¥¼ ë‚´ë°€ê±°ë‚˜ ì‚¼í‚¬ ë•Œ ë©ì–´ë¦¬ê°€ ìœ„ë¡œ ì˜¬ë¼ê°).\n    - **Treatment:** **Sistrunk Procedure** (ë‚­ì¢… + ì„¤ê³¨(Hyoid bone) ì¼ë¶€ê¹Œì§€ ì œê±°í•´ì•¼ ì¬ë°œ ì•ˆ í•¨).\n- **Dermoid Cyst (ìœ í”¼ ë‚­ì¢…):**\n    - í”¼ì§€/í”¼ë¶€ ì¡°ì§ì´ ê°‡íŒ ê²ƒ.\n    - **Differential:** í˜€ë¥¼ ë‚´ë°€ì–´ë„ **ì›€ì§ì´ì§€ ì•ŠìŒâŒ.**\n### B. Lateral Masses (ì¸¡ë©´)\n- **Branchial Cleft Cyst (ìƒˆì—´ ë‚­ì¢…):**\n    - **Location:** **Anterior to SCM** (í‰ì‡„ìœ ëŒê·¼ ì•ìª½).\n    - ë°œìƒí•™ì  ì”ì¬ë¬¼.\n- **Lymphadenopathy (ì„íŒŒì„ ì—¼):**\n    - **Reactive:** ì‘ê³ , ë¶€ë“œëŸ½ê³ , ì••í†µì´ ìˆìŒ(Tender).\n    - **Infectious (Mycobacterium Avium Complex):**\n        - **Violaceous Node:** ë³´ë¼ìƒ‰/ìì£¼ìƒ‰ìœ¼ë¡œ ë³€í•œ ë¦¼í”„ì ˆ.\n        - **Action:** â˜… **Excision (ì ˆì œ).** (I&D ê¸ˆì§€ - ëˆ„ê³µ(Fistula)ì´ ìƒê²¨ ê³„ì† ì§„ë¬¼ì´ ë‚˜ì˜´).\n### C. Posterior Masses (ë’¤ìª½)\n- **Cystic Hygroma (ë‚­ì„± íˆê·¸ë¡œë§ˆ):**\n    - **Association:** **Turner Syndrome.**\n    - **Feature:** **Transilluminates** (ë¹›ì„ ë¹„ì¶”ë©´ í†µê³¼í•¨ - ë§‘ì€ ë¦¼í”„ì•¡ì´ ì°¨ ìˆìŒ).\n---\n## 6. Scary Stuff: Head & Neck Cancer ğŸ¦€\n### Squamous Cell Carcinoma (í¸í‰ìƒí”¼ì„¸í¬ì•”)\n- **Patient:** 50ì„¸ ì´ìƒ í¡ì—°ì/ìŒì£¼ì.\n- **Presentation:** ìš°ì¸¡ ê·€ í†µì¦(**Referred Otalgia**) + ì •ìƒ ê·€ ê²€ì‚¬ ì†Œê²¬.\n    - ê·€ëŠ” ë©€ì©¡í•œë° ê·€ê°€ ì•„í”„ë‹¤ë©´? â†’ ë‡Œì‹ ê²½ 9ë²ˆ, 10ë²ˆì„ ê³µìœ í•˜ëŠ” **ì¸í›„ë‘(Throat)ì˜ ì•”**ì„ ì˜ì‹¬í•´ì•¼ í•¨. **Panendoscopy** í•„ìš”.\n### Nasopharyngeal Carcinoma (ë¹„ì¸ë‘ì•”)\n- **Demographics:** ì•„ì‹œì•„ì¸(Endemic to Asia), **EBV Virus** ì—°ê´€, ì “ê°ˆ(Salted fish) ì„­ì·¨.\n- **Triad:**\n    1. Nasal Obstruction (ì½”ë§‰í˜).\n    2. Neck Mass (ê²½ë¶€ ì¢…ê´´).\n    3. â˜… **Unilateral Otitis Media in an Adult** (ì„±ì¸ì—ì„œ í•œìª½ ì¤‘ì´ì—¼).\n        - ì„±ì¸ì€ ì¤‘ì´ì—¼ì´ ì˜ ì•ˆ ìƒê¹€. í•œìª½ì— ë¬¼ì´ ì°¼ë‹¤ë©´ ì•”ë©ì–´ë¦¬ê°€ ìœ ìŠ¤íƒ€í‚¤ì˜¤ê´€ì„ ë§‰ê³  ìˆëŠ” ê²ƒ.\n### Oral Leukoplakia (êµ¬ê°• ë°±ë°˜ì¦)\n- **White Patch:** ì…ì•ˆì˜ í•˜ì–€ ë°˜ì .\n- **First Step:** **Can you wipe it off? (ë‹¦ì´ëŠ”ê°€?)**\n    - Yes: **Thrush (Candidiasis/ì•„êµ¬ì°½).**\n    - No:\n        - **Oral Hairy Leukoplakia:** í˜€ ì¸¡ë©´(Lateral tongue), ê³¨íŒì§€ ëª¨ì–‘(Corrugated), **Not Pre-cancerous.** (EBV/HIV ì—°ê´€).\n        - **Oral Leukoplakia:** ë‹¦ì´ì§€ ì•ŠìŒ. **Pre-cancerous (ì „ì•”ì„±).** â˜… **Biopsy (ì¡°ì§ê²€ì‚¬) í•„ìˆ˜.**","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-232"}
{"chunk_type":"transcript_chunk","text":"---\n## 7. Pediatric Airway Sounds ğŸ‘¶\n- **Laryngomalacia (í›„ë‘ì—°í™”ì¦):**\n    - **Inspiratory Stridor (í¡ê¸°ì‹œ í˜‘ì°©ìŒ).**\n    - **Worse when Supine (ëˆ„ìš°ë©´ ì•…í™”)**, Better when Prone (ì—ë“œë¦¬ë©´ í˜¸ì „).\n    - **Prognosis:** Reassurance (ìì—° í˜¸ì „ë¨).\n- **Vascular Ring (í˜ˆê´€ ê³ ë¦¬):**\n    - **Worse with Feeding.**\n    - **Better with Neck Extension** (ëª©ì„ ë’¤ë¡œ ì –íˆë©´ ê¸°ë„ê°€ í´ì ¸ì„œ ì†Œë¦¬ê°€ ì¤„ì–´ë“¦).\n    - Cf. Retropharyngeal abscess: neck extension ì•ˆë¨! Fever, drooling.\n---\n## 8. Laryngeal Papillomatosis (í›„ë‘ ìœ ë‘ì¢…) ğŸ—£ï¸\n- **Cause:** HPV 6 & 11 (Vertical transmission).\n- **Symptom:** **Hoarseness (ì‰° ëª©ì†Œë¦¬)** in a child.\n- **Exam:** Finger-like growths on vocal cords.\n- **Treatment:** **Surgical Debridement.** (Recurrent nature).\n---\n## ğŸ”¥ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n1. **Pale/Blueish Mucosa + Sneezing:** Allergic Rhinitis (Treat: Intranasal Steroids).\n2. **Beefy Red Mucosa + No Eye Symptoms:** Non-Allergic Rhinitis (Treat: Vasomotor agents).\n3. **Septal Hematoma:** Drain immediately (Prevent saddle nose).\n4. **Midline Neck Mass (Moves with tongue):** Thyroglossal Duct Cyst (Sistrunk procedure).\n5. **Lateral Neck Mass (Anterior to SCM):** Branchial Cleft Cyst.\n6. **Violaceous Lymph Node:** Mycobacterium Avium (Excision, No I&D).\n7. **Adult with Unilateral Ear Fluid:** Nasopharyngeal Carcinoma (Check EBV).\n8. **White Patch (Can't wipe off):** Biopsy (Leukoplakia).\n9. **Stridor Worse Supine:** Laryngomalacia.\n---\n### ğŸ’¡ Provocative Final Thought\n\"ë°±ì‹ ì´ ì§ˆë³‘ì˜ ì§€í˜•ë„ë¥¼ ë°”ê¿¨ìŠµë‹ˆë‹¤. *H. influenzae* (Epiglottitis)ëŠ” ì‚¬ë¼ì§€ê³  ìˆì§€ë§Œ, ë°±ì‹  ê±°ë¶€ ìš´ë™ìœ¼ë¡œ ë‹¤ì‹œ ëŒì•„ì˜¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ìš°ë¦¬ê°€ ë°°ìš°ëŠ” 'êµê³¼ì„œì ' ì§ˆë³‘ë“¤ì€ ê³ ì •ëœ ê²ƒì´ ì•„ë‹ˆë¼ ì‚´ì•„ ì›€ì§ì´ëŠ” ìƒíƒœê³„ì…ë‹ˆë‹¤. í•­ìƒ 'Sick vs Not Sick'ì„ êµ¬ë³„í•˜ëŠ” ì§ê´€ì„ ìœ ì§€í•˜ì‹­ì‹œì˜¤.\"\n**Verification (0:00~0:30 Dictation)**\n> \"Welcome back to the deep dive. Today we are uh on a mission. We've pulled together the highest yield resources to do something a little different. Yeah. We're doing a focused, high-intensity review, really specifically for everyone out there grinding for the USMLE Step 2. So if you're cramming or just refining your knowledge, this is for you. We're cutting straight through the noise, uh no fluff today. We're looking at the concepts, the anatomy and the red flags that actually show up on the test. Step 2 is just a different beast.\"\n>\n---\n# ğŸ« USMLE Step 2 Deep Dive: ì¢…ê²©ë™ (Mediastinum) ì™„ì „ ì •ë³µ\nì´ ê°•ì˜ëŠ” USMLE Step 2 ì‹œí—˜ì„ ì¤€ë¹„í•˜ëŠ” í•™ìƒë“¤ì„ ìœ„í•´ êµ°ë”ë”ê¸°ë¥¼ ë¹¼ê³ (no fluff), ì‹œí—˜ì— ì‹¤ì œ ë“±ì¥í•˜ëŠ” ê°œë…, í•´ë¶€í•™, ê·¸ë¦¬ê³  Red Flag(ìœ„í—˜ ì‹ í˜¸)ë¥¼ ì§‘ì¤‘ì ìœ¼ë¡œ ë‹¤ë£¹ë‹ˆë‹¤. ì„ìƒì  ì¶”ë¡ (Clinical Reasoning)ì„ ì¤‘ì‹¬ìœ¼ë¡œ ì¢…ê²©ë™ ì§ˆí™˜ì„ ë§ˆìŠ¤í„°í•´ ë´…ì‹œë‹¤.\n## 1. Introduction: ìœ„ì¹˜ê°€ ê³§ ì§„ë‹¨ì´ë‹¤ (Location is Everything)\n- **í•µì‹¬ ê°œë…:** ì¢…ê²©ë™(Mediastinum)ì€ ì‹¬ì¥, ëŒ€í˜ˆê´€, ê¸°ë„, ì‹ë„ ë“±ì´ ë¹½ë¹½í•˜ê²Œ ëª¨ì—¬ ìˆëŠ” ìš°ë¦¬ ëª¸ì—ì„œ ê°€ì¥ ë³µì¡í•œ ê³µê°„ì…ë‹ˆë‹¤.\n- **ì‹œí—˜ íŒ:** ë¬¸ì œì˜ ì§€ë¬¸(Stem)ì—ì„œ ì¢…ê´´(Mass)ì˜ ìœ„ì¹˜(ì•, ì¤‘ê°„, ë’¤)ë¥¼ ì•„ëŠ” ê²ƒì´ ì§„ë‹¨ì˜ ê°€ì¥ ì¤‘ìš”í•œ ë‹¨ì„œì´ì ì§€ë„(Map)ì…ë‹ˆë‹¤.\n- **ì „ëµ:** ì¢…ê²©ë™ì„ **ì „ë°©(Anterior), ì¤‘ë°©(Middle), í›„ë°©(Posterior)** êµ¬íšìœ¼ë¡œ ë‚˜ëˆ„ì–´ ì ‘ê·¼í•©ë‹ˆë‹¤.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-252"}
{"chunk_type":"transcript_chunk","text":"## 2. ì „ë°© ì¢…ê²©ë™ (Anterior Mediastinum): The \"4 Ts\"\nì „ë°© ì¢…ê²©ë™ì€ í‰ê³¨(Sternum)ê³¼ ì‹¬ì¥ ì‚¬ì´ì˜ ê³µê°„ì…ë‹ˆë‹¤. ì´ê³³ì˜ ì¢…ê´´ëŠ” **'4 Ts'**ë¡œ ê¸°ì–µí•´ì•¼ í•©ë‹ˆë‹¤.\n### ğŸš© 1. Thymoma (í‰ì„ ì¢…)\n- **ì—°ê´€ ì§ˆí™˜:** **â˜… ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ (Myasthenia Gravis)**. í‰ì„ ì¢… í™˜ìì˜ 30~50%ê°€ ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì„ ë™ë°˜í•©ë‹ˆë‹¤.\n- **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤:** ì „ë°© ì¢…ê´´ + ì•ˆê²€í•˜ìˆ˜(Ptosis) ë˜ëŠ” í•˜ë£¨ ì¤‘ ì‹¬í•´ì§€ëŠ” ê·¼ë ¥ ì•½í™”.\n- **ì¶”ê°€ ì—°ê´€ì„±:** ìˆœìˆ˜ ì í˜ˆêµ¬ ë¬´í˜•ì„±ì¦(Pure red cell aplasia)ê³¼ë„ ì—°ê´€ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸš© 2. Thyroid Neoplasm (ê°‘ìƒì„  ì¢…ì–‘)\n- **íŠ¹ì§•:** ì¼ë°˜ì ì¸ ëª©ì˜ ê²°ì ˆì´ ì•„ë‹Œ, í‰ê³½ ë‚´ë¡œ ìë¼ ë‚´ë ¤ì˜¨ **í‰ê³¨í•˜ ê°‘ìƒì„ ì¢…(Substernal Goiter)**ì…ë‹ˆë‹¤.\n- **ì˜ìƒ ì†Œê²¬:** ì—‘ìŠ¤ë ˆì´ìƒ ê¸°ê´€(Trachea)ì´ ì˜†ìœ¼ë¡œ ë°€ë¦° ì†Œê²¬(Deviation)ì´ í”í•©ë‹ˆë‹¤.\n- **ì¦ìƒ:** ì••ë°• ì¦ìƒ (ì‚¼í‚´ ê³¤ë€, í˜‘ì°©ìŒ ë“±).\n- **â˜… Pemberton's Sign (í¨ë²„íŠ¼ ì§•í›„):**\n    - í™˜ìì—ê²Œ ì–‘íŒ”ì„ ë¨¸ë¦¬ ìœ„ë¡œ ë“¤ê²Œ í–ˆì„ ë•Œ, í‰ê³¨í•˜ ê°‘ìƒì„ ì¢…ì´ í‰ê³½ ì…êµ¬ë¥¼ ë§‰ì•„ ì¼ì‹œì ì¸ **ìƒëŒ€ì •ë§¥ ì¦í›„êµ°(SVC syndrome)**ì„ ìœ ë°œí•©ë‹ˆë‹¤.\n    - ì–¼êµ´ì´ ë¶‰ì–´ì§€ê³ (Flushed), ëª©ì˜ ì •ë§¥ì´ í™•ì¥ë©ë‹ˆë‹¤.\n### ğŸš© 3. Teratoma (ê¸°í˜•ì¢…) & Germ Cell Tumors\n- **ëŒ€ìƒ:** ì Šì€ ì„±ì¸ (ì£¼ë¡œ 15~35ì„¸ ë‚¨ì„±).\n- **ì¢…ë¥˜:**\n    - **Teratoma:** ì¹˜ì•„ë‚˜ ë¨¸ë¦¬ì¹´ë½ ë“±ì„ í¬í•¨.\n    - **Seminoma (ì •ìƒí”¼ì¢…) & Non-seminoma.**\n- **ì§„ë‹¨ ë§ˆì»¤ (Biomarkers):** ì Šì€ ë‚¨ì„±ì—ê²Œ ì „ë°© ì¢…ê´´ê°€ ìˆë‹¤ë©´ ë°˜ë“œì‹œ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n    - **Non-seminoma:** Beta-HCGì™€ AFP ë‘˜ ë‹¤ ìƒìŠ¹.\n    - **Seminoma:** ì£¼ë¡œ Beta-HCGë§Œ ìƒìŠ¹ (AFPëŠ” ìƒìŠ¹í•˜ì§€ ì•ŠìŒ).\n### ğŸš© 4. \"Terrible\" Lymphoma (ë¦¼í”„ì¢…)\n- **ì£¼ì˜ì :** ë¦¼í”„ì¢…(íŠ¹íˆ í˜¸ì§€í‚¨ ë¦¼í”„ì¢…, ì Šì€ ì—¬ì„±)ì´ ì „ë°© ì¢…ê²©ë™ì— ìƒê¸¸ ìˆ˜ ìˆì§€ë§Œ, ë¦¼í”„ì ˆì€ ì–´ë””ì—ë‚˜ ìˆìœ¼ë¯€ë¡œ **â˜… ë¦¼í”„ì¢…ì€ ì „ë°©, ì¤‘ë°©, í›„ë°© ì–´ë””ì„œë“  ë°œìƒí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.** (\"Tunnel vision\"ì„ ê°–ì§€ ë§ ê²ƒ!)\n### ğŸ’¡ í‰ì„ (Thymus)ì— ëŒ€í•œ ì¤‘ìš”í•œ ë‚˜ì´ë³„ ê·œì¹™\n| êµ¬ë¶„ | ì‹ ìƒì•„/ì˜ì•„ (<3ì„¸) | ì„±ì¸ |\n| --- | --- | --- |\n| **ì •ìƒ ì†Œê²¬** | **Thymic Sail Sign** (ê±°ëŒ€í•œ ì‚¼ê°í˜• ê·¸ë¦¼ì)ì€ ì •ìƒ ìƒë¦¬ì  ì†Œê²¬ì„. | í‰ì„ ì€ ìœ„ì¶•ë˜ì–´ ì§€ë°©ìœ¼ë¡œ ë³€í•¨. ì—‘ìŠ¤ë ˆì´ì—ì„œ ë³´ì´ë©´ ì•ˆ ë¨. |\n| **ë³‘ì  ì†Œê²¬** | **â˜… ê·¸ë¦¼ìê°€ ì—†ëŠ” ê²½ìš°:** ë©´ì—­ ê²°í• ì˜ì‹¬ (DiGeorge Syndrome, SCID). | **â˜… ìŒì˜ì´ ë³´ì´ëŠ” ê²½ìš°:** ë¬´ì¡°ê±´ ë³‘ì ì„ (Thymoma, Lymphoma, Germ cell tumor ë“±). ì •ë°€ ê²€ì‚¬ í•„ìš”. |\n---\n## 3. ì¤‘ë°© ì¢…ê²©ë™ (Middle Mediastinum): The Busy Center\nì‹¬ì¥, ì‹¬ë§‰(Pericardium), ëŒ€ë™ë§¥, ê¸°ë„, ì‹ë„, ê·¸ë¦¬ê³  **ë¦¼í”„ì ˆ(Lymph nodes)**ì´ ì¡´ì¬í•˜ëŠ” ë‚´ì¥ ê³µê°„(Visceral space)ì…ë‹ˆë‹¤.\n- **â˜… ë¦¼í”„ì ˆ ë¹„ëŒ€ (Lymphadenopathy):**\n    - ê°€ì¥ ë¨¼ì € ë– ì˜¬ë ¤ì•¼ í•  ì§ˆí™˜: **Sarcoidosis (ì‚¬ë¥´ì½”ì´ë“œì¦)**.\n    - **ì „í˜•ì  ì¦ìƒ:** í‘ì¸ ì—¬ì„±, ê¸°ì¹¨, **ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ ë¹„ëŒ€(Bilateral Hilar Lymphadenopathy)**.\n    - ê¸°íƒ€ ì›ì¸: íì•” ì „ì´, ì§„ê·  ê°ì—¼ ë“±.\n- **ë‚­ì¢… (Cysts):**\n    - **Bronchogenic cyst:** ê¸°ë„ì˜ ë°œë‹¬ ì´ìƒ.\n    - **Pericardial cyst:** ì‹¬ë§‰ì— ë¶™ì€ ì•¡ì²´ ì£¼ë¨¸ë‹ˆ (ì£¼ë¡œ ìš°ì—°íˆ ë°œê²¬).\n- **í˜ˆê´€ ë° ì‹ë„:** ëŒ€ë™ë§¥ê¶ ë™ë§¥ë¥˜(Aortic arch aneurysm), ì‹ë„ë‚˜ ê¸°ë„ì˜ ì¢…ì–‘.\n---\n## 4. í›„ë°© ì¢…ê²©ë™ (Posterior Mediastinum): Neuro Focus\nì²™ì¶”, êµê°ì‹ ê²½ì‚¬ìŠ¬(Sympathetic chain), ì²™ì¶”ì—ì„œ ë‚˜ì˜¤ëŠ” ì‹ ê²½ë“¤ì´ ìœ„ì¹˜í•œ ê³³ì…ë‹ˆë‹¤.\n- **í•µì‹¬ í…Œë§ˆ:** **â˜… ì‹ ê²½ (Neuro)**.\n- **ê°€ì¥ í”í•œ ì§„ë‹¨:** **Neurogenic tumor (ì‹ ê²½ì¸ì„± ì¢…ì–‘)**.\n    - Schwannoma (ì‹ ê²½ì´ˆì¢…), Neurofibroma (ì‹ ê²½ì„¬ìœ ì¢…).\n- **â˜… ë¤ë²¨ ì¢…ì–‘ (Dumbbell Tumor):**\n    - ì¢…ì–‘ì´ ì¶”ê°„ê³µ(Intervertebral foramen)ì„ í†µí•´ ìë¼ë‚˜ì„œ, ì¼ë¶€ëŠ” ì²™ì¶”ê´€ì—, ì¼ë¶€ëŠ” ì¢…ê²©ë™ì— ìœ„ì¹˜í•˜ì—¬ ë¤ë²¨ ëª¨ì–‘ì„ í˜•ì„±í•©ë‹ˆë‹¤.\n- **ê¸°íƒ€ ì›ì¸:** ì²™ì¶” ì „ì´(Spinal mets), ìˆ˜ë§‰ë¥˜(Meningocele), ë¦¼í”„ì¢…(ì¹´ë©œë ˆì˜¨ì²˜ëŸ¼ ì–´ë””ë“  ì¡´ì¬ ê°€ëŠ¥), ì‹ë„ ì—´ê³µ íƒˆì¥(Hiatus hernia - ì‹¬ì¥ ë’¤ì— ê±°ëŒ€í•œ ê³µê¸° ë°©ìš¸ì´ ë³´ì„).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-272"}
{"chunk_type":"transcript_chunk","text":"---\n## 5. ê¸‰ì„± ì¢…ê²©ë™ì—¼ (Acute Mediastinitis): ì‘ê¸‰ ìƒí™© ğŸš¨\nì ˆëŒ€ë¡œ ë†“ì³ì„œëŠ” ì•ˆ ë˜ëŠ” ì¹˜ëª…ì ì¸ ê´´ì‚¬ì„± ê°ì—¼ì…ë‹ˆë‹¤.\n### ì„ìƒ ì–‘ìƒ\n- **ì¦ìƒ:** ë§¤ìš° ìœ„ë…í•´ ë³´ì„(Toxic), ê³ ì—´, ë¹ˆë§¥, ì‹¬í•œ í‰ê³¨ ë’¤ í†µì¦(Retrosternal chest pain).\n- **ì˜ìƒ:** ì¢…ê²©ë™ í™•ì¥ (Mediastinal widening).\n### ì£¼ìš” ì›ì¸ 2ê°€ì§€\n1. **ìˆ˜ìˆ  í›„ (Post-operative):**\n    - ì‹¬ì¥ ìˆ˜ìˆ (Sternotomy) í›„ ì•½ 2ì£¼ ë’¤, í™˜ìê°€ íšŒë³µë˜ëŠ” ë“¯í•˜ë‹¤ê°€ ê°‘ìê¸° ê³ ì—´ì´ ë‚˜ê³  ìˆ˜ìˆ  ë¶€ìœ„ê°€ ë¶ˆì•ˆì •í•´ì§.\n    - **ì¹˜ë£Œ (Triad):** **â˜… ë°°ë†(Drainage), ë³€ì—°ì ˆì œ(Debridement), í•­ìƒì œ(Antibiotics).** ì¦‰ì‹œ ìˆ˜ìˆ ì‹¤ë¡œ ë³µê·€í•´ì•¼ í•¨.\n2. **ì¸ì ‘ ë¶€ìœ„ í™•ì‚° (Contiguous Spread) - â˜… Danger Space:**\n    - **ìœ„í—˜ ê³µê°„(Danger Space):** ë‘ê°œì €(Base of skull)ë¶€í„° íš¡ê²©ë§‰ê¹Œì§€ ì´ì–´ì§€ëŠ” ê¹Šì€ ëª© ê·¼ë§‰(Deep neck fascia) ì‚¬ì´ì˜ ê³µê°„. 'ê°ì—¼ì˜ ê³ ì†ë„ë¡œ'.\n    - **ì‹œë‚˜ë¦¬ì˜¤:** ì¸ë‘ë’¤ë†ì–‘(Retropharyngeal abscess)ì´ë‚˜ ì¹˜ê³¼ ê°ì—¼ì´ ì¤‘ë ¥ì— ì˜í•´ ì´ ê³µê°„ì„ íƒ€ê³  ë‚´ë ¤ì™€ **ê¸‰ì„± ê´´ì‚¬ì„± ì¢…ê²©ë™ì—¼**ì„ ìœ ë°œ.\n    - **ì¹˜ë£Œ:** ê¸°ë„ í™•ë³´(Airway first!) â†’ ìˆ˜ìˆ ì  ë°°ë†(ëª©+í‰ë¶€) â†’ ê´‘ë²”ìœ„ í•­ìƒì œ(í˜ê¸°ì„± ê·  ì»¤ë²„).\n---\n## 6. ê¸°ì¢…ê²©ë™ (Pneumomediastinum)\n- **ìœ í˜•:** ìë°œì„± ê¸°ì¢…ê²©ë™ (Spontaneous Pneumomediastinum).\n- **í™˜ì í”„ë¡œí•„:** í‚¤ê°€ í¬ê³  ë§ˆë¥¸ ì²­ì†Œë…„ê¸° ë‚¨ì„±.\n- **ìœ ë°œ ìš”ì¸:** ë°œì‚´ë°”(Valsalva) ì¡°ì‘ (ê¸°ì¹¨, êµ¬í† , í˜ì£¼ê¸° ë“±) í›„ ê°‘ì‘ìŠ¤ëŸ¬ìš´ í‰í†µ ë°œìƒ.\n- **â˜… Hammond's Sign:**\n    - ì²­ì§„ ì‹œ ì‹¬ì¥ ë°•ë™ì— ë§ì¶° **'ë°”ìŠ¤ë½'ê±°ë¦¬ê±°ë‚˜ 'í´ë¦­'í•˜ëŠ” ì†Œë¦¬(Crunching/Clicking)**ê°€ ë“¤ë¦¼. (ì‹¬ì¥ì´ ê³µê¸° ì£¼ë¨¸ë‹ˆë¥¼ ë•Œë¦¬ëŠ” ì†Œë¦¬).\n- **ì˜ˆí›„ ë° ì¹˜ë£Œ:**\n    - ì‹ë„ íŒŒì—´(Esophageal rupture)ì„ ë°°ì œí•œë‹¤ë©´, ëŒ€ë¶€ë¶„ **ì–‘ì„±(Benign)** ê²½ê³¼.\n    - **ì¹˜ë£Œ:** íœ´ì‹, í†µì¦ ì¡°ì ˆ, ë°œì‚´ë°” í”¼í•˜ê¸°. ê³¼ì‰ ì¹˜ë£Œ ê¸ˆì§€(Don't overtreat). ê³µê¸°ëŠ” ì €ì ˆë¡œ í¡ìˆ˜ë¨.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-292"}
{"chunk_type":"recap_summary","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| êµ¬íš | ì£¼ìš” ì§ˆí™˜ ë° íŠ¹ì§• |\n| --- | --- |\n| **ì „ë°© (Anterior)** | **4 Ts:** Thymoma(ì¤‘ì¦ê·¼ë¬´ë ¥ì¦), Thyroid(Pemberton's sign), Teratoma(Germ cell), Terrible Lymphoma.\n**Thymus:** ì†Œì•„ëŠ” í¼(ì •ìƒ- no: Digeorge, SCID ), ì„±ì¸ì€ ì•ˆ ë³´ì—¬ì•¼ ì •ìƒ-ìˆìœ¼ë©´ bx. |\n| **ì¤‘ë°© (Middle)** | **ë¦¼í”„ì ˆ & ë‚­ì¢…:** Sarcoidosis(ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ), Bronchogenic cysts. |\n| **í›„ë°© (Posterior)** | **ì‹ ê²½(Neuro):** Neurogenic tumors (Dumbbell shape). |\n| **ê¸‰ì„± ì¢…ê²©ë™ì—¼** | ìˆ˜ìˆ  í›„ ë˜ëŠ” Danger spaceë¥¼ í†µí•œ ê°ì—¼ í™•ì‚°. **ì¦‰ê°ì ì¸ ìˆ˜ìˆ ì  ë°°ë† í•„ìš”.** |\n| **ê¸°ì¢…ê²©ë™** | í‚¤ í¬ê³  ë§ˆë¥¸ ì†Œë…„ + ë°œì‚´ë°” + **Hammond's sign**. íœ´ì‹ìœ¼ë¡œ ì¹˜ë£Œ. |\n---\n## 8. ë§ˆì§€ë§‰ ì„ìƒ ì§„ì£¼ (Clinical Pearl): Clubbing & COPD ğŸ’\n- **ìƒí™©:** ì‹ ì²´ ê²€ì§„ì—ì„œ **ê³¤ë´‰ì§€(Digital Clubbing)**ê°€ ê´€ì°°ë¨.\n- **í”í•œ ì˜¤í•´:** ë§ì€ í•™ìƒë“¤ì´ ê³¤ë´‰ì§€ë¥¼ COPD(ë§Œì„±íì‡„ì„±íì§ˆí™˜)ì™€ ë°”ë¡œ ì—°ê²°ì§€ìŒ.\n- **â˜… íŒ©íŠ¸ ì²´í¬:** í•©ë³‘ì¦ì´ ì—†ëŠ” ë‹¨ìˆœ COPDëŠ” ê³¤ë´‰ì§€ë¥¼ ìœ ë°œí•˜ì§€ ì•ŠìŒ.\n- **Red Flag:** ë§Œì•½ ë§Œì„± COPD í™˜ìê°€ **ìƒˆë¡œìš´ ê³¤ë´‰ì§€**ë¥¼ ë³´ì¸ë‹¤ë©´?\n    - ë‹¨ìˆœíˆ COPD ë•Œë¬¸ì´ë¼ê³  ì¹˜ë¶€í•˜ë©´ ì•ˆ ë¨.\n    - **ìˆ¨ê²¨ì§„ ì•…ì„± ì¢…ì–‘(Occult Malignancy)**, íŠ¹íˆ **â˜… íì•”(Bronchogenic Carcinoma)**ì„ ì¦‰ì‹œ ì˜ì‹¬í•´ì•¼ í•¨.\n    - **í–‰ë™ ì§€ì¹¨:** ì¦‰ì‹œ CT ì´¬ì˜ ë“± ì •ë°€ ê²€ì‚¬ ì§„í–‰.\n# ğŸ« Obstructive Lung Disease: Battle Strategy âš”ï¸\nUSMLE Step 2ëŠ” ëª¨í˜¸í•œ ê²ƒì„ ì‹«ì–´í•©ë‹ˆë‹¤. **Binary(ì´ë¶„ë²•)**ì ì¸ ê²°ì •ì´ ìƒëª…ì…ë‹ˆë‹¤! âš–ï¸\nì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ **Acute Bronchitis(í•¨ì •)**ì™€ **COPD(ê´´ë¬¼)**ë¥¼ ì •ë³µí•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n---\n### 1. ğŸ¦  Acute Bronchitis (ê¸‰ì„± ê¸°ê´€ì§€ì—¼) : The Trap ğŸª¤","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-303"}
{"chunk_type":"transcript_chunk","text":"ì‹œí—˜ì—ì„œ ê°€ì¥ í”íˆ íŒŒëŠ” í•¨ì •ì…ë‹ˆë‹¤. \"í•­ìƒì œë¥¼ ì¤„ ê²ƒì¸ê°€ ë§ ê²ƒì¸ê°€?\"\n- **ì •ì˜ & ì›ì¸**: ëŒ€ê¸°ë„(Large airways)ì˜ ì—¼ì¦.\n    - â˜… **90% Viral** ğŸ¦ : Influenza, Rhinovirus ë“±. (BacteriaëŠ” ê±°ì˜ ì—†ìŒ! ğŸ™…â€â™‚ï¸)\n- **ì¦ìƒ ê¸°ê°„ ğŸ—“ï¸**: ê¸°ì¹¨ì€ **5ì¼ ~ 3ì£¼(3 weeks)**ê¹Œì§€ ê°ˆ ìˆ˜ ìˆìŒ.\n    - âš ï¸ **Trap**: 3ì£¼ ë™ì•ˆ ê¸°ì¹¨í•œë‹¤ê³  íë ´(Pneumonia)ì´ ì•„ë‹™ë‹ˆë‹¤!\n- **ì§„ë‹¨ (Diagnosis) ğŸ©º**:\n    - **Clinical Diagnosis**: ì„ìƒì ìœ¼ë¡œ ì§„ë‹¨í•¨.\n    - **No Systemic Signs**: ê³ ì—´(High fever) ğŸŒ¡ï¸, ì˜¤í•œ(Chills) ğŸ¥¶, ê²½ì§(Rigors) âŒ.\n    - **Lung Exam**: Wheezing(ìŒ•ìŒ•ê±°ë¦¼)ì€ OK, í•˜ì§€ë§Œ **Crackles(ì•…ì„¤ìŒ)**ì€ ì—†ì–´ì•¼ í•¨. ğŸ”‡\n    - **CXR?** ğŸ“¸: **No!** í™œë ¥ ì§•í›„ê°€ ì•ˆì •ì ì´ë©´ ì°ì§€ ë§ˆì„¸ìš”.\n- **ì¹˜ë£Œ (Treatment) ğŸ’Š**:\n    - ì˜¤ì§ **Symptom Control**: ì§„í†µì œ(NSAIDs), ê¸°ê´€ì§€ í™•ì¥ì œ.\n    - â˜… **No Antibiotics** ğŸš«: í™˜ìê°€ ì• ì›í•´ë„ í•­ìƒì œ ì£¼ë©´ ì‹œí—˜ì—ì„œ ê°ì ì…ë‹ˆë‹¤!\n---\n### 2. ğŸš¬ COPD: The Beast ğŸ¦\nCOPDëŠ” ë‘ ê°€ì§€ ë³‘íƒœìƒë¦¬ë¥¼ í¬í•¨í•˜ëŠ” **ìš°ì‚°(Umbrella) â˜‚ï¸** ê°™ì€ ê°œë…ì…ë‹ˆë‹¤.\n### A. Pathophysiology âš™ï¸\n1. **Chronic Bronchitis (ë§Œì„± ê¸°ê´€ì§€ì—¼)** ğŸš°:\n    - **\"Clogged, Wet Plumbing\"**: ë°°ê´€ì´ ë§‰íˆê³  ì –ì–´ ìˆìŒ.\n    - Goblet cell ê³¼ë‹¤ ë¶„ë¹„ â†’ ê°€ë˜(Mucus) ì½¸ì½¸ ğŸ¤®\n2. **Emphysema (íê¸°ì¢…)** ğŸˆ:\n    - **\"Old Balloon\"**: í—Œ í’ì„ ì²˜ëŸ¼ íƒ„ì„±(Elastic recoil)ì„ ìƒìŒ.\n    - ê³µê¸°ê°€ ë“¤ì–´ì˜¤ê¸´ í•˜ëŠ”ë° ë‚˜ê°€ì§€ ëª»í•¨ (**Air Trapping**) ğŸ“¦\n### B. Diagnosis (Gold Standard) ğŸ†\n- **Spirometry**: â˜… **FEV1/FVC < 0.7** ğŸ“‰\n- **Irreversible**: ê¸°ê´€ì§€ í™•ì¥ì œë¥¼ ì¨ë„ ëŒì•„ì˜¤ì§€ ì•ŠìŒ. (ì²œì‹ê³¼ ë‹¤ë¦„ â†”ï¸)\n- **Loop ëª¨ì–‘**: **\"Scooped out sail\"** (í‘¹ êº¼ì§„ ë›ë‹¨ë°° ëª¨ì–‘ â›µ)\n### C. Emphysema vs. Chronic Bronchitis êµ¬ë¶„ë²•: DLCO ğŸŒ¬ï¸\n- **Emphysema**: ë²½ì´ íŒŒê´´ë¨ ğŸšï¸ â†’ í‘œë©´ì  ê°ì†Œ â†’ **Low DLCO** â¬‡ï¸\n- **Chronic Bronchitis**: íí¬(Alveoli)ëŠ” ë©€ì©¡í•¨ âœ¨ â†’ **Normal DLCO** â¡ï¸\n    - *Tip*: íì‡„ì„± íŒ¨í„´ì¸ë° DLCOê°€ ë‚®ë‹¤? â†’ Emphysema!\n---\n### 3. ğŸš¨ COPD Exacerbation (ê¸‰ì„± ì•…í™”) : Emergency Room ğŸ¥\nì‘ê¸‰ì‹¤ì—ì„œ ìˆ¨ì´ ì°¨ì„œ ì˜¨ í™˜ì, **COPDì¸ê°€ ì‹¬ë¶€ì „(CHF)ì¸ê°€?** ì´ê²ƒì´ ë¬¸ì œì…ë‹ˆë‹¤. ğŸ¤”\n### A. The Classic Differential: ABG is King ğŸ‘‘\në‘ ì§ˆí™˜ ëª¨ë‘ ìŒ•ìŒ•ê±°ë¦´(Wheezing) ìˆ˜ ìˆìŠµë‹ˆë‹¤. êµ¬ë¶„ì€ **ê°€ìŠ¤(Gas)**ë¡œ í•©ë‹ˆë‹¤.\n| **Feature** | **ğŸš¬ COPD Exacerbation** | **ğŸ’” CHF (Heart Failure)** |\n| --- | --- | --- |\n| **ë¬¸ì œì ** | Air Trapping (ê³µê¸°ê°€ ê°‡í˜) ğŸ“¦ | Wet Lungs (ë¬¼ì— ì ê¹€) ğŸŒŠ |\n| **í™˜ê¸°** | CO2 Retain (ì´ì‚°í™”íƒ„ì†Œ ì €ë¥˜) â¬†ï¸ | Hyperventilate (ê³¼í˜¸í¡) ğŸŒ¬ï¸ |\n| **â˜… ABG** | **Respiratory Acidosis** (High CO2) ğŸ”´ | **Respiratory Alkalosis** (Low CO2) ğŸ”µ |\n| **Sound** | Wheezing ğŸ¶ | Crackles ğŸ¿ |\n### B. Treatment Steps (ìˆœì„œ ì¤‘ìš”!) 1ï¸âƒ£2ï¸âƒ£3ï¸âƒ£\n1. **Oxygen ğŸ…¾ï¸**:\n    - Target SpO2: **88 ~ 92%** ğŸ¯ (100% ì£¼ë©´ CO2 í˜¼ìˆ˜ ì™€ì„œ í°ì¼ ë‚¨ â˜ ï¸)\n2. **Meds ğŸ’Š**:\n    - Inhaled Bronchodilators (Albuterol + Ipratropium = Duoneb) ğŸ’¨\n    - â˜… **Systemic Steroids**: **Oral Prednisone** or IV. (í¡ì…ì œ ì•„ë‹˜! ì „ì‹  ìŠ¤í…Œë¡œì´ë“œ í•„ìˆ˜ ğŸ’ª)\n3. **Antibiotics ğŸ¦ **:\n    - ë¬´ì¡°ê±´ ì£¼ëŠ” ê±° ì•„ë‹˜! ğŸ™…\n    - **3 Cardinal Symptoms**: Dyspnea, Sputum Volume, **Sputum Purulence(ëˆ„ëŸ° ê°€ë˜)**.\n    - Rule: 2ê°€ì§€ ì¦ìƒ + ê·¸ì¤‘ í•˜ë‚˜ê°€ **Purulence**ì¼ ë•Œ íˆ¬ì—¬.\n4. **NIPPV (BiPAP) ğŸ­**:\n    - ì‚°ì¦(Acidosis)ì´ ê³„ì†ë˜ë©´ ì‚½ê´€(Intubation) ì „ì— ë¬´ì¡°ê±´ ì‹œë„!\n    - \"Blow off CO2\" ğŸŒ¬ï¸ â†’ ì‚½ê´€ì„ ë§‰ì•„ì£¼ëŠ” êµ¬ì„¸ì£¼.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-313"}
{"chunk_type":"transcript_chunk","text":"### 4. ğŸ›Œ Chronic Management (ë§Œì„± ê´€ë¦¬) : Long Game ğŸ¢\n\"í™˜ìë¥¼ ë” ì˜¤ë˜ ì‚´ê²Œ í•˜ëŠ” ê²ƒì€?\" (Mortality Benefit) ğŸ’€ğŸ“‰\n### A. Mortality Benefit (ìƒì¡´ìœ¨ ì¦ê°€) ğŸŒŸ\nì •ë‹µì€ ë”± ë‘ ê°œë¿ì…ë‹ˆë‹¤!\n1. **Smoking Cessation (ê¸ˆì—°)** ğŸš­: ë¬´ì¡°ê±´ 1ìˆœìœ„.\n2. **Long-term Oxygen (ì¬íƒ ì‚°ì†Œ)** ğŸ :\n    - í•˜ë£¨ 15ì‹œê°„ ì´ìƒ ì‚¬ìš©. ğŸ•’\n    - **Cutoff**: PaO2 â‰¤ 55 or SaO2 â‰¤ 88%. (ìš°ì‹¬ë¶€ì „ ìˆìœ¼ë©´ 59/89%)\n### B. Symptom Control (ì¦ìƒ ì™„í™”) ğŸ˜Œ\n- **LAMA > LABA**: ë¯¸ì£¼ì‹ ê²½(Vagal tone)ì´ ì¤‘ìš”í•˜ë¯€ë¡œ **LAMA(Tiotropium)**ê°€ First-line. ğŸ¥‡\n- **Inhaled Steroids (ICS)**: COPDì—ì„œëŠ” **Add-on**ì¼ ë¿, ë‹¨ë… ì‚¬ìš© ê¸ˆì§€ âŒ. (ì²œì‹ê³¼ë°˜ëŒ€! â˜… )\n---\n### 5. ğŸ”¥ Rapid Fire Recap (Summary) ğŸ”¥\nê°•ì˜ ë§ˆì§€ë§‰ì— ì •ë¦¬ëœ ë‚´ìš©ì„ ê·¸ëŒ€ë¡œ ë°›ì•„ì ì—ˆìŠµë‹ˆë‹¤. (ì‹œí—˜ ì§ì „ ë³µìŠµìš©!)\n- **Acute Bronchitis (ê¸‰ì„± ê¸°ê´€ì§€ì—¼)** ğŸ¦ :\n    - Viral(ë°”ì´ëŸ¬ìŠ¤ì„±)ì´ë‹¤.\n    - ê¸°ì¹¨ì€ 3ì£¼ ë¯¸ë§Œ.\n    - ì—´(Fever) ì—†ìŒ.\n    - **No Antibiotics (í•­ìƒì œ ê¸ˆì§€)!** ğŸ›‘\n- **COPD Diagnosis (ì§„ë‹¨)** ğŸ“Š:\n    - FEV1/FVC < 0.7.\n    - Irreversible (ë¹„ê°€ì—­ì ).\n    - Scooped out loop (í‘¹ êº¼ì§„ ê³¡ì„ ). ğŸ“‰\n- **Emphysema vs. Chronic Bronchitis** ğŸ†š:\n    - **DLCO**ë¡œ êµ¬ë¶„.\n    - Low DLCO = Emphysema (íê¸°ì¢…).\n    - Normal DLCO = Chronic Bronchitis (ë§Œì„± ê¸°ê´€ì§€ì—¼).\n- **COPD Exacerbation Differential (ê°ë³„ ì§„ë‹¨)** âš–ï¸:\n    - Acidosis (High CO2) = **COPD**. ğŸš¬\n    - Alkalosis (Low CO2) = **CHF**. ğŸ’”\n- **Exacerbation Management (ì•…í™” ì¹˜ë£Œ)** ğŸ› ï¸:\n    - Oxygen target **88-92%**. ğŸ¯\n    - Bronchodilators (ê¸°ê´€ì§€ í™•ì¥ì œ).\n    - **Systemic** Steroids (ì „ì‹  ìŠ¤í…Œë¡œì´ë“œ).\n    - Antibiotics (ê°€ë˜ê°€ ëˆ„ëŸ´ ë•Œë§Œ/Purulent). ğŸŸ¡\n    - **BiPAP** (ì‚°ì¦/Acidosisì¼ ë•Œ). ğŸ­\n- **Mortality Benefit (ì‚¬ë§ë¥  ê°ì†Œ)** ğŸ’€â¬‡ï¸:\n    - **Stop Smoking (ê¸ˆì—°)**. ğŸš­\n    - Oxygen (ì‚°ì†Œí¬í™”ë„ 88% ë¯¸ë§Œì¼ ë•Œ). ğŸ…¾ï¸\n- **Bonus Curveball: Asthma-COPD Overlap** âš¾:\n    - í¡ì—°ìì¸ë° ì²œì‹ íŠ¹ì§•(Eosinophils ë“±)ì´ ë³´ì´ë©´?\n    - ìƒì ë°–ì—ì„œ ìƒê°í•˜ì„¸ìš”! **Inhaled Steroids(ICS)**ë¥¼ ë” ì¼ì° ì“°ëŠ” ê²ƒì´ ì •ë‹µì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. âœ¨\n---\n# ğŸ« USMLE Deep Dive: Asthma & Obstructive Lung Diseases\n**Topic:** Asthma, Status Asthmaticus, Look-alikes (Bronchiectasis, ABPA)\n## ğŸŒ³ The Big Picture: Diagnosis Tree\nê°•ì˜ ì‹œì‘ ì „, ë¨¸ë¦¿ì†ì— ì§€ë„ë¥¼ ê·¸ë ¤ë´…ì‹œë‹¤.\nPlaintext\n`Obstructive Lung Disease (FEV1/FVC < 0.7)\nâ”‚\nâ”œâ”€â”€ Asthma (ê°€ì—­ì  Reversible)\nâ”‚   â”œâ”€â”€ Diagnosis: Methacholine Challenge (Rule out), Bronchodilator test\nâ”‚   â”œâ”€â”€ Emergency: Status Asthmaticus (\"Silent Chest\", Normal PCO2 is BAD)\nâ”‚   â””â”€â”€ Variants: Exercise-induced, Pregnancy\nâ”‚\nâ””â”€â”€ Differential Diagnosis (The Look-alikes)\n    â”œâ”€â”€ COPD (ë¹„ê°€ì—­ì , Low DLCO in Emphysema)\n    â”œâ”€â”€ Bronchiectasis (Structural damage, \"Cupfuls of sputum\")\n    â””â”€â”€ ABPA (Allergic reaction, High IgE, Brown mucus)`\n---\n## 1. Pathophysiology & Diagnosis Basics","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-333"}
{"chunk_type":"transcript_chunk","text":"ì²œì‹(Asthma)ì€ ê¸°ë³¸ì ìœ¼ë¡œ **\"ê¸°ë„(Airway)ì˜ ë¬¸ì œ\"**ì´ì§€ íí¬(Alveoli)ì˜ ë¬¸ì œê°€ ì•„ë‹™ë‹ˆë‹¤.\n- **Core Concept:** **\"Roach Motel\"** í˜„ìƒ. ê³µê¸°ê°€ ë“¤ì–´ì˜¬ ìˆ˜ëŠ” ìˆì§€ë§Œ(Inspiration OK), ë‚˜ê°ˆ ìˆ˜ê°€ ì—†ìŠµë‹ˆë‹¤(Expiration blocked).\n    - ì´ìœ : ì—¼ì¦(Inflammation)ê³¼ í‰í™œê·¼ ìˆ˜ì¶•(Smooth muscle constriction)ìœ¼ë¡œ ê¸°ë„ê°€ ì¢ì•„ì§€ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n- **Spirometry (PFT) Criteria:**\n    - **Obstruction:** FEV1/FVC ratio < 0.7 (70%).\n    - **Reversibility (The Key Differentiator):** ê¸°ê´€ì§€ í™•ì¥ì œ(Bronchodilator) íˆ¬ì—¬ í›„ FEV1ì´ **12% ì´ìƒ AND 200ml ì´ìƒ** ì¦ê°€í•˜ë©´ ì²œì‹ìœ¼ë¡œ í™•ì§„í•©ë‹ˆë‹¤.\n- **Methacholine Challenge Test:**\n    - ì–¸ì œ ì“°ëŠ”ê°€? í™˜ìê°€ ì¦ìƒì€ í˜¸ì†Œí•˜ëŠ”ë° ë³‘ì›ì—ì„œ PFTë¥¼ ì°ìœ¼ë‹ˆ **ì •ìƒ(Normal)**ì¼ ë•Œ.\n    - ì›ë¦¬: ê¸°ë„ë¥¼ ìê·¹í•˜ì—¬ ì¼ë¶€ëŸ¬ ìˆ˜ì¶•ì‹œí‚´ (Provocation). FEV1ì´ 20% ì´ìƒ ë–¨ì–´ì§€ë©´ ì–‘ì„±.\n    - **High Yield Point:** ì´ ê²€ì‚¬ëŠ” **Negative Predictive Value(ìŒì„± ì˜ˆì¸¡ë„)**ê°€ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. ì¦‰, ê²°ê³¼ê°€ ìŒì„±ì´ë©´ \"ì²œì‹ì´ ì ˆëŒ€ ì•„ë‹ˆë‹¤\"ë¼ê³  ë°°ì œ(Rule out)í•˜ëŠ” ë° ì“°ì…ë‹ˆë‹¤.\n### ğŸ“Š Visuals: Flow-Volume Loop & DLCO\nì‹œí—˜ ë¬¸ì œì— ê·¸ë¦¼ì´ë‚˜ ìˆ˜ì¹˜ë§Œ ëœë  ë‚˜ì˜¬ ë•Œë¥¼ ëŒ€ë¹„í•˜ì„¸ìš”.\n1. **Flow-Volume Loop:**\n    - **Asthma/COPD:** í˜¸ê¸°(Expiration) ê³¡ì„ ì´ ì•„ì´ìŠ¤í¬ë¦¼ ìŠ¤ì¿±ìœ¼ë¡œ íŒŒë‚¸ ë“¯ ì•ˆìœ¼ë¡œ í‘¹ êº¼ì ¸ ìˆìŒ (**Scooped out**).\n    - **âš ï¸ Trap (Box Shape):** ìœ„ì•„ë˜ê°€ ëª¨ë‘ í‰í‰í•œ ì‚¬ê°í˜• ëª¨ì–‘(Box-shaped) ë£¨í”„ëŠ” ì²œì‹ì´ ì•„ë‹ˆë¼ **Upper Airway Obstruction** (ì˜ˆ: Tracheal stenosis, Vocal cord dysfunction)ì…ë‹ˆë‹¤.\n2. **DLCO (Diffusing Capacity):** ì²œì‹ê³¼ COPDë¥¼ êµ¬ë¶„í•˜ëŠ” ê²°ì •ì  ë‹¨ì„œ(Tie-breaker).\n    - **Asthma:** DLCO **ì •ìƒ(Normal) í˜¹ì€ ì¦ê°€(Increased)**. (ì´ìœ : íí¬ ìì²´ëŠ” ë©€ì©¡í•˜ê±°ë‚˜ ê³µê¸°ê°€ ê°‡í˜€ì„œ ìš©ì ì´ ëŠ˜ì–´ë‚˜ë¯€ë¡œ).\n    - **Emphysema (COPD):** DLCO **ê°ì†Œ(Low)**. (ì´ìœ : íí¬ê°€ íŒŒê´´ë˜ì–´ ê°€ìŠ¤ êµí™˜ ë©´ì ì´ ì¤„ì–´ë“¦).\n---\n## 2. Acute Exacerbation (Status Asthmaticus) ğŸ”¥\nì‘ê¸‰ì‹¤ ì„¸íŒ…ì…ë‹ˆë‹¤. í™˜ìê°€ ìˆ¨ì„ í—ë–¡ì´ë©° ë“¤ì–´ì˜µë‹ˆë‹¤. **ê°€ì¥ ë§ì´ ì¶œì œë˜ëŠ” íŒŒíŠ¸**ì…ë‹ˆë‹¤.\n### ğŸš© Danger Signs (Red Flags)\n- **Wheezingì´ ì•ˆ ë“¤ë¦´ ë•Œ (Absent Wheezing):** ì¢‹ì€ ê²Œ ì•„ë‹™ë‹ˆë‹¤. ê¸°ë„ê°€ ë„ˆë¬´ ê½‰ ë§‰í˜€ì„œ ê³µê¸°ê°€ ì•„ì˜ˆ ì•ˆ í†µí•˜ëŠ” **\"Silent Chest\"** ìƒíƒœì…ë‹ˆë‹¤. í˜¸í¡ ë¶€ì „(Respiratory collapse) ì§ì „ì˜ ì´ˆì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n- **Normal PCO2 (e.g., 40-45 mmHg):**\n    - ì›ë˜ ì²œì‹ ë°œì‘ ì´ˆê¸°ì—ëŠ” ê³¼í˜¸í¡(Hyperventilation) ë•Œë¬¸ì— PCO2ê°€ ë‚®ì•„ì•¼(Respiratory Alkalosis) ì •ìƒì…ë‹ˆë‹¤.\n    - ë§Œì•½ PCO2ê°€ \"ì •ìƒ ë²”ìœ„\"ë¡œ ëŒì•„ì™”ë‹¤ë©´? í™˜ìê°€ ì§€ì³ì„œ(Fatigue) ë” ì´ìƒ ê³¼í˜¸í¡ì„ ëª»í•˜ê³  **CO2ê°€ ìŒ“ì´ê¸° ì‹œì‘í–ˆë‹¤**ëŠ” ëœ»ì…ë‹ˆë‹¤. **ì¦‰ì‹œ ì‚½ê´€(Intubation)**ì„ ì¤€ë¹„í•´ì•¼ í•©ë‹ˆë‹¤.\n### ğŸš‘ Emergency Treatment Algorithm\nìˆœì„œëŒ€ë¡œ ì™¸ìš°ì„¸ìš”. (O -> B -> S -> M -> I)\n1. **Oxygen:** SpO2 88-92% ëª©í‘œ (ì„ì‹ ë¶€ëŠ” >95%).\n2. **Bronchodilators (Dual):** SABA (Albuterol) + SAMA (Ipratropium). ì‘ê¸‰ì‹¤ì—ì„œëŠ” ì´ ë‘˜ì„ ì„ì€ **DuoNeb**ì´ Albuterol ë‹¨ë…ë³´ë‹¤ íš¨ê³¼ê°€ ì¢‹ìŠµë‹ˆë‹¤.\n3. **Systemic Steroids:** **Oral(ê²½êµ¬)ì´ë‚˜ IVë‚˜ íš¨ê³¼ëŠ” ê°™ìŠµë‹ˆë‹¤.** í•˜ì§€ë§Œ íš¨ê³¼ê°€ ë‚˜íƒ€ë‚˜ëŠ” ë° 4~6ì‹œê°„ì´ ê±¸ë¦¬ë¯€ë¡œ **ì˜¤ìë§ˆì ë°”ë¡œ(ASAP)** íˆ¬ì—¬í•´ì•¼ í•©ë‹ˆë‹¤ (Methylprednisolone IV or Prednisone PO).\n    - *ì£¼ì˜:* Inhaled Steroid(í¡ì…ì œ)ëŠ” ê¸‰ì„±ê¸°ì— ì“°ì§€ ì•ŠìŠµë‹ˆë‹¤.\n4. **Magnesium Sulfate (IV):** ì´ˆê¸° ì¹˜ë£Œì—ë„ ë°˜ì‘ì´ ì—†ì„ ë•Œ ì”ë‹ˆë‹¤. ê¸°ê´€ì§€ í‰í™œê·¼ì„ ì´ì™„ì‹œí‚µë‹ˆë‹¤.\n5. **Intubation:** ì˜ì‹ ì €í•˜, ì‚°ì¦ ì‹¬í™”(pH < 7.1), PCO2 ìƒìŠ¹ ì‹œ ìµœí›„ì˜ ìˆ˜ë‹¨.\n    - *ì°¸ê³ :* Epinephrineì€ Anaphylaxisê°€ ì•„ë‹Œ ì´ìƒ ì²œì‹ ë°œì‘ì— ë£¨í‹´ìœ¼ë¡œ ì“°ì§€ ì•ŠìŠµë‹ˆë‹¤.\n---\n## 3. Chronic Management & Special Cases\ní‡´ì› í›„ ì™¸ë˜ ê´€ë¦¬ ì „ëµì…ë‹ˆë‹¤.\n### ğŸ’Š Treatment Steps (Step-up Therapy)\n- **ì ˆëŒ€ ê¸ˆê¸°:** LABA (Long-acting beta agonist)ë¥¼ **ë‹¨ë…(Monotherapy)**ìœ¼ë¡œ ì“°ë©´ ì‚¬ë§ë¥ ì´ ì¦ê°€í•©ë‹ˆë‹¤. ë¬´ì¡°ê±´ ICSì™€ ì„ì–´ ì¨ì•¼ í•©ë‹ˆë‹¤. ì—¼ì¦ì´ ë¬¸ì œì¸ê±°ì§€, ë¬´ì‘ì • ë„“íˆê³ , ì—¼ì¦ì€ ë¬´ì‹œí•˜ë©´ì•ˆëœë‹¤!\n- **Step 1 (Mild Intermittent):** ì¦ìƒ ìˆì„ ë•Œë§Œ **SABA** (Albuterol) í˜¹ì€ Low-dose ICS-Formoterol (PRN).\n- **Step 2 (Mild Persistent):** **Daily Low-dose ICS** (Inhaled Corticosteroid) ì¶”ê°€.\n- **Step 3:** Low-dose ICS + **LABA** ì¶”ê°€.\n- **Step 5 (Refractory):** **Biologics** ê³ ë ¤.\n    - High IgE (Allergic): **Omalizumab** (Anti-IgE).\n    - High Eosinophils: **Mepolizumab, Reslizumab** (Anti-IL5).\n- *Side Effect:* ICS ì‚¬ìš© í›„ êµ¬ê°• ìº”ë””ë‹¤ì¦(Oral Thrush) ì˜ˆë°©ì„ ìœ„í•´ ì…ì„ í—¹êµ¬ê²Œ(Gargle/Rinse) êµìœ¡í•©ë‹ˆë‹¤.\n### ğŸ¤° Pregnancy & Asthma\n- **Rule:** **\"ì—„ë§ˆê°€ ìˆ¨ ëª» ì‰¬ë©´ ì•„ê¸°ë„ ìˆ¨ ëª» ì‰°ë‹¤.\"** ì¹˜ë£Œ ì•ˆ í•˜ëŠ” ê²ƒì´ ì•½ë¬¼ ë¶€ì‘ìš©ë³´ë‹¤ í›¨ì”¬ ìœ„í—˜í•©ë‹ˆë‹¤.\n- Target SpO2: **> 95%** (ì¼ë°˜ì¸ë³´ë‹¤ ë†’ê²Œ ì¡ìŒ).\n- ì•ˆì „í•œ ì•½ë¬¼: Albuterol(SABA), Budesonide(ICS) ëª¨ë‘ ì•ˆì „í•©ë‹ˆë‹¤. ì ê·¹ì ìœ¼ë¡œ ì¹˜ë£Œí•˜ì„¸ìš”.\n- **ì£¼ì˜:** ë¶„ë§Œ ì¤‘ ìê¶ ìˆ˜ì¶•ì„ ì–µì œí•  ìˆ˜ ìˆìœ¼ë¯€ë¡œ Epinephrineì€ í”¼í•©ë‹ˆë‹¤ (ë‹¨, ì•„ë‚˜í•„ë½ì‹œìŠ¤ ì œì™¸).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-353"}
{"chunk_type":"transcript_chunk","text":"### ğŸƒ Exercise-Induced Bronchoconstriction (EIB)\n- ì¦ìƒ: ìš´ë™ ì‹œì‘ 5~10ë¶„ í›„ ê¸°ì¹¨/ìŒ•ìŒ•ê±°ë¦¼, íœ´ì‹ ì‹œ í˜¸ì „ë¨.\n- ê¸°ì „: ì°¨ê°‘ê³  ê±´ì¡°í•œ ê³µê¸°ê°€ ê¸°ë„ë¡œ ë“¤ì–´ì˜¤ë©° ë°œìƒ.\n- ì¹˜ë£Œ: ìš´ë™ **10~20ë¶„ ì „**ì— SABA (Albuterol) ì‚¬ìš©. (ë§¤ì¼ ìš´ë™í•˜ëŠ” ì„ ìˆ˜ë¼ë©´ Daily ICS+LABA ê³ ë ¤).\n---\n## 4. The \"Look-alikes\" (Differential Diagnosis)\nì²œì‹ì¸ ì¤„ ì•Œì•˜ëŠ”ë° ì•½ì´ ì•ˆ ë“£ë‚˜ìš”? ì´ê±¸ ì˜ì‹¬í•˜ì„¸ìš”.\n### A. Bronchiectasis (ê¸°ê´€ì§€í™•ì¥ì¦)\n- **íŠ¹ì§•:** ê¸°ë„ê°€ ì˜êµ¬ì ìœ¼ë¡œ ëŠ˜ì–´ë‚˜ê³  íŒŒê´´ë¨. ì„¬ëª¨(Cilia)ê°€ ë§ê°€ì ¸ ê°€ë˜ ë°°ì¶œ ëª» í•¨.\n- **Keyword:** **\"Cupfuls of sputum\"** (ê°€ë˜ê°€ ì»µì„ ì±„ìš¸ ì •ë„ë¡œ ë§ì´ ë‚˜ì˜´), ëƒ„ìƒˆê°€ ì§€ë…í•¨(Foul-smelling).\n- **CT ì†Œê²¬:**\n    - **Signet Ring Sign:** ê¸°ë„ê°€ í˜ˆê´€ë³´ë‹¤ ì»¤ì ¸ì„œ ë°˜ì§€ ëª¨ì–‘ì²˜ëŸ¼ ë³´ì„.\n    - **Tram-tracking:** ê¸°ì°¨ ì„ ë¡œì²˜ëŸ¼ í‰í–‰í•˜ê²Œ ëŠ˜ì–´ë‚œ ê¸°ë„.\n- **ì¹˜ë£Œ:** Pulmonary Hygiene (ê°€ë˜ ë°°ì¶œ ë¬¼ë¦¬ì¹˜ë£Œ), ê°ì—¼ ì‹œ í•­ìƒì œ.\n### B. ABPA (Allergic Bronchopulmonary Aspergillosis)\n- **í™˜ìêµ°:** ê¸°ì¡´ì— **Asthma**ë‚˜ **Cystic Fibrosis(ë‚­ì„±ì„¬ìœ ì¦)**ê°€ ìˆëŠ” í™˜ì.\n- **ë³‘íƒœìƒë¦¬:** íì— ìˆëŠ” *Aspergillus*(ê³°íŒ¡ì´)ì— ëŒ€í•´ ê³¼ë„í•œ **ì•Œë ˆë¥´ê¸° ë°˜ì‘**ì„ ë³´ì„ (ê°ì—¼ ì•„ë‹˜!).\n- **Triad (ì§„ë‹¨ ë‹¨ì„œ):**\n    1. Asthma history.\n    2. **Brown Mucus Plugs** (ê°ˆìƒ‰ ê°€ë˜ ë©ì–´ë¦¬).\n    3. **Sky-high IgE** (>1000) & Eosinophilia.\n- **ì¹˜ë£Œ:** Systemic Steroids (ì•Œë ˆë¥´ê¸° ì–µì œ) + Itraconazole (ê³°íŒ¡ì´ ì–µì œ - Antigen burden ì¤„ì´ê¸°).\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-373"}
{"chunk_type":"recap_summary","text":"## ğŸ¯ Recap (ì‹œí—˜ ì§ì „ ìš”ì•½)\níŒŸìºìŠ¤íŠ¸ ë§ˆì§€ë§‰ 1ë¶„ ìš”ì•½ì…ë‹ˆë‹¤. ì´ ë‚´ìš©ì€ ìë‹¤ê°€ë„ íŠ€ì–´ë‚˜ì™€ì•¼ í•©ë‹ˆë‹¤.\n1. **Diagnosis:** Spirometry FEV1/FVC **< 0.7**. Albuterol ë°˜ì‘ì„± ìˆìŒ (**>12% AND 200ml**).\n2. **Rule Out:** PFT ì •ìƒì¸ë° ì˜ì‹¬ë˜ë©´ **Methacholine Challenge**. (Negative result = No Asthma).\n3. **Status Asthmaticus Rx:** **Oxygen â†’ DuoNeb (SABA/SAMA) â†’ Systemic Steroids (Early!) â†’ Magnesium**.\n4. **Scary Sign:** ì²œì‹ ë°œì‘ ì¤‘ **\"Normal PCO2\"**ëŠ” í˜¸í¡ ê·¼ìœ¡ì´ ì§€ì³¤ë‹¤ëŠ” ëœ». **Intubation** ì¤€ë¹„!.\n5. **Pregnancy:** SpO2 **>95%** ìœ ì§€. PCO2ê°€ ì •ìƒì´ë©´ íƒœì•„ì—ê²ŒëŠ” ì‚°ì†Œ ë¶€ì¡±ì¼ ìˆ˜ ìˆìŒ (ì„ì‚°ë¶€ëŠ” ì›ë˜ ê³¼í˜¸í¡ ìƒíƒœì„).\n6. Bronchiectasis: HRCT: signet ring sign, tramtrack, prulent sputum â†‘ , foul smelling\n7. **ABPA:** ì²œì‹,CF í™˜ì + **ê°ˆìƒ‰ ê°€ë˜(Brown mucus)** + **ë†’ì€ IgE** + í ì¹¨ìœ¤(Infiltrates). ì¹˜ë£ŒëŠ” **Steroid + Itraconazole**.\n8. **Asthma Medication Rule:** **LABA ë‹¨ë… ì‚¬ìš© ê¸ˆì§€** (ì‚¬ë§ë¥  ì¦ê°€). í•­ìƒ ICSì™€ í•¨ê»˜.\n---\n---\n# ğŸ« USMLE Deep Dive: Restrictive Lung Diseases\n**Topic:** Interstitial Lung Disease (ILD), Hypersensitivity Pneumonitis, Sarcoidosis, Pulmonary Hypertension, OSA, Breath-holding spells\n## ğŸŒ³ The Big Picture: Diagnosis Tree\nì œí•œì„± íì§ˆí™˜ì€ \"íê°€ ë”±ë”±í•´ì„œ ê³µê¸°ê°€ ëª» ë“¤ì–´ê°€ëŠ” ë³‘\"ì…ë‹ˆë‹¤. ì§„ë‹¨ì˜ ê°ˆë¦¼ê¸¸(Fork in the road)ì€ **DLCO(Diffusing Capacity)**ì…ë‹ˆë‹¤.\nPlaintext","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-383"}
{"chunk_type":"transcript_chunk","text":"`Restrictive Lung Disease (TLC < 80%, FEV1/FVC Normal or High)\nâ”‚\nâ”œâ”€â”€ Low DLCO (í ìì²´ì˜ ë¬¸ì œ: Interstitial Lung Disease)\nâ”‚   â”œâ”€â”€ Hypersensitivity Pneumonitis (Acute vs Chronic)\nâ”‚   â”œâ”€â”€ Sarcoidosis (Young African American female, Hilar Adenopathy)\nâ”‚   â”œâ”€â”€ Pneumoconiosis (Silicosis, Asbestosis etc.)\nâ”‚   â”œâ”€â”€ Drug/Radiation Induced (Bleomycin, Amiodarone, Methotrexate)\nâ”‚   â””â”€â”€ Idiopathic Pulmonary Fibrosis (IPF: Diagnosis of Exclusion)\nâ”‚\nâ””â”€â”€ Normal DLCO (í ë°–ì˜ ë¬¸ì œ: Extrinsic Restriction)\n    â”œâ”€â”€ Chest Wall (Obesity, Kyphoscoliosis)\n    â””â”€â”€ Neuromuscular (ALS, Myasthenia Gravis, Guillain-Barre)`\n---\n## 1. Diagnostic Framework: The Mechanics\nì œí•œì„± íì§ˆí™˜(Restrictive Lung Disease)ì˜ í•µì‹¬ ê°œë…ì„ ë¨¼ì € ì¡ê³  ê°‘ì‹œë‹¤.\n- **Pathophysiology:** íê°€ ë”±ë”±í•œ ê°€ì£½ ì£¼ë¨¸ë‹ˆ(Stiff leather bag)ì²˜ëŸ¼ ë³€í–ˆìŠµë‹ˆë‹¤. íŒ½ì°½ì´ ì•ˆ ë˜ë‹ˆ ê³µê¸° ìš©ì (Volume)ì´ ì¤„ì–´ë“­ë‹ˆë‹¤.\n- **PFT Findings (Must Know):**\n    - **TLC (Total Lung Capacity):** **ê°ì†Œ (Low)**. ì´ê²Œ ì •ì˜ì…ë‹ˆë‹¤.\n    - **FEV1/FVC Ratio:** **ì •ìƒ í˜¹ì€ ì¦ê°€ (Normal or Increased > 0.8)**.\n        - ì´ìœ : ê³µê¸° ì–‘ ìì²´ëŠ” ì ì§€ë§Œ, ê¸°ë„ëŠ” ë»¥ ëš«ë ¤ ìˆì–´ì„œ ë‚´ë±‰ëŠ” ì†ë„(Recoil)ëŠ” ì—„ì²­ ë¹ ë¦…ë‹ˆë‹¤ (ë§ˆì¹˜ íŒ½íŒ½í•œ ê³ ë¬´ì¤„ì²˜ëŸ¼).\n- **The \"Fork in the Road\" - DLCO:**\n    - **Low DLCO:** í ì¡°ì§(Interstitium)ì´ë‚˜ í˜ˆê´€ì´ ë§ê°€ì ¸ì„œ ê°€ìŠ¤ êµí™˜ì´ ì•ˆ ë¨. â†’ **ILD, Pulmonary HTN**.\n    - **Normal DLCO:** íëŠ” ë©€ì©¡í•œë° ë°–ì—ì„œ ëª» ëŠ˜ì–´ë‚˜ê²Œ ëˆ„ë¦„. â†’ **ë¹„ë§Œ, ì²™ì¶”ì¸¡ë§Œì¦, ì‹ ê²½ê·¼ìœ¡ì§ˆí™˜**.\n---\n## 2. Hypersensitivity Pneumonitis (ê³¼ë¯¼ì„± íë ´)\n**\"Bird Fancier's Lung\"** ë˜ëŠ” **\"Farmer's Lung\"**. ì™¸ë¶€ í•­ì›(ìƒˆ, ê³°íŒ¡ì´ ë“±)ì— ëŒ€í•œ ì•Œë ˆë¥´ê¸° ë°˜ì‘ì…ë‹ˆë‹¤.\n### A. Acute Form (ê¸‰ì„±)\n- **Scenario:** ë¹„ë‘˜ê¸°ì¥ ì²­ì†Œ í›„ 4~6ì‹œê°„ ë’¤ ê°‘ìê¸° ì—´ë‚˜ê³  ê¸°ì¹¨í•¨ (Flu-like symptoms).\n- **Key Feature:** **ì›”ìš”ì¼ ì•„ì¹¨ ì¶œê·¼í•˜ë©´ ì•„í”„ê³ , ì£¼ë§ì— ì‰¬ë©´ ì¢‹ì•„ì§.** (í•­ì› ë…¸ì¶œ ì‹œì—ë§Œ ì¦ìƒ ë°œìƒ).\n- **Treatment:** **íšŒí”¼(Avoidance)**. ì›ì¸ë§Œ í”¼í•˜ë©´ 100% ì¢‹ì•„ì§ (Reversible).\n### B. Chronic Form (ë§Œì„±)\n- **Scenario:** ë‚®ì€ ë†ë„ë¡œ ì§€ì† ë…¸ì¶œ (ì§‘ì•ˆì— ê³°íŒ¡ì´ ë“±). ì„œì„œíˆ ìˆ¨ì´ ì°¨ê³  ë§ˆë¥¸ ê¸°ì¹¨. ì—´(Fever)ì€ ì—†ìŒ.\n- **Diagnosis:**\n    - **BAL (Bronchoalveolar Lavage):** **High Lymphocytes** (ë¦¼í”„êµ¬ ì¦ê°€).\n        - *ë¹„êµ:* IPFë‚˜ ë‹¤ë¥¸ ì§ˆí™˜ì€ ì£¼ë¡œ Neutrophilì´ ì¦ê°€í•¨.\n- **CT Finding:** **Upper lobe fibrosis**.\n- **Treatment:** ì›ì¸ íšŒí”¼ + ìŠ¤í…Œë¡œì´ë“œ. (ì´ë¯¸ ì„¬ìœ í™”ê°€ ì§„í–‰ë˜ë©´ ë¹„ê°€ì—­ì ì¼ ìˆ˜ ìˆìŒ).\n---\n## 3. Sarcoidosis (ìœ ìœ¡ì¢…ì¦)\n**\"The Systemic Granuloma Machine\"**. ì „ì‹  ì§ˆí™˜ì´ì§€ë§Œ íë¥¼ ê°€ì¥ ì¢‹ì•„í•©ë‹ˆë‹¤.\n- **Patient Profile:** 20~40ëŒ€ **African American Female**.\n- **Classic Presentation:** ìš°ì—°íˆ ì°ì€ X-rayì—ì„œ ë°œê²¬ëœ **Bilateral Hilar Lymphadenopathy (BHL)**. ì¦ìƒì€ ì—†ì„ ìˆ˜ë„ ìˆê³ , ë§ˆë¥¸ ê¸°ì¹¨ì´ë‚˜ í˜¸í¡ê³¤ë€ì´ ìˆì„ ìˆ˜ ìˆìŒ.\n- **Systemic Symptoms:**\n    - **Skin:** **Erythema Nodosum** (ì •ê°•ì´ì˜ ì•„í”ˆ ë¶‰ì€ ê²°ì ˆ), Lupus Pernio (ì½”/ëº¨ì˜ ë³´ë¼ìƒ‰ ë°œì§„ - íŠ¹ì´ë„ ë†’ìŒ).\n    - **â˜… Eyes:** **Uveitis** (Red eye, Pain, Photophobia). ëª¨ë“  Sarcoidosis í™˜ìëŠ” ì•ˆê³¼ ê²€ì§„ í•„ìˆ˜!\n    - **â˜… Heart:** AV Block (Syncope, Sudden death ìœ„í—˜).\n    - **Neuro:** Bell's Palsy (CN 7 palsy).\n- **Labs (The Calcium Connection):**\n    - **Hypercalcemia:** ìœ¡ì•„ì¢…(Granuloma) ë‚´ì˜ Macrophageê°€ ì œë©‹ëŒ€ë¡œ **Vitamin Dë¥¼ í™œì„±í™”**ì‹œì¼œ ì¹¼ìŠ˜ í¡ìˆ˜ë¥¼ ëŠ˜ë¦¼. (PTHëŠ” ë‚®ìŒ).\n    - **High ACE Level:** ìœ¡ì•„ì¢…ì—ì„œ ë¶„ë¹„. (ì§„ë‹¨ì  ê°€ì¹˜ëŠ” ë‚®ìŒ, ê²½ê³¼ ê´€ì°°ìš©).\n- **Treatment:**\n    - **â˜… No Symptoms:** **ì¹˜ë£Œ ì•ˆ í•¨ (Observation)**. ëŒ€ë¶€ë¶„ 2ë…„ ë‚´ ì €ì ˆë¡œ ì¢‹ì•„ì§.\n    - **Symptoms/Organ Damage:** **Systemic Steroids**.\n---\n## 4. Pulmonary Hypertension (íë™ë§¥ ê³ í˜ˆì••)\níí˜ˆê´€ì˜ ì••ë ¥ì´ ë†’ì•„ì ¸ ìš°ì‹¬ë¶€ì „(Right Heart Failure)ìœ¼ë¡œ ì´ì–´ì§€ëŠ” ë³‘ì…ë‹ˆë‹¤.\n- **Classification (WHO Groups):**\n    - **Group 1 (PAH):** íë™ë§¥ ìì²´ ë¬¸ì œ. (Idiopathic, Connective Tissue Disease, HIV, Drugs).\n    - **Group 2:** **Left Heart Disease** (ê°€ì¥ í”í•¨). ì¢Œì‹¬ë¶€ì „ìœ¼ë¡œ í”¼ê°€ íë¡œ ì—­ë¥˜.\n    - **Group 3:** **Lung Disease** (Hypoxia). COPD, ILD ë“±ìœ¼ë¡œ ì¸í•œ í˜ˆê´€ ìˆ˜ì¶•. (hypoxic vasoconstriction)\n    - **Group 4:** **Chronic Thromboembolic (CTEPH)**. ë§Œì„± íìƒ‰ì „ì¦.\n- **Diagnosis:**\n    - ìš´ë™í•˜ë‹¤ê°€ ì‚¬ê³ , loud P2, backup sign (JVD..)\n    - **Screening:** **Echocardiogram (ì‹¬ì´ˆìŒíŒŒ)**. RV pressure ì¶”ì •.\n    - **Confirmation (Gold Standard):** **Right Heart Catheterization (RHC)**. ì§ì ‘ ì••ë ¥ì„ ìŸ€ì„ ë•Œ **mPAP â‰¥ 20 mmHg**.\n- **Treatment:**\n    - Group 2, 3: ì›ì¸ ì§ˆí™˜(ì‹¬ë¶€ì „, COPD) ì¹˜ë£Œ. í˜ˆê´€í™•ì¥ì œ í•¨ë¶€ë¡œ ì“°ë©´ ì•ˆ ë¨ (V/Q mismatch ì•…í™” ìœ„í—˜).\n    - Group 1 (PAH): **Pulmonary Vasodilators** (Sildenafil, Bosentan, Epoprostenol).\n    - Group 4 (CTEPH): ìˆ˜ìˆ  ê°€ëŠ¥í•˜ë©´ **Thrombectomy** (ì™„ì¹˜ ê°€ëŠ¥).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-393"}
{"chunk_type":"transcript_chunk","text":"---\n## 5. Sleep & Pediatrics (Low Yield but Tricky)\n### ğŸ˜´ Obstructive Sleep Apnea (OSA)\n- **Risk Factors:** Obesity, Thick neck (>17 inches men, >16 inches women).\n- **Screening:** **STOP-BANG** questionnaire.\n- **Diagnosis:** **Polysomnography (Sleep Study)**. AHI (Apnea-Hypopnea Index) > 5.\n- **Treatment:** Weight loss + **CPAP** (Gold Standard).\n### ğŸ‘¶ Breath-Holding Spells (Pediatrics)\n- **Scenario:** 6ê°œì›”~6ì„¸ ì•„ì´ê°€ ìš¸ê±°ë‚˜ í™”ë‚˜ì„œ ìˆ¨ì„ ì°¸ë‹¤ê°€ íŒŒë—ê²Œ ì§ˆë¦¬ê³ (Cyanotic) ê¸°ì ˆí•¨(Pass out).\n- **Management:** **Reassurance**. ì •ìƒ ë°œë‹¬ ê³¼ì •ì„. ê·¸ëƒ¥ ë‘ë©´ ê¹¨ì–´ë‚¨.\n- **Workup:** ë¹ˆí˜ˆ(Iron deficiency anemia)ì´ ìˆìœ¼ë©´ ë” ìì£¼ ë°œìƒí•˜ë¯€ë¡œ **CBC/Ferritin** ì²´í¬í•´ ë³¼ ìˆ˜ ìˆìŒ.\n---\n## ğŸ¯ Recap (High Yield Summary)\nì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”.\n1. **Restrictive Lung Disease:** **Low TLC**, **Normal/High FEV1/FVC**.\n2. **DLCO is King:**\n    - Low DLCO = **Interstitial Lung Disease (ILD)** (Lung tissue problem).\n    - Normal DLCO = **Chest Wall/Neuromuscular** (Pump problem).\n3. **Hypersensitivity Pneumonitis:**\n    - Acute: **Flu-like**, Avoidance = Cure.\n    - Chronic: Upper lobe fibrosis, **Lymphocytosis on BAL**.\n4. **Sarcoidosis:** **Black female**, **Hilar Adenopathy**, **Hypercalcemia** (High Vit D), Non caseating granuloma, AV block, **Uveitis**. ë¬´ì¦ìƒì´ë©´ ì¹˜ë£Œ X â˜…\n5. **Pulmonary HTN:** screening: Echo â†’ í™•ì§„ì€ **Right Heart Cath**. Group 2(Left heart)ê°€ ì œì¼ í”í•¨. loud P2. know the group.\n6. OSA - ì•„ì´ì˜ ê²½ìš° ì†Œë³€ë¬¸ì œ, ì•„ì´ëŠ” ìˆ˜ìˆ !\n7. **Idiopathic Pulmonary Fibrosis (IPF):**\n    - **Honeycombing** (CT), **Velcro crackles** (Exam).\n    - ì¹˜ë£ŒëŠ” **Antifibrotics** (Pirfenidone, Nintedanib) - ì§„í–‰ë§Œ ëŠ¦ì¶¤.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-413"}
{"chunk_type":"transcript_chunk","text":"# LM_ pulmo 2\n# ğŸ« Pulmonary Embolism (PE) : The USMLE Framework\n### âš¡ One Line Vibe\n**\"Unstable patient gets Heparin first; Stable patient gets the Scan first.\"** (ì‚´ ë†ˆì€ ê²€ì‚¬í•˜ê³ , ì£½ì„ ë†ˆì€ ì¼ë‹¨ ì•½ë¶€í„° ì³ë¼.)\n### ğŸ“ Summary\nì´ ê°•ì˜ëŠ” USMLE Step 2 CKë¥¼ ìœ„í•´ Pulmonary Embolism(PE)ì˜ ì§„ë‹¨ ì•Œê³ ë¦¬ì¦˜(Wells Criteria), ìƒë¦¬í•™ì  ì‚¬ë§ ê¸°ì „(Obstructive Shock), ê·¸ë¦¬ê³  í™˜ìì˜ Stabilityì— ë”°ë¥¸ ì¹˜ë£Œ ì „ëµ(Anticoagulation vs Thrombolysis)ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë˜í•œ ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” íŠ¹ìˆ˜ ìƒí™©(Fat/Air Embolism, Pregnancy)ì— ëŒ€í•œ \"High Yield\" í¬ì¸íŠ¸ë“¤ì„ ì§šì–´ì¤ë‹ˆë‹¤.\n---\n### ğŸŒ³ Top-down Classification (Mental Model)\nPEë¼ëŠ” ê±°ëŒ€í•œ ìˆ²ì„ ë³¼ ë•Œ, í™˜ìê°€ **\"ì£½ì–´ê°€ëŠëƒ(Massive)\" ì•„ë‹ˆë©´ \"ë²„í‹°ê³  ìˆëŠëƒ(Stable/Submassive)\"**ê°€ ê°€ì¥ ì¤‘ìš”í•œ ê°ˆë¦¼ê¸¸ì…ë‹ˆë‹¤.\n`PULMONARY_EMBOLISM_WORKFLOW\n â”œâ”€â”€ 1. Initial_Approach (The Fork in the Road)\n â”‚    â”œâ”€â”€ Hemodynamically_Unstable (BP < 90/50)\n â”‚    â”‚    â””â”€â”€ â˜… ACTION: Empiric Anticoagulation (Start Heparin NOW) -> Bedside Echo\n â”‚    â””â”€â”€ Hemodynamically_Stable\n â”‚         â””â”€â”€ â˜… ACTION: Risk Stratification (Wells Score)\n â”‚\n â”œâ”€â”€ 2. Diagnostic_Algorithm (Wells Score Cutoff = 4)\n â”‚    â”œâ”€â”€ PE_Likely (Score > 4)\n â”‚    â”‚    â””â”€â”€ GO_TO: CT Pulmonary Angio (CTPA)\n â”‚    â””â”€â”€ PE_Unlikely (Score <= 4)\n â”‚         â””â”€â”€ GO_TO: D-Dimer (High Negative Predictive Value)\n â”‚              â”œâ”€â”€ Negative -> Go Home (PE Excluded)\n â”‚              â””â”€â”€ Positive -> CTPA\n â”‚\n â”œâ”€â”€ 3. Pathophysiology (Why they die)\n â”‚    â””â”€â”€ RV_Afterload_Spike -> RV_Dilation -> Septal_Bowing -> LV_Compression -> Obstructive_Shock\n â”‚\n â”œâ”€â”€ 4. Treatment_Hierarchy\n â”‚    â”œâ”€â”€ Standard (Stable) -> Anticoagulation (Heparin, LMWH, DOACs)\n â”‚    â”œâ”€â”€ Massive (Shock) -> Thrombolysis (tPA) or Embolectomy\n â”‚    â””â”€â”€ Contraindication to AC -> IVC Filter\n â”‚\n â””â”€â”€ 5. The_Cousins (Non-Thrombotic)\n      â”œâ”€â”€ Fat_Embolism (Long bone fx + Petechial Rash)\n      â””â”€â”€ Air_Embolism (Central line/Surgery + Position maneuver)`\n---\n## 2. Diagnosis: Wells Criteria (The Gatekeeper)\në¬´í„±ëŒ€ê³  CTë¶€í„° ì°ì§€ ë§ê³ , **Pre-test Probability**ë¥¼ ë¨¼ì € ê³„ì‚°í•´ì•¼ í•¨.\n***ì…ì›ì¤‘ì¸ í™˜ìê°€ ìˆ¨ì°¨ê³ , pleuritic chest pain, mild fever.. now what..?***\n### ğŸ”¢ Modified Wells Criteria ì ìˆ˜ ê³„ì‚°ë²•\n- **+3.0ì  (ê°€ì¥ í¼):**\n    1. **Clinical signs of DVT:** ë‹¤ë¦¬ê°€ ë¶€ì—ˆê±°ë‚˜(Swollen leg), ì¢…ì•„ë¦¬ í†µì¦(Tenderness).\n    2. **Alternative diagnosis less likely than PE:** \"ì´ê±° ë§ê³ ëŠ” ì„¤ëª…ì´ ì•ˆ ë¨\" (ì„ìƒì˜ì˜ ì£¼ê´€ì  íŒë‹¨ì´ ì¤‘ìš”). íë ´ì•„ë‹ˆë‹¤â€¦\n- **+1.5ì :**\n    1. **Previous History:** ê³¼ê±° PE ë˜ëŠ” DVT ë³‘ë ¥.\n    2. **Tachycardia:** ì‹¬ë°•ìˆ˜ > 100íšŒ. â˜… \n    3. **Recent Surgery or Immobilization:**\n        - ìµœê·¼ 4ì£¼ ì´ë‚´ ì£¼ìš” ìˆ˜ìˆ .\n        - 3ì¼ ì´ìƒì˜ ì¹¨ìƒ ì•ˆì •(Bed rest).\n- **+1.0ì :**\n    1. **Hemoptysis:** ê°í˜ˆ (ê¸°ì¹¨í•  ë•Œ í”¼ ë‚˜ì˜´ -> ì•”ì´ë‚˜ íê²½ìƒ‰ ì‹œì‚¬).\n    2. **Active Cancer:** í˜„ì¬ ì¹˜ë£Œ ì¤‘ì´ê±°ë‚˜ 6ê°œì›” ë‚´ ì¹˜ë£Œë°›ì€ ì•”.\n---\n## 3. The Diagnostic Algorithm (Action Plan)\n### A. ì ìˆ˜ í•´ì„ (The Split)\n- **Score â‰¤ 4 (PE Unlikely):**\n    - **Action:** **D-Dimer** ê²€ì‚¬.\n    - **ì´ìœ :** D-DimerëŠ” **Negative Predictive Value(ìŒì„± ì˜ˆì¸¡ë„)**ê°€ ë§¤ìš° ë†’ìŒ. ì¦‰, ìˆ˜ì¹˜ê°€ ì •ìƒì´ë©´(<500) PEëŠ” ì ˆëŒ€ ì•„ë‹ˆë¼ê³  ë³´ê³  **Workup ì¢…ë£Œ(ì§‘ì— ë³´ëƒ„)** ê°€ëŠ¥.\n    - **ì£¼ì˜:** ì–‘ì„± ë‚˜ì˜¤ë©´ ë¹„íŠ¹ì´ì ì´ë¯€ë¡œ CT ì°ì–´ì•¼ í•¨.\n- **Score > 4 (PE Likely):**\n    - Anticoagualtion â†’ CTPA\n    - **Action:** **CT Pulmonary Angiography (CTPA)** ì§í–‰.\n    - **í•µì‹¬:** D-dimer ê±´ë„ˆëœ€ (ì‹œê°„ ë‚­ë¹„).","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-1"}
{"chunk_type":"transcript_chunk","text":"### B. The \"Safety First\" Rule (ë§¤ìš° ì¤‘ìš” â˜…)\n- ë§Œì•½ í™˜ìê°€ **Likely Score (>4)**ì´ê³  **Distress(í˜¸í¡ê³¤ë€ ë“±)**ê°€ ì‹¬í•˜ë‹¤ë©´?\n- **CT ì°ìœ¼ëŸ¬ ê°€ê¸° ì „ì— í•­ì‘ê³ ì œ(Heparin)ë¶€í„° íˆ¬ì—¬.**\n- *Logic:* CTì‹¤ë¡œ ì´ë™í•˜ëŠ” ë„ì¤‘ ì‚¬ë§í•  í™•ë¥ ì´ í—¤íŒŒë¦° í•œ ë²ˆ ë§ê³  ì¶œí˜ˆ ìƒê¸¸ í™•ë¥ ë³´ë‹¤ ë†’ìŒ.\n- *ì˜ˆì™¸:* ë‡Œì¶œí˜ˆ, í™œì„± ì¶œí˜ˆ(GI bleed) ë“± ê¸ˆê¸°ì¦ì´ ìˆì„ ë•Œë§Œ ì œì™¸.\n### C. Imaging Modalities (ì˜ìƒ ê²€ì‚¬)\n1. **CT Pulmonary Angiography (CTPA):** Gold Standard. í™•ì§„ ê²€ì‚¬.\n2. **V/Q Scan (Ventilation/Perfusion):**\n    - **ì‚¬ìš© ëŒ€ìƒ:** ì‹ ë¶€ì „(Renal failure), ì¡°ì˜ì œ ì•Œë ˆë¥´ê¸°(Contrast allergy), **ì„ì‚°ë¶€(Pregnancy)**.\n    - *Note:* ì„ì‚°ë¶€ëŠ” íƒœì•„ ë°©ì‚¬ì„  í”¼í­ ë¬¸ì œì™€ ì¡°ì˜ì œ ì´ìŠˆ ë•Œë¬¸ì— V/Qê°€ ì„ í˜¸ë˜ê¸°ë„ í•¨.\n---\n## 4. Signs & Symptoms\n### ğŸ©» Chest X-ray Signs (ì˜¤ë””ì˜¤ì—ì„œ ì–¸ê¸‰ëœ 3ëŒ€ì¥)\nì—‘ìŠ¤ë ˆì´ëŠ” ë³´í†µ ì •ìƒì´ì§€ë§Œ, ë‹¤ìŒ ì†Œê²¬ì´ ë³´ì´ë©´ PEë¥¼ ê°•ë ¥ ì‹œì‚¬.\n1. **Hampton's Hump:**\n    - íì˜ ê°€ì¥ìë¦¬(Periphery)ì— ë³´ì´ëŠ” **ìê¸° ëª¨ì–‘(Wedge-shaped)ì˜ ìŒì˜**.\n    - ì˜ë¯¸: íê²½ìƒ‰(Lung infarction)ì´ ì¼ì–´ë‚œ ë¶€ìœ„.\n2. **Westermark Sign:**\n    - í˜ˆê´€ì´ ê°‘ìê¸° ëš ëŠê²¨ ë³´ì„(Sharp cutoff). ê·¸ ë’¤ìª½ íì•¼ê°€ ì–´ë‘¡ê²Œ ë³´ì„(Oligemia).\n    - ì˜ë¯¸: í˜ˆì „ ë•Œë¬¸ì— í”¼ê°€ ì•ˆ ê°€ì„œ í˜ˆê´€ ìŒì˜ì´ ì‚¬ë¼ì§„ ê²ƒ.\n3. **Fleischner Sign:**\n    - ì¤‘ì‹¬ íë™ë§¥(Central Pulmonary Artery)ì´ ë¹µë¹µí•˜ê²Œ ëŠ˜ì–´ë‚¨(Dilated).\n    - ì˜ë¯¸: ë§‰íŒ ê³³ ë’¤ìª½ìœ¼ë¡œ ì••ë ¥ì´ ì°¨ì„œ í˜ˆê´€ì´ ë¶ˆë£©í•´ì§(Bulging).\n### âš¡ ECG (ì‹¬ì „ë„)\n- **Sinus Tachycardia:** ê°€ì¥ í”í•œ ì†Œê²¬ (Most common).\n- **S1Q3T3:**\n    - Lead Iì—ì„œ SíŒŒ ê¹Šì–´ì§, Lead IIIì—ì„œ QíŒŒì™€ TíŒŒ ì—­ìœ„(Inversion).\n    - *Real Talk:* ì¡±ë³´ì—ëŠ” ë‚˜ì˜¤ì§€ë§Œ ì‹¤ì œë¡œëŠ” ë“œë¬¾(Rare).\n- **T-wave Inversions (V1-V4):**\n    - *Right Heart Strain(ìš°ì‹¬ì‹¤ ë¶€í•˜)**ì„ ë³´ì—¬ì£¼ëŠ” ë” ì˜ˆë¯¼í•œ ì§€í‘œ.\n### ğŸŒ¡ ê¸°íƒ€ ì¦ìƒ\n- **Syncope (ì‹¤ì‹ ):** ë§¤ìš° ìœ„í—˜í•œ ì§•í›„(Ominous sign). Cardiac Outputì´ ìˆœê°„ì ìœ¼ë¡œ 0ì´ ë˜ì—ˆë‹¤ëŠ” ëœ». ì‹¬í˜ˆê´€ ë¶•ê´´ ì§ì „.\n- **Fever:** ì•½ 15%ì—ì„œ ë¯¸ì—´ ë°œìƒ ê°€ëŠ¥. í ì¡°ì§ ê´´ì‚¬(Infarction)ë¡œ ì¸í•œ ì—¼ì¦ ë°˜ì‘. íë ´ìœ¼ë¡œ ì˜¤ì¸í•˜ì§€ ë§ ê²ƒ.\n---\n## 5. Pathophysiology: Mechanism of Death\ní™˜ìëŠ” ì™œ ì£½ëŠ”ê°€? (Hypoxia ë•Œë¬¸ì´ ì•„ë‹˜)\n1. **Obstruction:** í˜ˆì „ì´ íë™ë§¥ì„ ë§‰ìŒ.\n2. **RV Afterload Spike:** ìš°ì‹¬ì‹¤ì´ í”¼ë¥¼ ì§œë‚´ë ¤ëŠ”ë° ì••ë ¥ì´ ê¸‰ìƒìŠ¹.\n3. **RV Dilation & Septal Bowing:** ìš°ì‹¬ì‹¤ì´ ëŠ˜ì–´ë‚˜ë©´ì„œ ì‹¬ì‹¤ ì¤‘ê²©(Septum)ì„ **ì™¼ìª½(LV)ìœ¼ë¡œ ë°€ì–´ë²„ë¦¼**.\n4. **LV Compression:** ì¢Œì‹¬ì‹¤ì´ ì°Œë¶€ëŸ¬ì ¸ì„œ í”¼ë¥¼ ëª» ì±„ì›€ (Preload ê°ì†Œ).\n5. **Obstructive Shock:** ì¢Œì‹¬ì‹¤ì—ì„œ ë‚˜ê°€ëŠ” í”¼ê°€ ì—†ì–´ì„œ í˜ˆì•• ì¶”ë½ -> ì‚¬ë§.\n---\n## 6. Treatment Hierarchy (ê³„ì¸µë³„ ì¹˜ë£Œ)\ní™˜ìë¥¼ ì„¸ ê°€ì§€ ë²„í‚·(Bucket)ìœ¼ë¡œ ë¶„ë¥˜í•˜ì—¬ ì¹˜ë£Œí•¨.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-21"}
{"chunk_type":"transcript_chunk","text":"### 1) Low Risk (Stable)\n- **ì •ì˜:** í˜ˆì•• ì •ìƒ, RV ê¸°ëŠ¥ ì •ìƒ.\n- **ì¹˜ë£Œ:** **Anticoagulation** (Heparin, LMWH, DOACs). ëª¸ì´ ì•Œì•„ì„œ í˜ˆì „ ë…¹ì¼ ë•Œê¹Œì§€ ë” ì•ˆ ìƒê¸°ê²Œ ë§‰ì•„ì¤Œ.\n### 2) Submassive PE (The Gray Area)\n- **ì •ì˜:** **í˜ˆì••ì€ ì •ìƒ(Stable)**ì´ì§€ë§Œ, **RV Dysfunction** ì¦ê±°ê°€ ìˆìŒ.\n    - Echoì—ì„œ RV Dilation.\n    - Troponin ìƒìŠ¹, BNP ìƒìŠ¹.\n- **ì¹˜ë£Œ:** ì¼ë‹¨ì€ **Anticoagulation**.\n    - ICUì—ì„œ ë§¤ì˜ ëˆˆìœ¼ë¡œ ê°ì‹œ(Hawk-like watch). í˜ˆì•• ë–¨ì–´ì§€ë©´ ë°”ë¡œ Massiveë¡œ ê°„ì£¼í•˜ê³  tPA ê³ ë ¤.\n### 3) Massive PE (Unstable = Emergency)\n- **ì •ì˜:** **Hypotension (SBP < 90)** ë˜ëŠ” Shock.\n- **ì¹˜ë£Œ:** **Thrombolysis (tPA)**.\n    - ì•½ë¬¼ë¡œ ì „ì‹  í˜ˆì „ì„ ë…¹ì„(Systemic Fibrinolysis).\n    - **tPA ê¸ˆê¸°ì‹œ:** Surgical Embolectomy (ìˆ˜ìˆ ) ë˜ëŠ” Catheter-directed thrombolysis.\n### 4) IVC Filter\n- **ì ì‘ì¦:**\n    1. í•­ì‘ê³ ì œ **ì ˆëŒ€ ê¸ˆê¸°** (Active GI Bleed, Brain Bleed).\n    2. í•­ì‘ê³ ì œë¥¼ ì¼ëŠ”ë°ë„ **PEê°€ ì¬ë°œ**í•¨ (Failure of anticoagulation).\n- *Note:* ì¥ê¸°ì ìœ¼ë¡œëŠ” í•„í„° ìì²´ê°€ í˜ˆì „ ì†ŒìŠ¤(Source)ê°€ ë˜ì–´ DVT ìœ„í—˜ì„ ë†’ì¼ ìˆ˜ ìˆìŒ.\n---\n## 7. Special High-Yield Variants (íŠ¹ìˆ˜ ìƒí™©)\n### ğŸ¦´ Fat Embolism Syndrome\n- **ì›ì¸:** ì¥ê³¨ ê³¨ì ˆ(Long bone fx, Femur) í›„ ê³¨ìˆ˜ ì§€ë°© ìœ ì¶œ.\n- **íƒ€ì´ë°:** ë¶€ìƒ í›„ **24~72ì‹œê°„** ë’¤ ë°œë³‘.\n- **Classic Triad:**\n    1. **Hypoxemia:** í˜¸í¡ ê³¤ë€.\n    2. **Neurologic abnormalities:** í˜¼ë€(Confusion), ì˜ì‹ ë³€í™”.\n    3. **Petechial Rash (â˜…):** ê°€ìŠ´, ê²¨ë“œë‘ì´(Axilla), ëª©ì— ë¶‰ì€ ë°˜ì . (ê°€ì¥ íŠ¹ì§•ì ).\n- **ì¹˜ë£Œ:** **Supportive Care** (ì‚°ì†Œ ê³µê¸‰). í—¤íŒŒë¦° ì•ˆ ì”€(ì§€ë°©ì´ë¼ ì•ˆ ë…¹ìŒ). ì˜ˆë°©(ì¡°ê¸° ê³¨ì ˆ ê³ ì •)ì´ ìµœì„ .\n### ğŸ«§ Air Embolism\n- **ì›ì¸:** ì¤‘ì‹¬ì •ë§¥ê´€(Central line) ì œê±° ì‹œ, ìˆ˜ìˆ  ì¤‘, ìŠ¤ì¿ ë²„ ë‹¤ì´ë¹™.\n- **ê¸°ì „:** ê³µê¸° ë°©ìš¸ì´ ìš°ì‹¬ì‹¤(RV) ìœ ì¶œë¡œ(Outflow tract)ë¥¼ ë§‰ì•„ë²„ë¦¼ (Air Lock).\n- **ì¹˜ë£Œ:** **Durant's Maneuver (Left Lateral Decubitus)**.\n    - í™˜ìë¥¼ **ì™¼ìª½ìœ¼ë¡œ ëˆ•íˆê³  ë¨¸ë¦¬ë¥¼ ë‚®ì¶¤**. â˜…\n    - *ì›ë¦¬:* ê³µê¸°ë¥¼ ê°€ë²¼ìš°ë‹ˆê¹Œ ìš°ì‹¬ì‹¤ ê¼­ëŒ€ê¸°(Apex)ë¡œ ë„ì›Œ ë³´ë‚´ê³ , í˜ˆì•¡ì€ ì•„ë˜ìª½ìœ¼ë¡œ í˜ëŸ¬ë‚˜ê°€ê²Œ í•¨.\n### ğŸ¤° Amniotic Fluid Embolism\n- **ìƒí™©:** ë¶„ë§Œ ì¤‘/ì§í›„.\n- **ì¦ìƒ:** ê°‘ì‘ìŠ¤ëŸ¬ìš´ ì‡¼í¬ + **DIC**(í”¼ê°€ ì•ˆ ë©ˆì¶¤).\n- **ì˜ˆí›„:** ì‚¬ë§ë¥  ë§¤ìš° ë†’ìŒ.\n### ğŸ¦€ Trousseau's Syndrome\n- **ì¦ìƒ:** ì—¬ê¸°ì €ê¸° ì˜®ê²¨ ë‹¤ë‹ˆëŠ” ì •ë§¥ì—¼ (Migratory Thrombophlebitis).\n- **ì˜ë¯¸:** **Occult Malignancy** (ìˆ¨ê²¨ì§„ ì•”, íŠ¹íˆ ì·Œì¥ì•”) ì˜ì‹¬í•´ì•¼ í•¨.\n## 8. Deep Vein Thrombosis (DVT): The Source\n**\"ëª¨ë“  PEëŠ” ì–´ë””ì„ ê°€ ë‚ ì•„ì™”ë‹¤. ê·¸ê³³ì„ ì°¾ì•„ë¼.\"**","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-41"}
{"chunk_type":"transcript_chunk","text":"PEë¥¼ ì§„ë‹¨í•˜ê³  ëì´ ì•„ë‹™ë‹ˆë‹¤. í˜ˆì „ì´ ì–´ë””ì„œ ì™”ëŠ”ì§€(Source)ë¥¼ ì•„ëŠ” ê²ƒì´ ì˜ˆí›„ì™€ ì¹˜ë£Œì— ì§ê²°ë©ë‹ˆë‹¤.\n### A. Location Matters: Proximal vs. Distal (ì¡±ë³´ ë­í‚¹ 1ìœ„)\nëª¨ë“  DVTê°€ íë¡œ ë‚ ì•„ê°€ëŠ” ê²ƒì€ ì•„ë‹™ë‹ˆë‹¤. ìœ„ì¹˜ê°€ í•µì‹¬ì…ë‹ˆë‹¤.\n1. **Proximal DVT (ìœ„í—˜êµ° â˜…):**\n    - **ìœ„ì¹˜:** **Popliteal(ì˜¤ê¸ˆì •ë§¥)**, **Femoral(ëŒ€í‡´ì •ë§¥)**, **Iliac(ì¥ê³¨ì •ë§¥)** veins.\n    - **íŠ¹ì§•:** ì—¬ê¸°ì„œ ìƒê¸´ í˜ˆì „ì´ ë©ì–´ë¦¬ê°€ í¬ê³ , íë¡œ ë‚ ì•„ê°ˆ í™•ë¥ (Embolization risk)ì´ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. PEì˜ 90% ì´ìƒì´ ì—¬ê¸°ì„œ ì˜µë‹ˆë‹¤.\n    - **ì¹˜ë£Œ:** ë¬´ì¡°ê±´ **Anticoagulation**.\n2. **Distal DVT (Calf Veins):**\n    - **ìœ„ì¹˜:** ë¬´ë¦ ì•„ë˜ ì¢…ì•„ë¦¬ ì •ë§¥ë“¤.\n    - **íŠ¹ì§•:** ì‘ì•„ì„œ íë¡œ ë‚ ì•„ê°€ë„ ì‹¬ê°í•œ PEë¥¼ ì˜ ì•ˆ ì¼ìœ¼í‚µë‹ˆë‹¤.\n    - **ê´€ë¦¬:** ë¬´ì¡°ê±´ ì•½ì„ ì“°ê¸°ë³´ë‹¤, ì´ˆìŒíŒŒ(Serial Ultrasound)ë¡œ ìœ„ë¡œ ì˜¬ë¼ì˜¤ëŠ”ì§€(Propagation) ì§€ì¼œë³´ê¸°ë„ í•©ë‹ˆë‹¤.\n### B. Upper Extremity DVT: Paget-Schroetter Syndrome\n\"ë‹¤ë¦¬ì—ë§Œ ìƒê¸°ëŠ” ê²Œ ì•„ë‹ˆë‹¤.\" (ì˜¤ë””ì˜¤ì—ì„œ ì–¸ê¸‰ëœ 'Effort Thrombosis')\n- **íƒ€ê²Ÿ:** ì Šê³  ê±´ê°•í•œ ìš´ë™ì„ ìˆ˜ (ì•¼êµ¬ íˆ¬ìˆ˜, ì—­ë„ ì„ ìˆ˜, ìˆ˜ì˜ ì„ ìˆ˜ ë“±).\n- **ê¸°ì „:** ì–´ê¹¨ ê·¼ìœ¡(Scalene muscles ë“±)ì´ ë„ˆë¬´ ë¹„ëŒ€í•´ì ¸ì„œ ì‡„ê³¨ ë°‘ì˜ ì •ë§¥(Subclavian vein)ì„ **ë¬¼ë¦¬ì ìœ¼ë¡œ ëˆŒëŸ¬ì„œ(Compress)** í˜ˆì „ì´ ìƒê¹€.\n- **ì¦ìƒ:** ì Šì€ ë‚¨ìê°€ ìš´ë™ í›„ ê°‘ìê¸° íŒ”ì´ ë¶“ê³  ì•„í””.\n- **ì¹˜ë£Œ:** ì¼ë°˜ DVTì™€ ë‹¤ë¥´ê²Œ **Catheter-directed Thrombolysis**ë¥¼ ë” ì ê·¹ì ìœ¼ë¡œ ê³ ë ¤í•˜ê³ , ê·¼ë³¸ ì›ì¸ í•´ê²°ì„ ìœ„í•´ **ìˆ˜ìˆ (ë¼ˆë‚˜ ê·¼ìœ¡ ì œê±°)**ì´ í•„ìš”í•  ìˆ˜ ìˆìŒ.\n### C. unprovoked DVT in an elderly â†’ ì•” ì˜ì‹¬ â†’ì•” ê²€ì‚¬ â˜…\n### D. Phlegmasia Cerulea Dolens (The Limb Threat)\nPEì—ì„œì˜ 'Massive PE'ì— í•´ë‹¹í•˜ëŠ”, ë‹¤ë¦¬ì—ì„œì˜ ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n- **ì˜ë¯¸:** **\"Painful Blue Edema\"** (ì•„í”„ê³  íŒŒë—ê²Œ ë¶“ëŠ”ë‹¤).\n- **ê¸°ì „:** ë‹¤ë¦¬ì˜ **ëª¨ë“ ** ì •ë§¥ì´ í˜ˆì „ìœ¼ë¡œ ê½‰ ë§‰í˜ â†’ í”¼ê°€ ì „í˜€ ëª» ë¹ ì ¸ë‚˜ê° â†’ ë™ë§¥í˜ˆë„ ëª» ë“¤ì–´ì˜´(ì••ë ¥ ì°¨ì´ ë•Œë¬¸ì—) â†’ **ë‹¤ë¦¬ ê´´ì‚¬(Ischemia/Gangrene)**.\n- **ì¦ìƒ:** ë‹¤ë¦¬ê°€ ì—„ì²­ë‚˜ê²Œ ë¶“ê³ , ì‹œí¼ë ‡ê²Œ ë³€í•˜ë©°(Cyanosis), ë§¥ë°•ì´ ì•ˆ ë§Œì ¸ì§ˆ ìˆ˜ë„ ìˆìŒ.\n- **ì¹˜ë£Œ:** ë‹¨ìˆœ í•­ì‘ê³ ì œë¡œëŠ” ë¶€ì¡±í•¨. ë‹¤ë¦¬ë¥¼ ì ˆë‹¨(Amputation)í•˜ì§€ ì•Šìœ¼ë ¤ë©´ **Thrombolysis(í˜ˆì „ìš©í•´ìˆ )** ë˜ëŠ” **Thrombectomy(ìˆ˜ìˆ ì  ì œê±°)**ê°€ ì¦‰ì‹œ í•„ìš”í•¨.\n### E. Diagnosis: Ultrasound Strategy\n- **ê²€ì‚¬ëª…:** **Compression Ultrasonography**.\n- **ì›ë¦¬:** ì •ìƒ ì •ë§¥ì€ ì´ˆìŒíŒŒ í”„ë¡œë¸Œë¡œ ëˆ„ë¥´ë©´ ì°Œê·¸ëŸ¬ì ¸ì•¼(Collapsible) í•¨. ì•ˆ ì°Œê·¸ëŸ¬ì§€ë©´(Non-compressible) ì•ˆì— ë­”ê°€ ê½‰ ì°¨ ìˆë‹¤ëŠ” ëœ» = **DVT ì–‘ì„±**.\n---","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-61"}
{"chunk_type":"recap_summary","text":"## 9. Final Decision Table (Recap Summary)\n| **ìƒí™© (Patient Snapshot)** | **í–‰ë™ (The Move)** |\n| --- | --- |\n| **Stable Patient (BP > 90)** | Wells Score ê³„ì‚° |\n| **Wells â‰¤ 4 (Unlikely)** | D-dimer |\n| **Wells > 4 (Likely)** | CT Angio (CTPA) |\n| **Likely PE + Severe Distress** | **Heparin ë¨¼ì €** íˆ¬ì—¬ í›„ CT ì´ë™ |\n| **Unstable (BP < 90, Massive)** | Bedside Echo â†’ **tPA (Thrombolysis)** |\n| **Renal Failure / Pregnancy** | V/Q Scan |\n| **Femur Fx + Rash + Confusion** | Fat Embolism (Supportive Care) |\n| **Central Line removal + Shock** | Left Lateral Decubitus (Air Embolism) |\n| **75, unprovoked DVT** | cancer screening |\n# ğŸ« USMLE Deep Dive: ARDS (Acute Respiratory Distress Syndrome)\n**Topic:** Berlin Criteria, Ventilation Strategy (LTVV), PEEP, Prone Positioning\n## ğŸŒ³ The Big Picture: Hypoxemia Algorithm\ní™˜ìê°€ ìˆ¨ì´ ì°¨ì„œ X-rayë¥¼ ì°ì—ˆëŠ”ë° **ì–‘ìª½ íê°€ í•˜ì–—ê²Œ(Bilateral White-out)** ë³€í–ˆìŠµë‹ˆë‹¤. ì´ê²Œ ì‹¬ì¥ ë•Œë¬¸ì¼ê¹Œìš”, í ë•Œë¬¸ì¼ê¹Œìš”?\nPlaintext\n`Bilateral Opacities on CXR (White-out)\nâ”‚\nâ”œâ”€â”€ Cardiogenic Pulmonary Edema (ì‹¬ë¶€ì „)\nâ”‚   â”œâ”€â”€ PCWP > 18 mmHg (High)\nâ”‚   â”œâ”€â”€ JVD present, S3 gallop\nâ”‚   â””â”€â”€ Rx: Diuretics (Lasix), Inotropes\nâ”‚\nâ””â”€â”€ Non-Cardiogenic Pulmonary Edema (ARDS)\n    â”œâ”€â”€ PCWP < 18 mmHg (Normal/Low)\n    â”œâ”€â”€ Berlin Criteria ë§Œì¡± (1ì£¼ì¼ ì´ë‚´ ë°œë³‘)\n    â”œâ”€â”€ P/F Ratio < 300\n    â””â”€â”€ Rx: Mechanical Ventilation (Low Tidal Volume, High PEEP)`\n---\n## 1. Pathophysiology: \"The Leaky Capillary\"","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-75"}
{"chunk_type":"transcript_chunk","text":"ARDSëŠ” íê°€ ë¬¼ì— ë¹ ì§„ ê²Œ ì•„ë‹ˆë¼, í˜ˆê´€ì—ì„œ ë¬¼ì´ ìƒˆì–´ ë‚˜ì™€ íí¬ë¥¼ ë§ê°€ëœ¨ë¦¬ëŠ” ë³‘ì…ë‹ˆë‹¤.\n- **Mechanism:** Sepsisë‚˜ Trauma ê°™ì€ ì „ì‹  ì—¼ì¦ ë°˜ì‘ â†’ ì‚¬ì´í† ì¹´ì¸ í­í’(Cytokine Storm) â†’ íí˜ˆê´€ íˆ¬ê³¼ì„± ì¦ê°€ â†’ ë‹¨ë°±ì§ˆì´ í’ë¶€í•œ ì‚¼ì¶œì•¡ì´ íí¬ë¡œ ìƒ™ë‹ˆë‹¤.\n- **Result:**\n    - **Hyaline Membrane:** ì£½ì€ ì„¸í¬ ì°Œêº¼ê¸°ë“¤ì´ ë§‰ì„ í˜•ì„±í•´ ê°€ìŠ¤ êµí™˜ì„ ì°¨ë‹¨í•©ë‹ˆë‹¤.\n    - **Baby Lungs:** ì •ìƒì ìœ¼ë¡œ ê¸°ëŠ¥í•˜ëŠ” íí¬ê°€ ê·¹ì†Œìˆ˜ë¡œ ì¤„ì–´ë“¤ì–´, ë§ˆì¹˜ ì•„ê¸° íì²˜ëŸ¼ ìš©ì ì´ ì‘ì•„ì§‘ë‹ˆë‹¤.\n    - **Shunt Physiology:** í”¼ê°€ íë¥¼ ì§€ë‚˜ê°€ë„ ì‚°ì†Œë¥¼ ëª» ë°›ìŠµë‹ˆë‹¤ (V/Q = 0). ì‚°ì†Œë¥¼ ì•„ë¬´ë¦¬ ì¤˜ë„(100% O2) êµì •ì´ ì˜ ì•ˆ ë©ë‹ˆë‹¤.\n---\n## 2. Diagnosis: Berlin Criteria\nARDS ì§„ë‹¨ì„ ìœ„í•œ 4ê°€ì§€ í•„ìˆ˜ ì¡°ê±´ì…ë‹ˆë‹¤. ì‹œí—˜ì—ì„œ \"ARDSì¸ê°€?\"ë¥¼ ë¬¼ìœ¼ë©´ ì´ ê¸°ì¤€ì„ ëŒ€ì…í•˜ì„¸ìš”.\n1. **Timing (ì‹œê¸°):** ì›ì¸ ì§ˆí™˜(Sepsis, Pneumonia ë“±) ë°œìƒ **1ì£¼ì¼ ì´ë‚´(Within 1 week)** ê¸‰ì„± ë°œë³‘.\n2. **Imaging (ì˜ìƒ):** X-rayë‚˜ CTìƒ **Bilateral Opacities** (ì–‘ìª½ í ì¹¨ìœ¤).\n3. **Origin (ì›ì¸):** **Not fully explained by heart failure**. (ì‹¬ì¥ ì´ˆìŒíŒŒ ì •ìƒ, í˜¹ì€ PCWP < 18mmHg).\n4. **Oxygenation (ì‚°ì†Œí™”):** P/F Ratio (PaO2 / FiO2)ë¡œ ì¤‘ì¦ë„ ë¶„ë¥˜.\n    - **Mild:** 200 < P/F â‰¤ 300\n    - **Moderate:** 100 < P/F â‰¤ 200\n    - **Severe:** P/F â‰¤ 100\n---\n## 3. Treatment: Lung Protective Ventilation â˜…\nê°€ì¥ ì¤‘ìš”í•œ íŒŒíŠ¸ì…ë‹ˆë‹¤. ARDS í™˜ìëŠ” ì‚°ì†Œ ë¶€ì¡±ìœ¼ë¡œ ì£½ëŠ” ê²Œ ì•„ë‹ˆë¼, **ì¸ê³µí˜¸í¡ê¸°ê°€ íë¥¼ ì°¢ì–´ì„œ(Volutrauma)** ì£½ìŠµë‹ˆë‹¤.\n### A. Low Tidal Volume Ventilation (LTVV)â˜…â˜…â˜…â˜…\n**Goal:** íí¬ ê³¼íŒ½ì°½ ë°©ì§€ (Prevent Volutrauma/Barotrauma).\n- **Setting:** **6 mL/kg** of Predicted Body Weight (PBW). (ì¼ë°˜ì ì¸ 8-10mL/kgë³´ë‹¤ í›¨ì”¬ ì ê²Œ ì¤ë‹ˆë‹¤).\n    - *ì£¼ì˜:* ì‹¤ì œ ì²´ì¤‘ì´ ì•„ë‹ˆë¼ **í‚¤(Height)**ë¡œ ê³„ì‚°í•œ ì˜ˆìƒ ì²´ì¤‘ì„ ì”ë‹ˆë‹¤. ì‚´ìª˜ë‹¤ê³  íê°€ ì»¤ì§€ëŠ” ê±´ ì•„ë‹ˆë‹ˆê¹Œìš”.\n- **Mortality Benefit:** ì‚¬ë§ë¥ ì„ ë‚®ì¶”ëŠ” ê²ƒì´ ì…ì¦ëœ **ê°€ì¥ ì¤‘ìš”í•œ ì¹˜ë£Œ**ì…ë‹ˆë‹¤.\n### B. PEEP (Positive End-Expiratory Pressure)\n- **Role:** ìˆ¨ì„ ë‚´ì‰´ ë•Œ íí¬ê°€ ìª¼ê·¸ë¼ë“¤ì§€ ì•Šê²Œ ì••ë ¥ì„ ê±¸ì–´ì¤ë‹ˆë‹¤ (Recruitment). ì°Œê·¸ëŸ¬ì§„ íí¬ë¥¼ í´ì„œ ì‚°ì†Œ êµí™˜ ë©´ì ì„ ëŠ˜ë¦½ë‹ˆë‹¤.\n- **Strategy:** ì‚°ì†Œ ë†ë„(FiO2)ë¥¼ ë¬´ì‘ì • ë†’ì´ëŠ” ê²ƒë³´ë‹¤, **PEEPì„ ë†’ì—¬ì„œ** FiO2ë¥¼ 60% ì´í•˜ë¡œ ë‚®ì¶”ëŠ” ê²ƒì´ ëª©í‘œì…ë‹ˆë‹¤ (ì‚°ì†Œ ë…ì„± ì˜ˆë°©).\n### C. Permissive Hypercapnia (í—ˆìš©ì  ê³ íƒ„ì‚°í˜ˆì¦) 7.25ê¹Œì§€ëŠ” ê´€ì°°\n- TV(Tidal Volume)ë¥¼ 6mL/kgë¡œ ì¤„ì´ë©´ í™˜ê¸°ê°€ ë¶€ì¡±í•´ì„œ **CO2ê°€ ìŒ“ì…ë‹ˆë‹¤(Acidosis)**.\n- **Rule:** pHê°€ **7.25** ì´ìƒì´ê¸°ë§Œ í•˜ë©´, PCO2ê°€ ë†’ì•„ë„ **ê·¸ëƒ¥ ë‘¡ë‹ˆë‹¤**. CO2 ì¡ê² ë‹¤ê³  TVë¥¼ ëŠ˜ë¦¬ë©´ íê°€ í„°ì§€ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n---\n## 4. Refractory Hypoxemia Strategies\nì¸ê³µí˜¸í¡ê¸°ë¥¼ ë‹¬ì•˜ëŠ”ë°ë„ ì‚°ì†Œí¬í™”ë„ê°€ ì•ˆ ì˜¤ë¥´ë©´ ì–´ë–»ê²Œ í• ê¹Œìš”?\n### A. Prone Positioning (ë³µìœ„ ìš”ë²•) â˜…","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-85"}
{"chunk_type":"transcript_chunk","text":"- **What:** í™˜ìë¥¼ **ì—ë“œë ¤ ëˆ•í™ë‹ˆë‹¤(Face down)**.\n- **Mechanism:** ì‹¬ì¥ì— ëˆŒë ¤ ìˆë˜ ë“± ìª½ í(Dorsal lung)ê°€ í´ì§€ë©´ì„œ í™˜ê¸°-ê´€ë¥˜ ë¶ˆê· í˜•(V/Q mismatch)ì´ ê°œì„ ë©ë‹ˆë‹¤.\n- **Indication:** **Severe ARDS (P/F Ratio < 150)** í™˜ìì—ì„œ í•˜ë£¨ 16ì‹œê°„ ì´ìƒ ì‹œí–‰ ì‹œ **ì‚¬ë§ë¥  ê°ì†Œ** íš¨ê³¼ê°€ ìˆìŠµë‹ˆë‹¤.\n### B. Paralytics (Neuromuscular Blockade)\n- í™˜ìê°€ ì¸ê³µí˜¸í¡ê¸°ì™€ ì‹¸ìš°ë©°(Fighting) í ì†ìƒì„ ì•…í™”ì‹œí‚¬ ë•Œ, **Cisatracurium** ê°™ì€ ê·¼ì´ì™„ì œë¥¼ ì¨ì„œ í˜¸í¡ ê·¼ìœ¡ì„ ë§ˆë¹„ì‹œí‚µë‹ˆë‹¤. ì´ˆê¸°(48ì‹œê°„ ì´ë‚´)ì— ì‚¬ìš©í•˜ë©´ ìƒì¡´ìœ¨ì„ ë†’ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### C. ECMO (ì²´ì™¸ë§‰ì‚°ì†Œê³µê¸‰)\n- ëª¨ë“  ë°©ë²•ì´ ì‹¤íŒ¨í–ˆì„ ë•Œ ìµœí›„ì˜ ìˆ˜ë‹¨(Last resort)ì…ë‹ˆë‹¤.\n---\n## 5. Common Causes & Look-alikes\n- **Sepsis:** ê°€ì¥ í”í•œ ì›ì¸.\n- **Pancreatitis:** ì·Œì¥ íš¨ì†Œê°€ ì „ì‹ ì„ ëŒë©° íë¥¼ ê³µê²©.\n- **TRALI (Transfusion Related Acute Lung Injury):** ìˆ˜í˜ˆ í›„ 6ì‹œê°„ ì´ë‚´ì— ê°‘ìê¸° ìˆ¨ì´ ì°¸. ARDSì˜ ì¼ì¢…ì…ë‹ˆë‹¤. no cardiomegaly, no diuretics.\n    - vs TACO (overload): ì´ë‡¨ì œ ì‚¬ìš©, cardiomegaly æœ‰\n- *Key Distinction:*\n    - **PCWP (Wedge Pressure):**\n        - ARDS: **Normal or Low (< 18)**.\n        - CHF (Cardiogenic): **High (> 18)**.\n    - ì´ ìˆ˜ì¹˜ë¥¼ ì£¼ë©´ ì§„ë‹¨ì´ ëë‚œ ê±°ë‚˜ ë‹¤ë¦„ì—†ìŠµë‹ˆë‹¤.\n---\n## ğŸ¯ Recap (High Yield Summary)\nARDS íŒŸìºìŠ¤íŠ¸ì˜ í•µì‹¬ ìš”ì•½ì…ë‹ˆë‹¤.\n1. **Diagnosis (Berlin):** 1ì£¼ì¼ ì´ë‚´ ê¸‰ì„± ë°œë³‘ + ì–‘ì¸¡ì„± íì¹¨ìœ¤ + **ì‹¬ë¶€ì „ ì•„ë‹˜ (PCWP < 18)**.\n2. **Ventilation Rule #1:** **Low Tidal Volume (6 mL/kg)**. ì´ê²ƒë§Œì´ **ì‚¬ë§ë¥ (Mortality)**ì„ ë‚®ì¶¥ë‹ˆë‹¤.\n3. **Permissive Hypercapnia:** TVë¥¼ ë‚®ì¶°ì„œ CO2ê°€ ì˜¤ë¥´ë”ë¼ë„, pH > 7.25ë©´ **í—ˆìš©(Permit)**í•´ë¼.\n4. **Oxygenation:** ì‚°ì†Œê°€ ë¶€ì¡±í•˜ë©´ FiO2ë¥¼ ì˜¬ë¦¬ê¸° ì „ì— **PEEP**ì„ ì˜¬ë ¤ì„œ íí¬ë¥¼ í´ë¼.\n5. **Refractory:** P/F < 150ì´ë©´ í™˜ìë¥¼ **ì—ë“œë ¤ ëˆ•í˜€ë¼(Prone Positioning)**.\n6. **Fluid Management:** íê°€ ë¶€ì–´ ìˆìœ¼ë¯€ë¡œ **Dry lung** (ì´ë‡¨ì œ ì‚¬ìš© ë“±)ì„ ìœ ì§€í•˜ëŠ” ê²ƒì´ ìœ ë¦¬í•©ë‹ˆë‹¤.\n---\n# ğŸ« USMLE Deep Dive: Lung Cancer & Solitary Pulmonary Nodule (SPN)\n**Topic:** Lung Cancer Screening, Nodule Algorithm, Cancer Types, Paraneoplastic Syndromes\n## ğŸŒ³ The Big Picture: Diagnosis Tree\níì•” ë¬¸ì œì˜ 80%ëŠ” \"X-rayì—ì„œ ë­ê°€ ë³´ì´ëŠ”ë° ë‹¤ìŒ ì¡°ì¹˜ëŠ”?\"ì…ë‹ˆë‹¤.\n`Lung Mass/Nodule on CXR\nâ”‚\nâ”œâ”€â”€ 1. Old X-ray Comparison (ê°€ì¥ ë¨¼ì €!)\nâ”‚   â”œâ”€â”€ Unchanged > 2 years: Benign (Stop workup)\nâ”‚   â””â”€â”€ New or Changed: Go to CT Chest\nâ”‚\nâ”œâ”€â”€ 2. CT Chest Characterization\nâ”‚   â”œâ”€â”€ Low Risk (Small < 0.8cm, Smooth, Calcified): Serial CT\nâ”‚   â”œâ”€â”€ Intermediate Risk: PET scan or Biopsy\nâ”‚   â””â”€â”€ High Risk (Large > 2cm, Spiculated, Smoker): Excision/Biopsy\nâ”‚\nâ””â”€â”€ 3. Diagnosis & Staging\n    â”œâ”€â”€ Central Lesion: Bronchoscopy (EBUS)\n    â””â”€â”€ Peripheral Lesion: CT-guided Biopsy (Transthoracic)`\n---\n## 1. Screening Guidelines (USPSTF 2021 Update)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-105"}
{"chunk_type":"transcript_chunk","text":"USMLEëŠ” ìµœì‹  ê°€ì´ë“œë¼ì¸ì„ ì‚¬ë‘í•©ë‹ˆë‹¤. ìˆ˜ì¹˜ê°€ ë°”ë€Œì—ˆìœ¼ë‹ˆ ê¼­ ì—…ë°ì´íŠ¸í•˜ì„¸ìš”.\n- **ëŒ€ìƒ:** **50ì„¸ ~ 80ì„¸** (ê³¼ê±° 55ì„¸ì—ì„œ ë‚®ì•„ì§).\n- **í¡ì—°ë ¥:** **20 Pack-year** ì´ìƒ (ê³¼ê±° 30ì—ì„œ ë‚®ì•„ì§).\n- **í˜„ì¬ ìƒíƒœ:** í˜„ì¬ í¡ì—°ìì´ê±°ë‚˜, ëŠì€ ì§€ **15ë…„ ì´ë‚´**.\n- **ê²€ì‚¬:** **Low-dose CT (LDCT)** ë§¤ë…„ ì‹œí–‰ (Every year).\n    - *X-rayëŠ” ìŠ¤í¬ë¦¬ë‹ ë„êµ¬ê°€ ì•„ë‹˜!*\n---\n## 2. Solitary Pulmonary Nodule (SPN) Algorithm\nìš°ì—°íˆ ë°œê²¬ëœ \"ë™ì „ ëª¨ì–‘ì˜ ìŒì˜(Coin lesion)\"ì„ ì–´ë–»ê²Œ í•  ê²ƒì¸ê°€?\n### A. First Step: Comparison\n- ë¬´ì¡°ê±´ **ê³¼ê±° ì˜ìƒ(Previous X-ray)**ì„ ì°¾ìœ¼ì„¸ìš”.\n- **2ë…„ê°„ í¬ê¸° ë³€í™”ê°€ ì—†ë‹¤** = **Benign** (ì–‘ì„±). ì¶”ê°€ ê²€ì‚¬ ë¶ˆí•„ìš”.\n### B. Risk Stratification (Benign vs Malignant)\n| **Feature** | **Benign (ì°©í•œ ë†ˆ)** | Intermediate | **Malignant (ë‚˜ìœ ë†ˆ)** |\n| --- | --- | --- | --- |\n| **Size** | < 0.8 cm |  | **> 2.0 cm** (í¬ë©´ ë‚˜ì˜ë‹¤) |\n| **Margin** | Smooth (ë§¤ëˆ) |  | **Spiculated** (ì¹¨ìƒ, ì‚ì£½ì‚ì£½) |\n| **Calcification** | **Popcorn** (Hamartoma), Concentric |  | Eccentric (í•œìª½ìœ¼ë¡œ ì¹˜ìš°ì¹¨), Sparse |\n| **Patient** | Non-smoker, Young (<45) |  | Smoker, Older (>60) |\n|  | serial CT scan | PET scan or biopsy | ìˆ˜ìˆ ! straight to OR â˜…  |\n- *Popcorn Calcification* = **Hamartoma** (Pulmonary Hamartoma). ê°€ì¥ í”í•œ ì–‘ì„± ì¢…ì–‘. ê·¸ëƒ¥ ë‘¡ë‹ˆë‹¤.\n- eccentric ì•ˆì¢‹ìŒ.\n---\n## 3. Types of Lung Cancer (The \"Big 4\")\nì‹œí—˜ì—ì„œëŠ” \"í¡ì—°í•˜ëŠ” ë‚¨ìê°€ X ì¦ìƒìœ¼ë¡œ ì™”ë‹¤. ë¬´ìŠ¨ ì•”ì¸ê°€?\"ë¥¼ ë¬»ìŠµë‹ˆë‹¤.\nìœ„ì¹˜ì™€ paraneoplasaticì„ ì—°ê²°í•˜ì„¸ìš”.\n### A. Small Cell Lung Cancer (SCLC) - \"The Bad One\"\n- **ìœ„ì¹˜:** **Central** (ê¸°ê´€ì§€ ê·¼ì²˜).\n- **íŠ¹ì§•:** í¡ì—°ê³¼ ê°•ë ¥í•œ ì—°ê´€. ì „ì´ê°€ ë§¤ìš° ë¹ ë¦„ (ìˆ˜ìˆ  ë¶ˆê°€ëŠ¥).\n- **Paraneoplastic Syndromes (Neuroendocrine):**\n    1. **ACTH:** **Cushing Syndrome** (Moon face, Buffalo hump, ê³ í˜ˆë‹¹).\n    2. **SIADH:** **Hyponatremia** (ì €ë‚˜íŠ¸ë¥¨í˜ˆì¦, ì˜ì‹ ì €í•˜, Seizure).\n    3. **Lambert-Eaton Syndrome:** ê·¼ë ¥ ì•½í™” (ìš´ë™í•˜ë©´ í˜¸ì „ë¨ ddx MG), ì… ë§ˆë¦„. (Ca2+ ì±„ë„ ê³µê²©).\n- **ì¹˜ë£Œ:** **Chemotherapy + Radiation**. (ìˆ˜ìˆ  X).\n### B. Non-Small Cell Lung Cancer (NSCLC)\n- ìˆ˜ìˆ (Resection)ì´ ê°€ëŠ¥í•˜ë‹¤ë©´ ìˆ˜ìˆ ì´ ì›ì¹™ì…ë‹ˆë‹¤.\n- ìˆ˜ìˆ ê°€ëŠ¥ì—¬ë¶€: FEV1, DLCO ê²€ì‚¬. (FEV >1.5L, DLCO>60%) â˜…\n    - ì•ˆë˜ë©´, wedge resectionâ€¦\n- ë‹´ë°° ëŠì„ê±°ë©´ 4-8ì£¼ ì „ì— ëŠìœ¼ì„¸ìš”.\n    - 1-2ì „ì— ëŠìœ¼ë©´ ì˜¤íˆë ¤ ì•ˆì¢‹ì„ ìˆ˜ë„ ìˆìŒ. ëŠê³  ì§í›„ëŠ” mucus ì–‘ì´ ëŠ˜ê¸° ë•Œë¬¸.\n1. **Squamous Cell Carcinoma (í¸í‰ìƒí”¼ì„¸í¬ì•”):**\n    - **ìœ„ì¹˜:** **Central**. (Remember \"**S**\" for **S**moking, **S**entral).\n    - **íŠ¹ì§•:** **Cavitation** (ì¤‘ì•™ ê´´ì‚¬ lung abscessê°™ì´ ìƒê²¼ëŠ”ë° ê°ì—¼ ì§•í›„ê°€ ì—†ìŒ). **Keratin Pearls** (ë³‘ë¦¬).\n    - **Paraneoplastic:** **PTHrP** ë¶„ë¹„ â†’ **Hypercalcemia** (ë¼ˆ ì „ì´ ì—†ëŠ”ë° ì¹¼ìŠ˜ ë†’ìŒ). â†’ stone bones groans throans â˜…\n2. **Adenocarcinoma (ì„ ì•”):**\n    - **ìœ„ì¹˜:** **Peripheral** (í ê°€ì¥ìë¦¬).\n    - **íŠ¹ì§•:** **Most Common** (ì „ì²´ 1ìœ„). **Non-smoker**, **Female**ì—ì„œ ê°€ì¥ í”í•¨.\n    - ê´€ë ¨: Hypertrophic Osteoarthropathy (Clubbing, ì†ëª©/ë°œëª© í†µì¦).\n    - COPDí™˜ìì—ì„œ new clubbing â†’ search for cancer! â˜…\n3. **Large Cell Carcinoma:**\n    - **ìœ„ì¹˜:** Peripheral.\n    - beta hcg formation.\n    - **íŠ¹ì§•:** ì§„ë‹¨ ë°°ì œ í›„ ë‚¨ëŠ” ê²ƒ. ì˜ˆí›„ ë‚˜ì¨. **Gynecomastia**(ì—¬ì„±í˜• ìœ ë°© - breast tenderness) ìœ ë°œ ê°€ëŠ¥.\n---\n## 4. Special Scenarios & Complications\n### A. Pancoast Tumor (Superior Sulcus Tumor)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-125"}
{"chunk_type":"transcript_chunk","text":"íì˜ ê¼­ëŒ€ê¸°(Apex)ì— ìƒê¸´ ì•”ì´ ì£¼ë³€ ì‹ ê²½ì„ ëˆ„ë¦…ë‹ˆë‹¤.\n- **Triad:**\n    1. **Shoulder Pain:** ìƒì™„ì‹ ê²½ì´(Brachial plexus) ì¹¨ë²”.\n    2. **Horner's Syndrome:** êµê°ì‹ ê²½ì ˆ ì¹¨ë²”. (**Ptosis**ëˆˆêº¼í’€ ì²˜ì§, **Miosis**ë™ê³µ ì¶•ì†Œ, **Anhidrosis**ë¬´ë°œí•œ).\n    3. **Hand Muscle Atrophy:** C8-T1 ì‹ ê²½ ì¹¨ë²”.\n### B. SVC Syndrome (ìƒëŒ€ì •ë§¥ ì¦í›„êµ°)\n- **ì¦ìƒ:** ì•„ì¹¨ì— ì–¼êµ´ì´ í‰í‰ ë¶“ê³ (Facial plethora), ëª©ê³¼ ê°€ìŠ´ì˜ ì •ë§¥ì´ ëŠ˜ì–´ë‚¨(Distended veins). íŒ”ì„ ë“¤ë©´ ì–´ì§€ëŸ¬ì›€(Pemberton's sign).\n- **ì›ì¸:** Small Cell Lung Cancerê°€ SVCë¥¼ ëˆŒëŸ¬ì„œ ë°œìƒ.\n- **ì²˜ì¹˜:** ì‘ê¸‰ ë°©ì‚¬ì„  ì¹˜ë£Œ(Radiation)ë¡œ ì¢…ì–‘ í¬ê¸° ì¤„ì´ê¸°.\n### C. Carcinoid Tumor\n- **íŠ¹ì§•:** ì‹ ê²½ë‚´ë¶„ë¹„ ì¢…ì–‘. ë§¹ì¥(Appendix) ë‹¤ìŒìœ¼ë¡œ íì— í˜¸ë°œ.\n- í ì‹¤ì§ˆì— ìƒê¸°ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ ê¸°ë„ì— ìƒê¹€. â†’ ê°í˜ˆ ì¦ìƒ, obstruction ê°€ëŠ¥ â†’ obstruction ì§„í–‰ì‹œ mucus plugging, pneumoniae í˜¸ë°œ\n- 20ëŒ€, ì²­ì†Œë…„ì´ ì§€ì†ì ì¸ ê°™ì€ ê³³ì—ì„œ íë ´ë°œìƒì‹œ ì˜ì‹¬ê°€ëŠ¥.\n    - recurrent pneumoia in the same lobe â†’ cancer! â†’ CT scan (no X ray)\n- **ì¦ìƒ:** **Carcinoid Syndrome** (Flushing, Diarrhea, Wheezing).\n    - *ì£¼ì˜:* íì— ìƒê¸´ CarcinoidëŠ” ê°„(Liver)ì„ ì•ˆ ê±°ì¹˜ê³  ë°”ë¡œ ì „ì‹ ìœ¼ë¡œ ë¬¼ì§ˆì„ ì˜ê¸° ë•Œë¬¸ì—, ê°„ ì „ì´ê°€ ì—†ì–´ë„ ì¦ìƒì´ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.\n---\n## ğŸ¯ Recap (High Yield Summary)\nì´ê²ƒë§Œì€ ê¼­ ì™¸ìš°ê³  ì‹œí—˜ì¥ì— ë“¤ì–´ê°€ì„¸ìš”.\n1. **Nodule First Step:** **Compare with Old X-ray**. 2ë…„ê°„ ë³€í™” ì—†ìœ¼ë©´ Benign.\n2. **Screening:** **Age 50-80**, **20 Pack-year**, Quit < 15y â†’ **Annual Low-dose CT**.\n3. **Small Cell (SCLC):** **Central**, **ACTH(Cushing)/SIADH(Low Na)**, **Chemo/Rad** (No Surgery).\n4. **Squamous Cell:** **Central**, **Hypercalcemia (PTHrP)**.\n5. **Adenocarcinoma:** **Peripheral**, **Non-smoker**.\n6. **Pancoast:** ì–´ê¹¨ í†µì¦ + **Horner's Syndrome** (ëˆˆ ì‘ì•„ì§).\n7. **Hoarseness:** ì‰° ëª©ì†Œë¦¬ê°€ ë‚˜ë©´ **Recurrent Laryngeal Nerve** ì¹¨ë²” â†’ ìˆ˜ìˆ  ë¶ˆê°€ëŠ¥(Unresectable) ì‹ í˜¸ì¼ ìˆ˜ ìˆìŒ.\n---\n# ğŸ« USMLE Deep Dive: Pulmonary Miscellaneous (Real)\n**Topic:** Chronic Cough, Hyperventilation (Tetany), HAPE vs Pneumonia, DAH, Pediatric (Choanal Atresia, CDH), Diaphragmatic Paralysis\n## 1. Chronic Cough (ë§Œì„± ê¸°ì¹¨)\nUSMLEê°€ ì‚¬ë‘í•˜ëŠ” \"ê¸°ì¹¨ì´ ì•ˆ ë©ˆì¶°ìš”\" ì‹œë‚˜ë¦¬ì˜¤ì…ë‹ˆë‹¤.\n- **ì •ì˜:** **8ì£¼ ì´ìƒ** ì§€ì†ë˜ëŠ” ê¸°ì¹¨. (ê°ê¸° ì•„ë‹˜).\n- **Step 1: Check Meds (ê°€ì¥ ë¨¼ì €!)**\n    - í™˜ìê°€ **ACE Inhibitor (Lisinopril ë“±)**ë¥¼ ë¨¹ê³  ìˆëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”. ì•½ì„ ëŠê³  ARBë¡œ ë°”ê¾¸ëŠ” ê²Œ ì •ë‹µì…ë‹ˆë‹¤.\n- **The Big 3 Causes: ì´ê±° í•´ê²°í•´ë³´ê³  ì•ˆë˜ë©´ ê·¸ë•Œ x-ray ì°ëŠ”ë‹¤!**\n    1. **UACS (Upper Airway Cough Syndrome, í›„ë¹„ë£¨):**\n        - **Trap:** ë¶€ë¹„ë™ CTë¶€í„° ì°ì§€ ë§ˆì„¸ìš”.\n        - **Tx:** **1ì„¸ëŒ€ í•­íˆìŠ¤íƒ€ë¯¼ì œ (Chlorpheniramine, Brompheniramine)**. (ì¡¸ë¦° ì•½).\n        - *Why?* ì•Œë ˆë¥´ê¸° íš¨ê³¼ê°€ ì•„ë‹ˆë¼, **Anticholinergic(í•­ì½œë¦°)** íš¨ê³¼ë¡œ ì½§ë¬¼ì„ ë§ë ¤ë²„ë¦¬ëŠ” ê²Œ ì¹˜ë£Œì˜ í•µì‹¬ì´ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. ì‹ ì•½(Loratadine ë“±)ì€ ë„ˆë¬´ ê¹¨ë—í•´ì„œ íš¨ê³¼ê°€ ì—†ìŠµë‹ˆë‹¤.\n    2. **Asthma:** PFT í™•ì¸.\n    3. **GERD:** ì—­ë¥˜ ì¦ìƒ í™•ì¸.\n## 2. Hyperventilation Syndrome & Tetany\nì Šì€ í™˜ìê°€ ê³¼í˜¸í¡ìœ¼ë¡œ ì‘ê¸‰ì‹¤ì— ì™”ëŠ”ë° ì†ì´ ë’¤í‹€ë¦½ë‹ˆë‹¤.\n- **Presentation:** ë¶ˆì•ˆ(Anxiety) + ê³¼í˜¸í¡ + **Carpopedal Spasm** (ì†ë°œì´ ì˜¤ê·¸ë¼ë“¦, Tetany).\n- **Mechanism (Physiology): ê³¼í•œ ì•Œì¹¼ë¦¬ì¦ì—ì„œëŠ” hypocalcemiaì¦ìƒì´ ë‚˜íƒ€ë‚œë‹¤.**\n    - ê³¼í˜¸í¡ â†’ CO2 ë‚ ì•„ê° â†’ Respiratory Alkalosis (pH ìƒìŠ¹) â†’ ì•Œë¶€ë¯¼(Albumin ìŒì´ì˜¨)ì´ ìˆ˜ì†Œì´ì˜¨(H+)ì„ ë±‰ê³  ëŒ€ì‹  **ì¹¼ìŠ˜(Calcium)ê³¼ ê²°í•©** â†’ í˜ˆì¤‘ **Ionized Calcium(ì´ì˜¨í™” ì¹¼ìŠ˜)** ë†ë„ ê¸‰ë½ â†’ **Tetany** ë°œìƒ.\n    - *Note:* Total Calciumì€ ì •ìƒì…ë‹ˆë‹¤. **Ionized Calcium**ì´ ë‚®ì€ ê²Œ ë²”ì¸ì…ë‹ˆë‹¤.\n- **Management:**\n    - **Paper Bag (ì¢…ì´ë´‰íˆ¬):** **ê¸ˆê¸°(Contraindicated)!** ì €ì‚°ì†Œì¦(Hypoxia) ìœ„í—˜ì´ ìˆì–´ ë” ì´ìƒ ì“°ì§€ ì•ŠìŠµë‹ˆë‹¤.\n    - **Tx:** **Breathing Retraining** (í˜¸í¡ ì½”ì¹­) + ë¶ˆì•ˆ ì¡°ì ˆ(Benzodiazepines).\n## 3. High Altitude Pulmonary Edema (HAPE):\nì €ì‚°ì†Œì¦ â†’ì¼ë¶€ë¶„í˜ˆê´€ìˆ˜ì¶•, ì¼ë¶€ë¶„ íë¶€ì¢… â†’ íë ´ê°™ì•„ë³´ì„","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-145"}
{"chunk_type":"transcript_chunk","text":"ê³ ì‚°ë³‘ì´ íë ´ì²˜ëŸ¼ ë³´ì¼ ë•Œ ê°ë³„ë²•ì…ë‹ˆë‹¤. SOB, infiltrates, crackles..\n- ë†’ì€ ê³ ë„ì—ì„œ ì‚°ì†Œ ë¶€ì¡±\nâ†’ hypoxic vasoconstriction only ì¼ë¶€ë¶€ìœ„ë§Œ!\nâ†’ í˜ˆê´€ ìˆ˜ì¶• ì•ˆëœë°ëŠ” í˜ˆê´€ íˆ¬ê³¼ì„±ì´ ì˜¤íˆë ¤ ì¦ê°€, í˜ˆë¥˜ëŸ‰ ì¦ê°€\nâ†’ íë¶€ì¢… ë°œìƒ\n- **Scenario:** ê³ ì§€ëŒ€ ë“±ë°˜ í›„ ìˆ¨ì´ ì°¨ê³  X-rayì— ì¹¨ìœ¤(Infiltrates)ì´ ë³´ì„. íë ´(Pneumonia)ê³¼ ë˜‘ê°™ì´ ìƒê²¼ìŠµë‹ˆë‹¤.\n- **Differentiation (HAPE vs Pneumonia):**\n    1. **Timing:** HAPEëŠ” ë„ì°© í›„ **2~4ì¼ ë‚´** ê¸‰ê²©íˆ ë°œìƒ.\n    2. **Labs:** **Procalcitonin**. (íë ´ì€ ë†’ìŒ, HAPEëŠ” **ì •ìƒ**).\n    3. **Response:** HAPEëŠ” **ì‚°ì†Œ(O2)**ë§Œ ì¤˜ë„ ë“œë¼ë§ˆí‹±í•˜ê²Œ ì¢‹ì•„ì§. (íë ´ì€ í•­ìƒì œ ì—†ìœ¼ë©´ ëŠë¦¼).\n## 4. Diffuse Alveolar Hemorrhage (DAH) : ë£¨í‘¸ìŠ¤, ë² ê²Œë„ˆ\níí¬ì— í”¼ê°€ ì°¨ëŠ” ë³‘ì…ë‹ˆë‹¤. (Lupus, Wegener's ë“± ìê°€ë©´ì—­ì§ˆí™˜).\n- **Biggest Trap:** í™˜ìì˜ **50%ëŠ” ê°í˜ˆ(Hemoptysis)ì´ ì—†ìŠµë‹ˆë‹¤**. (í”¼ê°€ íí¬ì— ê°‡í˜€ì„œ ë°–ìœ¼ë¡œ ì•ˆ ë‚˜ì˜´). ê°í˜ˆ ì—†ë‹¤ê³  ë°°ì œí•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤. â˜…\n- **Diagnosis:**\n    - **Bronchoscopy with Lavage:** ì„¸ì²™ì„ í• ìˆ˜ë¡ ì ì  **ë” ë¶‰ì€ ë¬¼(Bloodier aliquots)**ì´ ë‚˜ì˜´.\n- **Tx:** ê¸°ì €ì§ˆí™˜ì¹˜ë£Œ (i.e. ê³ ìš©ëŸ‰ ìŠ¤í…Œë¡œì´ë“œ). (í•­ì‘ê³ ì œ ê¸ˆê¸°).\n## 5. Decompression Sickness: \në…¹ì•„ìˆë˜ ì§ˆì†Œê°€ ë‹¤ë¥¸ê³³ (ê´€ì ˆ, ë‡Œ, í)ë¡œ ê°„ë‹¤.\n<aside>\nğŸ’¡\níƒ„ì‚°ìº” ë”¸ë•Œ ìƒìƒ\në…¹ì•„ìˆë˜ ì§ˆì†Œê°€ ê³µê¸°ë°©ìš¸ì´ ë˜ì–´ì„œ ë‚˜ì™€ì„œ ë‹¤ë¥¸ê³³(ê´€ì ˆ, ë‡Œ, í)ë¡œ ê°„ë‹¤.\n</aside>\n- Diverê°€ air tankì—ì„œ ë§ˆì‹  nitrogenì´ í•˜ê°•í•˜ë©´ì„œ ê³ ì••ë ¥ì— í”¼ì— ì˜ ë…¹ìŒ\n- ê¸‰ê²©í•œ ìƒìŠ¹ì— ì˜í•´ì„œ ì••ë ¥ì´ ë‚®ì•„ì§€ë©´ì„œ nitrogenì´ ë”ì´ìƒ ë…¹ì§€ ì•Šê³  ê³µê¸°ë°©ìš¸ë¡œ ë‚˜ì˜´\n- ê³µê¸°ë°©ìš¸ì´ ê´€ì ˆì— ê°€ë©´ type 1 (MSK), ê³µê¸° ë°©ìš¸ì´ systemic circulationìœ¼ë¡œ íí˜ˆê´€, ë‡Œí˜ˆê´€ìœ¼ë¡œ ê°€ë©´ type 2.\n- ì¹˜ë£Œ: IV hydration, hyperbaric oxygen\n---","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-165"}
{"chunk_type":"recap_summary","text":"**Recap (One-Liner)**\n- **Chronic Cough:** ACEi í™•ì¸ â†’ UACSë©´ **1ì„¸ëŒ€ í•­íˆìŠ¤íƒ€ë¯¼ì œ**.\n- **Tetany:** ê³¼í˜¸í¡ â†’ **Low Ionized Calcium**. ì¢…ì´ë´‰íˆ¬ ì“°ì§€ ë§ˆë¼.\n- **HAPE:** ì‚°ì†Œ ì£¼ë©´ ë°”ë¡œ ì¢‹ì•„ì§. Procalcitonin ì •ìƒ.\n- **DAH:** ê°í˜ˆ ì—†ì„ ìˆ˜ë„ ìˆìŒ. BALì—ì„œ í”¼ ë‚˜ì˜´.\n- **Blue Feeding/Pink Crying:** **Choanal Atresia**.\n- **Scaphoid Abdomen:** **CDH**. **Bag-Mask ê¸ˆì§€**.\n- **Sniff Test:** Paradoxical movement = **Diaphragmatic Paralysis**.\nì´ì œ íŒŒì¼ ë‚´ìš©ê³¼ ì •í™•íˆ ì¼ì¹˜í•  ê²ƒì…ë‹ˆë‹¤. í˜¼ë€ì„ ë“œë ¤ ì£„ì†¡í•©ë‹ˆë‹¤. ì´ ë‚´ìš©ìœ¼ë¡œ ì •ë¦¬í•´ ë‘ì‹œë©´ ë©ë‹ˆë‹¤.\n---\n---\n**Verify (ê²€ì¦): 0:00~0:30 êµ¬ê°„ ë°›ì•„ì“°ê¸°**\n\"Welcome back to the deep dive. Today we are tackling a really high-stakes area for USMLE Step 2, and that's pediatric pulmonology. It's a big one. It really is. And looking at the stack of resources we have here, everything from Nelson's to the latest guidelines, we need to be really clear about our mission. Mm-hm. We're not here to just, you know, define terms. Step 1 is done. This is all about management, clinical reasoning, and frankly, avoiding the traps they set for you on the exam. That's exactly right.\"\n---\n# ğŸ« USMLE Step 2 Deep Dive: Pediatric Pulmonology (ì†Œì•„ í˜¸í¡ê¸°í•™)\nì´ ê°•ì˜ëŠ” USMLE Step 2ë¥¼ ìœ„í•´ ê°€ì¥ ì¤‘ìš”í•œ **ì†Œì•„ í˜¸í¡ê¸°í•™**ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœí•œ ìš©ì–´ ì •ì˜(Step 1 ìˆ˜ì¤€)ë¥¼ ë„˜ì–´, **ê´€ë¦¬(Management), ì„ìƒ ì¶”ë¡ (Clinical Reasoning), ê·¸ë¦¬ê³  ì‹œí—˜ í•¨ì • í”¼í•˜ê¸°**ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-176"}
{"chunk_type":"transcript_chunk","text":"## 1. Introduction: Step 2ë¥¼ ìœ„í•œ ì‚¬ê³ ë°©ì‹ ì „í™˜ (Mindset Shift)\n- **Step 1 vs. Step 2:** ê¸°ì „(Mechanism)ì„ ë¬»ëŠ” ë‹¨ê³„ì—ì„œ **\"ë‹¤ìŒ ë‹¨ê³„ëŠ” ë¬´ì—‡ì¸ê°€?(What is the next best step?)\"**ë¥¼ ë¬»ëŠ” ë‹¨ê³„ë¡œ ì´ë™í•´ì•¼ í•©ë‹ˆë‹¤.\n- **ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤:** íŒŒë€ ì•„ê¸°(Blue baby), ì§ˆì‹í•˜ëŠ” ìœ ì•„(Choking toddler), ì½” ê³ ëŠ” ì–´ë¦°ì´(Snoring kid) ë“±ì˜ ì„ìƒ ìƒí™©(Vignette)ì´ ì£¼ì–´ì§‘ë‹ˆë‹¤.\n- **ê²°ì •:** ë³‘ë¦¬í•™ì  ì§€ì‹ë„ ì¤‘ìš”í•˜ì§€ë§Œ, **CTë¥¼ ì°ì„ ê²ƒì¸ê°€? ì‚½ê´€(Intubate)í•  ê²ƒì¸ê°€? ì•ˆì‹¬ì‹œí‚¬ ê²ƒì¸ê°€(Reassure)?** ë¥¼ ê²°ì •í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n- **ë†’ì€ ì¤‘ìš”ë„:** ì†Œì•„ì˜ ê¸°ë„ëŠ” ë¹¨ëŒ€ë§Œí¼ ì‘ê³ , íëŠ” ì´ˆ ë‹¨ìœ„ë¡œ ê¸‰ê²©í•œ ìƒë¦¬í•™ì  ë³€í™”ë¥¼ ê²ªê¸° ë•Œë¬¸ì— ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.\n## 2. ì ‘ê·¼ í”„ë ˆì„ì›Œí¬ (Framework) ğŸ§ \nì—°ëŒ€ê¸°ì (Chronologically) ë° í•´ë¶€í•™ì (Anatomically) ì ‘ê·¼ë²•ì„ ì‚¬ìš©í•©ë‹ˆë‹¤.\n1. **ì‹ ìƒì•„ ê¸°ë„ (Newborn Airway):** êµ¬ì¡°ì  ë§‰í˜ (ì˜ˆ: Choanal Atresia).\n2. **í ì¡°ì§ (Lung Tissue):** NRDS (ì‹ ìƒì•„ í˜¸í¡ê³¤ë€ ì¦í›„êµ°), íê³ í˜ˆì••.\n3. **ìœ ì•„ê¸° (Toddler Years):** ì™¸ë¶€ í™˜ê²½ê³¼ì˜ ìƒí˜¸ì‘ìš© (ì˜ˆ: ì´ë¬¼ì§ˆ í¡ì¸).\n4. **ìˆ˜ë©´ ë° í–‰ë™ (Sleep & Behavioral):** ìˆ˜ë©´ ë¬´í˜¸í¡ì¦(OSA), í˜¸í¡ ì •ì§€ ë°œì‘(Breath-holding spells).\n5. **í™˜ê²½ì  ìœ„í—˜ (Environmental Risks):** SIDS (ì˜ì•„ ëŒì—°ì‚¬ ì¦í›„êµ°), ìµì‚¬(Drowning).\n---\n## 3. ì‹ ìƒì•„ ê¸°ë„ (Newborn Airway): Choanal Atresia (í›„ë¹„ê³µ íì‡„)\nê°€ì¥ ìƒë¶€ ê¸°ë„ì—ì„œ ì‹œì‘í•˜ëŠ” êµ¬ì¡°ì  ë¬¸ì œì…ë‹ˆë‹¤.\n![image.png](LM_%20pulmo%202/image.png)\n### ğŸš© ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤: The Pink Cries, Blue Feeds\n- **ìˆ˜ìˆ˜ê»˜ë¼ ê°™ì€ ì¦ìƒ:** ì•„ê¸°ê°€ ì¡°ìš©íˆ ìˆê±°ë‚˜ ìˆ˜ìœ í•  ë•ŒëŠ” ì²­ìƒ‰ì¦(Cyanotic)ì„ ë³´ì´ê³  ê´´ë¡œì›Œí•˜ì§€ë§Œ, **ìš¸ê¸° ì‹œì‘í•˜ë©´ ë¶„í™ìƒ‰(Pink)ìœ¼ë¡œ ëŒì•„ì˜¤ê³  ê±´ê°•í•´ ë³´ì…ë‹ˆë‹¤.**\n- **ìƒë¦¬í•™ì  ì´ìœ :** ì‹ ìƒì•„ëŠ” **â˜… ì˜ë¬´ì  ë¹„ê°• í˜¸í¡ì (Obligate Nasal Breathers)**ì…ë‹ˆë‹¤.\n    - í•´ë¶€í•™ì ìœ¼ë¡œ ë†’ì€ í›„ë‘ê°œ(Epiglottis)ê°€ ì—°êµ¬ê°œ(Soft palate)ì™€ ë§ë¬¼ë ¤ ìˆ˜ìœ  ì¤‘ì—ë„ ìˆ¨ì„ ì‰´ ìˆ˜ ìˆê²Œ ë˜ì–´ ìˆìŠµë‹ˆë‹¤.\n    - í›„ë¹„ê³µ(Choana)ì´ ë¼ˆë‚˜ ë§‰ìœ¼ë¡œ ë§‰í˜€ ìˆìœ¼ë©´ ì½”ë¡œ ìˆ¨ì„ ì‰´ ìˆ˜ ì—†ì–´ ì‚¬ì‹¤ìƒ ì§ˆì‹ ìƒíƒœê°€ ë©ë‹ˆë‹¤.\n    - ìš¸ ë•ŒëŠ” ì…ì„ ì—´ì–´ êµ¬ê°• í˜¸í¡ì„ í•˜ë¯€ë¡œ ì‚°ì†Œ ê³µê¸‰ì´ ê°€ëŠ¥í•´ì§‘ë‹ˆë‹¤.\n### ğŸ©º ì§„ë‹¨ ë° ê´€ë¦¬ (Step 2 Key Steps)\n1. **â˜… ì²« ë²ˆì§¸ ë‹¨ê³„ (Bedside):** **ì¹´í…Œí„° í†µê³¼ ì‹œë„ (Pass a Catheter).**\n    - ì‘ì€ í¡ì… ì¹´í…Œí„°(6~8 Fr)ë¥¼ ì½§êµ¬ë©ìœ¼ë¡œ ë„£ì–´ ë¹„ì¸ë‘ë¡œ í†µê³¼ì‹œì¼œ ë´…ë‹ˆë‹¤.\n    - **ì €í•­ì´ ëŠê»´ì ¸ í†µê³¼í•˜ì§€ ëª»í•˜ë©´(Cannot pass catheter sign)**, ì¶”ì • ì§„ë‹¨ì´ ë©ë‹ˆë‹¤.\n2. **í™•ì§„ (Confirmation):** **CT ìŠ¤ìº”** (ê³¨ì„±ì¸ì§€ ë§‰ì„±ì¸ì§€ í™•ì¸, ìˆ˜ìˆ  ê³„íš ìˆ˜ë¦½).\n3. **ì–‘ì¸¡ì„±(Bilateral) vs. í¸ì¸¡ì„±(Unilateral):**\n    - **ì–‘ì¸¡ì„±:** **ì‘ê¸‰ ìƒí™©(Emergency).** ì¦‰ì‹œ êµ¬ê°• ê¸°ë„(Oral airway) í™•ë³´ ë˜ëŠ” ì‚½ê´€ í•„ìš”.\n    - **í¸ì¸¡ì„±:** ì‹ ìƒì•„ê¸°ì— ë†“ì¹  ìˆ˜ ìˆìœ¼ë©°, í•™ë ¹ê¸°ì— **ë§Œì„±ì ì¸ í•œìª½ ì½§ë¬¼(Chronic one-sided nasal discharge)**ë¡œ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸ§¬ CHARGE ì¦í›„êµ° ì—°ê´€ì„±\nChoanal Atresia í™˜ìì˜ ì•½ 50%ëŠ” CHARGE ì¦í›„êµ°ì„ ë™ë°˜í•©ë‹ˆë‹¤. ì‹œí—˜ì—ì„œëŠ” í•œ ê°€ì§€ ë‹¨ì„œë¥¼ ì£¼ê³  ë‚˜ë¨¸ì§€ë¥¼ ë¬»ìŠµë‹ˆë‹¤.\n- **C:** **Coloboma** (ëˆˆì˜ ê²°ì†, ì—´ì‡  êµ¬ë© ëª¨ì–‘ ë™ê³µ).\n- **H:** **Heart defects** (ì‹¬ì¥ ê¸°í˜• - TOF, VSD, ASD ë“±). **â˜… ëª¨ë“  í™˜ìì—ê²Œ ì‹¬ì¥ì´ˆìŒíŒŒ(Echocardiogram) í•„ìˆ˜.**\n- **A:** **Atresia of the choanae.**\n- **R:** **Retardation** of growth and development.\n- **G:** **Genital hypoplasia** (ì ë³µê³ í™˜, ì‘ì€ ìŒê²½ ë“±).\n- **E:** **Ear anomalies** (ê·€ ê¸°í˜•, ë‚œì²­). **â˜… ì²­ë ¥ ê²€ì‚¬(Audiometry) í•„ìˆ˜.**\n- **í™•ì§„:** CHD7 ìœ ì „ì ë³€ì´ ê²€ì‚¬.\n---\n## 4. í ì¡°ì§ (Lung Tissue): NRDS (ì‹ ìƒì•„ í˜¸í¡ê³¤ë€ ì¦í›„êµ°)\në¯¸ìˆ™ì•„(Preemie) í˜¸í¡ë¶€ì „ì˜ ê°€ì¥ í”í•œ ì›ì¸ì…ë‹ˆë‹¤.\n### ğŸ§ª ë³‘íƒœìƒë¦¬: Surfactant Deficiency (ê³„ë©´í™œì„±ì œ ê²°í•)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-186"}
{"chunk_type":"transcript_chunk","text":"- **í•µì‹¬ ë¬¸ì œ:** ë¯¸ìˆ™ì•„ëŠ” **ê³„ë©´í™œì„±ì œ(Surfactant)**ê°€ ë¶€ì¡±í•©ë‹ˆë‹¤.\n- **LaPlaceì˜ ë²•ì¹™ (P = 2T/r):**\n    - ë¯¸ìˆ™ì•„ì˜ íí¬ëŠ” ë°˜ì§€ë¦„(r)ì´ ë§¤ìš° ì‘ìŠµë‹ˆë‹¤.\n    - ê³„ë©´í™œì„±ì œê°€ ì—†ìœ¼ë©´ í‘œë©´ì¥ë ¥(T)ì„ ì¤„ì´ì§€ ëª»í•´, íí¬ë¥¼ ì—´ì–´ë‘ê¸° ìœ„í•œ ì••ë ¥(P)ì´ ì—„ì²­ë‚˜ê²Œ ì»¤ì§‘ë‹ˆë‹¤.\n    - **ê²°ê³¼:** ìˆ¨ì„ ë‚´ì‰´ ë•Œë§ˆë‹¤ íí¬ê°€ ì™„ì „íˆ ì°Œê·¸ëŸ¬ì§ (**Atelectasis**, ë¬´ê¸°í). ë‹¤ìŒ ìˆ¨ì„ ì‰´ ë•Œë§ˆë‹¤ ë§‰ëŒ€í•œ ì—ë„ˆì§€ê°€ ì†Œëª¨ë©ë‹ˆë‹¤.\n- **ì„ìƒ ì§•í›„:** ë™ë™ê±°ë¦¼(Grunting - PEEPì„ ë§Œë“¤ì–´ ê¸°ë„ ìœ ì§€ ì‹œë„), ì½” ë²Œë ê±°ë¦¼(Nasal flaring), í‰ë¶€ í•¨ëª°(Retractions).\n- **X-ray ì†Œê²¬:** **â˜… ë‚®ì€ í ìš©ì  (Low lung volumes) + ê°„ìœ ë¦¬ ìŒì˜ (Ground-glass appearance) + ê³µê¸° ê¸°ê´€ì§€ ìŒì˜ (Air bronchograms).**\n    - **Air bronchogram ì„¤ëª…:** ê±´ê°•í•œ íëŠ” ê³µê¸°(ê²€ì€ìƒ‰)ë¡œ ì°¨ ìˆì§€ë§Œ, NRDSì—ì„œëŠ” íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ê³  ì•¡ì²´ë¡œ ì°¨ì„œ í•˜ì–—ê²Œ ë³´ì…ë‹ˆë‹¤(Opaque). ë°˜ë©´, ì—°ê³¨ë¡œ ì§€ì§€ë˜ëŠ” ê¸°ê´€ì§€ëŠ” ê³µê¸°ê°€ ì°¨ ìˆì–´ ê²€ê²Œ ë³´ì´ë¯€ë¡œ, í•˜ì–€ ë°°ê²½ ì†ì—ì„œ ê²€ì€ ë‚˜ë­‡ê°€ì§€ì²˜ëŸ¼ ë‘ë“œëŸ¬ì ¸ ë³´ì…ë‹ˆë‹¤.\n### ğŸ’Š ê´€ë¦¬ (Management)\n1. **ì˜ˆë°© (Best Treatment):** **ì‚°ì „ ìŠ¤í…Œë¡œì´ë“œ (Betamethasone).**\n    - ë¶„ë§Œ 48ì‹œê°„ ì „ íˆ¬ì—¬ ì‹œ íƒœì•„ì˜ 2í˜• íí¬ì„¸í¬ë¥¼ ìê·¹í•˜ì—¬ ê³„ë©´í™œì„±ì œ ìƒì„±ì„ ì´‰ì§„í•©ë‹ˆë‹¤.\n2. **í˜¸í¡ ë³´ì¡° (Respiratory Support):**\n    - **1ë‹¨ê³„:** **CPAP (Continuous Positive Airway Pressure).** ì§€ì†ì ì¸ ì–‘ì••ì„ ì œê³µí•˜ì—¬ íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ì§€ ì•Šê²Œ 'ë¶€ëª©(Splint)' ì—­í• ì„ í•©ë‹ˆë‹¤.\n    - **ì‹¤íŒ¨ ê¸°ì¤€:** ì‚°ì†Œ ìš”êµ¬ëŸ‰ ì¦ê°€ (ì˜ˆ: FiO2 40% -> 50%).\n    - **2ë‹¨ê³„:** **ì‚½ê´€(Intubation) ë° ì™¸ë¶€ ê³„ë©´í™œì„±ì œ(Exogenous Surfactant) íˆ¬ì—¬.** íŠœë¸Œë¥¼ í†µí•´ ì§ì ‘ íë¡œ ì´ì£¼ë©´ ì¦‰ê°ì ì¸ íš¨ê³¼ê°€ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n3. **í•©ë³‘ì¦ ì˜ˆë°©:** **BPD (ê¸°ê´€ì§€íì´í˜•ì„±ì¦).**\n    - ê¸°ê³„ì  í™˜ê¸°(ì••ë ¥, ìš©ëŸ‰ ì†ìƒ)ë¡œ ì¸í•œ í ì†ìƒì„ ë§‰ê¸° ìœ„í•´ ê°€ëŠ¥í•œ í•œ ë¹¨ë¦¬ íŠœë¸Œë¥¼ ì œê±°í•´ì•¼ í•©ë‹ˆë‹¤. (LISA/MIST ê°™ì€ ë¹„ì¹¨ìŠµì  íˆ¬ì—¬ë²•ë„ ìˆìŒ).\n    - **BPD ì •ì˜:** ìƒí›„ 28ì¼ ì´í›„ì—ë„ ì‚°ì†Œ ë³´ì¶©ì´ í•„ìš”í•œ ë¯¸ìˆ™ì•„. X-rayì—ì„œ ê±°í’ˆ ëª¨ì–‘(Bubbly/Cystic)ê³¼ ê³¼íŒ½ì°½ ì†Œê²¬ì„ ë³´ì„.\n---\n## 5. ì§€ì†ì„± ì‹ ìƒì•„ íê³ í˜ˆì•• (PPHN)\nNRDSì™€ ë¹„ìŠ·í•´ ë³´ì¼ ìˆ˜ ìˆì§€ë§Œ ì›ì¸ì´ ë‹¤ë¦…ë‹ˆë‹¤.\n### ğŸ©¸ ë³‘íƒœìƒë¦¬: ë°°ê´€ ë¬¸ì œ (Plumbing Problem)\n- í ì¡°ì§ ìì²´ëŠ” ê´œì°®ì§€ë§Œ, íí˜ˆê´€ì´ ê½‰ ë‹«í˜€ ìˆì–´(Clamped shut) í˜ˆì•¡ ìˆœí™˜ ì „í™˜(íƒœì•„ ìˆœí™˜ -> ì¶œìƒ í›„ ìˆœí™˜)ì— ì‹¤íŒ¨í•œ ìƒíƒœì…ë‹ˆë‹¤.\n- í˜ˆì•¡ì´ íë¥¼ ìš°íšŒí•˜ì—¬ ìš°ì‹¬ì‹¤ì—ì„œ **ë™ë§¥ê´€(PDA)**ì´ë‚˜ ë‚œì›ê³µ(Foramen Ovale)ì„ í†µí•´ ì „ì‹  ìˆœí™˜ìœ¼ë¡œ ë°”ë¡œ ë¹ ì ¸ë‚˜ê°‘ë‹ˆë‹¤ (Right-to-Left Shunt).\n### ğŸ©º ì§„ë‹¨ (Diagnosis)\n- **â˜… íŠ¹ì§•ì  ì†Œê²¬:** **ë¯¸ë¶„ì  ì²­ìƒ‰ì¦ (Differential Cyanosis).**\n    - ì˜¤ë¥¸ì†(Pre-ductal blood)ì˜ ì‚°ì†Œí¬í™”ë„ëŠ” ë†’ì§€ë§Œ(95%), ë°œ(Post-ductal blood)ì˜ ì‚°ì†Œí¬í™”ë„ëŠ” ë‚®ìŠµë‹ˆë‹¤(85%). **10% ì´ìƒì˜ ì°¨ì´**ê°€ ë‚˜ë©´ ì§„ë‹¨ì ì…ë‹ˆë‹¤.\n- **X-ray:** **íê°€ ê¹¨ë—í•¨(Clear lungs)** ë˜ëŠ” íí˜ˆê´€ ìŒì˜ ê°ì†Œ (NRDSì˜ í•˜ì–€ íì™€ ëŒ€ì¡°ë¨).\n### ğŸ’Š ì¹˜ë£Œ (Treatment)\n1. **ì‚°ì†Œ (Oxygen):** ê·¸ ìì²´ë¡œ ê°•ë ¥í•œ íí˜ˆê´€ í™•ì¥ì œì…ë‹ˆë‹¤.\n2. **â˜… Magic Bullet:** **í¡ì… ì‚°í™”ì§ˆì†Œ (Inhaled Nitric Oxide, iNO).**\n    - ì„ íƒì  íí˜ˆê´€ í™•ì¥ì œ. ì „ì‹  í˜ˆì••ì„ ë–¨ì–´ëœ¨ë¦¬ì§€ ì•Šê³  íë™ë§¥ë§Œ í™•ì¥ì‹œí‚µë‹ˆë‹¤.\n    - iNO ì‹¤íŒ¨ ì‹œ **ECMO** ê³ ë ¤.\n---\n## 6. ìœ ì•„ê¸° (Toddler): ì´ë¬¼ì§ˆ í¡ì¸ (Foreign Body Aspiration)\nì›€ì§ì„ì´ í™œë°œí•´ì§€ê³  ì…ìœ¼ë¡œ ëª¨ë“  ê²ƒì„ ê°€ì ¸ê°€ëŠ” ì‹œê¸°ì…ë‹ˆë‹¤.\n### ğŸ¥œ ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤\n- **íŠ¹ì§•:** **ê°‘ì‘ìŠ¤ëŸ¬ìš´ ë°œë³‘ (Sudden Onset).**\n    - ë©€ì©¡í•˜ê²Œ ë†€ë˜ ì•„ì´ê°€ ê°‘ìê¸° ê¸°ì¹¨, ì¼ì¼ê±°ë¦¼(Choking), ì²œëª…ìŒ(Wheezing)ì„ ë³´ì…ë‹ˆë‹¤. ì—´ì´ë‚˜ ì½§ë¬¼ ë“± ê°ì—¼ ì¦ìƒì€ ì—†ìŠµë‹ˆë‹¤.\n- **ìœ„ì¹˜:** í•´ë¶€í•™ì ìœ¼ë¡œ ë” ë„“ê³  ìˆ˜ì§ì— ê°€ê¹Œìš´ **ì˜¤ë¥¸ìª½ ì£¼ê¸°ê´€ì§€(Right Mainstem Bronchus)**ì— ì˜ ê±¸ë¦½ë‹ˆë‹¤.\n### ğŸ©º ì‹ ì²´ ê²€ì‚¬ ë° ì§„ë‹¨\n- **ì²­ì§„:** **â˜… ë‹¨ìŒì„± ì²œëª…ìŒ (Monophonic Wheeze).**\n    - ì²œì‹(Asthma)ì˜ ë‹¤ìŒì„± ì²œëª…ìŒ(Polyphonic wheeze - ì˜¤ì¼€ìŠ¤íŠ¸ë¼ì²˜ëŸ¼ ë‹¤ì–‘í•œ ìŒ)ê³¼ ë‹¬ë¦¬, ê³ ì •ëœ í•˜ë‚˜ì˜ íì‡„ ì§€ì ì—ì„œ ë‚˜ëŠ” ë‹¨ì¼ ìŒ(í”¼ë¦¬ ì†Œë¦¬)ì…ë‹ˆë‹¤.\n    - í™˜ì¸¡ì˜ í˜¸í¡ìŒ ê°ì†Œ(Diminished breath sounds).\n- **X-rayì˜ í•¨ì •:** **â˜… ì •ìƒ X-rayê°€ í¡ì¸ì„ ë°°ì œí•˜ì§€ ëª»í•¨.** (ë•…ì½© ë“±ì€ ë°©ì‚¬ì„  íˆ¬ê³¼ì„±ì´ë¼ ì•ˆ ë³´ì„).\n- **2ì°¨ì  ì§•í›„ (Ball-valve effect):**\n    - ìˆ¨ì„ ë“¤ì´ì‰´ ë•ŒëŠ” ê³µê¸°ê°€ ë“¤ì–´ê°€ì§€ë§Œ, ë‚´ì‰´ ë•ŒëŠ” ë§‰í˜€ì„œ ëª» ë‚˜ì˜´ -> **ê³µê¸° í¬íš (Air Trapping).**\n    - X-rayì—ì„œ í™˜ì¸¡ íì˜ **ê³¼íŒ½ì°½(Hyperinflation)**, íš¡ê²©ë§‰ì´ ëˆŒë¦¬ê³  ì‹¬ì¥ì´ ë°˜ëŒ€ìª½ìœ¼ë¡œ ë°€ë¦¬ëŠ” ì†Œê²¬ (ê±°ëŒ€í•œ Red Flag). ë°˜ëŒ€ë¡œ ì™„ì „íˆ ë§‰íˆë©´ ë¬´ê¸°íê°€ ì˜¬ ìˆ˜ë„ ìˆìŒ.\n### ğŸ’Š ê´€ë¦¬ (Management)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-206"}
{"chunk_type":"transcript_chunk","text":"- **ì˜ì‹¬ì´ ê°•ë ¥í•˜ë©´ (High Suspicion) (History, focal wheeze):** **X-rayê°€ ì •ìƒì´ë¼ë„** ìˆ˜ìˆ ì‹¤ë¡œ ì§í–‰í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Gold Standard:** **â˜… ê²½ì§ì„± ê¸°ê´€ì§€ë‚´ì‹œê²½ (Rigid Bronchoscopy).**\n    - ì§„ë‹¨ê³¼ ì¹˜ë£Œë¥¼ ë™ì‹œì— í•©ë‹ˆë‹¤.\n    - **ì™œ Flexibleì´ ì•„ë‹Œ Rigidì¸ê°€?** ìœ ì—°í•œ ë‚´ì‹œê²½ì€ ì‹œì•¼ í™•ë³´ì—” ì¢‹ì§€ë§Œ ë¬¼ê±´ì„ ì§‘ê¸° ì–´ë µìŠµë‹ˆë‹¤. ê²½ì§ì„± ë‚´ì‹œê²½ì€ í™˜ê¸°ë„ ê°€ëŠ¥í•˜ê³ , í° ê²¸ì(Forceps)ë¥¼ ë„£ì–´ ë¯¸ë„ëŸ¬ìš´ ì´ë¬¼ì§ˆì„ ë‹¨ë‹¨íˆ ì¡ì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸ‘ƒ ì½§ì† ì´ë¬¼ì§ˆ (Nasal Foreign Body)\n- **ì‹œë‚˜ë¦¬ì˜¤:** **ì¼ì¸¡ì„±(Unilateral)**, ì•…ì·¨ê°€ ë‚˜ëŠ”(Foul-smelling), ë†ì„± ì½§ë¬¼(Purulent discharge).\n- **ì£¼ì˜:** 3ì„¸ ì•„ì´ì˜ ë¶€ë¹„ë™ì—¼ì€ ê±°ì˜ ì–‘ì¸¡ì„±ì…ë‹ˆë‹¤. í•œìª½ì—ì„œë§Œ ëƒ„ìƒˆë‚˜ëŠ” ì½§ë¬¼ì´ ë‚˜ì˜¤ë©´ 100% ì´ë¬¼ì§ˆì…ë‹ˆë‹¤.\n- **ì‘ê¸‰ ìƒí™©:** **ë‹¨ì¶”í˜• ë°°í„°ë¦¬(Button Battery).**\n    - ì ë§‰ì˜ ìˆ˜ë¶„ê³¼ ë°˜ì‘í•´ ì „ë¥˜ë¥¼ ë°œìƒì‹œì¼œ ìˆ˜ì‚°í™”ë¬¼(Lye)ì„ ìƒì„±, **í™”í•™ì  í™”ìƒ ë° ì•¡í™” ê´´ì‚¬(Liquefactive necrosis)**ë¥¼ ìœ ë°œí•©ë‹ˆë‹¤. 2ì‹œê°„ ë§Œì— ë¹„ì¤‘ê²©ì´ë‚˜ ì‹ë„ ì²œê³µ ê°€ëŠ¥. **ì¦‰ì‹œ ì œê±° í•„ìš”.**\n- **ì œê±° íŒ:** **Parent's Kiss Technique.**\n    - ë¶€ëª¨ê°€ ì•„ì´ì˜ ì…ì— ì…ì„ ëŒ€ê³ , ì •ìƒ ì½§êµ¬ë©ì„ ë§‰ì€ ë’¤ ê°•í•˜ê²Œ ìˆ¨ì„ ë¶ˆì–´ë„£ì–´ ì´ë¬¼ì§ˆì„ íŠ€ì–´ë‚˜ì˜¤ê²Œ í•©ë‹ˆë‹¤.\n---\n## 7. ìˆ˜ë©´ ë° í–‰ë™ (Sleep & Behavioral)\n### ğŸ˜´ íì‡„ì„± ìˆ˜ë©´ ë¬´í˜¸í¡ì¦ (OSA) in Kids\n- **ì›ì¸:** ì„±ì¸(ë¹„ë§Œ)ê³¼ ë‹¬ë¦¬ ì†Œì•„ì˜ ì£¼ì›ì¸ì€ **í¸ë„ ë° ì•„ë°ë…¸ì´ë“œ ë¹„ëŒ€ (Adenotonsillar Hypertrophy).**\n- **ì¦ìƒ:** ì½”ê³¨ì´ë³´ë‹¤ **í–‰ë™ ë¬¸ì œ**ë¡œ ë‚˜íƒ€ë‚˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤.\n    - **â˜… ì—­ì„¤ì  ê³¼ì‰í–‰ë™ (Paradoxical Hyperactivity):** ì¡¸ë ¤í•˜ì§€ ì•Šê³  ADHDì²˜ëŸ¼ ì‚°ë§Œí•˜ê³  ì¶©ë™ì ì…ë‹ˆë‹¤. (ADHD ì•½ ì²˜ë°© ì „ ìˆ˜ë©´ í™•ì¸ í•„ìˆ˜!)\n    - **ì´ì°¨ì„± ì•¼ë‡¨ì¦ (Secondary Enuresis):** ì†Œë³€ì„ ì˜ ê°€ë¦¬ë˜ ì•„ì´ê°€ ë°¤ì— ë‹¤ì‹œ ì‹¤ìˆ˜ë¥¼ í•¨. (ì‹¬ì¥ì´ í˜¸í¡ ë…¸ë ¥ìœ¼ë¡œ ì¸í•œ ìŒì••ì„ ì²´ì•¡ ê³¼ë‹¤ë¡œ ì˜¤ì¸í•˜ì—¬ ANP/BNP ë¶„ë¹„ -> ì´ë‡¨ ì‘ìš©).\n- **ì§„ë‹¨:** **ìˆ˜ë©´ë‹¤ì›ê²€ì‚¬ (Polysomnogram).** ì†Œì•„ ê¸°ì¤€ì€ ë” ì—„ê²©í•¨ (AHI 1~2 ì´ìƒì´ë©´ ë¹„ì •ìƒ).\n- **ì¹˜ë£Œ:** **í¸ë„ ë° ì•„ë°ë…¸ì´ë“œ ì ˆì œìˆ  (T&A).** ëŒ€ë¶€ë¶„ ì™„ì¹˜ë¨.\n### ğŸ˜¤ í˜¸í¡ ì •ì§€ ë°œì‘ (Breath-holding Spells)\n- **ìœ í˜• 1: ì²­ìƒ‰ì¦í˜• (Cyanotic Type)**\n    - **ìœ ë°œ ìš”ì¸:** ë¶„ë…¸(Anger), ì¢Œì ˆ(Frustration).\n    - **ê²½ê³¼:** ìš¸ë‹¤ê°€ -> ìˆ¨ì„ ë©ˆì¶”ê³  -> íŒŒë˜ì§€ê³  -> ê¸°ì ˆí–ˆë‹¤ê°€ -> **ì¦‰ì‹œ íšŒë³µë¨.**\n- **ìœ í˜• 2: ì°½ë°±í˜• (Pallid Type)**\n    - **ìœ ë°œ ìš”ì¸:** í†µì¦(Pain), ê³µí¬(Fear) (ì˜ˆ: ë¨¸ë¦¬ë¥¼ ë¶€ë”ªí˜).\n    - **ê¸°ì „:** **ë¯¸ì£¼ì‹ ê²½ ë°˜ì‚¬ (Vasovagal response).** ì‹¬ë°•ìˆ˜ ì €í•˜ -> ì°½ë°±í•´ì§ -> ê¸°ì ˆ.\n- **ê°ë³„ ì§„ë‹¨:** **ê°„ì§ˆ(Epilepsy)ê³¼ì˜ ì°¨ì´ì .**\n    - í˜¸í¡ ì •ì§€ ë°œì‘ì€ **ë°˜ë“œì‹œ ìœ ë°œ ìš”ì¸(Provocation)ì´ ìˆìŒ.**\n    - íšŒë³µì´ ë¹ ë¥´ê³  **ë°œì‘ í›„ í˜¼ëˆ(Post-ictal state)ì´ ì—†ìŒ.** (ê°„ì§ˆì€ íšŒë³µì— ì‹œê°„ ê±¸ë¦¼).\n- **ê´€ë¦¬:** **ì•ˆì‹¬ì‹œí‚¤ê¸° (Reassurance).** ë¶€ëª¨ì—ê²Œ ë¬´í•´í•˜ë‹¤ëŠ” ê²ƒì„ ì„¤ëª…í•©ë‹ˆë‹¤.\n- **â˜… Lab Test:** **ì²  ê²°í•ì„± ë¹ˆí˜ˆ (Iron deficiency anemia)** í™•ì¸. ì² ë¶„ ë¶€ì¡±ê³¼ ì—°ê´€ì„±ì´ ë†’ìœ¼ë©° ì¹˜ë£Œ ì‹œ ë¹ˆë„ê°€ ì¤„ì–´ë“¤ ìˆ˜ ìˆìŒ.\n---\n## 8. í™˜ê²½ì  ìœ„í—˜ (Environmental Risks)\n### ğŸ›Œ ì˜ì•„ ëŒì—°ì‚¬ ì¦í›„êµ° (SIDS)\n- **ì •ì˜:** 1ê°œì›”~1ì„¸ ì‚¬ì´ ì˜ì•„ì˜ ì„¤ëª…í•  ìˆ˜ ì—†ëŠ” ì‚¬ë§.\n- **Triple Risk Model:** ì·¨ì•½í•œ ì˜ì•„(ë‡Œê°„ ì´ìƒ) + ê²°ì •ì  ë°œë‹¬ ì‹œê¸°(2~4ê°œì›”) + ì™¸ë¶€ ìŠ¤íŠ¸ë ˆìŠ¤(ì—ë“œë ¤ ì¬ìš°ê¸° ë“±).\n- **ìœ„í—˜ ìš”ì¸:**\n    - **â˜… ì—ë“œë ¤ ì¬ìš°ê¸° (Prone sleeping) - ê°€ì¥ í° êµì • ê°€ëŠ¥í•œ ìœ„í—˜ ì¸ì.**\n    - í‘¹ì‹ í•œ ì¹¨êµ¬, ì—„ë§ˆì˜ í¡ì—°(ì‚°ì „/ì‚°í›„), ê³¼ì—´(Overheating), **ë¶€ëª¨ì™€ì˜ ì¹¨ëŒ€ ê³µìœ (Bed sharing - íŠ¹íˆ ì†ŒíŒŒë‚˜ ì•ˆë½ì˜ì).**\n- **ë³´í˜¸ ìš”ì¸:** **ë°© ê³µìœ (Room sharing - ì¹¨ëŒ€ëŠ” ë”°ë¡œ),** ê³µê°ˆì –ê¼­ì§€(Pacifier) ì‚¬ìš©.\n### ğŸŠ ìµì‚¬ (Drowning)\n- **ë³‘íƒœìƒë¦¬:** ë¬¼(ë‹´ìˆ˜/í•´ìˆ˜ ìƒê´€ì—†ìŒ)ì´ ê³„ë©´í™œì„±ì œë¥¼ ì”»ì–´ëƒ„ -> ë¬´ê¸°í(Atelectasis) -> V/Q ë¶ˆì¼ì¹˜ -> ì €ì‚°ì†Œì¦(Hypoxia) -> ARDS.\n- **ê´€ë¦¬:**\n    - **ì¦ìƒì´ ìˆë‹¤ë©´ (ê¸°ì¹¨, í˜¸í¡ìˆ˜ ì¦ê°€ ë“±):** **ìµœì†Œ 6~8ì‹œê°„ ë³‘ì› ê´€ì°°** í•„ìˆ˜. **ì§€ì—°ì„± íë¶€ì¢…(Delayed pulmonary edema)** ìœ„í—˜ ë•Œë¬¸.\n- **ì˜ì‹ ì—†ì´ êµ¬ì¡° ë˜ì—ˆì„ ê²½ìš°ì˜ˆí›„ ì¸ì:** **ì ìˆ˜ ì‹œê°„(Subversion duration) 5ë¶„ ë¯¸ë§Œ**ì´ ê°€ì¥ ì¤‘ìš”. ê·¸ ì™¸ ì¦‰ê°ì ì¸ ì‹¬íì†Œìƒìˆ (CPR) ì—¬ë¶€, ì´ˆê¸° ì‚°ë„(pH < 7.1ì€ ë‚˜ì¨).\n    - **ì˜ˆì™¸:** **ì–¼ìŒë¬¼(Icy cold water)**ì— ë¹ ì§„ ê²½ìš° ì‹ ê²½ ë³´í˜¸ íš¨ê³¼(Neuroprotective)ë¡œ ì¸í•´ ì¥ì‹œê°„ ì ìˆ˜ í›„ì—ë„ ìƒì¡´ ê°€ëŠ¥ì„±ì´ ìˆìŒ (ë“œë¬¼ì§€ë§Œ).\n---","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-226"}
{"chunk_type":"recap_summary","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| ìƒí™© (Scenario) | ì§„ë‹¨ (Diagnosis) | í•µì‹¬ ì¡°ì¹˜ (Key Action) |\n| --- | --- | --- |\n| **ì‹ ìƒì•„, í‰ì†Œ íŒŒë—ê³  ìš¸ë©´ ë¶„í™ìƒ‰** | **Choanal Atresia** | ì¹´í…Œí„° í†µê³¼ ì‹œë„ -> CT -> **ìˆ˜ìˆ ** (ì–‘ì¸¡ì„±ì€ ì‘ê¸‰) |\n| **ë¯¸ìˆ™ì•„, ë™ë™ê±°ë¦¼, ê°„ìœ ë¦¬ ìŒì˜ X-ray** | **NRDS** | CPAP -> (í•„ìš”ì‹œ) ì‚½ê´€ & Surfactant |\n| **ì²­ìƒ‰ì¦ ì•„ê¸°, í ê¹¨ë—í•¨, ì°¨ë³„ì  ì²­ìƒ‰ì¦** | **PPHN** | **Inhaled Nitric Oxide (iNO)** |\n| **ìœ ì•„, ê°‘ì‘ìŠ¤ëŸ¬ìš´ ê¸°ì¹¨, ë‹¨ìŒì„± ì²œëª…ìŒ** | **Foreign Body Aspiration** | **Rigid Bronchoscopy** (X-ray ì •ìƒì´ì–´ë„!) |\n| **í•œìª½ ì½§ë¬¼, ì•…ì·¨** | **Nasal Foreign Body** | ì œê±° (ë°°í„°ë¦¬ëŠ” ì‘ê¸‰!) |\n| **ì½” ê³ ëŠ” ì•„ì´, ë‚®ì— ì‚°ë§Œí•¨(ADHD?), ì•¼ë‡¨ì¦** | **Pediatric OSA** | **Adenotonsillectomy (T&A)** |\n| **ìš¸ë‹¤ê°€ íŒŒë˜ì§€ê³  ê¸°ì ˆ, ê¸ˆë°© íšŒë³µ** | **Breath-holding Spell** | ì•ˆì‹¬ì‹œí‚¤ê¸°, **ì² ë¶„(Ferritin) ì²´í¬** |\n| **ë¬¼ì— ë¹ ì§, ê¸°ì¹¨ ì¡°ê¸ˆ í•¨** | **Drowning (Risk of ARDS)** | **6~8ì‹œê°„ ë³‘ì› ê´€ì°°** (ì§‘ì— ë³´ë‚´ì§€ ë§ ê²ƒ!) |\n---\n## 8. ë§ˆì§€ë§‰ ì¡°ì–¸ (Final Thoughts)\nStep 2ëŠ” ì—¬ëŸ¬ë¶„ì˜ ê²°ë‹¨ë ¥ì„ í‰ê°€í•©ë‹ˆë‹¤. ë³‘ì„ ì•„ëŠ” ê²ƒë§Œìœ¼ë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. **ë¬´ì—‡ì„ í•  ê²ƒì¸ê°€(What to do)**ë¥¼ ì•Œì•„ì•¼ í•©ë‹ˆë‹¤.\n- CT ì „ì— ì¹´í…Œí„° ë¨¼ì €.\n- ì´ë¬¼ì§ˆ ì˜ì‹¬ë˜ë©´ CT ëŒ€ì‹  ë‚´ì‹œê²½.\n- NRDSì—ëŠ” ì‚½ê´€ ì „ì— CPAP.\n- ì•Œê³ ë¦¬ì¦˜ì„ ìˆ™ì§€í•˜ê³ , í™˜ìë¥¼ ì‹œê°í™”í•˜ì—¬, **ë‹¤ìŒ ë‹¨ê³„(Next Step)**ë¥¼ ì •í™•íˆ ì„ íƒí•˜ì„¸ìš”! Good luck! ğŸ€\n**Verify (ê²€ì¦) (0:00~0:30):**\n> Host: \"Welcome back to the deep dive. Yeah. I spent last night staring at a stack of notes that... I'm not gonna lie, looked a little bit like blueprints for a submarine.\"\nCo-host: \"A submarine, huh? I can see that.\"\nHost: \"Seriously. We are talking about pressure gradients, fluid dynamics, vacuum seals and, you know, catastrophic structural failures. But we aren't talking about engineering. We are talking about the human chest. Specifically, we are cracking open the high yield, high stakes world of pulmonary surgery for USMLE Step 2.\"\n>\n---\n# ğŸ« USMLE Step 2 Deep Dive: Pulmonary Surgery (í ìˆ˜ìˆ ) ì™„ì „ ì •ë³µ","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-242"}
{"chunk_type":"transcript_chunk","text":"ì´ ê°•ì˜ëŠ” ë‹¨ìˆœíˆ í•´ë¶€í•™ì  êµ¬ì¡°ë¥¼ ì™¸ìš°ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, í‰ê³½ì´ë¼ëŠ” **'ì••ë ¥ì´ ê°€í•´ì§„ ìƒì(Pressurized Box)'**ì˜ ë¬¼ë¦¬í•™ì  ì›ë¦¬(ì••ë ¥ êµ¬ë°°, ìœ ì²´ ì—­í•™, ì§„ê³µ ë°€ë´‰)ë¥¼ ì´í•´í•˜ì—¬ ì„ìƒì  ìƒí™©ì— ëŒ€ì²˜í•˜ëŠ” ëŠ¥ë ¥ì„ ê¸°ë¥´ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. **\"ë‹µì„ ì™¸ìš°ì§€ ë§ê³  ë„ì¶œí•´ë‚´ë¼(Derive the answer)\"**ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n## 1. Introduction: í‰ê³½ì€ ë¬¼ë¦¬í•™ì˜ ë¬¸ì œë‹¤ (The Physics of the Chest)\n- **ê´€ì ì˜ ì „í™˜:** í ìˆ˜ìˆ ì€ ë‹¨ìˆœíˆ ìë¥´ê³  ê¿°ë§¤ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì••ë ¥ê³¼ ê³µê°„ì„ ë‹¤ë£¨ëŠ” ë¬¼ë¦¬í•™ ë¬¸ì œì…ë‹ˆë‹¤.\n- **í•µì‹¬ ê°œë…:** **ê³µê¸°(Air), í˜ˆì•¡(Blood), ê³µê°„(Space)**, ê·¸ë¦¬ê³  ì´ë“¤ì„ ì›€ì§ì´ëŠ” **ì••ë ¥(Pressure)**.\n- **ë¡œë“œë§µ:**\n    1. ìˆ˜ìˆ  ì „ ìµœì í™” (Pre-op Optimization)\n    2. ìˆ˜ìˆ  í›„ ê´€ë¦¬ ë° í•©ë³‘ì¦ íƒ€ì„ë¼ì¸ (Post-op Care & Timeline)\n    3. í‰ë¶€ ì™¸ìƒ (Blunt Chest Trauma)\n    4. êµ¬ì¡°ì  ì‹¤íŒ¨ (Structural Failures)\n---\n## 2. ìˆ˜ìˆ  ì „ ìµœì í™” (Pre-operative Optimization)\n### ğŸš¬ í¡ì—° (Smoking)\n- **í”í•œ ì‹œë‚˜ë¦¬ì˜¤:** í•˜ë£¨ í•œ ê°‘ì”© 30ë…„ê°„ í¡ì—°í•œ íì•” í™˜ìê°€ íì—½ ì ˆì œìˆ (Lobectomy)ì„ ì•ë‘ê³  ìˆìŒ.\n- **í•µì‹¬ ì§ˆë¬¸:** ìˆ˜ìˆ  ì „ ì–¸ì œ ê¸ˆì—°í•´ì•¼ í•˜ëŠ”ê°€?\n- **â˜… Magic Number:** **ìˆ˜ìˆ  ì „ 4~8ì£¼ ì´ìƒ ê¸ˆì—°í•´ì•¼ í•¨.**\n- **ìƒë¦¬í•™ì  ì´ìœ  (The Cellular Logic):**\n    - **ì„¬ëª¨(Cilia)ì˜ ë§ˆë¹„:** í¡ì—°ì€ íì˜ ì²­ì†Œë¶€ì¸ ì„¬ëª¨ë¥¼ ë§ˆë¹„ì‹œí‚¤ê³  íŒŒê´´í•©ë‹ˆë‹¤.\n    - **ì ì•¡ ê³¼ë‹¤ ë¶„ë¹„:** ìê·¹ìœ¼ë¡œ ì¸í•´ ì ì•¡ ë¶„ë¹„ ì„¸í¬(Goblet cells)ê°€ ì ì•¡ì„ ê³¼ë‹¤ ìƒì„±í•©ë‹ˆë‹¤. (Traffic jam ìƒíƒœ).\n- **ì—­ì„¤ì  ìœ„í—˜ (The Trap):** ìˆ˜ìˆ  ì§ì „(1~2ì£¼ ì „)ì— ê¸ˆì—°í•˜ëŠ” ê²ƒì€ ì˜¤íˆë ¤ ìœ„í—˜í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n    - ê¸ˆì—° ì§í›„ ì„¬ëª¨ ê¸°ëŠ¥ì€ ë°”ë¡œ ëŒì•„ì˜¤ì§€ ì•Šì§€ë§Œ, ì ì•¡ ë°°ì¶œì„ ìœ„í•œ ì—¼ì¦ ë°˜ì‘ ë“±ìœ¼ë¡œ ê°€ë˜ ì–‘ì´ ëŠ˜ê³  ì ë„ê°€ ë³€í•˜ì—¬ ê¸°ë„ê°€ ê³¼ë¯¼í•´ì§‘ë‹ˆë‹¤. ì´ë•Œ ìˆ˜ìˆ í•˜ë©´ ë§ˆì·¨ ì¤‘ ê°€ë˜ì— ìµì‚¬í•˜ê±°ë‚˜ ê¸°ë„ ê²½ë ¨ì´ ì¼ì–´ë‚  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸ§® í ê¸°ëŠ¥ í‰ê°€ (Pulmonary Reserve)\n- **ì§€í‘œ:** FEV1 (1ì´ˆê°„ ê°•ì œ í˜¸ê¸°ëŸ‰) & DLCO (ì¼ì‚°í™”íƒ„ì†Œ í™•ì‚°ëŠ¥).\n- **ê¸°ì¤€:** FEV1 > 1.5L, DLCO > 60%ì´ë©´ ì•ˆì „ì§€ëŒ€(Safe zone).\n- **â˜… Gray Zone ì „ëµ:** ë§Œì•½ FEV1ì´ 1.2Lë¡œ ë‚®ë‹¤ë©´ ìˆ˜ìˆ ì„ ì·¨ì†Œí•˜ëŠ”ê°€? **NO.**\n    - **Next Step:** **V/Q Scan (í™˜ê¸°-ê´€ë¥˜ ìŠ¤ìº”)**ì„ ì‹œí–‰í•˜ì—¬ **ì˜ˆìƒ ìˆ˜ìˆ  í›„ FEV1 (Predicted Post-operative FEV1)**ì„ ê³„ì‚°í•©ë‹ˆë‹¤.\n    - **ë…¼ë¦¬:** ë§Œì•½ ì œê±°í•˜ë ¤ëŠ” íì—½ì´ ì´ë¯¸ ì•”ìœ¼ë¡œ ì¸í•´ ê¸°ëŠ¥ì„ ì „í˜€ ëª»í•˜ê³  ìˆë‹¤ë©´(Dead weight), ì´ë¥¼ ì œê±°í•´ë„ í™˜ìì˜ í ê¸°ëŠ¥ ì†ì‹¤ì€ ì—†ìŠµë‹ˆë‹¤. ì˜¤íˆë ¤ 40% ê¸°ëŠ¥ì„ í•˜ë˜ íì—½ì„ ë–¼ì–´ë‚´ë©´ ì „ì²´ ê¸°ëŠ¥ì˜ 40%ë¥¼ ìƒëŠ” ê²ƒì…ë‹ˆë‹¤. ì¦‰, **í•´ë¶€í•™ì  ì†ì‹¤ì´ ì•„ë‹Œ ê¸°ëŠ¥ì  ì†ì‹¤(Functional Loss)**ì„ ë”°ì ¸ì•¼ í•©ë‹ˆë‹¤.\n---\n## 3. ìˆ˜ìˆ  í›„ ê´€ë¦¬ (Post-operative Care): ì €ì‚°ì†Œì¦ íƒ€ì„ë¼ì¸ â³\nìˆ˜ìˆ  í›„ ì €ì‚°ì†Œì¦ì˜ ì›ì¸ì€ **ì‹œê°„(Time)**ì— ë”°ë¼ ë‹¬ë¼ì§‘ë‹ˆë‹¤.\n### ğŸ•’ ì¦‰ì‹œ (Immediate Post-op)\n- **ì›ì¸:** **ê¸°ë„(Airway) ë˜ëŠ” ì•½ë¬¼(Drugs).**\n    - í˜€ê°€ ë’¤ë¡œ ë§ë¦¼, ì‚½ê´€ìœ¼ë¡œ ì¸í•œ í›„ë‘ ë¶€ì¢…, ì”ë¥˜ ë§ˆì·¨ì œ/ì§„í†µì œ íš¨ê³¼(í˜¸í¡ ìš•êµ¬ ì €í•˜).\n- **ì´ˆê¸° ëª‡ ì‹œê°„ í›„:** ì²œëª…ìŒ(Wheezing) -> ê¸°ê´€ì§€ ê²½ë ¨(Bronchospasm).\n### ğŸ“… 1ì¼ ~ 5ì¼ ì°¨ (The Danger Zone)\nê°€ì¥ ì¤‘ìš”í•œ ê°ë³„ ì§„ë‹¨ì€ **íë ´(Pneumonia) vs ë¬´ê¸°í(Atelectasis)** ì…ë‹ˆë‹¤.\n### A. ë¬´ê¸°í (Atelectasis) - Day 2~3 ğŸ†\n- **ì›ì¸:** **â˜… í†µì¦(Pain).**\n    - í†µì¦ ë•Œë¬¸ì— ìˆ¨ì„ ì–•ê²Œ ì‰¼(Splinting) -> íí¬ë¥¼ ì—´ì–´ì£¼ëŠ” ì••ë ¥ ë¶€ì¡± -> íí¬ê°€ í’ì„ ì²˜ëŸ¼ ìª¼ê·¸ë¼ë“¦(Collapse).\n- **ë³‘íƒœìƒë¦¬:** íí¬ëŠ” ë‹«í˜€ ìˆì§€ë§Œ í˜ˆë¥˜ëŠ” ê³„ì† íë¦„ -> ì‚°ì†Œ êµí™˜ ì•ˆ ë¨ (**Shunt**) -> ì €ì‚°ì†Œì¦ -> ê³¼í˜¸í¡(Hyperventilation) -> ì´ì‚°í™”íƒ„ì†Œ ë°°ì¶œ (ì €íƒ„ì‚°í˜ˆì¦).\n- **â˜… ê³µì‹:** **ì €ì‚°ì†Œì¦(Hypoxia) + í˜¸í¡ì„± ì•Œì¹¼ë¦¬ì¦(Respiratory Alkalosis) = ë¬´ê¸°í.** (CO2ê°€ ë†’ì„ ê²ƒì´ë¼ëŠ” ì°©ê° ê¸ˆì§€!)\n- **X-ray ì†Œê²¬:** **ìš©ì  ê°ì†Œ(Volume Loss).** ì°Œê·¸ëŸ¬ì§„ í ìª½ìœ¼ë¡œ ê¸°ê´€ì´ë‚˜ ì‹¬ì¥ì´ ë‹¹ê²¨ì§ (**Pull**). (í‰ìˆ˜ë‚˜ ì¢…ì–‘ì€ ë°€ì–´ëƒ„ - **Push**).\n- **ì¹˜ë£Œ (Management):**\n    1. **Incentive Spirometry (ìœ ë°œ íí™œëŸ‰ê³„):** í™˜ìê°€ ìŠ¤ìŠ¤ë¡œ ê¹Šì€ ìˆ¨ì„ ì‰¬ì–´ ìŒì••ì„ ë§Œë“¤ì–´ íí¬ë¥¼ í´ê²Œ í•¨.\n    2. **CPAP:** ì–‘ì••ìœ¼ë¡œ ê°•ì œë¡œ í´ì¤Œ.\n    3. **â˜… ê·¼ë³¸ ì¹˜ë£Œ:** **ì ê·¹ì ì¸ í†µì¦ ì¡°ì ˆ (Aggressive Pain Control).** (Epidural, Nerve block ë“±). í†µì¦ì„ ì—†ì• ì•¼ ê¹Šì€ ìˆ¨ì„ ì‰´ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì „ì‹  ë§ˆì•½ì„± ì§„í†µì œëŠ” í˜¸í¡ì„ ì–µì œí•  ìˆ˜ ìˆìœ¼ë¯€ë¡œ ì£¼ì˜.\n### B. íë ´ (Pneumonia) - Day 3~5\n- **ì¦ìƒ:** **ë°œì—´(Fever), ë†ì„± ê°€ë˜(Purulent sputum), ë°±í˜ˆêµ¬ ì¦ê°€.**\n- **ê°ë³„ì :** X-rayì—ì„œ íì—½ ê²½ê³„(Lobar consolidation)ê°€ ëšœë ·í•˜ë©°, ë¬´ê¸°íì²˜ëŸ¼ ë‹¹ê²¨ì§€ëŠ” ì†Œê²¬ì€ ì—†ìŠµë‹ˆë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-252"}
{"chunk_type":"transcript_chunk","text":"### C. íìƒ‰ì „ì¦ (PE) - Day 3 ì´í›„\n- **ë‹¨ì„œ:** í‰í†µ, ë¹ˆë§¥, ì‚°ì†Œë¥¼ ì¤˜ë„ í•´ê²°ë˜ì§€ ì•ŠëŠ” ì €ì‚°ì†Œì¦(V/Q mismatch), ê¹¨ë—í•œ X-ray.\n---\n## 4. í‰ë¶€ ì™¸ìƒ (Blunt Chest Trauma) ğŸ’¥\nì•Œê³ ë¦¬ì¦˜ì˜ ì²« ë²ˆì§¸ ë¶„ê¸°ì : **ì•ˆì •(Stable) vs ë¶ˆì•ˆì •(Unstable)?**\n- **ë¶ˆì•ˆì •:** eFAST (ì´ˆìŒíŒŒ) -> ìˆ˜ìˆ ì‹¤(OR). (ì§„ë‹¨ë³´ë‹¤ ì†Œìƒì´ ë¨¼ì €).\n- **ì•ˆì •:** CT ìŠ¤ìº”ìœ¼ë¡œ ì •ë°€ í‰ê°€.\n### ğŸ”¨ 1. ëŠ‘ê³¨ ê³¨ì ˆ (Rib Fractures)\n- **ë…¸ì¸ í™˜ì:** ë‹¨ìˆœ ê³¨ì ˆë„ ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŒ. í†µì¦ -> ë¬´ê¸°í -> íë ´ -> ì‚¬ë§.\n- **ì¹˜ë£Œ:** **ì ê·¹ì ì¸ í†µì¦ ì¡°ì ˆ (Nerve block, Epidural).** ë¶•ëŒ€ë¡œ ê°ëŠ” ê²ƒ(Wrapping)ì€ ì ˆëŒ€ ê¸ˆê¸° (ìˆ¨ì„ ëª» ì‰¬ê²Œ ë§Œë“¦).\n### ğŸŒªï¸ 2. ë™ìš” ê°€ìŠ´ (Flail Chest)\n- **ì •ì˜:** 3ê°œ ì´ìƒì˜ ì—°ì†ëœ ëŠ‘ê³¨ì´ 2êµ°ë° ì´ìƒ ê³¨ì ˆë˜ì–´ í‰ë²½ì—ì„œ ë¶„ë¦¬ëœ ìƒíƒœ.\n- **ì§•í›„:** **â˜… ì—­ì„¤ì  í˜¸í¡ ìš´ë™ (Paradoxical Chest Wall Motion).**\n    - í¡ê¸° ì‹œ(ìŒì••): ë¶„ë¦¬ëœ í‰ë²½ì´ ì•ˆìœ¼ë¡œ ë¹¨ë ¤ ë“¤ì–´ê°.\n    - í˜¸ê¸° ì‹œ(ì–‘ì••): ë°–ìœ¼ë¡œ íŠ€ì–´ ë‚˜ì˜´.\n- **ë¬¸ì œì :** ë¹„íš¨ìœ¨ì ì¸ í˜¸í¡ + **í íƒ€ë°•ìƒ(Pulmonary Contusion)** ë™ë°˜.\n- **ì¹˜ë£Œ:** í†µì¦ ì¡°ì ˆ. ì‹¬í•˜ë©´ ì‚½ê´€ í›„ **ì–‘ì•• í™˜ê¸°(PPV)**. (ì–‘ì••ì´ ë‚´ë¶€ì—ì„œ 'ê³µê¸° ë¶€ëª©(Pneumatic Splint)' ì—­í• ì„ í•˜ì—¬ í‰ë²½ì„ ë°–ìœ¼ë¡œ ë°€ì–´ì£¼ê³  ê³ ì •í•¨).\n### ğŸ« 3. í íƒ€ë°•ìƒ (Pulmonary Contusion)\n- **ì •ì˜:** íì˜ ë©(Bruise). ëª¨ì„¸í˜ˆê´€ì´ í„°ì ¸ í˜ˆì•¡ê³¼ ë‹¨ë°±ì§ˆì´ íí¬ë¡œ ìƒˆì–´ ë‚˜ì˜´.\n- **íŠ¹ì§• (Blooming):**\n    - ì´ˆê¸° X-rayëŠ” ì •ìƒì¼ ìˆ˜ ìˆìŒ.\n    - **6~24ì‹œê°„ í›„** í•˜ì–—ê²Œ **ì¹¨ìœ¤(Infiltrate)**ì´ ë‚˜íƒ€ë‚˜ë©° ì¦ìƒ(ì €ì‚°ì†Œì¦) ì•…í™”.\n    - íì—½ ê²½ê³„ë¥¼ ë”°ë¥´ì§€ ì•Šê³  ë¶ˆê·œì¹™í•¨ (Messy patch). (íë ´ê³¼ ì°¨ì´ì  â˜… nonlobular, nonanatomical)\n- **â˜… ìˆ˜ì•¡ ê´€ë¦¬ (Fluid Management):**\n    - **ì›ì¹™:** **\"Dry lungs = Happy lungs\".**\n    - **ì´ìœ :** ì†ìƒëœ í˜ˆê´€(Leaky capillaries)ì— ìˆ˜ì•¡ì„ ìŸì•„ë¶€ìœ¼ë©´ ì •ìˆ˜ì••(Hydrostatic pressure)ì´ ë†’ì•„ì ¸ ë¬¼ì´ íí¬ë¡œ ì½¸ì½¸ ìŸì•„ì§ -> í™˜ìë¥¼ ë‚´ë¶€ì—ì„œ ìµì‚¬ì‹œí‚´.\n    - ì €í˜ˆì••ì´ ì˜¤ì§€ ì•ŠëŠ” ì„ ì—ì„œ ìˆ˜ì•¡ì„ ì œí•œ(Euvolumic or slightly negative balance)í•´ì•¼ í•¨.\n### ğŸ©¸ 4. í˜ˆí‰ (Hemothorax) - pleural space /\n- ì„ìƒì ì˜ì˜: ì „ì²´ í”¼ì˜ 50%ë‚˜ pleural spaceì•ˆìœ¼ë¡œ ë“¤ì–´ì˜¬ ìˆ˜ ìˆì„ ì •ë„ë¡œ ê³µê°„ì´ ë„“ìŒ. ëª¸ë°–ìœ¼ë¡œ í”¼ ì•ˆë‚˜ë„ ëª¸ ì•ˆìª½ì—ì„œ ì—„ì²­ë‚œ ì¶œí˜ˆì´ ìˆì„ ìˆ˜ ìˆë‹¤.\n- **ì§„ë‹¨:** íƒ€ì§„ ì‹œ ë‘”íƒìŒ(Dullness) (ê¸°í‰ì€ ê³µëª…ìŒ/Hyper-resonant).\n- **ì¹˜ë£Œ:** í‰ê´€ ì‚½ì… (Tube Thoracostomy).\n- ì¼ë‹¨ ì ì€ì–‘ì´ë¼ë„ chest tubeëŠ” ì‚½ì…í•˜ê³  ìˆ˜ìˆ í• ì§€ëŠ” ì•„ë˜ ê¸°ì¤€ìœ¼ë¡œ ì •í•œë‹¤.\nâ˜… í‰ê´€: thoracoStomy, ìˆ˜ìˆ : thoracOtomy\n- **â˜… ìˆ˜ìˆ (Thoracotomy) ì ì‘ì¦ (ë°˜ë“œì‹œ ì•”ê¸°):**\n    1. **ì¦‰ì‹œ ë°°ì•¡ëŸ‰ > 1,500mL (1.5L).**\n    2. **ì§€ì†ì ì¸ ì¶œí˜ˆ > 200mL/hr (2~4ì‹œê°„ ë™ì•ˆ).**\n    3. í˜ˆì—­í•™ì  ë¶ˆì•ˆì • ë° ì§€ì†ì ì¸ ìˆ˜í˜ˆ ìš”êµ¬.\n- **ì£¼ì˜:** ì ì€ ì–‘ì´ë¼ë„ ë°˜ë“œì‹œ ë°°ì•¡í•´ì•¼ í•¨. ë‚¨ê²¨ë‘ë©´ í”¼ê°€ êµ³ì–´(Clot) íë¥¼ ê°€ë‘ëŠ” **Fibrothorax(ì„¬ìœ í‰)**ê°€ ë˜ê±°ë‚˜ ê°ì—¼ë˜ì–´ **ë†í‰(Empyema)**ì´ ë¨.\n### 5. Hemoptysis\n- secure the airway\n- bad lung down\n---\n## 5. êµ¬ì¡°ì  ì‹¤íŒ¨ (Structural Failures) ğŸ—ï¸\n### ğŸŒ¬ï¸ ê¸°ê´€ì§€ íŒŒì—´ (Tracheobronchial Injury)\n- Traumaí™˜ìì—ì„œ pneumothoraxê°€ ìƒê²¼ê³  pneumothoraxë¥¼ ì¹˜ë£Œí•˜ëŠ” ê³¼ì •ì—ì„œ ì˜ì‹¬í•˜ëŠ” ìƒí™©. ê³µê¸°ë¹¼ë ¤ê³  í‰ê´€ì´ë‚˜ ìŒì••ì„ ê±¸ì—ˆëŠ”ë°â€¦\n- **ë‹¨ì„œ:**\n    - **ì§€ì†ì ì¸ ë‹¤ëŸ‰ì˜ ê³µê¸° ëˆ„ì¶œ (Persistent Large Air Leak):** í‰ê´€ ë°°ì•¡í†µ(Pleur-evac)ì—ì„œ ê±°í’ˆì´ ë©ˆì¶”ì§€ ì•Šê³  ê³„ì† ë³´ê¸€ê±°ë¦¼.\n    - íê°€ í´ì§€ì§€ ì•ŠìŒ.\n    - ì‹¬í•œ í”¼í•˜ ê¸°ì¢… (Subcutaneous Emphysema - ë½€ë“œë“ê±°ë¦¬ëŠ” ëŠë‚Œ).\n    - **Hamman's Sign:** ì‹¬ì¥ ë°•ë™ì— ë§ì¶° ë“¤ë¦¬ëŠ” 'ë°”ìŠ¤ë½' ì†Œë¦¬ (ì¢…ê²©ë™ ê¸°ì¢…). Pneumomediastinum\n- **ì§„ë‹¨:** ê¸°ê´€ì§€ ë‚´ì‹œê²½ (Bronchoscopy) to see the tear.\n- **ì¹˜ë£Œ:** ìˆ˜ìˆ ì  ë´‰í•©.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-272"}
{"chunk_type":"transcript_chunk","text":"### ğŸ†™ íš¡ê²©ë§‰ íŒŒì—´ (Diaphragmatic Rupture)\n- **ì‹œë‚˜ë¦¬ì˜¤:** ì‹¬í•œ ë‘”ìƒ í›„ ë³µë¶€ ë‚´ì¥(ìœ„, ì¥)ì´ í‰ê°•ìœ¼ë¡œ ë°€ë ¤ ì˜¬ë¼ê°. (ì£¼ë¡œ ì™¼ìª½ - ì˜¤ë¥¸ìª½ì€ ê°„ì´ ë§‰ì•„ì¤Œ).\n- **ì§•í›„:** í˜¸í¡ ê³¤ë€ + **í‰ë¶€ì—ì„œ ì¥ìŒ(Bowel sound)ì´ ë“¤ë¦¼.**\n- **â˜… The Tube Sign:** ë¹„ìœ„ê´€(L-tube, NG tube)ì„ ë„£ê³  X-rayë¥¼ ì°ì—ˆë”ë‹ˆ íŠœë¸Œ ëì´ ê°€ìŠ´(í‰ê°•) ì•ˆì— ë§ë ¤ ì˜¬ë¼ê°€ ìˆìŒ.\n- **ì¹˜ë£Œ:** ìˆ˜ìˆ ì  ì •ë³µ ë° ë´‰í•©.\n### ğŸ‘ƒDiaphragmatic Paralysis\n- ìˆ˜ìˆ ì‹œ phrenic n. ì†ìƒ\n| **êµ¬ë¶„** | **ì •ìƒ íš¡ê²½ë§‰** | **ì¼ì¸¡ì„± íš¡ê²½ë§‰ ë§ˆë¹„** |\n| --- | --- | --- |\n| **í¡ê¸° ì‹œ ì›€ì§ì„** | ì•„ë˜ë¡œ ë‚´ë ¤ê° (ìˆ˜ì¶•) | **ìœ„ë¡œ ì˜¬ë¼ê° (ì—­ì„¤ì  ì›€ì§ì„)** |\n| **X-ray ì†Œê²¬** | ë” ëª¨ì–‘ì´ ì•„ë˜ì— ìœ„ì¹˜ | **í•œìª½ íš¡ê²½ë§‰ì´ ë†’ê²Œ ì†Ÿì•„ ìˆìŒ** |\n| **ì£¼ìš” ê²€ì‚¬** | ì¼ë°˜ ì‹ ì²´ê²€ì§„ | **Sniff Test (í‚í‚ ê²€ì‚¬)** â˜… |\n- **â˜… Sniff Testë€?**\níˆ¬ì‹œ ì´¬ì˜(Fluoroscopy)ì„ í•˜ë©´ì„œ ì½”ë¡œ \"í‚!\" í•˜ê³  ìˆ¨ì„ ë“¤ì´ë§ˆì‹œê²Œ í•©ë‹ˆë‹¤. ì´ë•Œ ë§ˆë¹„ëœ ìª½ì´ ì‘¥ ì˜¬ë¼ê°€ëŠ” ê±¸ ëˆˆìœ¼ë¡œ ì§ì ‘ í™•ì¸í•˜ëŠ” ê²€ì‚¬ì˜ˆìš”! ğŸ‘ƒâœ¨\n---\n## 6. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| ìƒí™© (Scenario) | ì§„ë‹¨/ìƒíƒœ | í•µì‹¬ ì¡°ì¹˜/ê°œë… (Key Action) |\n| --- | --- | --- |\n| **ìˆ˜ìˆ  ì „ í¡ì—°ì** | ìœ„í—˜ ê°ì†Œë¥¼ ìœ„í•œ ê¸ˆì—° ê¸°ê°„ | **4~8ì£¼ ì´ìƒ** ê¸ˆì—° (ì§§ìœ¼ë©´ ì˜¤íˆë ¤ ìœ„í—˜) |\n| **ìˆ˜ìˆ  ì „ íê¸°ëŠ¥ ì €í•˜** | FEV1 < 1.5L | **V/Q Scan**ìœ¼ë¡œ ìˆ˜ìˆ  í›„ ì˜ˆìƒ FEV1 ê³„ì‚° |\n| **ìˆ˜ìˆ  í›„ 2ì¼ì°¨ ì €ì‚°ì†Œì¦ + ì•Œì¹¼ë¦¬ì¦** | **Atelectasis (ë¬´ê¸°í)** | í†µì¦ ì¡°ì ˆ + Incentive Spirometry (X-ray: Volume loss) |\n| **ìˆ˜ìˆ  í›„ 5ì¼ì°¨ ë°œì—´, ë†ì„± ê°€ë˜** | **Pneumonia (íë ´)** | í•­ìƒì œ (X-ray: Lobar consolidation) |\n| **ëŠ‘ê³¨ ê³¨ì ˆ ë…¸ì¸** | í•©ë³‘ì¦ ê³ ìœ„í—˜êµ° | **ì ê·¹ì  í†µì¦ ì¡°ì ˆ** (Nerve block), í‰ë¶€ ì••ë°• ê¸ˆì§€ |\n| **ê°€ìŠ´ì´ ë”°ë¡œ ì›€ì§ì„ (ì—­ì„¤ì  í˜¸í¡)** | **Flail Chest (ë™ìš” ê°€ìŠ´)** | ì–‘ì•• í™˜ê¸° (PPV) = Pneumatic Splint |\n| **ì™¸ìƒ í›„ 6ì‹œê°„ ë’¤ í•˜ì–€ í** | **Pulmonary Contusion** | **ìˆ˜ì•¡ ì œí•œ (Fluid Restriction)** |\n| ì™¸ìƒ í›„ ê°í˜ˆ | hemotopysis | bad lung down |\n| **í‰ê´€ì—ì„œ í”¼ê°€ ì½¸ì½¸ (>1.5L)** | Massive Hemothorax | **ì†ŒëŸ‰ì´ë¼ë„ í‰ê´€ì‚½ì… â†’ ì¶œí˜ˆëŸ‰ ë§ìœ¼ë©´ 1.5 ì´ìƒ ì¦‰ì‹œ ìˆ˜ìˆ  (Thoracotomy)** |\n| **í‰ê´€ì—ì„œ ê³µê¸° ë°©ìš¸ ê³„ì† ë‚˜ì˜´** | **Bronchial Rupture** | ê¸°ê´€ì§€ ë‚´ì‹œê²½ í›„ ìˆ˜ìˆ  |\n| **ê°€ìŠ´ì—ì„œ ì¥ ì†Œë¦¬ê°€ ë“¤ë¦¼** | **Diaphragmatic Rupture** | NG tube ì‚½ì… í›„ X-ray (Tube sign) -> ìˆ˜ìˆ  |\n| ìˆ˜ìˆ  í›„ ìˆ¨ì‰¬ê¸° í˜ë“¤ê³  í•œìª½ íš¡ê²½ë§‰ì´ ì˜¬ë¼ê° | Diaphragmatic paralysis | sniff testì—ì„œ ìˆ¨ ë“¤ì´ì‰´ë•Œ í•œìª½ì´ ì˜¬ë¼ê°. |\n---\n## 7. ë§ˆì§€ë§‰ ì² í•™ (Final Thought) ğŸ’¡\n- **í†µì¦ì€ ê³§ ë³‘ë¦¬ë‹¤ (Pain creates pathology):** í†µì¦ì„ ë‹¨ìˆœí•œ í™˜ìì˜ í˜¸ì†Œ(Subjective complaint)ë¡œ ë³´ì§€ ë§ê³ , í˜¸í¡ë¶€ì „(Objective pathology)ì„ ìœ ë°œí•˜ëŠ” ì›ì¸ìœ¼ë¡œ ë³´ê³  ì¹˜ë£Œí•´ì•¼ í•©ë‹ˆë‹¤.\n- **ì¦ìƒ ì¹˜ë£Œê°€ ê³§ ì§ˆë³‘ ì¹˜ë£Œë‹¤:** í†µì¦ ì¡°ì ˆì€ ë‹¨ìˆœí•œ ì¹œì ˆì´ ì•„ë‹ˆë¼, í™˜ìì˜ ìƒëª…ì„ êµ¬í•˜ëŠ” ì†Œìƒìˆ (Resuscitation)ì˜ ì¼ë¶€ì…ë‹ˆë‹¤.\n- **Happy Lungs are Dry Lungs!** (í íƒ€ë°•ìƒì—ì„œ).","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-292"}
